0000950170-22-009663.txt : 20220512 0000950170-22-009663.hdr.sgml : 20220512 20220512161050 ACCESSION NUMBER: 0000950170-22-009663 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 75 CONFORMED PERIOD OF REPORT: 20220331 FILED AS OF DATE: 20220512 DATE AS OF CHANGE: 20220512 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Renovacor, Inc. CENTRAL INDEX KEY: 0001799850 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-39271 FILM NUMBER: 22917897 BUSINESS ADDRESS: STREET 1: 201 BROADWAY STREET 2: SUITE 310 CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 610-424-2650 MAIL ADDRESS: STREET 1: 201 BROADWAY STREET 2: SUITE 310 CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: Chardan Healthcare Acquisition 2 Corp. DATE OF NAME CHANGE: 20200306 FORMER COMPANY: FORMER CONFORMED NAME: Chardan Healthcare Acquisition III Corp. DATE OF NAME CHANGE: 20200113 10-Q 1 rcor-20220331.htm 10-Q 10-Q
three yearsQ10001799850false--12-310001799850srt:ScenarioPreviouslyReportedMemberus-gaap:ConvertiblePreferredStockMember2020-12-310001799850rcor:PublicWarrantsMember2022-01-012022-03-310001799850rcor:TwoThousandTwentyOneOmnibusIncentivePlanMemberrcor:EarnoutRsuMember2022-03-310001799850rcor:PreFundedWarrantsMember2022-03-310001799850rcor:PrivatePlacementWarrantsMember2020-04-012020-04-300001799850rcor:SecondMilestoneMemberrcor:OldRenovacorMember2022-01-012022-03-310001799850srt:RestatementAdjustmentMember2020-12-310001799850rcor:LiabilityClassifiedWarrantsMember2021-12-310001799850rcor:TwoThousandEighteenStockOptionAndGrantPlanMember2022-03-310001799850rcor:ChardanHealthcareAcquisitionCorporationMember2022-01-012022-03-310001799850rcor:FeldmanConsultingAgreementMember2022-03-310001799850rcor:EarnoutShareLiabilityMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001799850us-gaap:CommonStockMemberrcor:OldRenovacorMember2022-01-012022-03-310001799850rcor:PrivatePlacementWarrantsMember2020-04-300001799850us-gaap:EmployeeStockOptionMember2022-03-3100017998502022-05-120001799850rcor:SecondMilestoneMember2022-01-012022-03-310001799850us-gaap:CommonStockMember2020-12-310001799850rcor:AmusaMemberus-gaap:SubsequentEventMember2022-04-012022-04-300001799850srt:ScenarioPreviouslyReportedMemberus-gaap:CommonStockMember2020-12-310001799850us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2022-03-310001799850us-gaap:MeasurementInputRiskFreeInterestRateMemberrcor:PrivatePlacementWarrantsMember2022-03-310001799850rcor:PIPEInvestmentMember2022-01-012022-03-310001799850rcor:TwoThousandTwentyOneOmnibusIncentivePlanMember2022-03-310001799850us-gaap:AdditionalPaidInCapitalMember2022-01-012022-03-310001799850rcor:TwoThousandTwentyOneOmnibusIncentivePlanMemberus-gaap:RestrictedStockUnitsRSUMember2022-03-310001799850us-gaap:SubsequentEventMember2022-04-300001799850rcor:ConvertiblePromissoryNoteMemberrcor:MergerAgreementAndNotePurchaseAgreementMember2021-07-202021-07-200001799850us-gaap:AdditionalPaidInCapitalMembersrt:ScenarioPreviouslyReportedMember2020-12-310001799850rcor:PrivatePlacementWarrantsMember2021-09-010001799850rcor:EarnoutSharesMemberus-gaap:MeasurementInputPriceVolatilityMember2022-03-310001799850rcor:PrivatePlacementWarrantsMember2022-01-012022-03-310001799850rcor:ConvertiblePromissoryNoteMemberrcor:MergerAgreementAndNotePurchaseAgreementMember2021-07-200001799850us-gaap:RetainedEarningsMember2020-12-310001799850rcor:ThirdMilestoneMemberrcor:OldRenovacorMember2022-03-310001799850rcor:LiabilityClassifiedWarrantsMemberrcor:April2020PrivatePlacementWarrantsMember2021-12-310001799850us-gaap:CommonStockMember2022-01-012022-03-310001799850us-gaap:GeneralAndAdministrativeExpenseMember2021-01-012021-03-310001799850us-gaap:AdditionalPaidInCapitalMembersrt:RestatementAdjustmentMember2020-12-310001799850srt:MinimumMemberus-gaap:OtherMachineryAndEquipmentMember2022-01-012022-03-310001799850us-gaap:MeasurementInputPriceVolatilityMemberrcor:PrivatePlacementWarrantsMember2022-03-310001799850rcor:EarnoutSharesMember2022-01-012022-03-310001799850rcor:WarrantLiabilityMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001799850us-gaap:MeasurementInputSharePriceMemberrcor:EarnoutSharesMember2021-12-310001799850rcor:MeasurementInputFairValuePerShareMemberrcor:EarnoutSharesMember2022-03-310001799850rcor:PublicWarrantsMember2021-09-012021-09-010001799850rcor:TempleLicenseAgreementMembersrt:MinimumMember2019-08-012019-08-310001799850rcor:OldRenovacorMember2022-01-012022-03-310001799850us-gaap:GeneralAndAdministrativeExpenseMember2022-01-012022-03-310001799850us-gaap:AdditionalPaidInCapitalMember2020-12-310001799850rcor:WarrantLiabilityMemberus-gaap:FairValueInputsLevel3Member2022-03-310001799850rcor:MarketBasedRestrictedStockUnitsMember2022-03-310001799850rcor:EarnoutShareLiabilityMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001799850us-gaap:SubsequentEventMemberrcor:GrossmanMember2022-04-012022-04-300001799850us-gaap:AdditionalPaidInCapitalMember2021-03-310001799850rcor:WarrantLiabilityMemberus-gaap:FairValueInputsLevel3Member2021-12-310001799850us-gaap:FairValueInputsLevel1Memberus-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMember2022-03-310001799850rcor:FeldmanConsultingAgreementMember2019-08-012019-08-310001799850us-gaap:WarrantMember2022-01-012022-03-310001799850us-gaap:MeasurementInputExpectedTermMemberrcor:EarnoutSharesMember2021-01-012021-12-310001799850srt:MaximumMemberus-gaap:OtherMachineryAndEquipmentMember2022-01-012022-03-310001799850rcor:EquityClassifiedWarrantsMember2021-12-310001799850rcor:FirstMilestoneMemberrcor:OldRenovacorMember2022-03-310001799850us-gaap:CommonStockMember2022-01-012022-03-310001799850rcor:EarnoutShareLiabilityMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2022-03-310001799850us-gaap:ResearchAndDevelopmentExpenseMember2022-01-012022-03-310001799850us-gaap:RetainedEarningsMember2022-01-012022-03-310001799850rcor:SecondMilestoneMemberrcor:SponsorMember2022-01-012022-03-310001799850us-gaap:CommonStockMembersrt:RestatementAdjustmentMember2020-12-310001799850rcor:EquityClassifiedWarrantsMemberrcor:September2021PreFundedWarrantsMember2022-03-310001799850rcor:EarnoutShareLiabilityMemberus-gaap:FairValueInputsLevel3Member2022-03-310001799850rcor:PIPEInvestmentMember2022-03-310001799850us-gaap:MeasurementInputSharePriceMemberrcor:EarnoutSharesMember2022-03-310001799850rcor:SponsorSharesMember2020-06-012020-06-300001799850us-gaap:RetainedEarningsMember2022-03-310001799850us-gaap:PrivatePlacementMemberrcor:MergerAgreementMember2021-09-020001799850rcor:TempleLicenseAgreementMember2021-07-010001799850us-gaap:EmployeeStockOptionMember2021-01-012021-12-310001799850rcor:SeriesARedeemableConvertiblePreferredStockMember2021-09-012021-09-010001799850rcor:MergerAndPipeFinancingMember2022-03-310001799850srt:MinimumMemberus-gaap:SubsequentEventMember2022-04-012022-04-3000017998502022-01-012022-03-310001799850us-gaap:MeasurementInputExpectedTermMemberrcor:PrivatePlacementWarrantsMember2022-01-012022-03-310001799850rcor:ChardanHealthcareInvestmentsLimitedLiabilityCompanyMember2022-02-012022-02-280001799850us-gaap:SubsequentEventMemberrcor:ChardanInvestments2LimitedLiabilityCompanyMember2022-04-012022-04-300001799850rcor:AmusaMember2022-02-012022-02-280001799850us-gaap:FairValueMeasurementsRecurringMember2022-03-310001799850us-gaap:CommonStockMember2021-12-310001799850us-gaap:RestrictedStockUnitsRSUMember2022-01-012022-03-310001799850rcor:TempleLicenseAgreementMember2021-01-012021-03-310001799850rcor:OldRenovacorMember2022-03-310001799850rcor:MeasurementInputFairValuePerWarrantMemberrcor:PrivatePlacementWarrantsMember2021-12-310001799850srt:ScenarioPreviouslyReportedMember2020-12-310001799850rcor:PreFundedWarrantsMember2022-01-012022-03-310001799850rcor:ChardanHealthcareAcquisitionCorporationAndOldRenovacorMember2022-01-012022-03-310001799850us-gaap:EmployeeStockOptionMember2022-01-012022-03-310001799850rcor:ChardanHealthcareInvestmentsLimitedLiabilityCompanyMember2022-03-310001799850rcor:EarnoutSharesMember2022-01-012022-03-310001799850us-gaap:CommonStockMember2021-03-310001799850rcor:EarnoutSharesMemberrcor:MeasurementInputProbabilityOfChangeInControlMember2022-03-310001799850rcor:PreFundedWarrantsMembersrt:MaximumMember2022-01-012022-03-310001799850rcor:EarnoutShareLiabilityMemberus-gaap:FairValueMeasurementsRecurringMember2022-03-310001799850us-gaap:MeasurementInputSharePriceMemberrcor:PrivatePlacementWarrantsMember2022-03-310001799850rcor:MarketBasedRestrictedStockUnitsMember2022-01-012022-03-310001799850rcor:TwoThousandTwentyOneOmnibusIncentivePlanMember2022-01-012022-03-310001799850rcor:PipeInvestorsMember2022-01-012022-03-310001799850rcor:WarrantLiabilityMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2022-03-310001799850rcor:PipeInvestorsMember2022-03-3100017998502021-12-310001799850rcor:FeldmanConsultingAgreementMember2021-01-012021-03-310001799850rcor:SecondMilestoneMemberrcor:OldRenovacorMember2022-03-310001799850rcor:StockOptionsMember2022-01-012022-03-310001799850us-gaap:MeasurementInputExercisePriceMemberrcor:PrivatePlacementWarrantsMember2021-12-310001799850rcor:SharesEarnoutMember2022-03-310001799850rcor:MeasurementInputFairValuePerShareMemberrcor:EarnoutSharesMember2021-12-310001799850rcor:ThirdMilestoneMember2022-01-012022-03-310001799850us-gaap:AccountingStandardsUpdate201602Member2022-03-310001799850us-gaap:WarrantMember2022-03-310001799850us-gaap:RetainedEarningsMember2021-03-310001799850rcor:EarnoutSharesMemberus-gaap:MeasurementInputPriceVolatilityMember2021-12-310001799850rcor:SponsorOwnershipMember2022-03-310001799850us-gaap:MeasurementInputExpectedTermMemberrcor:PrivatePlacementWarrantsMember2021-01-012021-12-310001799850rcor:TimeBasedRestrictedStockUnitsMember2022-01-012022-03-310001799850rcor:PreFundedWarrantsMember2022-03-310001799850rcor:EquityClassifiedWarrantsMemberrcor:September2021PreFundedWarrantsMember2021-12-310001799850us-gaap:CommonStockMember2022-03-3100017998502021-03-310001799850rcor:SharesEarnoutMember2021-12-310001799850us-gaap:FairValueMeasurementsRecurringMember2021-12-310001799850rcor:TwoThousandEighteenStockOptionAndGrantPlanMember2022-01-012022-03-310001799850rcor:EarnoutShareLiabilityMemberus-gaap:FairValueInputsLevel3Member2022-01-012022-03-310001799850rcor:SponsorSupportAgreementMember2022-01-012022-03-310001799850rcor:PrivatePlacementWarrantsMember2022-01-012022-03-3100017998502021-09-010001799850rcor:SponsorSharesMember2018-12-012018-12-310001799850rcor:MarketBasedRestrictedStockUnitsMember2021-12-310001799850rcor:FirstMilestoneMember2022-01-012022-03-310001799850rcor:WarrantLiabilityMemberus-gaap:FairValueMeasurementsRecurringMember2022-03-310001799850us-gaap:RetainedEarningsMembersrt:ScenarioPreviouslyReportedMember2020-12-310001799850rcor:LiabilityClassifiedWarrantsMemberrcor:April2020PrivatePlacementWarrantsMember2022-03-310001799850rcor:CommonStockWarrantsMember2022-01-012022-03-3100017998502020-12-310001799850rcor:TempleLicenseAgreementMember2022-03-310001799850us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001799850rcor:PrivatePlacementWarrantsMemberus-gaap:MeasurementInputExercisePriceMember2022-03-310001799850rcor:TempleLicenseAgreementMember2019-08-012019-08-310001799850rcor:FirstMilestoneMemberrcor:OldRenovacorMember2022-01-012022-03-310001799850srt:MaximumMemberus-gaap:SubsequentEventMember2022-04-012022-04-300001799850rcor:April2020PublicWarrantsMemberrcor:EquityClassifiedWarrantsMember2022-03-310001799850us-gaap:CommonStockMember2021-01-012021-03-310001799850rcor:EarnoutSharesMemberrcor:OldRenovacorMember2022-01-012022-03-310001799850us-gaap:AdditionalPaidInCapitalMember2021-01-012021-03-310001799850rcor:TempleLicenseAgreementMemberus-gaap:CommonStockMember2019-08-012019-08-310001799850rcor:ThirdMilestoneMemberrcor:OldRenovacorMember2022-01-012022-03-3100017998502021-01-012021-03-310001799850us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMember2022-03-310001799850rcor:WarrantLiabilityMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001799850us-gaap:RestrictedStockMembersrt:MaximumMember2022-01-012022-03-310001799850us-gaap:AdditionalPaidInCapitalMember2021-12-310001799850us-gaap:RetainedEarningsMember2021-12-310001799850rcor:LiabilityClassifiedWarrantsMember2022-03-310001799850rcor:MeasurementInputFairValuePerWarrantMemberrcor:PrivatePlacementWarrantsMember2022-03-310001799850rcor:FirstMilestoneMemberrcor:SponsorMember2022-01-012022-03-310001799850us-gaap:MeasurementInputSharePriceMemberrcor:PrivatePlacementWarrantsMember2021-12-310001799850us-gaap:ConvertiblePreferredStockMembersrt:RestatementAdjustmentMember2020-12-3100017998502022-03-310001799850rcor:ChardanHealthcareAcquisitionCorporationMember2022-03-310001799850rcor:EarnoutShareLiabilityMemberus-gaap:FairValueInputsLevel3Member2021-12-310001799850rcor:TempleLicenseAgreementMember2022-01-012022-03-310001799850us-gaap:ResearchAndDevelopmentExpenseMember2021-01-012021-03-310001799850us-gaap:RetainedEarningsMember2021-01-012021-03-310001799850us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001799850us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2022-03-310001799850us-gaap:SubsequentEventMember2022-04-012022-04-300001799850us-gaap:MeasurementInputRiskFreeInterestRateMemberrcor:EarnoutSharesMember2022-03-310001799850rcor:SponsorSharesMember2020-04-012020-04-300001799850us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001799850rcor:PublicWarrantsMember2022-03-310001799850rcor:EarnoutSharesMember2022-03-310001799850rcor:StockOptionsMember2021-01-012021-03-310001799850us-gaap:MeasurementInputRiskFreeInterestRateMemberrcor:PrivatePlacementWarrantsMember2021-12-310001799850rcor:ThirdMilestoneMemberrcor:SponsorMember2022-01-012022-03-310001799850rcor:SponsorMember2022-01-012022-03-310001799850us-gaap:EmployeeStockOptionMember2021-01-012021-03-310001799850us-gaap:PrivatePlacementMemberrcor:MergerAgreementMember2021-09-022021-09-020001799850rcor:EquityClassifiedWarrantsMember2022-03-310001799850rcor:April2020PublicWarrantsMemberrcor:EquityClassifiedWarrantsMember2021-12-310001799850rcor:SeriesARedeemableConvertiblePreferredStockMember2021-09-010001799850rcor:TimeBasedRestrictedStockUnitsMember2022-03-310001799850rcor:PublicWarrantsMember2021-09-010001799850us-gaap:MeasurementInputExpectedTermMemberrcor:EarnoutSharesMember2022-01-012022-03-310001799850rcor:TempleLicenseAgreementMemberus-gaap:CommonStockMember2020-11-012020-11-300001799850us-gaap:FairValueInputsLevel1Memberus-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001799850rcor:FeldmanConsultingAgreementMember2022-01-012022-03-310001799850us-gaap:MeasurementInputRiskFreeInterestRateMemberrcor:EarnoutSharesMember2021-12-310001799850us-gaap:AdditionalPaidInCapitalMember2022-03-310001799850us-gaap:EmployeeStockOptionMember2021-12-310001799850rcor:WarrantLiabilityMemberus-gaap:FairValueInputsLevel3Member2022-01-012022-03-310001799850us-gaap:MeasurementInputPriceVolatilityMemberrcor:PrivatePlacementWarrantsMember2021-12-310001799850rcor:TempleLicenseAgreementMember2021-07-012021-07-010001799850rcor:EarnoutRsuMember2021-10-012021-12-310001799850rcor:EarnoutSharesMemberrcor:MeasurementInputProbabilityOfChangeInControlMember2021-12-31iso4217:USDxbrli:sharesxbrli:pureutr:sqftxbrli:sharesrcor:TradingDayiso4217:USD

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 10-Q

 

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2022

OR

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from __________ to __________

Commission File Number: 001-39271

 

img88120184_0.jpg 

Renovacor, Inc.

(Exact Name of Registrant as Specified in its Charter)

 

 

Delaware

83-3169838

( State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer
Identification No.)

201 Broadway, Suite 310

Cambridge, Massachusetts

02139

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area code: (610) 424-2650

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange on which registered

Common Stock, par value $0.0001 per share

 

RCOR

 

NYSE American LLC

Warrants to purchase common stock at an exercise price of $11.50 per share

 

RCOR.WS

 

NYSE American LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

 

 

Accelerated filer

 

 

 

 

 

Non-accelerated filer

 

 

Smaller reporting company

 

 

 

 

 

 

 

 

Emerging growth company

 

 

 

 

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No

As of May 12, 2022, the registrant had 17,267,423 shares of common stock, $0.0001 par value per share, outstanding.

 

 

 

 


 

Renovacor, Inc.

Form 10-Q

 

Table of Contents

 

 

 

Page

PART I.

FINANCIAL INFORMATION

 

Item 1.

Financial Statements (Unaudited)

1

 

Condensed Consolidated Balance Sheets

1

 

Condensed Consolidated Statements of Operations

2

 

Condensed Consolidated Statements of Cash Flows

3

 

Condensed Consolidated Statements of Stockholders’ Equity (Deficit)

4

 

Notes to Unaudited Condensed Consolidated Financial Statements

5

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

26

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

37

Item 4.

Controls and Procedures

37

 

 

 

PART II.

OTHER INFORMATION

 

Item 1.

Legal Proceedings

38

Item 1A.

Risk Factors

38

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

38

Item 3.

Defaults Upon Senior Securities

38

Item 4.

Mine Safety Disclosures

38

Item 5.

Other Information

38

Item 6.

Exhibits

39

Signatures

40

 

 


 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). All statements, other than statements of historical fact, included or incorporated in this Quarterly Report on Form 10-Q regarding our strategy, future operations, clinical trials, collaborations, intellectual property, cash resources, financial position, future revenues, projected costs, prospects, plans and objectives of management are forward-looking statements. These forward-looking statements can generally be identified by the use of forward-looking terminology, including the terms “believes,” “estimates,” “anticipates,” “expects,” “seeks,” “projects,” “intends,” “plans,” “may,” “will, "could," “should,” "potential," "likely," "projects," "target," "continue," "will," "schedule," "would" or, in each case, their negative or other variations or comparable terminology, although not all forward-looking statements contain these identifying words. We cannot guarantee that we will actually achieve the plans, intentions or expectations disclosed in our forward-looking statements and you should not place undue reliance on our forward-looking statements. These forward-looking statements involve known and unknown risks, uncertainties, and other factors, which may be beyond our control, and which may cause our actual results, performance, or achievements to be materially different from future results, performance, or achievements expressed or implied by such forward-looking statements.

 

Factors that may impact such forward-looking statements include:

our ability to maintain the listing of our common stock and public warrants on the New York Stock Exchange, or NYSE, and operate as a public company;
our ability to recognize the anticipated benefits of our business combination with Chardan Healthcare Acquisition 2 Corp., or Chardan;
our ability to raise additional capital to fund our operations and continue the development of our current and future product candidates;
the accuracy of our projections and estimates regarding our expenses, capital requirements, cash utilization, and need for additional financing;
the initiation, progress, success, cost, and timing of our development activities, preclinical studies and future clinical trials;
the timing, scope and likelihood of regulatory filings and approvals, including final regulatory approval of our product candidates;
the preclinical nature of our business and our ability to successfully advance current and future product candidates through development activities, preclinical studies, and clinical trials;
the timing of our future Investigational New Drug, or IND, applications and the likelihood of, and our ability to obtain and maintain, regulatory clearance of such IND applications for our product candidates;
the novelty of our approach to the treatment of BAG3 mutation-associated dilated cardiomyopathy, or DCM, utilizing adeno-associated virus, or AAV, BAG3-based gene therapies to target BAG3 mutations, and the challenges we will face due to the novel nature of such technology;
our dependence on the success of our product candidates, in particular REN-001;
the potential scope and value of our intellectual property and proprietary rights;
our ability, and the ability of our licensors, to obtain, maintain, defend, and enforce intellectual property and proprietary rights protecting our product candidates, and our ability to develop and commercialize our product candidates without infringing, misappropriating, or otherwise violating the intellectual property or proprietary rights of third parties;
the success of competing therapies that are or become available;
regulatory developments and approval pathways in the United States and foreign countries for our product candidates;
the performance of third parties in connection with the development of our product candidates, including third parties conducting our future clinical trials as well as third-party suppliers and manufacturers;
our ability to attract and retain strategic collaborators with development, regulatory, and commercialization expertise;
the extent to which health epidemics and other outbreaks of communicable diseases, including the COVID-19 pandemic, geopolitical turmoil, including the ongoing invasion of Ukraine by Russia or increased trade restrictions between the United States, Russia, China, and other countries, social unrest, political instability, terrorism, or other acts of war could ultimately impact our business, including supply chain, labor, development activities, preclinical studies, and future clinical trials;

i


 

the public opinion and scrutiny of AAV/BAG3-based gene therapies for the treatment of heart failure and our potential impact on public perception of our products and product candidates;
our ability to successfully commercialize our product candidates and develop sales and marketing capabilities, if our product candidates are approved;
our ability to generate revenue from future product sales and our ability to achieve and maintain profitability;
the size and growth of the potential markets for our product candidates and our ability to serve those markets;
changes in applicable laws or regulations;
our ability to recruit and retain key members of management and other clinical and scientific personnel;
the volatility of capital markets and other macroeconomic factors, including due to geopolitical tensions or the outbreak of hostilities or war;
the possibility that we may be adversely impacted by other economic, business, and/or competitive factors; and
other risks and uncertainties, including those listed under the caption “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2021 (our “2021 Form 10-K”), our Quarterly Reports on Form 10-Q and the other documents we file with the Securities and Exchange Commission (the “SEC”).

 

There are a number of important factors that could cause our actual results to differ materially from those indicated or implied by forward-looking statements. These important factors include those set forth under Part I, Item 1A "Risk Factors" in our 2021 Form 10-K, which was filed with the SEC on March 24, 2022, and in our other disclosures and filings with the SEC. These factors and the other cautionary statements made in this Quarterly Report on Form 10-Q should be read as being applicable to all related forward-looking statements whenever they appear in this Quarterly Report on Form 10-Q.

 

In addition, any forward-looking statements represent our estimates only as of the date that this Quarterly Report on Form 10-Q is filed with the SEC and should not be relied upon as representing our estimates as of any subsequent date. All forward-looking statements included in this Quarterly Report on Form 10-Q are made as of the date hereof, and are expressly qualified in their entirety by this cautionary notice. We disclaim any intention or obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as may be required by law.

ii


 

PART I—FINANCIAL INFORMATION

Item 1. Financial Statements.

Renovacor, Inc.

Condensed Consolidated Balance Sheets

(Unaudited)

 

 

 

March 31,

 

 

December 31,

 

(In thousands, except share and per share amounts)

 

2022

 

 

2021*

 

ASSETS

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

Cash and cash equivalents

 

$

70,084

 

 

$

78,790

 

Prepaid expenses

 

 

1,623

 

 

 

1,763

 

Total current assets

 

 

71,707

 

 

 

80,553

 

Property and equipment, net

 

 

362

 

 

 

379

 

Other

 

 

42

 

 

 

67

 

Total assets

 

$

72,111

 

 

$

80,999

 

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

Accounts payable

 

$

1,781

 

 

$

1,536

 

Accrued expenses

 

 

1,616

 

 

 

2,498

 

Total current liabilities

 

 

3,397

 

 

 

4,034

 

Warrant liability

 

 

3,885

 

 

 

11,165

 

Share earnout liability (includes 500,000 shares of Common stock, $0.0001 par value per share, subject to forfeiture, issued and outstanding at March 31 2022 and December 31, 2021 –– Note 3)

 

 

4,090

 

 

 

12,256

 

Total liabilities

 

 

11,372

 

 

 

27,455

 

 

 

 

 

 

 

 

Commitments and contingencies (Note 8)

 

 

 

 

 

 

 

 

 

 

 

 

 

Stockholders’ equity:

 

 

 

 

 

 

Preferred stock, $0.0001 par value per share; 1,000,000 shares authorized; none issued or outstanding at March 31, 2022 and December 31, 2021

 

 

 

 

 

 

Common stock, $0.0001 par value per share; 100,000,000 shares authorized; 16,756,042 shares issued and outstanding at March 31, 2022 and December 31, 2021

 

 

2

 

 

 

2

 

Additional paid-in capital

 

 

73,141

 

 

 

72,540

 

Accumulated deficit

 

 

(12,404

)

 

 

(18,998

)

Total stockholders’ equity

 

 

60,739

 

 

 

53,544

 

Total liabilities and stockholders’ equity

 

$

72,111

 

 

$

80,999

 

———————

* The condensed balance sheet at December 31, 2021 has been derived from the audited financial statements at that date.
 

The accompanying notes are an integral part of these condensed consolidated financial statements.

1


 

Renovacor, Inc.

Condensed Consolidated Statements of Operations

(Unaudited)

 

 

 

Three months ended

 

 

 

March 31,

 

(In thousands, except share and per share amounts)

 

2022

 

 

2021

 

Operating expenses:

 

 

 

 

 

 

Research and development

 

$

5,930

 

 

$

1,155

 

General and administrative

 

 

2,925

 

 

 

526

 

Loss from operations

 

 

(8,855

)

 

 

(1,681

)

Other income (expense):

 

 

 

 

 

 

Interest income

 

 

4

 

 

 

 

Change in fair value of warrant liability

 

 

7,280

 

 

 

 

Change in fair value of share earnout liability

 

 

8,166

 

 

 

 

Other expense

 

 

(1

)

 

 

 

Net income (loss)

 

$

6,594

 

 

$

(1,681

)

 

 

 

 

 

 

 

Net income (loss) per share

 

 

 

 

 

 

 Basic

 

$

0.37

 

 

$

(0.27

)

 Diluted

 

$

0.36

 

 

$

(0.27

)

Weighted-average number of common shares used in computing net income (loss) per share –– (Note 13)

 

 

 

 

 

 

 Basic

 

 

17,471,266

 

 

 

6,274,566

 

 Diluted

 

 

17,628,835

 

 

 

6,274,566

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

 

2


 

Renovacor, Inc.

Condensed Consolidated Statements of Cash Flows

(Unaudited)

 

 

 

Three months ended

 

 

 

March 31,

 

(In thousands)

 

2022

 

 

2021

 

CASH FLOWS FROM OPERATING ACTIVITIES:

 

 

 

 

 

 

Net income (loss)

 

$

6,594

 

 

$

(1,681

)

Adjustments to reconcile net income (loss) to net cash used in operating activities:

 

 

 

 

 

 

Stock-based compensation

 

 

601

 

 

 

7

 

Gain on change in fair value of warrant liability

 

 

(7,280

)

 

 

 

Gain on change in fair value of share earnout liability

 

 

(8,166

)

 

 

 

Depreciation expense

 

 

17

 

 

 

1

 

Change in assets and liabilities:

 

 

 

 

 

 

Prepaid expenses

 

 

140

 

 

 

(678

)

Other assets

 

 

25

 

 

 

 

Accounts payable

 

 

298

 

 

 

375

 

Accrued expenses

 

 

(522

)

 

 

197

 

Net cash used in operating activities

 

 

(8,293

)

 

 

(1,779

)

CASH FLOWS FROM INVESTING ACTIVITIES:

 

 

 

 

 

 

Acquisitions of property and equipment

 

 

(360

)

 

 

 

Net cash used in investing activities

 

 

(360

)

 

 

 

CASH FLOWS FROM FINANCING ACTIVITIES:

 

 

 

 

 

 

Merger-related costs

 

 

(53

)

 

 

(80

)

Net cash used in financing activities

 

 

(53

)

 

 

(80

)

Net decrease in cash and cash equivalents

 

 

(8,706

)

 

 

(1,859

)

Cash and cash equivalents at beginning of period

 

 

78,790

 

 

 

5,384

 

Cash and cash equivalents at end of period

 

$

70,084

 

 

$

3,525

 

 

 

 

 

 

 

 

SUPPLEMENTAL DISCLOSURES OF NONCASH ACTIVITIES:

 

 

 

 

 

 

Deferred merger costs in accounts payable

 

$

 

 

$

644

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

3


 

Renovacor, Inc.

Condensed Consolidated Statements of Stockholders’ Equity (Deficit)

(Unaudited)

 

 

 

 

Three Months Ended March 31, 2022

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Additional

 

 

 

 

 

Total

 

 

 

Common Stock

 

 

Paid-in-

 

 

Accumulated

 

 

Stockholders'

 

(In thousands, except share amounts)

 

Shares

 

 

Amount

 

 

Capital

 

 

Deficit

 

 

Equity

 

Balance, December 31, 2021

 

 

16,756,042

 

 

$

2

 

 

$

72,540

 

 

$

(18,998

)

 

$

53,544

 

Stock-based compensation

 

 

 

 

 

 

 

 

601

 

 

 

 

 

 

601

 

Net income

 

 

 

 

 

 

 

 

 

 

 

6,594

 

 

 

6,594

 

Balance, March 31, 2022

 

 

16,756,042

 

 

$

2

 

 

$

73,141

 

 

$

(12,404

)

 

$

60,739

 

 

 

 

 

Three Months Ended March 31, 2021

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total

 

 

 

Convertible

 

 

 

 

 

 

 

 

 

Additional

 

 

 

 

 

Stockholders'

 

 

 

Preferred Stock

 

 

 

Common Stock

 

 

Paid-in-

 

 

Accumulated

 

 

Equity

 

(In thousands, except share amounts)

 

Shares

 

 

Amount

 

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Deficit

 

 

(Deficit)

 

Balance, December 31, 2020

 

 

2,578,518

 

 

$

10,074

 

 

 

 

1,953,368

 

 

$

 

 

$

121

 

 

$

(4,897

)

 

$

(4,776

)

Retroactive application of reverse recapitalization (Note 3)

 

 

(2,578,518

)

 

 

(10,074

)

 

 

 

4,321,198

 

 

 

1

 

 

 

10,073

 

 

 

 

 

 

10,074

 

Balance, December 31, 2020, effect of Merger

 

 

 

 

$

 

 

 

 

6,274,566

 

 

$

1

 

 

$

10,194

 

 

$

(4,897

)

 

$

5,298

 

Issuance of restricted common stock

 

 

 

 

 

 

 

 

 

30,495

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock-based compensation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

7

 

 

 

 

 

 

7

 

Net loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1,681

)

 

 

(1,681

)

Balance, March 31, 2021

 

 

 

 

$

 

 

 

 

6,305,061

 

 

$

1

 

 

$

10,201

 

 

$

(6,578

)

 

$

3,624

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

4


 

Renovacor, Inc.

Notes to Condensed Consolidated Financial Statements (Unaudited)

Note 1. Business and Organization

 

Renovacor, Inc. (the “Company,” or “Renovacor”) (f/k/a Chardan Healthcare Acquisition 2 Corp. ("Chardan")), a Delaware corporation, is a biotechnology company focused on delivering innovative precision therapies to improve the lives of patients and families battling genetically-driven cardiovascular and mechanistically-related diseases. The Company’s initial focus is on the treatment of BCL2-associated athanogene 3 (BAG3) mutation-associated dilated cardiomyopathy ("DCM") ("BAG3 DCM"). BAG3 DCM is a heritable rare disease that leads to early onset, rapidly progressing heart failure and significant mortality and morbidity. The Company’s lead product candidate, REN-001, is a recombinant adeno-associated virus ("AAV") 9-based gene therapy designed to deliver a fully functional BAG3 gene to augment BAG3 protein levels in cardiomyocytes and slow or halt progression of BAG3 DCM.

 

The Company is subject to risks common to companies in the biopharmaceutical industry, including, but not limited to, risks related to the successful development and commercialization of product candidates, fluctuations in operating results and financial risks, the ability to successfully raise additional funds when needed, protection of proprietary rights and patent risks, patent litigation, compliance with government regulations, dependence on key personnel and prospective collaborative partners, and competition from competing products in the marketplace.

 

Merger Agreement

 

Prior to September 2, 2021, the Company was a special purpose acquisition company formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business transaction with one or more businesses or entities. On September 2, 2021 (the "Closing Date"), the Company consummated the business combination contemplated by that certain Agreement and Plan of Merger, dated March 22, 2021 (the “Merger Agreement”), by and among the Company, CHAQ2 Merger Sub, Inc., a wholly owned subsidiary of the Company (“Merger Sub”), and Renovacor Holdings, Inc. (f/k/a Renovacor, Inc. ("Old Renovacor")). Pursuant to the Merger Agreement, (i) Merger Sub merged with and into Old Renovacor, with Old Renovacor as the surviving company in the merger and, after giving effect to such merger, continuing as a wholly owned subsidiary of the Company (the “Merger”) and (ii) the Company’s name was changed from Chardan Healthcare Acquisition 2 Corp. to Renovacor, Inc. (the “Merger” and, together with the other transactions contemplated by the Merger Agreement, the “Business Combination”).

 

Liquidity Considerations

 

The Company has evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about its ability to continue as a going concern within one year after the date the financial statements are issued. As of March 31, 2022, the Company had an accumulated deficit of $12.4 million and a cash and cash equivalents balance of $70.1 million. The Company has incurred losses and negative cash flows from operations since inception. The Company expects to continue to incur substantial operating losses and negative cash flows for the foreseeable future and will require additional capital as it continues to advance REN-001 and/or any future product candidates through development.

 

The Company follows the provisions of Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 205-40, Presentation of Financial Statements—Going Concern, which requires management to assess the Company’s ability to continue as a going concern within one year after the date the financial statements are issued. Management currently anticipates that the Company’s balance of cash and cash equivalents, as of March 31, 2022, is sufficient to enable the Company to continue as a going concern through the one-year period subsequent to the filing date of this Quarterly Report on Form 10-Q. Management’s operating plan, which underlies the analysis of the Company’s ability to continue as a going concern, involves the estimation of the amount and timing of future cash inflows and outflows. Actual results could vary from the operating plan.

 

The Company has and will continue to evaluate available alternatives to extend its operations beyond this date, which include financing its operations through a combination of equity offerings, debt financings, collaborations, strategic alliances and licensing arrangements. However, the Company may be unable to raise additional funds or enter into such other agreements or arrangements when needed on favorable terms, or at all. If the Company fails to raise capital or enter into such agreements or arrangements as, and when, needed, it may have to significantly delay, scale back or discontinue the development and commercialization of one or more of its product candidates.

 

5


 

Note 2. Summary of Significant Accounting Policies

 

Basis of Presentation

 

The accompanying unaudited interim condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the United States Securities and Exchange Commission (“SEC”) for interim financial reporting. Accordingly, they do not include all of the information and disclosures required by U.S. GAAP for complete financial statements as certain footnotes or other financial information that are normally required by U.S. GAAP can be condensed or omitted. These condensed consolidated statements are unaudited and, in the opinion of management, include all adjustments (consisting of normal recurring adjustments and accruals) necessary to fairly present the results of the interim periods. The results of operations and cash flows for the three months ended March 31, 2022 are not necessarily indicative of the results that may be expected for the fiscal year ended December 31, 2022 or any other future period.

 

Reverse Recapitalization

 

The Business Combination was accounted for as a reverse recapitalization in accordance with U.S. GAAP (the “Reverse Recapitalization”). Under this method of accounting, the Company is treated as the “acquired” company and Old Renovacor is treated as the acquirer for financial reporting purposes. As a result, the consolidated assets, liabilities and results of operations prior to the Business Combination are those of Old Renovacor. Additionally, the shares and corresponding capital amounts and losses per share, prior to the Business Combination, have been retroactively restated based on shares reflecting the applicable exchange ratio resulting from the Common Per Share Merger Consideration and/or the Preferred Per Share Merger Consideration (each as defined by the Merger Agreement).

 

Emerging Growth Company Status

 

The Company is an "emerging growth company", as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”). Under the JOBS Act, the Company may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statement with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

 

Use of Estimates

 

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, expense, and related disclosures. The Company bases estimates and assumptions on historical experience when available and on various factors that it believes to be reasonable under the circumstances. The Company evaluates its estimates and assumptions on an ongoing basis. Estimates relied upon in preparing these financial statements relate to, but are not limited to, the fair value of financial instruments, stock-based compensation assumptions and accrued expenses (including accrued and prepaid clinical costs). Actual results may differ from these estimates under different assumptions or conditions.

 

Concentration of Credit Risk

 

Financial instruments that subject the Company to significant concentrations of credit risk consist primarily of cash primarily held at one financial institution, which, at times, may exceed federally insured limits, and cash equivalents consisting of investments in money market funds managed by a variety of financial institutions. The Company's credit risk is managed by investing in only highly rated money market instruments. As a result, no significant additional credit risk is believed by management to be inherent in the Company’s assets and the Company has not experienced any losses in such accounts and believes it is not exposed to any significant risk on such accounts.

6


 

 

Cash and Cash Equivalents

 

The Company considers all highly liquid investments with maturities of 90 days or less when purchased to be “cash equivalents.” Cash and cash equivalents at March 31, 2022 consisted of cash and money market funds.

 

Property and Equipment, net

 

Property and equipment is carried at acquisition cost less accumulated depreciation, subject to review for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable in accordance with ASC 360-10-35, Impairment or Disposal of Long-Lived Assets. The cost of normal, recurring, or periodic repairs and maintenance activities related to property and equipment, if any, are expensed as incurred. The cost for planned major maintenance activities, including the related acquisition or construction of assets, is capitalized if the repair will result in future economic benefits.

 

Depreciation and amortization are computed using the straight-line method based on the estimated useful lives of the related assets. Equipment and other long-lived assets are depreciated over three to five years. When an asset is disposed of, the associated cost and accumulated depreciation is removed from the related accounts on the Company's balance sheet with any resulting gain or loss included in the Company's condensed consolidated statement of operations.

 

Financial Instruments

 

The fair value of the Company’s financial instruments is determined and disclosed in accordance with the three-tier fair value hierarchy specified in Note 4, Fair Value Measurements. The Company is required to disclose the estimated fair values of its financial instruments. As of March 31, 2022 and December 31, 2021, the Company’s financial instruments consisted of cash equivalents and warrant and share earnout liabilities. As of March 31, 2022, the Company did not have any other derivatives, hedging instruments or other similar financial instruments.

 

Warrant Liability

 

The Company accounts for stock warrants as either equity instruments, liabilities or derivative liabilities in accordance with ASC Topic 480, Distinguishing Liabilities from Equity ("ASC 480") and/or ASC Topic 815, Derivatives and Hedging ("ASC 815"), depending on the specific terms of the warrant agreement. Liability-classified warrants are recorded at their estimated fair values at each reporting period until they are exercised, terminated, reclassified or otherwise settled. Changes in the estimated fair value of liability-classified warrants are recorded in Change in Fair Value of Warrant Liability in the Company’s condensed consolidated statements of operations. Equity-classified warrants are recorded within additional paid-in capital at the time of issuance and not subject to remeasurement.

 

Share Earnout Liability

 

The Company accounts for share earnout arrangements that represent equity-linked instruments as either liabilities or equity instruments in accordance with ASC 815, unless such arrangements are within the scope of ASC Topic 718, Compensation–Stock Compensation ("ASC 718"), depending on the specific terms of the contract. Contracts classified as liabilities are recorded at their estimated fair values at each reporting period until they are no longer outstanding. Changes in the estimated fair value of liability-classified share earnout arrangements are recorded in Change in Fair Value of Share Earnout Liability in the Company’s condensed consolidated statements of operations.

 

Research and Development Expense

 

The Company expenses research and development expenses as incurred. The Company’s research and development expenses consist primarily of personnel-related expenses such as salaries, stock-based compensation, and benefits, and external costs of outside vendors engaged to conduct preclinical development activities, including manufacturing of preclinical and clinical drug supply. The Company accrues for expenses related to development activities performed by third parties based on an evaluation of services received and efforts expended pursuant to the terms of the contractual arrangements. There may be instances in which payments made to the Company’s vendors will exceed the level of services provided and result in a prepayment of expenses. In accruing service fees, the Company estimates the time period over which services will be performed and the level of effort to be expended in each period. If the actual timing of the performance of services or the level of effort varies from the estimate, the Company will adjust the accrual or prepaid expense accordingly.

 

 

7


 

Stock-Based Compensation

 

The Company expenses stock-based compensation to employees and non-employees over the requisite service period, generally the vesting period, based on the estimated grant-date fair value of the awards. The Company accounts for forfeitures as they occur. Stock-based awards with graded-vesting schedules are recognized on a straight-line basis over the requisite service period for each separately vesting portion of the award. The Company estimates the fair value of stock option grants using the Black-Scholes option pricing model, and the assumptions used in calculating the fair value of stock-based awards represent management’s best estimates and involve inherent uncertainties and the application of management’s judgment. All stock-based compensation costs are recorded in general and administrative or research and development costs in the condensed consolidated statements of operations based upon the underlying individual’s role at the Company.

 

Income Taxes

 

In accordance with ASC 270, Interim Reporting, and ASC 740, Income Taxes, the Company is required at the end of each interim period to determine the best estimate of its annual effective tax rate and then apply that rate in providing for income taxes on a current year-to-date (interim period) basis. For the three months ended March 31, 2022 and 2021, the Company recorded no tax expense or benefit due to the expected current year loss and its historical losses. The Company has not recorded its net deferred tax asset as of either March 31, 2022 or December 31, 2021 because it maintained a full valuation allowance against all deferred tax assets as of these dates as management has determined that it is not more likely than not that the Company will realize these future tax benefits. As of March 31, 2022 and December 31, 2021, the Company had no uncertain tax positions.

 

Net Income (Loss) per Common Share

 

Basic net income (loss) per share of common stock is computed by dividing net loss applicable to common stockholders by the weighted-average number of shares of common stock outstanding during each period, which includes shares of common stock underlying the Pre-funded Warrant (as defined herein), as such warrant is exercisable, in whole or in part, for nominal cash consideration with no expiration date. Shares of common stock outstanding but subject to forfeiture and cancellation by the Company (e.g., Sponsor Earnout Shares, as defined in the Merger Agreement) are excluded from the weighted-average shares until the period in which such shares are no longer subject to forfeiture. Diluted net loss per share of common stock includes the effect, if any, from the potential exercise or conversion of securities, such as stock options, Public Warrants and Private Placement Warrants, and Sponsor Earnout Shares and Old Renovacor Earnout Shares (each as defined herein), which would result in the issuance of incremental shares of common stock, unless their effect would be anti-dilutive. See Note 13 for additional details.

 

New Accounting Pronouncements

 

From time to time, new accounting pronouncements are issued by the FASB and rules are issued by the SEC that the Company has or will adopt as of a specified date. Unless otherwise noted, management does not believe that any other recently issued accounting pronouncements issued by the FASB or guidance issued by the SEC had, or is expected to have, a material impact on the Company’s present or future consolidated financial statements.

 

Accounting Pronouncements Recently Adopted

 

In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842) ("ASU 2016-02"). ASU 2016-02 (amended by ASU 2019-10 and ASU 2020-05) is effective for non-public entities and emerging growth companies for fiscal years beginning after December 15, 2021 and interim periods within fiscal years beginning after December 15, 2022. The new standard establishes a right-of-use (ROU) model that requires a lessee to record a ROU asset and a lease liability on the balance sheet for all leases with terms longer than 12 months. Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition in the statement of operations. A modified retrospective transition approach is required at the beginning of the earliest comparative period presented in the financial statements, with certain practical expedients available. The Company adopted this standard effective January 1, 2022. The adoption did not have a material impact on the Company’s consolidated condensed financial statements as of the adoption date. However, should the Company enter into material operating leases in the future, such as real estate leases for its corporate headquarters and other office and lab space, the Company anticipates an increase in assets and liabilities due to the recognition of the required right-of use asset and corresponding lease liability for such lease obligations. See Note 14 for discussion of leasing transactions occurring after March 31, 2022.

 

 

8


 

Note 3. Merger and Recapitalization

 

Merger Agreement

 

As discussed in Note 1, on the Closing Date, the Company closed the Business Combination with Old Renovacor, as a result of which Old Renovacor became a wholly-owned subsidiary of the Company. While the Company was the legal acquirer of Old Renovacor in the business combination, for accounting purposes, the Merger is treated as a reverse recapitalization, whereby Old Renovacor is deemed to be the accounting acquirer, and the historical financial statements of Old Renovacor became the historical consolidated financial statements of the Company upon the closing of the Merger. Under this method of accounting, the Company was treated as the “acquired” company and Old Renovacor is treated as the acquirer for financial reporting purposes. Accordingly, for accounting purposes, the Merger was treated as the equivalent of Old Renovacor issuing stock for the net assets of the Company, accompanied by a recapitalization. The net assets of the Company were stated at historical cost, with no goodwill or other intangible assets recorded. Operations prior to the Merger are presented as those of Old Renovacor.

 

At the consummation of the Merger Agreement upon filing of a certificate of Merger, which occurred on the Closing Date (the "Effective Time"), an aggregate of 6,305,061 shares of the Company’s common stock, par value $0.0001 per share, plus 194,926 Exchanged Options (defined below) (the "Aggregate Merger Consideration") was issued to equityholders of Old Renovacor as of immediately prior to the Effective Time. Out of the Aggregate Merger Consideration, each holder of preferred stock of Old Renovacor, par value $0.0001 per share (the "Old Renovacor Preferred Stock") was entitled to receive a number of shares of the Company's common stock equal to the Preferred Per Share Merger Consideration (as defined in the Merger Agreement) with respect to such holder’s shares of Old Renovacor Preferred Stock. Each holder of common stock of Old Renovacor, par value $0.0001 per share (the "Old Renovacor Common Stock," and together with Old Renovacor’s preferred stock, the "Old Renovacor Capital Stock"), was entitled to receive a number of shares of the Company’s common stock equal to the Common Per Share Merger Consideration (as defined in the Merger Agreement) with respect to such holder’s shares of Old Renovacor Common Stock. In addition, pursuant to the Company's 2021 Investor Incentive Plan, a portion of the Aggregate Merger Consideration was allocated among certain Old Renovacor equityholders or their affiliates who elected to participate in the PIPE Investment on a pro rata basis based on their respective investment amounts.

 

Each option to purchase shares of Old Renovacor Common Stock ("Old Renovacor Option") outstanding as of immediately prior to the Effective Time was converted into an option to purchase a number of shares of the Company’s common stock (rounded down to the nearest whole number) equal to the product of the number of shares of Old Renovacor Common Stock subject to such Old Renovacor option and the Common Per Share Merger Consideration (an "Exchanged Option"), which Exchanged Option is subject to the same vesting terms applicable to the Old Renovacor Option as of immediately prior to the Effective Time.

 

The shares and corresponding capital amounts and loss per share related to Old Renovacor Common Stock prior to the Business Combination Transaction were retroactively restated to reflect the Common Per Share Merger Consideration and the Preferred Per Share Merger Consideration, as applicable.

 

Holders of Old Renovacor Capital Stock are entitled to receive up to an additional 1,922,816 shares of the Company’s common stock (the “Old Renovacor Earnout Shares”) as follows:

 

576,845 Old Renovacor Earnout Shares, in the aggregate, if at any time during the period beginning on the date of the Closing (the “Closing Date”) and ending on December 31, 2023 (the “First Earnout Period”), the volume-weighted average price ("VWAP") (as defined in the Merger Agreement) of the Company’s common stock over any twenty (20) Trading Days (as defined in the Merger Agreement) (which may or may not be consecutive) within any thirty (30) consecutive Trading Day period is greater than or equal to $17.50 per share of the Company’s common stock (the “First Milestone”).

 

An additional 576,845 Old Renovacor Earnout Shares, in the aggregate, if at any time during the period beginning on the Closing Date and ending on December 31, 2025 (the “Second Earnout Period”), the VWAP of the Company’s common stock over any twenty (20) Trading Days (which may or may not be consecutive) within any thirty (30) consecutive Trading Day period is greater than or equal to $25.00 per share of the Company’s common stock (the “Second Milestone”).

 

An additional 769,126 Old Renovacor Earnout Shares, in the aggregate, if at any time during the period beginning on the Closing Date and ending on December 31, 2027 (the “Third Earnout Period” and together with the First Earnout Period and the Second Earnout Period, each, an “Earnout Period” and collectively, the “Earnout Periods”), the VWAP of the Company’s common stock over any twenty (20) Trading Days (which may or may not be consecutive) within any thirty (30) consecutive Trading Day period is greater than or equal to $35.00 per share of the Company’s common stock (the “Third Milestone” and together with the First Milestone and the Second Milestone, the “Earnout Milestones”).

 

9


 

Upon the consummation of any Change in Control (as defined in the Merger Agreement) during any Earnout Period, any Earnout Milestone with respect to such Earnout Period that has not yet been achieved shall automatically be deemed to have been achieved regardless of the valuation of the Company’s common stock in such Change in Control transaction and the Company will take all actions necessary to provide for the issuance of the shares of the Company’s common stock comprising the applicable Old Renovacor Earnout Shares issuable in respect of such Earnout Milestone(s) prior to the consummation of such Change in Control.

 

Each holder of Old Renovacor's Capital Stock was entitled to such holder’s aggregate Per Share Earnout Consideration (as defined in the Merger Agreement) in respect of such shares of Old Renovacor's Capital Stock as described above. In addition, at the Effective Time, holders of Old Renovacor Options received the right to be granted an Earnout RSU Award (as defined in the Merger Agreement) in respect of such holder’s Old Renovacor Options, which entitle such holder to an aggregate number of shares of the Company's common stock equal to the aggregate Per Share Earnout Consideration in respect of the shares of Old Renovacor Capital Stock underlying such Old Renovacor Options, if any, subject to the satisfaction of the applicable vesting conditions with respect to the Exchanged Options issued in respect of such Renovacor Options at the Closing. See Note 11 for further details.

 

Further, under the terms of the Business Combination (as provided for in the Sponsor Support Agreement), certain Sponsor Shares totaling 500,000 were placed into escrow and subject to forfeiture (the "Sponsor Earnout Shares"). Such Sponsor Earnout Shares will be released from escrow if the weighted average sale price of the Company's common stock equals or exceeds the applicable Target Price (as set forth in the table below) for any 20 trading days within a 30-day trading period from the Effective Time until the applicable end date. Upon consummation of any Change in Control during any Earnout Period, any Earnout Milestone with respect to such Earnout Period that has not yet been achieved shall automatically be deemed to have been achieved regardless of the valuation of the per share common stock price in such Change in Control transaction. Any Sponsor Earnout Shares that remain unvested as of the expiration of the applicable earnout period shall be forfeited and canceled.

 

The Old Renovacor Earnout Shares and Sponsor Earnout Shares (collectively, the "Earnout Shares") are summarized, as set forth in the table below:

 

 

 

 

 

 

Old Renovacor

 

 

Sponsor

 

 

 

 

 

 

Target Price

 

 

Earnout Shares

 

 

Earnout Shares

 

 

Total

 

December 31, 2023

 

$

17.50

 

 

 

576,845

 

 

 

150,000

 

 

 

726,845

 

December 31, 2025

 

$

25.00

 

 

 

576,845

 

 

 

150,000

 

 

 

726,845

 

December 31, 2027

 

$

35.00

 

 

 

769,126

 

 

 

200,000

 

 

 

969,126

 

 

 

 

 

 

 

1,922,816

 

 

 

500,000

 

 

 

2,422,816

 

 

PIPE Investment (Private Placement)

 

Concurrently with the execution of the Merger Agreement, the Company entered into subscription agreements (the "Subscription Agreements"), with certain investors ("PIPE Investors"), including Chardan Healthcare, certain stockholders of Old Renovacor and certain other institutional and accredited investors, pursuant to which, on the Closing Date, and concurrently with the closing of the Business Combination, the PIPE Investors purchased an aggregate of 2,284,776 shares the Company's common stock, at a price of $10.00 per share, and a pre-funded warrant entitling the holder thereof to purchase 715,224 shares of the Company's common stock (the "Pre-Funded Warrant") at an initial purchase price of $9.99 per share underlying the Pre-Funded Warrant, for aggregate gross proceeds of approximately $30.0 million (the "PIPE Investment"). The Pre-Funded Warrant is immediately exercisable at an exercise price of $0.01 and is exercisable indefinitely, provided that the holder of the Pre-Funded Warrant is prohibited from exercising such Pre-Funded Warrant in an amount that would cause such holder’s beneficial ownership of our Common Stock to exceed 9.99%, which limitation may be increased up to 19.99% at the option of the holder from time to time.

 

 

10


 

The following table summarizes the elements of the net proceeds from the Merger:

 

(In thousands)

 

Amount

 

Cash – CHAQ trust and cash, net of redemptions

 

$

65,127

 

Cash – PIPE financing

 

 

29,993

 

Less: CHAQ and Old Renovacor transaction costs paid

 

 

(6,079

)

Less: Settlement of convertible note at closing

 

 

(2,500

)

   Effect of Merger, net of redemptions and transaction costs

 

$

86,541

 

 

The following table details the number of shares of common stock issued immediately following the consummation of the Merger:

 

 

 

Number of Shares

 

Common stock, outstanding prior to Merger

 

 

8,622,644

 

Less: redemption of CHAQ shares

 

 

(2,112,100

)

Common stock of CHAQ

 

 

6,510,544

 

CHAQ Founder shares

 

 

2,155,661

 

Shares issued in PIPE Financing

 

 

2,284,776

 

Merger and PIPE financing shares - common stock

 

 

10,950,981

 

Shares issued to Old Renovacor - common stock (1)

 

 

6,305,061

 

Total shares of common stock immediately after Merger (2)

 

 

17,256,042

 

____________________

(1)
The number of shares of common stock issued to Old Renovacor equityholders was determined based on (i) 1,987,636 shares of Old Renovacor Common Stock outstanding immediately prior to the closing of the Merger converted based on the Common Per Share Merger Consideration (as defined in the Merger Agreement) and (ii) 2,578,518 shares of Old Renovacor Preferred Stock outstanding immediately prior to the closing of the Merger converted based on the Preferred Per Share Merger Consideration (as defined in the Merger Agreement). All fractional shares were rounded down.
(2)
Includes 500,000 shares of common stock being held in escrow and subject to vesting or forfeiture based on satisfaction of the Earnout Milestones set forth in the Sponsor Support Agreement. Such shares are liability classified and included in the Share earnout liability as of December 31, 2021.

 

See Note 10 – Stockholders’ Equity for additional details of the Company’s capital stock.

 

11


 

Note 4. Fair Value Measurements

 

Assets and Liabilities Measured at Fair Value on a Recurring Basis

 

The Company applies the guidance in ASC 820, Fair Value Measurement, to account for financial assets and liabilities measured on a recurring basis. Fair value is measured at the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. As such, fair value is a market-based measurement that is determined based on assumptions that market participants would use in pricing an asset or liability.

 

The Company uses a fair value hierarchy, which distinguishes between assumptions based on market data (observable inputs) and an entity's own assumptions (unobservable inputs). The guidance requires that fair value measurements be classified and disclosed in one of the following three categories:

Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;
Level 2: Quoted prices in markets that are not active or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability; and
Level 3: Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e., supported by little or no market activity).

 

Determining which category an asset or liability falls within the hierarchy requires significant judgment. The Company evaluates its hierarchy disclosures each reporting period. There were no transfers between Level 1, 2 and 3 during the three months ended March 31, 2022.

 

The table below presents the liabilities measured and recorded in the financial statements at fair value on a recurring basis at March 31, 2022 and December 31, 2021 categorized by the level of inputs used in the valuation of each asset and liability.

 

 

 

March 31, 2022

 

(In thousands)

 

Total

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents – money market funds

 

$

69,089

 

 

$

69,089

 

 

$

 

 

$

 

Total assets

 

$

69,089

 

 

$

69,089

 

 

$

 

 

$

 

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

Warrant liability

 

$

3,885

 

 

$

 

 

$

 

 

$

3,885

 

Share earnout liability

 

 

4,090

 

 

 

 

 

 

 

 

 

4,090

 

Total liabilities

 

$

7,975

 

 

$

 

 

$

 

 

$

7,975

 

 

 

 

December 31, 2021

 

(In thousands)

 

Total

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents – money market funds

 

$

77,792

 

 

$

77,792

 

 

$

 

 

$

 

Total assets

 

$

77,792

 

 

$

77,792

 

 

$

 

 

$

 

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

Warrant liability

 

$

11,165

 

 

$

 

 

$

 

 

$

11,165

 

Share earnout liability

 

 

12,256

 

 

 

 

 

 

 

 

 

12,256

 

Total liabilities

 

$

23,421

 

 

$

 

 

$

 

 

$

23,421

 

 

 

 

12


 

Changes in Level 3 Liabilities Measured at Fair Value on a Recurring Basis

 

Warrant Liability and Earnout Share Liability

 

The reconciliation of the Company's warrant and earnout share liability measured at fair value on a recurring basis using unobservable inputs (Level 3) is as follows:

 

 

 

Warrant

 

 

Earnout Share

 

(In thousands)

 

Liability

 

 

Liability

 

Balance, December 31, 2021

 

$

11,165

 

 

$

12,256

 

Change in the fair value of liability

 

 

(7,280

)

 

 

(8,166

)

Balance, March 31, 2022

 

$

3,885

 

 

$

4,090

 

 

Assumptions Used in Determining Fair Value of Liability-Classified Warrants

 

The Company utilizes a Black-Scholes model to value the Private Placement Warrants at each reporting period, with changes in fair value recognized in the condensed consolidated statements of operations. The estimated fair value of the warrant liability is determined using Level 3 inputs. Inherent in an options pricing model are assumptions related to expected share-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the expected volatility of its common stock based on historical volatility of a peer group, considering the expected remaining life of the Private Placement Warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the valuation date for a maturity similar to the expected remaining life of the Private Placement Warrants. The expected life of the Private Placement Warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates to remain at zero.

 

The fair value of the Private Placement Warrants has been estimated with the following assumptions:

 

 

 

March 31,

 

 

December 31

 

 

 

2022

 

 

2021

 

Stock price

 

$

4.24

 

 

$

7.70

 

Strike price

 

$

11.50

 

 

$

11.50

 

Expected volatility

 

 

75.0

%

 

 

75.0

%

Risk-free interest rate

 

 

2.45

%

 

 

1.01

%

Expected dividend yield

 

 

 

 

 

 

Expected life (years)

 

 

3.07

 

 

 

3.31

 

Fair value per warrant

 

$

1.11

 

 

$

3.19

 

 

Assumptions Used in Determining Fair Value of Liability-Classified Earnout Shares

 

The Company utilizes a Monte Carlo simulation to value the Earnout Shares. The Company selected this model as it believes it is reflective of all significant assumptions that market participants would likely consider in negotiating the transfer of the Earnout Shares. Such assumptions include, among other inputs, expected stock price volatility, risk-free rates, and change in control assumptions. The Company estimates probability of a change in control based on both market data for the biotechnology industry and managements own assessment. The Company estimates the expected volatility of its common stock based on historical volatility of a peer group, considering the remaining term of the Earnout Shares. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the valuation date for a maturity similar to the expected remaining life of the Earnout Shares. The expected life of the Earnout Shares is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates to remain at zero.

 

The fair value of the Earnout Shares has been estimated with the following assumptions:

 

 

 

March 31,

 

 

December 31

 

 

 

2022

 

 

2021

 

Stock price

 

$

4.24

 

 

$

7.70

 

Probability of Change in Control

 

 

7.5

%

 

 

7.5

%

Expected volatility

 

 

75.0

%

 

 

75.0

%

Risk-free interest rate

 

 

2.41

%

 

 

1.35

%

Expected dividend yield

 

 

 

 

 

 

Expected life (years)

 

 

5.76

 

 

 

6.00

 

Fair value per share

 

$

1.69

 

 

$

5.06

 

 

13


 

 

Note 5. Property and Equipment

 

Property and equipment, net, consisted of the following:

 

 

 

March 31,

 

 

December 31,

 

($ in thousands)

 

2022

 

 

2021

 

Laboratory equipment

 

$

380

 

 

$

380

 

Less: accumulated amortization

 

 

(18

)

 

 

(1

)

Property and equipment, net

 

$

362

 

 

$

379

 

 

Note 6. Prepaid Expenses

 

Prepaid expenses consisted of the following:

 

 

 

March 31,

 

 

December 31,

 

($ in thousands)

 

2022

 

 

2021

 

Research and development costs

 

$

483

 

 

$

209

 

Insurance

 

 

882

 

 

 

1,369

 

Other

 

 

258

 

 

 

185

 

Total prepaid expenses

 

$

1,623

 

 

$

1,763

 

 

Note 7. Accrued Expenses

 

Accrued expenses consisted of the following:

 

 

 

March 31,

 

 

December 31,

 

($ in thousands)

 

2022

 

 

2021

 

Employee compensation and benefits

 

$

688

 

 

$

1,282

 

External research and development expenses

 

 

608

 

 

 

409

 

Property and equipment

 

 

 

 

 

360

 

Professional fees

 

 

149

 

 

 

347

 

Other

 

 

171

 

 

 

100

 

Total accrued expenses

 

$

1,616

 

 

$

2,498

 

 

Note 8. Commitments and Contingencies

 

Legal Proceedings

 

The Company is not currently subject to any material legal proceedings.

 

License and Sponsored Research Agreements

 

The Company is obligated to compensate Temple pursuant to the Temple License Agreement and is committed to funding the Temple SRA as further described in Note 9.

 

Lease Commitments

 

In April 2022, the Company entered into a lease agreement relating to office space in Cambridge, Massachusetts, as more fully described in Note 14.

 

14


 

Note 9. License and Sponsored Research Agreements

 

Temple University

 

In August 2019, Old Renovacor entered into an exclusive license agreement effective as of August 12, 2019 (the “Temple License Agreement”) and a sponsored research agreement, which was amended effective as of August 12, 2019, August 27, 2019 and further amended effective as of July 1, 2021 (as amended to date, the “Temple SRA”), each with Temple University (“Temple”). The Temple License Agreement was assigned to the Company in connection with the Merger. Pursuant to the Temple License Agreement, Temple granted the Company an exclusive, royalty-bearing, sublicensable, worldwide license to certain patent rights in certain inventions related to the use of BAG3 technology for the diagnosis, prevention or treatment of diseases in humans, and a non-exclusive license to use specified know-how and materials with a provision that Temple will retain the rights to practice the patent rights for non-commercial educational research purposes only and shall be free to sublicense these rights to other non-profit educational and research institutions solely for noncommercial research and educational purposes. Under the Temple SRA, Temple is primarily responsible for preclinical development activities with respect to licensed technology and know-how through the pursuit of specific investigational questions which, in the aggregate, are intended to provide important supporting data for a future IND-enabling studies and for potential future marketing efforts. The Company is responsible for all subsequent clinical development and commercialization activities with respect to the licensed technology and know-how.
 

 

Upon execution of the Temple License Agreement in 2019, Old Renovacor issued to Temple 97,879 shares of Old Renovacor Common Stock on the effective date of the transaction and agreed to issue Temple an additional 9,130 shares of Old Renovacor Common Stock upon the closing date of the second tranche of the Series A Convertible Preferred Stock, which occurred in November 2020. The Company also reimbursed Temple for the prosecution and maintenance costs incurred by Temple for the licensed patent rights prior to the Company entering into the License Agreement, and the Company is responsible for all the ongoing costs relating to the prosecution and maintenance of the Temple patent rights licensed to the Company going forward. The Company also agreed to pay Temple a minimum annual administrative fee of $20,000 per year beginning with the effective date of the Temple License Agreement and continuing each annual anniversary thereafter. Further, as required by Section 12.2 of the License Agreement, the Company was required to pay, and recorded to research and development expense during the third quarter of 2021, an assignment fee of $100,000 to Temple following closing of the Merger related to the assignment of the License Agreement from Old Renovacor to the Company.

 

The Temple License Agreement requires the Company to pay up to an aggregate of $1.25 million to Temple upon the achievement of certain developmental, regulatory and commercial milestones for the first licensed product that achieves said milestones regardless of the number of licensed products that achieve them. In addition, the Company is required to pay Temple a low single-digit royalty on net sales of any product utilizing the patent rights under the License Agreement, up to 50% of which may be reduced by payments Renovacor makes to third parties for freedom to operate. In addition, the Company must also pay a percentage of all consideration based on a percentage of sublicense consideration received by it, which percentage ranges from the mid-teens to mid-twenties depending on the stage of development at the time of the sublicense agreement.

 

The Temple License Agreement will remain effective until (i) the expiration date of the last-to-expire patents covered under the License Agreement (currently expected to occur in 2041); (ii) the termination by Temple upon (a) an uncured breach by the Company, with a 60-day notification period, (b) the Company’s filing of a voluntary petition in bankruptcy or related proceeding, providing such petition is not dismissed within 90 days after the filing thereof, (c) a failure by the Company to meet certain milestones set forth in the Licensed Agreement, or (d) non-payment of undisputed monies due to Temple, with a 30-day notification period. Additionally, the Company may terminate the entire agreement or with respect to an individual patent or patent application, if desired, subject a 90-day notification period.

 

As it relates to the Temple SRA, prior to the amendment entered into in August 2021 and effective as of July 1, 2021, Temple was to conduct certain preclinical activities for a three-year period, unless terminated sooner or extended by mutual written consent, for which the Company was obligated to fund approximately $0.9 million over the three-year initial term of the Temple SRA. The Temple SRA was further amended effective as of July 1, 2021 (the “2021 Amendment”) to, among other things, revise the period of performance, scope of work, and the budget. Following the 2021 Amendment, the Company is expected to fund up to a total of approximately $5.3 million to Temple through June 30, 2024, pursuant to the Temple SRA, of which approximately $1.5 million has been funded and/or incurred since inception of the Temple SRA through March 31, 2022.

 

During the three months ended March 31, 2022 and 2021, the Company recorded research and development expenses of approximately $0.2 million and $0.1 million, respectively, related to the Temple SRA.

 

15


 

Note 10. Stockholder’s Equity

 

Common Stock

 

Upon closing of the Merger, pursuant to the terms of the Second Amended and Restated Certificate of Incorporation, the Company was authorized to issue up to 100,000,000 shares of common stock, par value $0.0001 per share (the "Common Stock").

 

As discussed in Note 3, the Company has retroactively adjusted the shares issued and outstanding prior to September 2, 2021 to give effect to the Common Per Share Merger Consideration (as defined in the Merger Agreement) to determine the number of shares of common stock into which they were converted.

 

Prior to the Merger, the Company was authorized to issue up to 6,000,000 shares of common stock, of which 1,987,636 were issued and outstanding immediately prior to the Closing Date. See Note 3.

 

Preferred Stock

 

Upon closing of the Merger, pursuant to the terms of the Second Amended and Restated Certificate of Incorporation, the Company was authorized to issue up to 1,000,000 shares of undesignated preferred stock, par value $0.0001 (the "Undesignated Preferred Stock"). The Company's board of directors or any committee thereof is expressly authorized, to the fullest extent permitted by law, to provide by resolution or resolutions for, out of the unissued shares of Undesignated Preferred Stock, the issuance of the shares of Undesignated Preferred Stock in one or more series, and by filing a certificate of designations pursuant to the General Corporate Law of the State of Delaware, to establish or change from time to time the number of shares of each such series, and to fix the designations, powers, including voting powers, full or limited, or no voting powers, preferences and the relative, participating, optional or other special rights of the shares of each series and any qualifications, limitations and restrictions thereof.

 

As discussed in Note 3, the Company has retroactively adjusted the shares issued and outstanding prior to September 2, 2021 to give effect to the Preferred Per Share Merger Consideration (as defined in the Merger Agreement) to determine the number of shares of common stock into which they were converted.

 

Prior to the Merger, the Company was authorized to issue up to 3,333,283 shares of its Series A convertible preferred stock, par value $0.0001 ("Series A Preferred Stock"), of which 2,578,518 were issued and outstanding immediately prior to the Closing Date. See Note 3. The Series A Preferred Stock, prior to consummation of the Business Combination, was convertible into common stock at the option of the holder at any time and without payment of any additional consideration. Each share of Series A Preferred Stock was convertible into a number of fully paid shares of common stock as is determined by dividing the Series A Preferred Stock original issuance price ($4.065063) by the Series A Preferred Stock conversion price (initially equal to $4.065063). Provided, however, shares of Series A Preferred Stock would automatically be converted into shares of common stock upon either (a) the closing of an underwritten public offering at a price of at least $12.20 per share resulting in at least $60 million of gross proceeds, prior to deductions for underwriting discounts, commission, and expenses, or (b) the date and time, or occurrence of an event, specified by a vote of at least a majority of the holders of the Series A Preferred Stock then outstanding. The Series A Preferred Stock was subject to redemption under certain deemed liquidation events and the holders were entitled to a liquidation preference in the event of a voluntary or involuntary liquidation, dissolution or winding-up of the Company, or deemed liquidation event of the Company (which includes certain mergers and asset transfers). The liquidation preference was an amount equal $4.065063, plus cumulative accrued dividends to date on such shares.

 

Assumed Public Warrants

 

Prior to the Merger, the Company had outstanding 8,622,644 warrants (the "Public Warrants") which were issued in connection with the Company's initial public offering in April 2020 (the "Chardan IPO"). Each Public Warrant entitles the holder to purchase one-half of one share of the Company's common stock at an exercise price of $11.50 per whole share, subject to adjustment. No fractional shares will be issued upon exercise of the Public Warrants. Therefore, the Public Warrants must be exercised in multiples of two Public Warrants for one share of the Company's common stock. The Public Warrants became exercisable upon the closing of the Business Combination; provided the Company has an effective and current registration statement covering the shares of Company common stock issuable upon the exercise of the Public Warrants and a current prospectus relating to such shares of common stock. The Public Warrants will expire five years following the Closing Date or earlier upon redemption or liquidation.

 

 

16


 

The Company may redeem the Public Warrants:

in whole and not in part;
at a price of $0.01 per Public Warrant;
at any time during the exercise period;
upon a minimum of 30 days’ prior written notice of redemption;
if, and only if, the last sale price of the Company’s common stock equals or exceeds $16.00 per share for any 10 trading days within a 30-trading day period ending on the third business day prior to the date on which the Company sends the notice of redemption to the warrant holders; and
if, and only if, there is a current registration statement in effect with respect to the shares of common stock underlying such Public Warrants at the time of redemption and for the entire 30-day trading period referred to above and continuing each day thereafter until the date of redemption.

 

To date, certain of the above conditions have not been met to redeem the Public Warrants. If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement.

 

The exercise price and number of shares of Common Stock issuable upon exercise of the Public Warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. Additionally, in no event will the Company be required to net cash settle the Public Warrants.

 

The Company determined that the Public Warrants met all of the criteria for equity classification. Accordingly, upon closing of the Merger, the Public Warrants were recorded as a component of additional paid-in capital.

 

Assumed Private Placement Warrants

 

Prior to the Merger, the Company had outstanding 3,500,000 warrants (the "Private Placement Warrants") which were issued simultaneously with the closing of the Chardan IPO, pursuant to a private placement transaction. Each Private Placement Warrant is exercisable to purchase one share of common stock at an exercise price of $11.50. The Private Placement Warrants are identical to the Public Warrants except that the Private Placement Warrants (i) will be exercisable for cash (even if a registration statement covering the shares of common stock issuable upon exercise of such warrants is not effective) or on a cashless basis, at the holder’s option, and (ii) will not be non-redeemable by the Company, in each case, so long as they are held by the initial purchasers or their permitted transferees. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants. The Private Placement Warrants purchased by Chardan will not be exercisable more than five years from the effective date of the Chardan IPO, in accordance with FINRA Rule 5110(f)(2)(G)(i), as long as Chardan Capital Markets or any of its related persons beneficially own these Private Placement Warrants.

 

The Private Placement Warrants are not indexed to the Company’s common stock in the manner contemplated by ASC 815-40-15 because the holder of the instrument is not an input into the pricing of a fixed-for-fixed option on equity shares. The Company classifies the Private Placement Warrants as derivative liabilities in its condensed consolidated balance sheets. The Company measures the fair value of the warrants at the end of each reporting period and recognizes changes in the fair value from the prior period in the Company’s operating results for the current period. Refer to Note 4 for discussion of fair value measurement of the warrant liabilities.

 

 

17


 

The following table summarizes outstanding warrants to purchase shares of the Company’s common stock as of March 31, 2022 and December 31, 2021:

 

 

 

Number of Warrants

 

 

 

 

 

 

 

 

 

March 31,

 

 

December 31

 

 

Weighted-Average

 

 

 

 

 

 

2022

 

 

2021

 

 

Exercise Price

 

 

Expiration Date

 

Liability-classified Warrants

 

 

 

 

 

 

 

 

 

 

 

 

 

April 2020 Private Placement Warrants

 

 

3,500,000

 

 

 

3,500,000

 

 

 

$

11.50

 

 

4/23/2025

 

 

 

 

3,500,000

 

 

 

3,500,000

 

 

 

 

 

 

 

 

Equity-classified Warrants

 

 

 

 

 

 

 

 

 

 

 

 

 

April 2020 Public Warrants (1)

 

 

8,622,644

 

 

 

8,622,644

 

 

 

$

11.50

 

 

9/2/2026

 

September 2021 Pre-Funded Warrants (2)

 

 

715,224

 

 

 

715,224

 

 

 

$

0.01

 

 

 

 

 

 

 

9,337,868

 

 

 

9,337,868

 

 

 

 

 

 

 

 

Total outstanding

 

 

12,837,868

 

 

 

12,837,868

 

 

 

 

 

 

 

 

———————

(1)
Public Warrants assumed in the Merger. Each warrant share is exercisable for one-half share of common stock, provided, however, each warrant must be exercised in multiples of two.
(2)
Pre-Funded Warrant issued in connection with PIPE Investment (Note 3). Each warrant share is exercisable indefinitely for one share of common stock.

 

Capital Stock Reserves

 

As of March 31, 2022, the Company reserved the following shares of common stock for future issuance:

 

 

 

Amount

 

Shares issuable upon exercise of pre-funded warrants outstanding

 

 

715,224

 

Shares issuable upon exercise of warrants outstanding

 

 

7,811,322

 

Shares issuable upon issuance of contingent consideration (Earnout Shares and Earnout RSUs)

 

 

1,994,338

 

Shares issuable upon exercise of outstanding stock options

 

 

1,941,099

 

Shares issuable upon vesting of time-based restricted stock units

 

 

163,350

 

Shares reserved for future issuance under 2021 Incentive Plan

 

 

1,025,170

 

Total

 

 

13,650,503

 

 

 

18


 

Note 11. Stock-based Compensation

 

Equity Incentive Plans

 

As of March 31, 2022, the only equity compensation plan from which the Company may currently issue new awards is the Company’s 2021 Omnibus Incentive Plan (the “2021 Plan”), as more fully described below.

 

2018 Stock Option and Grant Plan

 

Prior to the Merger, Old Renovacor maintained its 2018 Stock Option and Grant Plan (the "2018 Plan"), under which Old Renovacor granted incentive stock options, non-qualified stock options and restricted stock awards to its employees and certain non-employees, including consultants, advisors and directors. The maximum aggregate shares of common stock that was subject to awards and issuable under the 2018 Plan was 1,118,869 prior to the Merger.

 

As more fully described in Note 3, in connection with the Merger, each Old Renovacor Option that was outstanding and unexercised immediately prior to the Effective Time (whether vested or unvested) was assumed by the Company and converted into an option to purchase an adjusted number of shares of the Company's common stock at an adjusted exercise price per share, based on the Per Common Share Merger Consideration, and will continue to be governed by substantially the same terms and conditions, including vesting, as were applicable to the former option. Each Exchanged Option is exercisable for a number of whole shares of common stock equal to the product of the number of shares of Old Renovacor Common Stock underlying such Old Renovacor Options multiplied by the Per Common Share Merger Consideration, and the per share exercise price of such Exchanged Option is equal to the quotient determined by dividing the exercise price per share of the Old Renovacor Option by the Per Common Share Merger Consideration. Following the closing of the Merger, no new awards may be made under the 2018 Plan.

 

Upon the closing of the Merger, the outstanding and unexercised Old Renovacor Options became options to purchase an aggregate 194,926 shares of the Company’s common stock at an average exercise price of $5.66 per share. The Company accounted for the Exchanged Options as a modification of the existing options. Incremental compensation costs, measured as the excess, if any, of the fair value of the modified options over the fair value of the original options immediately before its terms are modified, is measured based on the fair value of the underlying shares and other pertinent factors at the modification date. The impact of the option modifications were de minimis.

 

2021 Omnibus Incentive Plan

 

At the Effective Time, the Company adopted the 2021 Plan which permits the granting of incentive stock options, non-qualified options, stock appreciation rights, restricted stock, restricted stock units and other stock-based award, and performance awards to employees, directors, and non-employee consultants and/or advisors. As of March 31, 2022, 3,008,803 shares of Common Stock are authorized for issuance pursuant to awards under the 2021 Plan. The pool of available shares will be automatically increased on the first day of each calendar year, beginning January 1, 2022 and ending January 1, 2031, by an amount equal to the lesser of (i) 4% of the outstanding shares of our Common Stock determined on a fully-diluted basis as of the immediately preceding December 31 and (ii) such smaller number of shares as determined by the Company's board of directors.

 

In addition, any awards outstanding under the 2018 Plan upon the closing of the Business Combination, after adjustment for the Business Combination, remain outstanding. If any of those awards subsequently expire, terminate, or are surrendered or forfeited for any reason without issuance of shares after the closing of the Business Combination, the shares of the Company's common stock underlying those awards will automatically become available for issuance under the 2021 Plan. No new awards may be made under the 2018 Plan.

 

The exercise prices, vesting and other restrictions of the awards to be granted under the 2021 Plan are determined by the board of directors, except that no stock option may be issued with an exercise price less than the fair market value of the common stock at the date of the grant or have a term in excess of ten years. Options granted under the 2021 Plan are exercisable in whole or in part at any time subsequent to vesting.

 

As of March 31, 2022, options exercisable for 1,748,761 shares of common stock and 234,872 restricted stock units (including 71,522 Earnout RSUs) were outstanding, and 1,025,170 shares of common stock units remain available for future issuance under the 2021 Plan.

 

 

19


 

Accounting for Stock-based Compensation

 

The Company recognizes non-cash compensation expense for stock-based awards under the Company’s equity incentive plans over an award’s requisite service period, or vesting period, using the straight-line attribution method, based on their grant date fair value, determined using the Black-Scholes option-pricing model. Generally, the Company issues awards with only service-based vesting conditions and records the expense for these awards using the straight-line method. The Company recognizes forfeitures related to stock-based compensation awards as they occur and reverses any previously recognized compensation cost associated with forfeited awards in the period the forfeiture occurs.

 

The Company classifies stock-based compensation expense in the statement of operations in the same manner in which the award recipients’ payroll costs are classified or in which the award recipients’ service payments are classified. Total stock-based compensation expense attributable to stock-based payments made to employees, consultants and directors included in operating expenses in the Company's condensed consolidated statements of operations for the three months ended March 31, 2022 and 2021 was as follows:


 

 

 

Three months ended

 

 

 

March 31,

 

($ in thousands)

 

2022

 

 

2021

 

Research and development

 

$

345

 

 

$

3

 

General and administrative

 

 

256

 

 

 

4

 

Total stock-based compensation expense

 

$

601

 

 

$

7

 

 

Stock Option Awards

 

Assumptions Used in Determining Fair Value of Stock Options

 

Inherent in the Black-Scholes option-pricing model are the following assumptions:

 

Volatility. The Company lacks company-specific historical and implied volatility information. Therefore, the Company estimates the expected stock volatility based on the historical volatility of a publicly traded set of peer companies over a period of time commensurate with the expected term of the stock options. The Company expects to continue to do so until it has adequate historical data regarding the volatility of the Company's traded stock price.

 

Expected term. The Company uses the simplified method described in the SEC’s Staff Accounting Bulletin No. 107, Share-Based Payment (“SAB 107”), to determine the expected life of the option grants.

 

Risk-free interest rate. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant commensurate with the expected term assumption.

 

Dividend rate. The dividend rate is based on the historical rate, which the Company anticipates will remain at zero.

 

Forfeitures. The Company accounts for forfeitures when they occur. Ultimately, the actual expense recognized over the vesting period will be for only those shares that vest.

 

 

20


 

Prior to the Business Combination, the grant date fair value of the shares of Old Renovacor common stock was determined by the Old Renovacor's board of directors with the assistance of management using valuation methodologies which utilize certain assumptions including probability weighting of events, volatility, time to liquidation, a risk-free interest rate, and an assumption for a discount for lack of marketability. In determining the fair value of the shares of Old Renovacor's common stock, the methodologies used to estimate the enterprise value were performed using methodologies, approaches, and assumptions consistent with the American Institute of Certified Public Accountants Accounting and Valuation Guide, Valuation of Privately-Held-Company Equity Securities Issued as Compensation. Subsequent to the Business Combination, the Company utilizes the price of its publicly-traded common stock to determine the grant date fair value of awards.

 

The fair value of each option award at the date of grant was estimated using the Black-Scholes option pricing model. All options granted during the three months ended March 31, 2022 and 2021 were granted at exercise prices equal to the fair market value of the common stock on the dates of grant.

 

The following table provides the weighted-average assumptions used in determining the fair value of option awards to purchase 587,650 and 32,808 shares of common stock granted during the three months ended March 31, 2022 and 2021, respectively:

 

 

 

Three months ended

 

 

 

March 31,

 

 

 

2022

 

 

2021

 

Expected volatility

 

 

76.2

%

 

 

73.6

%

Risk-free interest rate

 

 

1.92

%

 

 

0.59

%

Expected dividend yield

 

 

 

 

 

 

Expected term (years)

 

 

6.08

 

 

 

6.08

 

 

The weighted average fair value of the options granted was $3.87 and $2.32 per share for the three months ended March 31, 2022 and 2021, respectively.

 

Stock Option Activity

 

The following table summarizes stock option activity for the three months ended March 31,2022:

 

($ in thousands, except share and per share data)

 

Stock
Options

 

 

Weighted-Average
Exercise Price

 

 

Weighted-Average
Remaining
Contractual Life
(in years)

 

 

Aggregate
Intrinsic
Value

 

Outstanding at December 31, 2021

 

 

1,376,937

 

 

$

7.61

 

 

 

9.5

 

 

$

676

 

Granted

 

 

587,650

 

 

 

5.76

 

 

 

 

 

 

 

Exercised

 

 

 

 

 

 

 

 

 

 

 

 

Forfeited

 

 

(23,488

)

 

 

7.54

 

 

 

 

 

 

 

Expired

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding at March 31, 2022 (1)

 

 

1,941,099

 

 

$

7.05

 

 

 

9.4

 

 

$

308

 

Exercisable at March 31, 2022

 

 

211,780

 

 

$

6.73

 

 

 

8.2

 

 

$

249

 

 

_____________________________________

(1)
Includes both vested stock options as well as unvested stock options for which the requisite service period has not been rendered but that are expected to vest based on achievement of a service condition.

 

The fair value of options that vested during the three months ended March 31, 2022 was less than $0.3 million. As of March 31, 2022, there was approximately $7.4 million of unrecognized stock-based compensation expense related to unvested stock options, which the Company expects to recognize over a weighted average period of 3.5 years.

 

 

21


 

Restricted Stock Awards

 

In connection with the closing of the Merger, all unvested restricted stock awards outstanding immediately prior to the Effective Time became fully vested, resulting in the recognition of less than $0.1 million in stock-based compensation expense. Additionally, pursuant to the provisions of the Merger Agreement, the Company issued 72,546 Earnout RSUs during the fourth quarter of 2021 which remain unvested at March 31, 2022, representing holders of Old Renovacor Options aggregate Per Share Earnout Consideration (as defined in the Merger Agreement) in respect of such shares of Old Renovacor Options. See Note 3 for details.

 

Restricted Stock Unit Activity

 

The following table summarizes restricted stock unit activity for the three months ended March 31, 2022:

 

 

 

Time-based Awards

 

 

Market-based Awards

 

($ in thousands, except per share data)

 

Number of Shares

 

 

Weighted-Average
Grant Date
Fair Value

 

 

Number of Shares

 

 

Weighted-Average
Grant Date
Fair Value

 

Nonvested shares at December 31, 2021

 

 

 

 

$

 

 

 

72,546

 

 

$

6.42

 

Granted

 

 

163,350

 

 

 

6.45

 

 

 

 

 

 

 

Forfeited

 

 

 

 

 

 

 

 

(1,024

)

 

 

6.42

 

Vested

 

 

 

 

 

 

 

 

 

 

 

 

Nonvested shares at March 31, 2022

 

 

163,350

 

 

$

6.45

 

 

 

71,522

 

 

$

6.42

 

 

As of March 31, 2022, there was $1.0 million of unrecognized compensation cost related to the time-based awards and $0.5 million of unrecognized compensation cost related to the market-based awards, which is expected to be recognized over a weighted average period of 3.8 and 5.76 years, respectively.

Note 12. Related Parties

 

Sponsor Ownership

 

Jonas Grossman, a member of the Company's board of directors since 2018, is a managing member of Chardan Capital Markets, LLC ("Chardan CM"), an affiliate of the Sponsor. Additionally, Gbola Amusa, a member of the Company's board of directors since June 2018, is a partner of Chardan CM. As of March 31, 2022, the Sponsor beneficially owned 1,605,661 shares of the Company’s common stock, excluding the Sponsor Earnout Shares being held in escrow and subject to vesting or forfeiture based on satisfaction of the Earnout Milestones set forth in that certain Sponsor Support Agreement, representing approximately 9.6% of the Company's outstanding common stock. An affiliate of the Sponsor, Chardan Healthcare Investments LLC, also owns 250,000 shares of the Company’s common stock.

 

In February 2022, Chardan Healthcare, an affiliate of the Sponsor, distributed 250,000 shares of the Company's stock for no consideration to certain of its members and employees representing each individual's pro-rata contributions to Chardan Healthcare, including 40,000 shares each to Messrs. Grossman and Amusa.

 

In April 2022, Chardan Investments 2, LLC, an affiliate of the Sponsor, distributed 1,605,661 shares of the Company's stock for no consideration to certain of its members representing each individual's pro-rata contributions to Chardan Investments 2, LLC, including 354,657 shares to Mr. Grossman and 238,588 shares to Mr. Amusa.

 

Prior to the Merger, in December 2018, the Sponsor and certain of its employees purchased 5,000,000 shares of the Company's Common Stock for an aggregate purchase price of $25,000 and, in April 2020, canceled 2,556,250 of their shares, resulting in 2,443,750 remaining shares owned by the Sponsor and certain of its employees ("Sponsor Shares"). In June 2020, an additional 288,089 Sponsor Shares were canceled, and 500,000 shares became Sponsor Earnout Shares pursuant to the Sponsor Support Agreement upon the closing of the Business Combination.

 

Further, in April 2020, the Sponsor purchased 3,500,000 Private Placement Warrants at $0.40 per warrant (for a total purchase price of $1.4 million), as more fully described in Note 10.

 

 

22


 

Convertible Note

 

On July 20, 2021, in accordance with the Merger Agreement and the Note Purchase Agreement, Old Renovacor issued a $2.5 million Convertible Promissory Note in exchange for $2.5 million in cash to be used to finance Old Renovacor’s operations through the consummation of the Merger. In connection with the consummation of the Merger, the total principal of $2.5 million converted automatically into shares of the Company’s common stock, at a price per share equal to $10.00. All accrued and unpaid interest was cash settled following the Closing Date.

 

PIPE Investment (Private Placement)

 

Concurrently with the execution of the Merger Agreement, the Company entered into Subscription Agreements with the PIPE Investors, including Chardan Healthcare Investments, LLC, an affiliate of the Sponsor, certain stockholders of Old Renovacor and certain other institutional and accredited investors, pursuant to which, on September 2, 2021, in connection with the consummation of the Business Combination, the PIPE Investors purchased an aggregate of 2,284,776 shares of the Company's common stock and the Pre-Funded Warrant to purchase 715,224 shares of the Company's Common Stock, as more fully described in Note 3.

 

Agreements with Dr. Arthur Feldman

 

In August 2019, Old Renovacor entered into a consulting agreement (the "Feldman Consulting Agreement") with its founder and 5% or greater stockholder, Dr. Arthur Feldman, pursuant to which Dr. Feldman agreed to perform certain consulting services for Old Renovacor in exchange for a consulting fee of $8,333 per calendar month. The Feldman Consulting Agreement has a term of three years, subject to automatic renewal for successive one-year terms unless earlier terminated. The Company amended the Feldman Consulting Agreement on September 2, 2021, to appoint Dr. Feldman as the Company's Chief Scientific Advisor.

 

The Company incurred consulting fees with Dr. Arthur Feldman, the founder and prior director Old Renovacor, of less than $0.1 million during each of the three months ended March 31, 2022 and 2021. As of March 31, 2022, no amounts were due to Dr. Feldman.

 

Agreements with Temple

 

Dr. Arthur Feldman, the Company's founder, 5% or greater stockholder and current Chief Scientific Advisor, is an employee of Temple. During the three months ended March 31, 2022 and 2021, the Company recorded research and development expenses of approximately $0.2 million and $0.1 million, respectively, related to the Temple SRA. See Note 8 for further information on the Temple SRA.

 

23


 

Note 13. Net Income (Loss) Per Share

 

Basic net income (loss) per share of common stock is computed by dividing net income (loss) by the weighted-average number of shares of common stock, which includes the shares underlying the outstanding Pre-Funded Warrant, as such warrant is exercisable, in whole or in part, for nominal cash consideration with no expiration date. Shares of common stock outstanding but subject to forfeiture and cancellation by the Company (e.g., Sponsor Earnout Shares – see Note 3) are excluded from the weighted-average number of shares until the period in which such shares are no longer subject to forfeiture.

 

The Company used the two-class method to compute net income per common share for the three months ended March 31, 2022 as the Company realized net income and has securities outstanding (Sponsor Earnout Shares) that entitle the holders to participate in cash dividends and earnings of the Company. Under this method, earnings are allocated to common stock and participating securities based on their respective rights to receive dividends, as if all undistributed earnings for the period were distributed. The holders of the Sponsor Earnout Shares, which are subject to forfeiture, are entitled to receive nonforfeitable cash dividends during the Earnout Periods on a basis equivalent to the dividend paid to holders of common stock, and therefore, these unvested shares subject to forfeiture and cancellation meet the definition of participating securities. The two-class method is not applicable during periods with a net loss.

 

Diluted net loss per share of common stock includes the effect, if any, from the potential exercise or conversion of securities, such as stock options, Public Warrants and Private Placement Warrants, and Sponsor Earnout Shares and Old Renovacor Earnout Shares, which would result in the issuance of incremental shares of common stock, unless their effect would be anti-dilutive.

 

 

 

Three months ended

 

 

 

March 31,

 

($ in thousands except per share data)

 

2022

 

 

2021

 

Net income (loss) per share — Basic:

 

 

 

 

 

 

Net income (loss)

 

$

6,594

 

 

$

(1,681

)

Less: Undistributed earnings to participating securities

 

 

(183

)

 

 

 

Net income (loss) attributable to common stockholders

 

$

6,411

 

 

$

(1,681

)

 

 

 

 

 

 

 

Net income (loss)

 

$

6,411

 

 

$

(1,681

)

Denominator for basic net income (loss) per share

 

 

17,471,266

 

 

 

6,274,566

 

Basic net income (loss) per common share

 

$

0.37

 

 

$

(0.27

)

 

 

 

 

 

 

 

Net income (loss) per share — Diluted:

 

 

 

 

 

 

Net income (loss)

 

$

6,594

 

 

$

(1,681

)

Less: Undistributed earnings to participating securities

 

 

(183

)

 

 

 

Numerator for diluted net income (loss) per share

 

$

6,411

 

 

$

(1,681

)

 

 

 

 

 

 

 

Denominator for basic net income (loss) per share

 

 

17,471,266

 

 

 

6,274,566

 

Plus: Incremental shares underlying “in the money” options outstanding

 

 

78,306

 

 

 

 

Plus: Incremental shares underlying time-based restricted stock units

 

 

79,263

 

 

 

 

Denominator for diluted net income (loss) per share

 

 

17,628,835

 

 

 

6,274,566

 

Diluted net income (loss) per common share

 

$

0.36

 

 

$

(0.27

)

 

The following outstanding potentially dilutive securities have been excluded from the calculation of diluted net loss per share for the three months ended March 31, 2022 and 2021, as their effect is anti-dilutive:

 

 

 

Three months ended

 

 

 

March 31,

 

 

 

2022

 

 

2021

 

Stock options

 

 

1,627,127

 

 

 

73,127

 

Restricted stock units

 

 

71,522

 

 

 

 

Common stock warrants

 

 

12,122,644

 

 

 

 

Earnout shares

 

 

2,422,816

 

 

 

 

Total

 

 

16,244,109

 

 

 

73,127

 

 

 

24


 

Note 14. Subsequent Events

 

The Company considers events or transactions that occur after the balance sheet date but prior to the issuance of the financial statements to provide additional evidence relative to certain estimates or to identify matters that require additional disclosure.

 

Lease Commitments

 

In April 2022, the Company entered into a sublease agreement (the “Sublease Agreement”) with Certara USA, Inc. (“Sublandlord"), pursuant to which the Company will sublease 3,815 rentable square feet of space located at 201 Broadway, Cambridge, Massachusetts 02139, known as Suite 310 (the “Suite 310 Space”) commencing on April 15, 2022 and expiring on April 14, 2024 (the “Sublease Term”), unless earlier terminated or extended in accordance with the provisions of the Sublease Agreement. The Suite 310 Space shall serve as the Company's headquarters. The Company shall have the option to extend the Sublease Term from April 15, 2024 through November 30, 2026 upon all of the same terms, conditions, covenants and agreements contained in the Sublease Agreement, subject to the conditions set forth therein.

 

The Company will pay an escalating base rent over the life of the Sublease Agreement of approximately $19,711 to $20,347 per month (or up to $20,983 per month in the event the Sublease Term is extended through November 30, 2026). In addition, the Company will pay its pro rata portion of property expenses and operating expenses for the property.

 

In accordance with ASC 842, the Company will record a right-of-use asset and corresponding lease liability related to the Sublease Agreement. The lease liability will be recorded and subsequently measured as the present value of the remaining lease payments using a discount rate determined at inception.

 

25


 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

The following discussion and analysis of our financial condition and results of operations should be read together with:

Our unaudited condensed consolidated financial statements and accompanying notes included in Part I, Item 1 of this Quarterly Report on Form 10-Q; and
Our financial statements and the accompanying notes thereto included in our 2021 Form 10-K, as well as the information contained under the heading "Management's Discussion and Analysis of Financial Condition and Results of Operations" in our 2021 Form 10-K .

In addition to historical information, this discussion and analysis includes forward-looking statements that are subject to risks and uncertainties, including those discussed in the section titled “Risk Factors,” set forth in Item 1A of our 2021 Form 10-K, that could cause actual results to differ materially from historical results or anticipated results.

 

Prior to September 2, 2021, we were known as Chardan Healthcare Acquisition 2 Corp. On September 2, 2021, we completed the Business Combination with Renovacor Holdings, Inc., a private company. For accounting purposes, Chardan Healthcare Acquisition 2 Corp. was deemed to be the acquired entity. Unless the context indicates otherwise, references in this section to the “Company,” “Renovacor,” “we,” “us,” “our” and similar terms refer to Renovacor, Inc. (f/k/a Chardan Healthcare Acquisition 2 Corp.) and our consolidated subsidiaries. References to “Chardan” refer to our predecessor company prior to the consummation of the Business Combination. References to “Old Renovacor” refer to Renovacor, Inc. prior to the consummation of the Business Combination and to Renovacor Holdings, Inc. (f/k/a Renovacor, Inc.), now the wholly owned subsidiary of Renovacor, upon the consummation of the Business Combination.

 

Overview

We are a biotechnology company focused on delivering innovative precision therapies to improve the lives of patients and families battling genetically-driven cardiovascular and mechanistically-related diseases. Our initial focus is on the treatment of BCL2-associated athanogene 3 (BAG3) mutation-associated dilated cardiomyopathy ("DCM") ("BAG3 DCM"). BAG3 DCM is a heritable rare disease that leads to early onset, rapidly progressing heart failure and significant mortality and morbidity. Our lead product candidate, REN-001, is a recombinant adeno-associated virus ("AAV") 9-based gene therapy designed to deliver a fully functional BAG3 gene to augment BAG3 protein levels in cardiomyocytes and slow or halt progression of BAG3 DCM.

 

We believe that development of a BAG3 gene replacement therapy for DCM patients who carry BAG3 gene mutations has the potential to prevent progression of DCM and heart failure. Diseases caused by monogenic defects are especially tractable targets for gene therapies. Recently approved therapies have successfully utilized AAV as a vehicle to deliver genes to patients suffering from these diseases and there are many additional ongoing clinical development programs utilizing AAV-based gene therapies to address monogenic diseases.

 

We believe we are the first company to apply AAV technology to patients with DCM specifically due to mutations in the BAG3 gene. REN-001 utilizes an AAV9 vector intended to deliver a healthy version of the BAG3 gene to produce functional BAG3 protein in patients with genetic mutations that cause insufficient levels of functional BAG3 protein. This approach has shown promise in multiple preclinical models, demonstrating production of functional BAG3 protein and improvement in cardiac function.

 

We plan to submit an Investigational New Drug ("IND") application in connection with our lead product candidate, REN-001, in the second half of 2022, and plan to initiate a phase I/II clinical trial of REN-001 in patients with BAG3 DCM following IND application acceptance by the U.S. Food and Drug Administration (“FDA”).

 

 

26


 

Research and Development

 

Our Pipeline

 

In addition to our lead product candidate, REN-001, we are currently developing a pipeline of innovative and proprietary BAG3-associated gene therapies for diseases with high unmet medical need associated with mutations in the BAG3 gene and mechanistically linked to BAG3's expression and function.

 

Our current pipeline is represented in the diagram below.

 

img88120184_1.jpg 

 

* The diagram above is representative of the current stage of our development and does not reflect our expectations of the clinical trials needed or an agreed upon pathway with the FDA for commercialization of our product candidates. We acknowledge that the required clinical studies and pathway to commercialization must be agreed upon with the FDA.

 

REN-001 (AAV9-BAG3): Our Lead Product Candidate

 

Overview

 

Our lead product candidate, REN-001, is an AAV9 vector-based gene therapy designed to treat BAG-3 associated DCM through delivery of a human BAG3 gene to express a fully functional human BAG3 protein in transduced cells. After transducing the cardiomyocyte, the vector translocates into the nucleus, where the capsid proteins dissociate, allowing the cell’s native expression machinery to initiate transcription of the BAG3 gene. Unlike wild-type AAVs, REN-001 lacks an S1 domain, which significantly limits the potential for the vector genome to integrate into the host chromosome. Instead, the gene has the potential to remain in the nucleus as episomal DNA.

 

Third-party studies have demonstrated that recombinant AAV-delivered episomal DNA persists in the nucleus of transfected non-proliferating cells for up to several years. This suggests that a single dose of REN-001 could provide prolonged BAG3 gene replacement in haploinsufficient cells transduced by the vector. Following transcription and translation of the BAG3 gene, the function of the BAG3 protein is expected to be restored, and disease progression has the potential to be halted or significantly slowed.

 

We are currently exploring the delivery of REN-001 through RCSI and plan to submit an IND for REN-001 in the second half of 2022.

 

 

27


 

Preclinical research and development for REN-001

 

We are currently conducting preclinical studies exploring the ability of a BAG3 gene therapy to treat patients suffering from DCM caused by BAG3 haploinsufficiency. In conducting preclinical research in this field to generate data validating this novel therapeutic approach, animal studies have been completed in several heart failure disease models, including studies involving mice subjected to trans-aortic constriction, mice suffering from left ventricular dysfunction following a myocardial infarction ("MI"), mice with left ventricular dysfunction post-ischemia and reperfusion, and large animal studies in pigs suffering from left ventricular dysfunction following an MI.

 

We have several preclinical studies of REN-001 currently in progress to further evaluate AAV9 transduction efficiency, safety, and efficacy in mouse and pig models. These studies include a dose-ranging efficacy study, a durability of effect study, and a natural history study (including survival analysis), each in BAG3 haploinsufficient mice, which continue to progress at the Feldman laboratory at Temple pursuant to the Temple SRA, as defined below. Preliminary data from our ongoing natural history study has demonstrated an impaired survival phenotype, alongside left ventricular dilation and cardiac function decline, findings that are consistent with several hallmark characteristics of DCM seen clinically in patients. These new data have been leveraged to optimize the design of our ongoing dose-ranging study.

 

Additionally, our good laboratory practice (“GLP”) toxicology and biodistribution study in normal Yucatan pigs using the RCSI route of administration is ongoing and has completed dosing.

 

We anticipate the availability of key data from our ongoing preclinical studies to support the potential IND submission in the second half of 2022.

 

Clinical Development Plan for REN-001

 

We completed a Type B Pre-IND meeting with the FDA on June 16, 2020 to obtain FDA feedback on REN-001. We plan to submit an IND for REN-001 in the second half of 2022 and initiate a phase I/II clinical trial of REN-001 in patients with BAG3-associated DCM if our IND submission is accepted by the FDA. We expect the phase I/II clinical trial will be conducted in two sequential parts consisting of dose escalation and dose expansion components. The dose escalation part will enroll cohorts of three to six subjects to identify a preferred dose and be followed by a dose expansion cohort to further explore the safety, tolerability and preliminary evidence of efficacy at the preferred dose. This will be an open label study with the goal of evaluating the safety and efficacy of REN-001. Safety and tolerability will be evaluated based on assessment of frequency and severity measures of adverse events and series of adverse events. Efficacy will be evaluated based on measures of cardiac structure and function, circulating biomarkers, and patient functional capacity and quality of life.

 

We will consult with the FDA following completion of our planned phase I/II clinical trial to determine the need for, and optimal design of, future clinical trials.

 

Other Target Indications

 

Our preclinical strategy includes plans to advance earlier stage research programs where we believe our BAG3 gene therapy technology has the potential to provide meaningful clinical benefit for diseases in areas of high unmet medical need. These research and discovery programs include BAG3-mediated diseases associated with the cardiovascular system and the central nervous system.

 

 

28


 

License and Sponsored Research Agreements

 

Our current license and sponsored research agreements include the Temple License Agreement and Temple SRA, each described under the caption “Item 1. Business — License and Sponsored Research Agreements” in our 2021 Form 10-K and within Note 9 of the accompanying notes to the condensed consolidated financial statements contained elsewhere in this Quarterly Report on Form 10-Q. In addition to our current arrangements, we may seek to enter into additional sponsored research agreements or collaborative alliances to support development and commercialization of REN-001 and/or research additional drug candidates.

 

The Business Combination

 

On September 2, 2021, we consummated the previously announced business combination contemplated by that certain Agreement and Plan of Merger, dated March 22, 2021 (the “Merger Agreement”), by and among the Company, CHAQ2 Merger Sub, Inc., a wholly owned subsidiary of the Company (“Merger Sub”), and Renovacor Holdings, Inc. (f/k/a Renovacor, Inc. ("Old Renovacor")). Pursuant to the Merger Agreement, on September 2, 2021 (the "Closing Date"), Merger Sub merged with and into Old Renovacor, with Old Renovacor as the surviving company in the merger and, after giving effect to such merger, continuing as a wholly owned subsidiary of the Company (the “Merger” and, together with the other transactions contemplated by the Merger Agreement, the “Business Combination”). On the Closing Date, the Company changed its name from Chardan Healthcare Acquisition 2 Corp. to Renovacor, Inc.

 

The Business Combination was accounted for as a reverse recapitalization in accordance with U.S. GAAP. Under this method of accounting, Chardan was treated as the “acquired” company and Old Renovacor is treated as the acquirer for financial reporting purposes as more fully explained in Note 3 of the accompanying notes to the condensed consolidated financial statements contained elsewhere in this Annual Report on Form 10-K.

 

Prior to the Business Combination, we were a special purpose acquisition company, formed for the purpose of acquiring, through a merger, share exchange, asset acquisition, stock purchase, reorganization, recapitalization, or other similar business transaction, one or more operating businesses or entities, and prior to consummation of the Business Combination, our operating activities consisted of our formation, initial public offering and costs associated with the Business Combination. The intended strategy of the combined company will continue to focus on Old Renovacor’s core product/service offerings related to precision medicine treatments for genetically-driven cardiovascular and mechanistically-related diseases, as more fully described below.

 

On September 2, 2021, our common stock, par value $0.0001 per share ("Common Stock") and our warrants originally issued in our initial public offering, began trading on the NYSE American LLC ("NYSE") under the ticker symbols “RCOR” and “RCOR.WS,” respectively.

 

COVID-19

 

We continue to monitor the potential impact of the novel coronavirus disease ("COVID-19") pandemic, including variants thereof such as the delta and omicron variants, on our business and financial statements. To date, we have not experienced material business disruptions. We are following, and will continue to follow, recommendations from the U.S. Centers for Disease Control and Prevention as well as federal, state, and local governments regarding working-from-home practices for non-essential employees. For example, the COVID-19 outbreak in Pennsylvania resulted in a temporary reduction in workforce presence at the Temple research facility, including the Feldman laboratory, located in Philadelphia, at which we operate. While the Feldman laboratory is currently operating at normal capacity, we cannot be certain that the Temple facility or the Feldman laboratory will not be closed in the future, or experience labor shortages, as a result of the COVID-19 outbreak. Accordingly, the full extent to which the COVID-19 pandemic will directly or indirectly impact our business, results of operations and financial condition, including expenses and manufacturing, supply chain, labor, preclinical and clinical trials and research and development costs, will depend on future developments that are highly uncertain at this time.

 

 

29


 

Results of Operations

 

Three Months Ended March 31, 2022 and 2021

 

Overview

 

During the three months ended March 31, 2022, our loss from operations totaled $8.9 million, a 427% increase compared to a loss from operations of $1.7 million for the three months ended March 31, 2021. Research and development expenses comprised the majority of our total operating expenses, as shown in the table below.

 

 

 

Three months ended

 

 

 

 

 

 

 

 

 

March 31,

 

 

 

 

 

 

 

($ in thousands)

 

2022

 

 

2021

 

 

$ Change

 

 

% Change

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

$

5,930

 

 

$

1,155

 

 

$

4,775

 

 

 

413

%

General and administrative

 

 

2,925

 

 

 

526

 

 

 

2,399

 

 

 

456

%

Total operating expenses

 

$

8,855

 

 

$

1,681

 

 

$

7,174

 

 

 

427

%

Loss from operations

 

$

(8,855

)

 

$

(1,681

)

 

$

(7,174

)

 

 

427

%

 

Research and Development Expenses

 

Research and development expenses consist of costs incurred for our research activities, including our discovery efforts, and the development of our programs. These expenses include:

employee-related expenses, including salaries, payroll taxes, related benefits and stock-based compensation expense for employees engaged in research and development functions;
expenses incurred in connection with the preclinical development of our product candidates and the development of research programs, including under agreements with third parties, such as consultants, contractors, preclinical laboratories, licensors, CMOs, and CROs; and
laboratory supplies and research materials.

 

We expense research and development costs as incurred. Non-refundable advance payments that we make for goods or services to be received in the future for use in research and development activities are recorded as prepaid expenses. The prepaid amounts are expensed as the related goods are delivered or the services are performed, or when it is no longer expected that the goods will be delivered or the services rendered.

 

Our direct external research and development expenses consist of costs that include fees, reimbursed materials, and other costs paid to consultants, contractors, CMOs and other research organizations in connection with our preclinical activities. We do not allocate employee costs, costs associated with our discovery efforts, laboratory supplies, facilities expenses, including depreciation or other indirect costs, to specific product development programs because these costs are deployed across multiple programs and, as such, are not separately classified.

 

 

30


 

In the table below, research and development expenses are set forth in the following categories: (i) compensation and related benefits and (ii) other external research and development costs.

 

 

 

Three months ended

 

 

 

 

 

 

 

 

 

March 31,

 

 

 

 

 

 

 

($ in thousands)

 

2022

 

 

2021

 

 

$ Change

 

 

% Change

 

Compensation and related benefits

 

$

2,001

 

 

$

35

 

 

$

1,966

 

 

 

5,617

%

Other external research and development costs

 

 

3,929

 

 

 

1,120

 

 

 

2,809

 

 

 

251

%

Total research and development expenses

 

$

5,930

 

 

$

1,155

 

 

$

4,775

 

 

 

413

%

 

Total research and development expenses were $5.9 million for the three months ended March 31, 2022, a 413% increase compared to total research and development expenses of $1.2 million for the three months ended March 31, 2021. The increase during the 2022 period was primarily due to increases in (i) compensation-related costs associated with the hiring of key personnel and overall increase in number of employees, (ii) drug supply costs associated with our preclinical activities, including IND-enabling studies and preparation for potential clinical trials, and (iii) external costs associated with the execution of ongoing preclinical studies as we prepare for an IND submission for REN-001, which is planned for the second half of 2022, and related clinical activities.

 

Substantially all research and development expenses incurred by us to date relate to the discovery and preclinical development of REN-001.

 

General and Administrative Expenses

 

General and administrative expenses consist primarily of salaries and personnel-related costs, including stock-based compensation, for personnel in executive, finance and accounting, and other administrative functions. General and administrative expenses also include legal fees relating to patent and corporate matters; professional fees paid for accounting, auditing, consulting, and tax services; insurance costs and travel expenses.

 

 

 

Three months ended

 

 

 

 

 

 

 

 

 

March 31,

 

 

 

 

 

 

 

($ in thousands)

 

2022

 

 

2021

 

 

$ Change

 

 

% Change

 

Compensation and related benefits

 

$

984

 

 

$

98

 

 

$

886

 

 

 

904

%

Professional and consulting fees

 

 

1,232

 

 

 

407

 

 

 

825

 

 

 

203

%

Other administrative costs

 

 

709

 

 

 

21

 

 

 

688

 

 

 

3,276

%

Total general and administrative expenses

 

$

2,925

 

 

$

526

 

 

$

2,399

 

 

 

456

%

 

Total general and administrative expenses were $2.9 million for the three months ended March 31, 2022, a 456% increase compared to total general and administrative expenses of $0.5 million for the three months ended March 31, 2021. The increase during the 2022 period was primarily due to increases in (i) compensation-related costs associated with the hiring of key personnel and overall increase in number of employees, (ii) professional and consulting fees due to increases in legal costs, fees incurred with investor/public relations firms, and contract labor, and (iii) other administrative costs related to additional spending as a result of our growth and operating as a publicly-traded company, including board fees and director and officer insurance.

 

 

31


 

Change in Fair Value of Warrant Liability

 

During the three months ended March 31, 2022, we recorded a change in the fair value of warrant liability, representing a non-cash warrant revaluation gain of approximately $7.3 million, related to our liability-classified Private Placement Warrants, as more fully described in Note 10 of the notes to the condensed consolidated financial statements appearing elsewhere in this Quarterly Report on Form 10-Q. Due to the nature of and inputs in the model used to assess the fair value of our outstanding Private Placement Warrants, it is not abnormal to experience significant fluctuations during each remeasurement period. These fluctuations may be due to a variety of factors, including changes in our stock price and changes in estimated stock price volatility over the remaining life of the warrants. Changes in the fair value of the warrant liability and resulting warrant revaluation gain for the three months ended March 31, 2022 was driven primarily by the decrease in our stock price as of March 31, 2022, compared to our stock price as of December 31, 2021.

 

Change in Fair Value of Share Earnout Liability

 

During the three months ended March 31, 2022, we recorded a change in fair value of share earnout liability, representing a non-cash share earnout revaluation gain of approximately $8.2 million, related to our liability-classified Earnout Shares, as more fully described in Note 4 of the notes to the condensed consolidated financial statements appearing elsewhere in this Quarterly Report on Form 10-Q. Due to the nature of and inputs in the model used to assess the fair value of the outstanding Earnout Shares, it is not abnormal to experience significant fluctuations during each remeasurement period. These fluctuations may be due to a variety of factors, including changes in our stock price and changes in estimated stock price volatility over the remaining life of the warrants. Changes in the fair value of the share earnout liability and resulting share earnout revaluation gain for the three months ended March 31, 2022 was driven primarily by the decrease in our stock price as of March 31, 2022, compared to our stock price as of December 31, 2021.

 

Net Income (Loss)

 

As a result of the factors discussed above, net income for the three months ended March 31, 2022 was $6.6 million, compared to net loss of $1.7 million for the three months ended March 31, 2021.

 

 

32


 

Financial Condition, Liquidity and Capital Resources

 

Financial Condition

 

As of March 31, 2022, we had an accumulated deficit of $12.4 million. To date, we have not generated any revenues.

 

Since our inception, we have focused substantially all of our resources on organizing and staffing the company, in-licensing key intellectual property, business planning, raising capital, conducting research and development activities, filing and prosecuting patent applications, and engaging in other preclinical activities. We do not have any products approved for sale and have not generated any revenue from product sales or from any other sources. To date, we have funded our operations with proceeds from the Business Combination and the PIPE Investment (as defined herein), sales of convertible preferred stock, and a convertible note. Since our inception, we have incurred significant operating losses. Our ability to generate any product revenue, and in particular to generate product revenue sufficient to achieve profitability, will depend on the successful development and eventual commercialization of one or more of our product candidates.

 

Liquidity and Capital Resources

 

Overview

 

We require cash to fund our operating expenses and to make capital expenditures. Historically, we have funded our cash requirements primarily through the sale of preferred stock, common stock, pre-funded warrants, common stock warrants and a convertible note. As of March 31, 2022 we had $70.1 million of cash and cash equivalents.

 

Funding Requirements

 

We believe that, based on our current operating plan, our existing cash and cash equivalents on hand as of March 31, 2022 will enable us to fund our operations into the second half of 2023. Specifically, we believe our available funds will be sufficient to enable us to perform the following:

complete IND-enabling studies for our REN-001 AAV-based gene therapy program and potentially submit an IND for REN-001;
fund our obligations under the Temple License Agreement and Temple SRA;
initiate our phase I/II trial in DCM patients with BAG3 mutation (REN-001); and
maintain the necessary level of general and administrative expense in order to support the business.

 

However, we have based this estimate on assumptions that may prove to be wrong, and our operating plan may change as a result of many factors currently unknown to us. In addition, we could utilize our available capital resources sooner than expected. Substantially all of our losses have resulted from expenses incurred in connection with our research and development programs and from general and administrative costs associated with our operations. We expect our expenses and capital expenditures to increase substantially in connection with our ongoing activities, particularly if and as we:

initiate IND-enabling studies for our REN-001 AAV-based gene therapy program;
continue our current research programs and preclinical development of product candidates from our current research programs;
advance additional product candidates into preclinical and clinical development;
advance our clinical-stage product candidate, if any, into later stage clinical trials;
seek to discover, validate, and develop additional product candidates, including carrying out activities related to our discovery stage programs;
seek regulatory approvals for any product candidates that successfully complete clinical trials;
scale up our manufacturing processes and capabilities, or arrange for a third party to do so on our behalf, to support our clinical trials of our product candidates and potential commercialization of any of our product candidates for which we may obtain marketing approval;
establish a sales, marketing, and distribution infrastructure or channel to commercialize any product candidate for which we may obtain regulatory approval;
acquire or in-license products, product candidates, or technologies;
maintain, expand, enforce, defend, and protect our intellectual property portfolio;

33


 

hire additional clinical, quality control, and scientific personnel; and
add operational, financial, and management information systems and personnel, including personnel to support our product development, planned future commercialization efforts, and our operations as a public company.

 

We will not generate revenue from product sales unless and until we successfully complete clinical development and obtain regulatory approval for one or more of our product candidates. If we obtain regulatory approval for any of our product candidates, we expect to incur significant expenses related to developing our commercialization capability to support product sales, marketing, and distribution. As a result, we will need substantial additional funding to support our continuing operations and pursue our growth strategy.

 

Until such time as we can generate significant revenue from product sales, if ever, we expect to finance our operations through a combination of equity offerings, debt financings, collaborations, strategic alliances and licensing arrangements. Additionally, we may receive up to an aggregate of approximately $89.8 million from the exercise of our warrants outstanding as of March 31, 2022, assuming the exercise in full of such warrants for cash. See Note 10 of the notes to the condensed consolidated financial statements appearing elsewhere in this Quarterly Report on Form 10-Q for additional details on our outstanding warrants. However, certain warrants may be exercised on a cashless basis and our warrants may never be exercised. If we fail to raise capital or enter into such agreements or arrangements as, and when, needed, we may have to significantly delay, scale back or discontinue the development and commercialization of one or more of our product candidates. The timing and amount of our funding requirements will depend on many factors, including:

the scope, progress, costs, and results of preclinical and clinical development for our other product candidates and development programs;
the number of and development requirements for other product candidates that we pursue;
the costs, timing and outcome of regulatory review of our product candidates;
the cost and timing of completion of commercial-scale manufacturing activities;
our ability to establish and maintain strategic collaborations, licensing or other arrangements and the financial terms of such arrangements;
the payment or receipt of milestones and receipt of other collaboration-based revenues, if any;
our efforts to enhance operational systems and hire additional personnel to satisfy our obligations as a public company, including enhanced internal controls over financial reporting;
the costs and timing of future commercialization activities, including product manufacturing, sales, marketing and distribution, for any of our product candidates for which we receive marketing approval;
the amount and timing of revenue, if any, received from commercial sales of our product candidates for which we receive marketing approval;
the costs and timing of preparing, filing and prosecuting patent applications, maintaining and enforcing our intellectual property and proprietary rights and defending any intellectual property-related claims;
the extent to which we acquire or in-license other products, product candidates or technologies;
the receptivity of the capital markets to financings by biotechnology companies generally and companies with product candidates and technologies similar to ours specifically;
the volatility of capital markets and other macroeconomic factors, including due to geopolitical tensions or the outbreak of hostilities or war; and
the impact of the ongoing coronavirus disease, COVID-19, to global economy and capital markets, and to our supply chain, business and our financial results.

 

 

34


 

In addition, increases in expenses or delays in clinical development may adversely impact our cash position and require additional funds or cost reductions.

 

Because of the numerous risks and uncertainties associated with pharmaceutical product development, we are unable to accurately predict the timing or amount of increased expenses or when, or if, it will be able to achieve or maintain profitability. Even if we are able to generate product sales, we may not become profitable. If we fail to become profitable or are unable to sustain profitability on a continuing basis, then we may be unable to continue our operations at planned levels and may be forced to reduce or terminate our operations, or relinquish rights to portions of our technology and/or product candidates.

 

Cash Flows

 

The following table provides a summary of the primary sources and uses of cash for the periods presented:

 

 

 

Three months ended

 

 

 

March 31,

 

(In thousands)

 

2022

 

 

2021

 

Net cash (used in) provided by:

 

 

 

 

 

 

Net cash used in operating activities

 

$

(8,293

)

 

$

(1,779

)

Net cash used in investing activities

 

 

(360

)

 

 

 

Net cash used in financing activities

 

 

(53

)

 

 

(80

)

Net decrease in cash

 

$

(8,706

)

 

$

(1,859

)

 

Operating Activities. Net cash used in operating activities for each period presented consists primarily of net income (loss) adjusted for non-cash gains or charges and changes in components of working capital. The increase in cash used in operating activities for the three months ended March 31, 2022, as compared to the same period in 2021, was primarily due to significant increases in expenditures and corresponding cash outflows related to our REN-001 development program, including payments to consultants and contract research and manufacturing organizations, as we prepare for our potential clinical activities for REN-001.

 

Investing Activities. Net cash used in investing activities for the three months ended March 31, 2022 consisted of $0.4 million in equipment purchases. There was no cash used in or provided by investing activities during the three months ended March 31, 2021.

 

Financing Activities. Net cash used in financing activities for each of the three months ended March 31, 2022 and 2021 consisted of less than $0.1 million in merger-related costs associated with the Business Combination.

 

Contractual Obligations and Commitments

 

During the three months ended March 31, 2022, there were no material changes outside the ordinary course of our business to our contractual obligations as disclosed in our 2021 Form 10-K.

 

 

 

35


 

Critical Accounting Policies and Significant Judgments and Estimates

 

This management’s discussion and analysis of financial condition and results of operations is based on our unaudited condensed consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. On an ongoing basis, management evaluates its estimates and judgments which are affected by the application of our accounting policies

 

Management bases its estimates and judgments on historical experience and on various other factors that are believed to be appropriate under the circumstances. Actual results may differ from these estimates under different assumptions or conditions.

 

We regard an accounting estimate or assumption underlying our financial statements as a “critical accounting estimate” where:

(i)
the nature of the estimate or assumption is material due to the level of subjectivity and judgment necessary to account for highly uncertain matters or the susceptibility of such matters to change; and
(ii)
the impact of the estimates and assumptions on financial condition or operating performance is material.

 

Our significant accounting policies are described in Note 2 of the accompanying notes to the unaudited condensed consolidated financial statements contained in this Quarterly Report on Form 10-Q. Not all of these significant policies, however, fit the definition of critical accounting policies and estimates. We believe that our accounting policies relating to (i) research and development prepayments, accruals and related expenses, (ii) warrant liabilities and related change in fair values (gains / losses), and (iii) share earnout liabilities and related change in fair values (gains / losses), fit the description of critical accounting estimates and judgments.

 

New Accounting Pronouncements

 

New accounting pronouncements are discussed in Note 2 in the notes to the condensed consolidated financial statements in this Quarterly Report on Form 10-Q.

 

Off-Balance Sheet Arrangements

 

As of March 31, 2022, we had no off-balance sheet arrangements, as defined in the rules and regulations of the SEC.

 

Emerging Growth Company Status

 

We are an emerging growth company, as defined in the JOBS Act. Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards issued subsequent to the enactment of the JOBS Act until such time as those standards apply to private companies. We elected to use this extended transition period for complying with new or revised accounting standards that have different effective dates for public and private companies until the earlier of the date that we (1) are no longer an emerging growth company, or (2) affirmatively and irrevocably opt out of the extended transition period provided in the JOBS Act. As a result, our financial statements may not be comparable to companies that comply with the new or revised accounting pronouncements as of public company effective dates.

 

We will remain an emerging growth company until the earliest of (1) the last day of the fiscal year following the fifth anniversary of the closing of the initial public offering of Chardan, (2) the last day of the fiscal year in which we have total annual gross revenue of at least $1.07 billion, (3) the last day of the fiscal year in which we are deemed to be a “large accelerated filer” as defined in Rule 12b-2 under the Securities Exchange Act of 1934, as amended, or the Exchange Act, which would occur if the market value of our common stock held by non-affiliates exceeded $700.0 million as of the last business day of the second fiscal quarter of such year, or (4) the date on which we have issued more than $1.0 billion in non-convertible debt securities during the prior three-year period.

 

 

36


 

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

 

Not Applicable.

Item 4. Controls and Procedures.

 

(a) Evaluation of Disclosure Controls and Procedures.

 

Our management, with the participation of our principal executive officer and principal financial officer, evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of March 31, 2022. In designing and evaluating our disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and our management necessarily applied its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Based on this evaluation, our principal executive officer and principal financial officer concluded that as of March 31, 2022, our disclosure controls and procedures were (1) designed to ensure that material information relating to us is made known to our principal executive officer and principal financial officer by others, particularly during the period in which this report was prepared, and (2) effective, in that they provide reasonable assurance that information required to be disclosed by us in the reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms.

 

(b) Changes in Internal Controls.

 

There were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the fiscal quarter ended March 31, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

37


 

PART II—OTHER INFORMATION

 

From time to time, we may become involved in various legal proceedings that arise in the ordinary course of our business. We are not currently a party to any material legal proceedings, and are not aware of any pending or threatened legal proceeding against us that we believe could have an adverse effect on our business, operating results or financial condition.

Item 1A. Risk Factors.

 

Investing in our securities involves a high degree of risk. You should consider carefully the risks and uncertainties discussed within Item 1A "Risk Factors" of our 2021 Form 10-K, together with all of the other information in this Quarterly Report on Form 10-Q, including the section “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and our unaudited condensed consolidated financial statements and related notes, before deciding whether to purchase any of our securities.

 

There have been no material changes to the disclosures related to this item from those set forth in our 2021 Form 10-K.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

 

None.

Item 3. Defaults Upon Senior Securities.

 

None.

Item 4. Mine Safety Disclosures.

 

None.

Item 5. Other Information.

 

None.

38


 

Item 6. Exhibits.

 

Exhibit

Number

 

Description

10.1#

 

Employment Agreement, by and between the Company and Frederick Driscoll, dated as of March 3, 2022 and effective as of March 28, 2022 (incorporated by reference to Exhibit 10.1 of the Registrant’s Current Report on Form 8-K, filed with the Securities & Exchange Commission on March 28, 2022).

31.1*

 

Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2*

 

Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1*^

 

Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.2*^

 

Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS

 

Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document.

101.SCH

 

Inline XBRL Taxonomy Extension Schema Document

101.CAL

 

Inline XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF

 

Inline XBRL Taxonomy Extension Definition Linkbase Document

101.LAB

 

Inline XBRL Taxonomy Extension Label Linkbase Document

101.PRE

 

Inline XBRL Taxonomy Extension Presentation Linkbase Document

104

 

Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

 

 

* Filed herewith.

# Indicates management contract or compensatory arrangement.

^ This certification is being furnished solely to accompany this Quarterly Report on Form 10-Q pursuant to 18 U.S.C. Section 1350, and is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference into any filing of the registrant under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

 

39


 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

Renovacor, Inc.

 

 

 

 

Date: May 12, 2022

 

By:

/s/ MAGDALENE COOK

 

 

 

Magdalene Cook

 

 

 

Chief Executive Officer

 

 

 

 

Date: May 12, 2022

 

By:

/s/ FREDERICK DRISCOLL

 

 

 

Frederick Driscoll

 

 

 

Chief Financial Officer

 

 

 

40


EX-31.1 2 rcor-ex31_1.htm EX-31.1 EX-31.1

 

Exhibit 31.1

CERTIFICATION PURSUANT TO

RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Magdalene Cook, certify that:

1.
I have reviewed this Quarterly Report on Form 10-Q of Renovacor, Inc.;
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.
The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
(a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
(b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

Date: May 12, 2022

 

By:

/s/ MAGDALENE COOK

 

 

 

Magdalene Cook

 

 

 

Chief Executive Officer

 

 


EX-31.2 3 rcor-ex31_2.htm EX-31.2 EX-31.2

 

Exhibit 31.2

CERTIFICATION PURSUANT TO

RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Frederick Driscoll, certify that:

1.
I have reviewed this Quarterly Report on Form 10-Q of Renovacor, Inc.;
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.
The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
(a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
(b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

Date: May 12, 2022

 

By:

/s/ FREDERICK DRISCOLL

 

 

 

Frederick Driscoll

 

 

 

Chief Financial Officer

(Principal Financial and Accounting Officer)

 

 


EX-32.1 4 rcor-ex32_1.htm EX-32.1 EX-32.1

 

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Renovacor, Inc. (the “Company”) on Form 10-Q for the period ending March 31, 2022, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1)
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

Date: May 12, 2022

 

By:

/s/ MAGDALENE COOK

 

 

 

Magdalene Cook

 

 

 

Chief Executive Officer

 

 


EX-32.2 5 rcor-ex32_2.htm EX-32.2 EX-32.2

 

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Renovacor, Inc. (the “Company”) on Form 10-Q for the period ending March 31, 2022, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1)
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

Date: May 12, 2022

 

By:

/s/ FREDERICK DRISCOLL

 

 

 

Frederick Driscoll

 

 

 

Chief Financial Officer

(Principal Financial and Accounting Officer)

 

 

 


GRAPHIC 6 img88120184_0.jpg GRAPHIC begin 644 img88120184_0.jpg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end GRAPHIC 7 img88120184_1.jpg GRAPHIC begin 644 img88120184_1.jpg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�=^W=YD_W>G1*UH4E5J*#ZF=6?)!R/4E\3: [!5UO368\ "Z3 MG]:ENM=TBQG,%WJME;S F.6X16P>AP37S9XMTV>RT?399O"<>CK)C%TEP9/ M/^4=1D@>M3^*HXD\9Z1&C07$0L+,*;]]B./*7'F$$8'KS7:L#!VM+OVZ'.\3 M)=#Z*@\0Z+7!J]A*^TMM2Y1C@#). >@'-2V6KZ9J3LECJ%I=,@RRP3*Y M]3@UXWX6>@+GC&[/%<7X236=$M&\8Z5^\ MCL+@0W4(SS&P!.?]D]/8X-0L%%WL^Q7UAJUT?3-MJVG7LTL-K?VL\L7^L2*9 M6*SCKQ7G5[X??7_$GB;1R%%K=V$4@8B7*3KC8WS<#H>G.*\K M_P"$@U'_ (0W_A!?)D^U?VEC9CG&?]7]?,YKJIX15/A?;[F1*NX[K_ASZ1/B M#11;+@F8R M>2UQ:,N0<<"0#_@/S?@:MX#W4XO_ (9D?6K-W6Q[C/XDT.UF,,^KV4<@."K3 MKD'WYJ_;W,%W")K>:.:)NCQL&4_B*\>\$6OA*;PY?/KCVXNP[ ^;)M<)M&"@ MSR%_[*@T76QX?N]2D7R5,GVE0JJ(M.B9@)3(0_EC8/O/_=&>IQD\=@:M0:I97%M+<)A[2$>9ZM)^6O0;Q3LYI:7.U_X2#1?^@O8?\ @2G^-65N M+:[M&EBD2> @@M$V\'UQBO!M'L9I_"]]<)X<2]1-^;XS%3#A1_"#SCK^-=Y\ M)%'_ CM^\4C&4W&"CCY5(48/XY_2NO$X&%*G*<97L[=/T?YF6&QTZM2,7&U MU?K^J_(]$&-HQTQ12C..>M%>8>D9]S_Q\-^'\JAJ:Y_X^&_#^50US2W9V1^% M'&ZW87MG?6(CUO4-MY="(KYG" ^E=%I>FRZ*B2E 752ZY /4"MO4-27P7K5OK;#_1-3TL M)*.QN(DS'GZCY16G9^$-0.LZ[%J2Z?<:#JTQFDC62039!RHR, #UYKIM0T'3 M-5L8+*^M5FM[=UDB1F8;648!R#GH30!YIJWAV+2/ V@37$$;:I-J4$UQ<,@\ MS=(2S+NQG'08]J]>O- '*CQ M#J OM*NK>_OKNSN]06W>1[6**T=7#<1@@3''&&R5.T\GI3K75M:DTE;MM4D, MM[JCZ?$/)CV6Z>:RA\;P !Z=*M'0-+.ERZ8;0&SD=I&C+,?F9BQ8'.0=QR"#QVQ0!Q5]<:AHF MM>(YH]1DGN([>P"3R1IO"M,00P"A3U;HHX([\UIWFJ:M+8:_K$&HFW32II4B ML_*0QRB(!FWDC=EN0-K+CCKWVE\)Z*HNLVLDC7?E^>\MS*[R>6VY,LS$\'WZ M #H,5)=>&M)O+R2ZGM69Y2C2H)G6.4K]TO&#M)-1 MM]2DMX],$$EO;"&-E.Z%'97)4L1DGH01D\],7-2N]=L+O4K"UU.2ZN(]-6^B M,D,8.]9"&087[K 8&P\S"A1T/' XQ4EQ M9*EU)J5M;1R:CY'D*9)612N[=M) ..><[2: .3N?%=Y=07^H:9,!8EK6SM6> M,%1)*5+2'N=HD48SC(INOZQJ_AY=4M8]3>Z9=/\ MD$\\48>)A(J%3M4*0N+N M]C"-/=SR2L0", NQ9L#GCIS0!6NM2O\ 0-1^S7VLK/!-I\UP9[B!1]F>,KEM MJ 90[^%.3E<;N:RVU356U%M-EO-5-M=:=175 MP^&-(AAN(1:F1)X?L[^?,\I\K^X"Y)5>>@P*2W\+Z1;7L=XMO+)!DXZF@#CO#]E=S:AX;BAU6X@SX=5VE6.(OM+1X1
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end EX-101.LAB 8 rcor-20220331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period Vesting period Other intangible assets Intangible Assets, Net (Including Goodwill) Intangible Assets, Net (Including Goodwill), Total Equity Classified Warrants [Member] Equity Classified Warrants [Member] Equity classified warrants. Temporary equity, authorized Temporary Equity, Shares Authorized Document Information [Line Items] Document Information [Line Items] Operating Expenses [Abstract] Operating expenses: Asset Class [Domain] Loss from operations Loss from operations Operating Income (Loss) Loss from operations Number of shares purchased for issuance under share-based payment arrangement Share-based Compensation Arrangement by Share-based Payment Award, Shares Purchased for Award Entity Emerging Growth Company Entity Emerging Growth Company Warrant liability Derivative Liability, Noncurrent Third Earnout Period [Member] Third milestone member. Third Milestone [Member] Weighted-Average Grant Date Fair Value, Forfeited Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Remain available for future issuance Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant Warrant price per share Warrant or rights price per share. Warrant Or Rights Price Per Share Warrant Or Rights Price Per Share Acquisitions of property and equipment Payments to Acquire Property, Plant, and Equipment Payments to Acquire Property, Plant, and Equipment, Total Total shares of common stock immediately after Merger Total shares of common stock immediately after Merger Shares of Common Stock Immediately After Merger Shares of common stock immediately after merger. Common stock, $0.0001 par value per share; 100,000,000 shares authorized; 16,756,042 shares issued and outstanding at March 31, 2022 and December 31, 2021 Common Stock, Value, Issued, Ending Balance Common Stock, Value, Issued, Beginning Balance Common Stock, Value, Issued, Total Common Stock, Value, Issued Entity Address, State or Province Entity Address, State or Province Interest income Interest Income (Expense), Net Interest Income (Expense), Net, Total Liabilities Total liabilities Risk-free interest rate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table] Debt, Policy [Policy Text Block] Convertible Note Goodwill Goodwill, Ending Balance Goodwill, Beginning Balance Goodwill, Total Sublease commencing date Sublease Commencing Date Sublease commencing date Schedule of Common Stock Shares Reserved for Future Issuance Common Stock Shares Reserved For Future Issuance [Table Text Block] Common stock shares reserved for future issuance. Class of Stock [Domain] Class of Stock Sublease base rent Sublease base rent. Prepaid Expenses Disclosure of Prepaid Expenses [Text Block] Disclosure of prepaid expenses. Fair Value Per Warrant [Member] Measurement input fair value per warrant . Measurement Input Fair Value Per Warrant [Member] Business Combinations [Abstract] Summary of Outstanding Warrants to Purchase Shares of Common Stock Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Business Acquisition [Line Items] Business Acquisition [Line Items] Common Stock Earnout Shares Issuable Common stock earnout shares issuable. Common stock, earnout shares issuable Prepaid Expense and Other Assets, Current [Abstract] General and Administrative [Member] General and Administrative Expense [Member] Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Weighted-Average Remaining Contractual Life, Exercisable Exchanged options issued Business Combination Exchanged Options Issued Business combination exchanged options issued. Annual administrative fee Administrative Fees Expense Fair Value, Recurring and Nonrecurring [Table] Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table] Significant Accounting Policies [Text Block] Summary of Significant Accounting Policies Long term service commitment period Long Term Service Commitment Period. Long Term Service Commitment Period Schedule of Related Party Transactions, by Related Party [Table] Schedule Of Related Party Transactions By Related Party [Table] City Area Code City Area Code Less: Undistributed earnings to participating securities Undistributed Earnings (Loss) Allocated to Participating Securities, Basic Undistributed Earnings (Loss) Allocated to Participating Securities, Basic, Total Merger Agreement member. Merger Agreement [Member] Merger Agreement [Member] Schedule of Assumptions Used in Determining the Fair Value of Option Awards Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Temporary Equity, Par or Stated Value Per Share Temporary equity, par value Share earnout liability (includes 500,000 shares of Common stock, $0.0001 par value per share, subject to forfeiture, issued and outstanding at March 31 2022 and December 31, 2021 --- Note 3) Share earnout liability Share Earnout Liability Other Other Prepaid Expense, Current Change in Accounting Principle, Accounting Standards Update, Adopted [true false] Accounting standards update, adopted [true false] Weighted-Average Exercise Price, Forfeited Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price April 2020 Public Warrants. April2020 Public Warrants [Member] April 2020 Public Warrants [Member] Common Stock, Convertible, Conversion Price, Increase Common stock exceeds price per share Commitments and contingencies (Note 8) Commitments and Contingencies Preferred Stock, Voting Rights Number of voting rights Class of Warrant Or Right [Line Items] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Schedule of Potentially Antidilutive Securities Excluded from Computation of Diluted Net Loss Per Share Issuance of Series A Preferred, shares Stock Issued During Period, Shares, New Issues Common stock, shares issued Scenario [Axis] Sponsored research agreement fund. Sponsored research agreement fund Sponsored Research Agreement Fund Earnout shares. Earnout Shares Earnout shares Basis of Accounting, Policy [Policy Text Block] Basis of Presentation Liabilities, Fair Value Disclosure [Abstract] Liabilities Financial and Nonfinancial Liabilities, Fair Value Disclosure Liabilities fair value Related Party [Domain] Related Party Sponsor [Member] Sponsor [Member] Sponsor [Member] Merger Agreement and Note Purchase Agreement [Member] Merger agreement and note purchase agreement. Market-based Awards [Member] Market-based Restricted Stock Units [Member] Market-based restricted stock units. Change in Accounting Principle, Accounting Standards Update, Immaterial Effect [true false] Accounting standards update, immaterial effect Income Statement [Abstract] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] Other Nonoperating Income (Expense) [Abstract] Other income (expense): Number of shares distributed to members and employees Number of Shares Distributed to Members and Employees Number of shares distributed to members and employees. Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Net income (loss) per share - Diluted: Net Income (Loss) Available to Common Stockholders, Diluted [Abstract] Reverse Recapitalization. Reverse Recapitalization Policy [Text Block] Reverse Recapitalization Committed share issuance Committed Share Issuance Committed share issuance Employee-related Liabilities, Current, Total Employee-related Liabilities, Current Employee compensation and benefits General and Administrative Expense, Total General and Administrative Expense General and administrative Property and equipment, net Property, Plant and Equipment, Net, Ending Balance Property, Plant and Equipment, Net, Beginning Balance Property, Plant and Equipment, Net Property and equipment, net Shares issued - common stock Common Stock, Shares, Issued, Total Common Stock, Shares, Issued Common stock, shares issued Number of shares, Forfeited Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period Grossman [Member] Grossman [Member] Grossman. Security Exchange Name Security Exchange Name Statistical Measurement [Domain] Statistical Measurement Derivative, Term of Contract Derivative, Term of Contract Net income (loss) attributable to common stockholders Net Income (Loss) Available to Common Stockholders, Basic Earnout RSUs [Member] Earnout RSU [Member] Earnout RSU. Chardan Investments 2 [Member] Chardan Investments 2 Limited Liability Company Member Chardan Investments 2 Limited Liability Company Member. Expected Volatility [Member] Measurement Input, Price Volatility [Member] Subsequent Event Type [Domain] Document Period End Date Document Period End Date Income Statement Location [Axis] Income Statement Location Revision of Prior Period [Domain] Revision of Prior Period Investments [Domain] Investments Total accrued expenses Accrued Liabilities, Current Accrued expenses Warrants and Rights Outstanding, Term Redemption written notice period Warrant [Member] Warrants [Member] Related Party Transaction [Axis] Related Party Transaction Numerator for diluted net income (loss) per share Net Income (Loss) Available to Common Stockholders, Diluted Common Stock, Shares Authorized Common stock, shares authorized Use of Estimates, Policy [Policy Text Block] Use of Estimates First Earnout Period [Member] First milestone member. First Milestone [Member] Service commitment renewal term Service Commitment Renewal Term. Service Commitment Renewal Term Related Party [Axis] Related Party Class of Stock [Axis] Class of Stock Adjustments to reconcile net income (loss) to net cash used in operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Sponsor Support Agreement [Member] Sponsor support agreement member. Sponsor Support Agreement [Member] Common Stock Warrants [Member] Common Stock Warrants [Member] Common Stock Warrants Sponsor Shares [Member] Sponsor shares. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Anti-dilutive Securities Research and development costs Prepaid Research And Development Costs Prepaid research and development costs. Stock Price [Member] Measurement Input, Share Price [Member] Significant Accounting Policies Table Line Items Significant Accounting Policies Table [Line Items] Significant Accounting Policies Table [Line Items] Extended sublease base rent Extended sublease base rent Entity Address, Address Line Two Current Fiscal Year End Date Current Fiscal Year End Date Equipment and Other Long-lived Assets [Member] Other Machinery and Equipment [Member] Document Information [Table] Document Information [Table] Assets [Abstract] ASSETS 2021 Omnibus Incentive Plan [Member] 2021 Incentive Plan [Member] Two thousand twenty one omnibus incentive plan. Two Thousand Twenty One Omnibus Incentive Plan [Member] Assets Assets, Fair Value Disclosure [Abstract] Business Description and Basis of Presentation [Text Block] Business and Organization Accounts Payable, Current, Total Accounts Payable, Current Accounts payable Debt Instrument, Name [Domain] April 2020 Private Placement Warrants Private Placement [Member] Private Placement [Member] Issued amount Debt Instrument, Face Amount Principal amount Common Stock, Par or Stated Value Per Share Common stock, par value PIPE Investment [Member] PIPE investment member. P I P E Investment [Member] Development regulatory and commercial milestone payment. Development regulatory and commercial milestone payment Development Regulatory And Commercial Milestone Payment Remaining shares owned by sponsor (in Shares) Stock Issued During Period, Shares, Other Denominator for basic net income (loss) per share Denominator for basic net income (loss) per share Basic Weighted Average Number of Shares Outstanding, Basic, Total Balance (in Shares) Balance (in Shares) Shares, Outstanding Additional Paid in Capital, Common Stock, Ending Balance Additional Paid in Capital, Common Stock, Beginning Balance Additional Paid in Capital, Common Stock Additional paid-in capital Probability of Change in Control [Member] Measurement input probability of change in control. Measurement Input Probability Of Change In Control [Member] Tax expense or benefit due to expected current year loss and its historical losses Current Income Tax Expense (Benefit) Current Income Tax Expense (Benefit), Total Stockholders' Equity Note [Abstract] Financial instrument policy. Financial Instrument Policy [Text Block] Financial Instruments Research and Development Expense, Policy [Policy Text Block] Research and Development Expense Fair Value by Liability Class [Domain] Fair Value by Liability Class Targeted or Tracking Stock, Stock [Table] Targeted Or Tracking Stock Stock [Table] Document Type Document Type Sponsor Earnout Shares. Sponsor Earnout Shares Sponsor earnout shares Revision of Prior Period [Axis] Revision of Prior Period Settlement of convertible note at closing. Settlement Of Convertible Note At Closing Less: Settlement of convertible note at closing Preferred stock, $0.0001 par value per share; 1,000,000 shares authorized; none issued or outstanding at March 31, 2022 and December 31, 2021 Preferred Stock, Value, Issued Preferred Stock, Value, Issued, Ending Balance Preferred Stock, Value, Issued, Beginning Balance Preferred Stock, Value, Issued, Total CHAQ [Member] Chardan Healthcare Acquisition Corporation [Member] Chardan Healthcare Acquisition Corporation. Schedule of Accrued Expenses Schedule of Accrued Liabilities [Table Text Block] Number of Warrants Outstanding Warrants Outstanding Warrants outstanding. Assets, Current Total current assets Liability Class [Axis] Liability Class Sponsor Ownership [Member]. Sponsor Ownership [Member] Sponsor Ownership [Member] Liability Classified Warrants [Member] Liability Classified Warrants [Member] Liability classified warrants. Stock Options [Member] Stock Options Outstanding [Member] Share-based Payment Arrangement, Option [Member] Research and Development Arrangement, Contract to Perform for Others, Type [Axis] Research and Development Arrangement, Contract to Perform for Others, Type Effect of Merger and recapitalization, Shares Effect of merger and recapitalization net of issuance costs shares. Effect Of Merger And Recapitalization Net Of Issuance Costs Shares Schedule of Merger to Unaudited Condensed Consolidated Statement of Changes in Stockholders' Equity (Deficit) Schedule of Merger to Unaudited Condensed Consolidated Statement of Changes in Stockholders' Equity (Deficit) [Table Text Block] Schedule of merger to unaudited condensed consolidated statement of changes in stockholders' equity (Deficit). Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Weighted-Average Remaining Contractual Life, Outstanding Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] SUPPLEMENTAL DISCLOSURES OF NONCASH ACTIVITIES: Earn out period end date Targeted or Tracking Stock, Issuance Date Targeted Issuance Date Antidilutive Securities [Axis] Antidilutive Securities Number of shares, Nonvested, Ending Balance Number of shares, Nonvested, Beginning Balance Number of shares, RSUs outstanding Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Insurance Prepaid Insurance Common stock, outstanding Common stock, outstanding Common Stock, Shares, Outstanding, Ending Balance Common Stock, Shares, Outstanding, Beginning Balance Common Stock, Shares, Outstanding Common stock, shares outstanding Class of Warrant or Right [Domain] Plan Name [Axis] Plan Name Less: accumulated amortization Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Ending Balance Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Beginning Balance Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Total Stock Options, Forfeited Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Stock Options, Forfeited Weighted-average number of common shares used in computing net income (loss) per share -- (Note 13) Weighted Average Number of Shares Outstanding, Diluted [Abstract] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Weighted-Average Exercise Price, Outstanding, Ending Balance Weighted-Average Exercise Price, Outstanding Net Cash Provided by (Used in) Operating Activities [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES: Weighted-Average Exercise Price Warrants exercise price (in Dollars per share) Exercise price Diluted net income (loss) per common share Diluted Diluted Earnings Per Share, Diluted Effect of Merger, net of redemptions and transaction costs Effect of Merger, net of Redemptions and Transaction Costs, Included in Cash Flow. Effect Of Merger Net Of Redemptions And Transaction Costs Included In Cash Flow Effect of Merger, net of redemptions and transaction costs Net income (loss) per share Earnings Per Share [Abstract] Net income (loss) Net income (loss) Net income (loss) Net losses Net loss Accrued Expenses Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block] Concentration Risk, Credit Risk, Policy [Policy Text Block] Concentration of Credit Risk Temporary Equity Conversion Into Permanent Equity Conversion Price Per Temporary Equity Conversion Into Permanent Equity Conversion Price Per Share Temporary equity conversion into permanent equity conversion price per share. Research and Development [Member] Research and Development Expense [Member] Summary of Number of Shares Common Stock Issued Immediately Following Consummation of Merger Summary of Number of Shares Common Stock Issued Immediately Following Consummation of Merger [Table Text Block] Summary of number of shares common stock issued immediately following consummation of merger. Document Fiscal Period Focus Document Fiscal Period Focus Royalty percentage. Royalty percentage Royalty Percentage Debt Instrument, Convertible, Threshold Consecutive Trading Days Number of consecutive trading days Accounting Policies [Abstract] Entity Address, Address Line One Entity Address, Address Line One Number of shares, options outstanding Stock Options Outstanding, Beginning balance Stock Options Outstanding, Ending Balance Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number September 2021 Pre-Funded Warrants [Member] September 2021 Pre-Funded Warrants. September2021 Pre Funded Warrants [Member] Liabilities, Current Total current liabilities Common stock and pre-funded warrants issued pursuant to PIPE financing Common stock and pre-funded warrants issued pursuant to PIPE financing, net of issuance costs. Common Stock And Pre Funded Warrants Issued Pursuant To P I P E Financing Net Of Issuance Costs Net income (loss) Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Entity Address, Postal Zip Code Entity Address, Postal Zip Code Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Aggregate Intrinsic Value, Outstanding Subsequent Event [Table] Temporary equity, Balance Temporary equity, Balance Temporary Equity, Carrying Amount, Attributable to Parent Old Renovacor [Member] Old renovacor member. Old Renovacor [Member] Proceeds from initial public offer Proceeds from Issuance Initial Public Offering Convertible Preferred Stock [Member] Convertible Preferred Stock [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Schedule of Research and Development Arrangement, Contract to Perform for Others [Table] Schedule Of Research And Development Arrangement Contract To Perform For Others [Table] Net Cash Provided by (Used in) Operating Activities Net cash used in operating activities 2018 Stock Option and Grant Plan [Member] 2018 stock option and grant plan. Two Thousand Eighteen Stock Option And Grant Plan [Member] Dr. Arthur Feldman consulting agreement member. Feldman Consulting Agreement [Member] Feldman Consulting Agreement [Member] Percentage of outstanding shares. Percentage Of Outstanding Shares Percentage of outstanding shares Cash and cash equivalents at end of period Cash and cash equivalents at beginning of period Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Total Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Equity Components [Axis] Equity Components Assets, Current [Abstract] Current assets: Time-based Restricted Stock Units [Member] Time-based Awards [Member] Time-based Restricted Stock Units [Member] Time-based Restricted Stock Units [Member] Entity Registrant Name Entity Registrant Name Maximum number of additional shares entitled to receive Maximum Number of Additional Shares Entitled to Receive Maximum number of additional shares entitled to receive. Previously Reported [Member] Previously Reported [Member] Lessee, Operating Sublease, Existence of Option to Extend [true false] Emerging Growth Company Status Emerging Growth Company Policies [Text Block] Emerging growth company. Stockholder's Equity Stockholders' Equity Note Disclosure [Text Block] Significant Accounting Policies Table Significant Accounting Policies [Table] Significant Accounting Policies [Table] Entity Interactive Data Current Entity Interactive Data Current Entity Address, City or Town Entity Address, City or Town Warrant liability. Warrant Liability [Member] Warrant Liability Expected Life (Years) [Member] Measurement Input, Expected Term [Member] Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term Expected term (years) Lessee, Operating Sublease, Option to Extend Trading Symbol Trading Symbol Related Party Transactions Disclosure [Text Block] Related Parties License and sponsored research agreements. License And Sponsored Research Agreements [Text Block] License and Sponsored Research Agreements CASH FLOWS FROM INVESTING ACTIVITIES: Net Cash Provided by (Used in) Investing Activities [Abstract] Schedule of Warrant and Earnout Share Liability Measured on Recurring Basis Using Unobservable Inputs Schedule of Warrant and Earnout Share Liability Measured on Recurring Basis Using Unobservable Input [Table Text Block] Schedule of warrant and earnout share liability measured on recurring basis using unobservable input. Convertible Promissory Note [Member] Convertible promissory note. Private Placement Warrants [Member] Private placement warrants. Private Placement Warrants [Member] Local Phone Number Local Phone Number Accounting Standards Update 2016-02 [Member] Pre Funded Warrants [Member] Pre Funded Warrants [Member] Pre-Funded Warrants [Member] Stock Options [Member] Stock Options [Member] Stock Options Balance Balance Stockholders' Equity Attributable to Parent Total stockholders’ equity Subsequent Event Type [Axis] Unrecognized Tax Benefits, Ending Balance Unrecognized Tax Benefits, Beginning Balance Unrecognized Tax Benefits Uncertain tax positions PIPE Investors [Member] PIPE Investors [Member] PIPE investors. Research and Development [Abstract] Preferred stock, shares issued Preferred Stock, Shares Issued Preferred Stock, Shares Issued, Total Assets, Fair Value Disclosure Asset fair value Additional shares issued upon closing of Series A convertible preferred stock Additional Shares Issued Upon Closing Of Second Tranche of Convertible Preferred Stock Additional shares issued upon closing of second tranche of convertible preferred stock. Statistical Measurement [Axis] Statistical Measurement Entity Small Business Entity Small Business Preferred Stock, Shares Outstanding, Beginning Balance Preferred Stock, Shares Outstanding, Ending Balance Preferred Stock, Shares Outstanding Preferred stock, shares outstanding Organization, Consolidation and Presentation of Financial Statements [Abstract] External research and development expenses. External Research And Development Expenses External research and development expenses Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV APIC, Share-based Payment Arrangement, Increase for Cost Recognition, Total APIC, Share-based Payment Arrangement, Increase for Cost Recognition Stock-based compensation Employee Trust [Abstract] Property, Plant and Equipment, Useful Life Useful life Plus: Incremental shares underlying "in the money" options outstanding Incremental Common Shares Attributable To Underlying in the Money Options Outstanding Incremental common shares attributable to underlying in the money options outstanding. Business Acquisition [Axis] Business Acquisition Gain on change in fair value of warrant liability Fair Value Adjustment of Warrants Change in fair value of warrant liability Class of Warrant or Right, Outstanding Number of warrants outstanding Sponsor research agreement funded and/or incurred from inception Sponsor Research Agreement Funded and/or Incurred From Inception Sponsor research agreement funded and/or incurred from inception. Targeted or Tracking Stock, Stock [Line Items] Targeted Or Tracking Stock Stock [Line Items] Weighted-Average Exercise Price, Granted Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Sale of Stock [Domain] Sale of Stock Common stock and pre-funded warrants issued pursuant to PIPE financing, shares Common stock and pre funded warrants issued pursuant to PIPE financing net of issuance costs shares. Common Stock And Pre Funded Warrants Issued Pursuant To P I P E Financing Net Of Issuance Costs Shares Temporary Equity, Shares Issued Temporary equity, issued Fair Value Per Share [Member] Measurement input fair value per share. Measurement Input Fair Value Per Share [Member] Weighted-Average Exercise Price, Expired Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Sublease expiring date Sublease expiring date Related Party Transaction [Line Items] Related Party Transaction [Line Items] Reconciliation of Elements of Merger to Condensed Consolidated Statement of Cash Flows [Table Text Block] Reconciliation of elements of merger to condensed consolidated statement of cash flows. Schedule of Merger to Unaudited Condensed Consolidated Statement of Cash Flows Plan Name [Domain] Plan Name Class of Stock [Line Items] Class Of Stock [Line Items] Depreciation, Total Depreciation Depreciation expense Total prepaid expense Prepaid expenses Prepaid Expense, Current Issuance of Series A Preferred Aggregate purchase price Stock Issued During Period, Value, New Issues Purchase price per share. Purchase Price Per Share Purchase price per share Fair Value, Liabilities Measured on Recurring Basis [Table Text Block] Schedule of Liabilities Measured at Fair Value on Recurring Basis Expected Dividend Yield [Member] Measurement Input, Expected Dividend Rate [Member] Purchase price of warrants Proceeds from Issuance of Warrants Due to related party Due to Related Parties, Current, Total Due to Related Parties, Current Share-based Payment Arrangement, Noncash Expense, Total Share-based Payment Arrangement, Noncash Expense Stock-based compensation Summary of Restricted Stock Unit Activity Schedule of Nonvested Restricted Stock Units Activity [Table Text Block] Share-based Payment Arrangement, Option, Activity [Table Text Block] Summary of Stock Option Activity Long-Lived Tangible Asset [Domain] Long-Lived Tangible Asset Related Party Transactions [Abstract] Derivative, Fair Value Hedge, Included in Effectiveness, Gain (Loss) Change in fair value of derivative liability Gain on change in fair value of derivative liability Shares issued Business Acquisition, Equity Interest Issued or Issuable, Number of Shares Sublease rentable space Sublease rentable space Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Stock Options, Exercisable Net cash used in financing activities Net Cash Provided by (Used in) Financing Activities Commitments and Contingencies Disclosure [Abstract] Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block] Summary of Prepaid Expenses and Other Current Assets Weighted-Average Grant Date Fair Value, Vested Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Assets Total assets Common Stock, Outstanding, Founder Shares. Common Stock Outstanding Founder Shares CHAQ Founder shares Level 2 [Member] Fair Value, Inputs, Level 2 [Member] Stock Options, Exercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Sponsor cancelled shares (in shares) Sponsor Cancelled Shares Sponsor cancelled shares. Less: transaction costs paid Transaction finance cost. Transaction Finance Cost Statement [Line Items] Statement [Line Items] Liabilities and Equity Total liabilities and stockholders’ equity Effect of Merger and recapitalization Effect of Merger and recapitalization, net of issuance costs. Effect Of Merger And Recapitalization Net Of Issuance Costs Document Quarterly Report Document Quarterly Report Class of Warrant or Right [Axis] Property, Plant and Equipment [Abstract] Statement of Cash Flows [Abstract] Additional Paid-in Capital [Member] Additional Paid-in Capital Title of 12(b) Security Title of 12(b) Security Cash - trust and cash, net of redemptions Cash, Net of Redemptions. Cash Net Of Redemptions Cash – net of redemptions Earnout Shares [Member] Earnout shares. Earnout Shares [Member] Sponsor shares placed into escrow subject to forfeiture Common Stock Held in Escrow and Subject to Vesting or Forfeiture Common stock held in escrow and subject to vesting or forfeiture. Common stock held in escrow and subject to vesting or forfeiture Level 3 [Member] Fair Value, Inputs, Level 3 [Member] Prepaid expense Increase (Decrease) in Prepaid Expense Common stock, outstanding prior to Merger Common stock outstanding prior to Merger Common stock, outstanding prior to Merger. Common Stock Outstanding Prior To Merger Conversion price per share Debt Instrument, Convertible, Conversion Price Award Type [Domain] Award Type Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV Schedule of Property and Equipment, Net Property, Plant and Equipment [Table Text Block] Deferred merger costs in accounts payable Deferred Merger Costs In Accounts Payable Deferred Merger Costs In Accounts Payable Level 1 [Member] Fair Value, Inputs, Level 1 [Member] Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures, Total Issuance of restricted common stock, shares Research and Development Arrangement, Contract to Perform for Others, Type [Domain] Research and Development Arrangement, Contract to Perform for Others, Type Net deferred tax asset Deferred Tax Assets, Net Deferred Tax Assets, Net, Total Restricted Stock [Member] Restricted Stock [Member] Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Number of Shares Less: redemption of CHAQ shares Area of Real Estate Property Options granted Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Stock Options, Granted Entity Current Reporting Status Entity Current Reporting Status Investment Type [Axis] Investment Type Measurement Input Type [Domain] Measurement Input Type Scenario [Domain] Money Market Funds [Member] Weighted-Average Grant Date Fair Value, Granted Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Warrant expiration date Warrants and Rights Outstanding, Maturity Date Expiration Date Net Income (Loss) per Common Share Earnings Per Share, Policy [Policy Text Block] Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Schedule of Stock-based Compensation Expense Summary of Elements of Net Proceeds From Merger Summary of elements of net proceeds from merger. Initial purchase price per share (in Dollars per share) Initial Purchase Price Per Share Initial purchase price per share. Income Statement Location [Domain] Income Statement Location Schedule of Assumptions Used in Determining Fair Value of Private Placement Warrants and Earnout Shares Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Class of Warrant or Right [Table] Basic net income (loss) per common share Basic Earnings Per Share, Basic Earnings Per Share, Basic, Total Preferred Stock, Shares Authorized Preferred stock, shares authorized Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Weighted-Average Exercise Price, Exercisable Accrued expenses Increase (Decrease) in Accrued Liabilities Increase (Decrease) in Accrued Liabilities, Total Target price Target Price Per Shares. Target Price Per Shares Minimum [Member] Minimum Measurement Frequency [Domain] Measurement Frequency Number of shares, Granted Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Risk-Free Interest Rate [Member] Measurement Input, Risk Free Interest Rate [Member] Pre - funded warrants to purchase common stock Class of Warrant or Right, Number of Securities Called by Warrants or Rights Schedule of Business Acquisitions, by Acquisition [Table] Schedule Of Business Acquisitions By Acquisition [Table] Adjustments to Additional Paid In Capital Share Based Compensation Vesting Of Restricted Common Stock Adjustments to additional paid in capital share based compensation vesting of restricted common stock. Vesting of restricted common stock Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] Net Cash Provided by (Used in) Financing Activities [Abstract] CASH FLOWS FROM FINANCING ACTIVITIES: Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Unrecognized stock-based expense Debt Instrument [Axis] Entity Filer Category Entity Filer Category Income Taxes Income Tax, Policy [Policy Text Block] Document Fiscal Year Focus Document Fiscal Year Focus Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table] Beneficial Ownership Limitation Percentage Percentage of beneficial ownership limitation. Percentage of beneficial ownership limitation Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Weighted average fair value of options granted Retained Earnings (Accumulated Deficit), Ending Balance Retained Earnings (Accumulated Deficit), Beginning Balance Retained Earnings (Accumulated Deficit), Total Retained Earnings (Accumulated Deficit) Accumulated deficit Accumulated deficit Entity Ex Transition Period Entity Ex Transition Period Fair Value Disclosures [Abstract] Agreement effective date Temple License Agreement Effective Date Temple license agreement effective date. Property and Equipment Property, Plant and Equipment Disclosure [Text Block] Proceeds from issuance of convertible promissory note, net of issuance costs Proceeds from Convertible Debt Proceeds from convertible debt Series A Redeemable Convertible Preferred Stock [Member] Series A redeemable convertible preferred stock. Maximum Maximum [Member] Maximum [Member] Entity Central Index Key Entity Central Index Key Second Earnout Period [Member] Second milestone member. Second Milestone [Member] Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree Temporary equity shares issued price per share Temporary Equity Shares Issued Price Per Share Temporary equity shares issued price per share. Payables and Accruals [Abstract] Measurement Input Type [Axis] Measurement Input Type Share Earnout Liability [Member] Earnout share liability. Earnout Share Liability [Member] Cash and Cash Equivalents Cash and Cash Equivalents, Policy [Policy Text Block] Entity Tax Identification Number Entity Tax Identification Number Equity Component [Domain] Equity Component Plus: Incremental shares underlying time-based restricted stock units Incremental Common Shares Attributable to Underlying Time-Based Restricted Stock Units Incremental common shares attributable to underlying time-based restricted stock units. Preferred stock, par value Preferred Stock, Par or Stated Value Per Share Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate Expected volatility Derivative Liability, Measurement Input Derivative Liability, Measurement Input Net income (loss) per share - Basic: Net Income (Loss) Available to Common Stockholders, Basic [Abstract] Property and Equipment, net Property, Plant and Equipment, Policy [Policy Text Block] Public Warrants. Public Warrants [Member] Public Warrants Unrecognized compensation cost, weighted average expected to be recognized period Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Other expense Other expense Other Expenses Other Expenses, Total Accounting standards update, adoption date Change in Accounting Principle, Accounting Standards Update, Adoption Date Less: Undistributed earnings to participating securities Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted, Total Subsequent Events [Abstract] Subsequent Event [Line Items] Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized Number of shares authorized for issuance Chardan Healthcare Investments Limited Liability Company [Member] Chardan Healthcare Investments Limited Liability Company. Chardan Healthcare Investments LLC [Member] Statement [Table] Statement [Table] Entity File Number Entity File Number Temple license agreement. Temple License Agreement [Member] Temple License Agreement [Member] Share Based Compensation Arrangement By Share Based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Number of shares distributed to related parties Number of Shares Distributed to Related Parties Number of shares distributed to related parties. Other assets Increase (Decrease) in Other Noncurrent Assets Retained Earnings [Member] Accumulated Equity (Deficit) Price per share Shares Issued, Price Per Share Accounting Standards Update [Domain] Accounting Standards Update [Axis] Increase (Decrease) in Accounts Payable, Total Increase (Decrease) in Accounts Payable Accounts payable Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Shares issued Shares, Issued, Ending Balance Shares, Issued, Beginning Balance Shares, Issued Shares issued in PIPE Financing Current liabilities: Liabilities, Current [Abstract] Stock-based Compensation Share-based Payment Arrangement [Text Block] Subsequent Event [Member] Commitments and Contingencies Disclosure [Text Block] Commitments and Contingencies Common Stock [Member] Common Stock [Member] Common Stock Amusa [Member] Amusa [Member] Amusa. Laboratory equipment Property, Plant and Equipment, Gross Property, Plant and Equipment, Gross, Ending Balance Property, Plant and Equipment, Gross, Beginning Balance Property, Plant and Equipment, Gross, Total Professional fees Accrued Professional Fees, Current Warrant Liability. Warrant Liability Policy [Text Block] Warrant Liability Stock Options, Expired Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period Cover [Abstract] Weighted-Average Grant Date Fair Value, Nonvested Shares, Beginning Balance Weighted-Average Grant Date Fair Value, Nonvested Shares, Ending Balance Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Asset Class [Axis] Related Party Transaction [Domain] Related Party Transaction Temporary equity, outstanding Temporary equity, Balance (in Shares) Temporary equity, Balance (in Shares) Temporary Equity, Shares Outstanding Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Statement of Stockholders' Equity [Abstract] Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Balance Balance Share-based Payment Arrangement [Abstract] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Research and Development Arrangement, Contract to Perform for Others [Line Items] Research And Development Arrangement Contract To Perform For Others [Line Items] Restricted stock units (Earnout RSUs) [Member] Restricted Stock Units [Member] Restricted stock units [Member] Long-Lived Tangible Asset [Axis] Long-Lived Tangible Asset Other Other Accrued Liabilities, Current Document Transition Report Document Transition Report Share Earnout Liability. Share Earnout Liability Policy [Text Block] Share Earnout Liability Merger-related costs Merger-related costs Payments of Merger Related Costs, Financing Activities Research and development expenses Research and Development Expense, Total Research and Development Expense Research and development Denominator for diluted net income (loss) per share Denominator for diluted net income (loss) per share Diluted Weighted Average Number of Shares Outstanding, Diluted Stock Issued During Period, Shares, Acquisitions Common stock purchased Merger and Recapitalization disclosure. Merger And Recapitalization Disclosure [Text Block] Merger and Recapitalization Stock-based compensation expense Share-based Payment Arrangement, Expense Total stock-based compensation expense Retroactive Application of Reverse Recapitalization [Member] Revision of Prior Period, Adjustment [Member] Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease), Total Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) Change in the fair value of liability Assignment fees Assignment Fees Assignment fees. Temple License Agreement Expiration Description Temple license agreement expiration description. Agreement expiration description Statement of Financial Position [Abstract] Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate Expected dividend yield Number of shares, Vested Number of shares, Vested Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Net decrease in cash and cash equivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect Stockholders' Equity Attributable to Parent [Abstract] Stockholders' equity:** Stock-Based Compensation Compensation Related Costs, Policy [Policy Text Block] Net Income (Loss) Attributable to Common Stockholders of Basic and Diluted Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Shares Earnout [Member] Shares earnout. Weighted-Average Exercise Price, Exercised Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Gross proceeds from issuance of shares to investors Gross Proceeds From Issuance Of Shares To Investors Amount of gross proceeds from issuance of shares to investors. Increase (Decrease) in Operating Capital [Abstract] Change in assets and liabilities: Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Common stock, capital shares reserved for future issuance Common Stock, Capital Shares Reserved for Future Issuance Shares available for issuance Total Merger and PIPE Financing [Member] Merger and PIPE Financing [Member] Merger and PIPE financing shares. Measurement Frequency [Axis] Measurement Frequency Award Type [Axis] Award Type Entity Shell Company Entity Shell Company Share price (in Dollars per share) Sale of Stock, Price Per Share Common stock par value Measurement Input, Exercise Price [Member] Strike Price [Member] Summary Of Earnout Shares Table. Summary Of Earnout Shares Table [Text Block] Summary of Earnout Shares Sponsored research agreement fund, net Sponsored research agreement fund net. Sponsored Research Agreement Fund Net Liabilities and Equity [Abstract] LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Warrant exercisable term. Warrant Exercisable Term Warrant exercisable term Net Income (Loss) Per Share Earnings Per Share [Text Block] Preferred stock outstanding prior to Merger Preferred Stock Outstanding Prior to Merger Preferred stock outstanding prior to merger. Gain on change in fair value of share earnout liability Loss on change in fair value of share earnout liability. Loss On Change In Fair Value Of Share Earnout Liability Change in fair value of share earnout liability Amendment Flag Amendment Flag Schedule of Stock by Class [Table] Schedule Of Stock By Class [Table] Minimum percentage of ownership held by Founder Minimum Percentage of Ownership Held by Founder Minimum percentage of ownership held by founder. Fair value of options, vested in period Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value Number of shares issue and sell to investors (in Shares) Sale of Stock, Number of Shares Issued in Transaction Common stock purchased Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value, Ending Balance Cash and Cash Equivalents, at Carrying Value, Beginning Balance Cash and Cash Equivalents, at Carrying Value, Total Cash and Cash Equivalents, at Carrying Value New Accounting Pronouncements, Policy [Policy Text Block] New Accounting Pronouncements Warrant or Right, Reason for Issuance, Description Warrant or Right, Reason for Issuance, Description Consulting Fees. Consulting Fees Consulting Fees Consulting fee amount per calendar month Consulting fee per calendar month. Consulting Fee Amount Per Calendar Month Property and equipment Accrued Property and Equipment Current Accrued property and equipment current. Fair Value, Recurring [Member] Fair Value, Recurring April 2020 Private Placement Warrants [Member] April 2020 Private Placement Warrants. April2020 Private Placement Warrants [Member] Subsequent Events [Text Block] Subsequent Events CHAQ and Old Renovacor [Member] Chardan Healthcare Acquisition Corporation and Old Renovacor [Member] Chardan Healthcare Acquisition Corporation and Old Renovacor [Member] Debt Instrument, Convertible, Threshold Trading Days Number of trading days Antidilutive Securities, Name [Domain] Antidilutive Securities, Name Other Other Assets, Noncurrent Other Assets, Noncurrent, Total Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value Aggregate Intrinsic Value, Exercisable Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent Percentage of outstanding shares Preclinical term. Preclinical term Preclinical Term Sale of Stock [Axis] Sale of Stock Fair Value Disclosures [Text Block] Fair Value Measurements EX-101.SCH 9 rcor-20220331.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 100000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 100010 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 100020 - Disclosure - Merger and Recapitalization - Summary of Number of Shares Common Stock Issued Immediately Following Consummation of Merger (Details) 2 link:presentationLink link:calculationLink link:definitionLink 100030 - Disclosure - Net Income (Loss) Per Share - Net Income (Loss) Attributable to Common Stockholders of Basic and Diluted (Details) 2 link:presentationLink link:calculationLink link:definitionLink 100040 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 100050 - Statement - Condensed Consolidated Statements of Operations (Unaudited) link:presentationLink link:calculationLink link:definitionLink 100060 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 100070 - Statement - Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) (Unaudited) link:presentationLink link:calculationLink link:definitionLink 100080 - Disclosure - Business and Organization link:presentationLink link:calculationLink link:definitionLink 100090 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 100100 - Disclosure - Merger and Recapitalization link:presentationLink link:calculationLink link:definitionLink 100110 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 100120 - Disclosure - Property and Equipment link:presentationLink link:calculationLink link:definitionLink 100130 - Disclosure - Prepaid Expenses link:presentationLink link:calculationLink link:definitionLink 100140 - Disclosure - Accrued Expenses link:presentationLink link:calculationLink link:definitionLink 100150 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 100160 - Disclosure - License and Sponsored Research Agreements link:presentationLink link:calculationLink link:definitionLink 100170 - Disclosure - Stockholder's Equity link:presentationLink link:calculationLink link:definitionLink 100180 - Disclosure - Stock-based Compensation link:presentationLink link:calculationLink link:definitionLink 100190 - Disclosure - Related Parties link:presentationLink link:calculationLink link:definitionLink 100200 - Disclosure - Net Income (Loss) Per Share link:presentationLink link:calculationLink link:definitionLink 100210 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 100220 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 100230 - Disclosure - Merger and Recapitalization (Tables) link:presentationLink link:calculationLink link:definitionLink 100240 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 100250 - Disclosure - Property and Equipment (Tables) link:presentationLink link:calculationLink link:definitionLink 100260 - Disclosure - Prepaid Expenses and Other Current Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 100270 - Disclosure - Accrued Expenses (Tables) link:presentationLink link:calculationLink link:definitionLink 100280 - Disclosure - Stockholder's Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 100290 - Disclosure - Stock-based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 100300 - Disclosure - Net Income (Loss) Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 100310 - Disclosure - Business and Organization - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 100320 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 100330 - Disclosure - Merger and Recapitalization - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 100340 - Disclosure - Merger and Recapitalization - Summary of Earnout Shares (Details) link:presentationLink link:calculationLink link:definitionLink 100350 - Disclosure - Merger and Recapitalization - Summary of Elements of Net Proceeds From Merger (Details) link:presentationLink link:calculationLink link:definitionLink 100360 - Disclosure - Merger and Recapitalization - Summary of Number of Shares Common Stock Issued Immediately Following Consummation of Merger (Details) link:presentationLink link:calculationLink link:definitionLink 100370 - Disclosure - Merger and Recapitalization - Summary of Number of Shares Common Stock Issued Immediately Following Consummation of Merger (Parenthetical) (Detail) link:presentationLink link:calculationLink link:definitionLink 100380 - Disclosure - Fair Value Measurements - Schedule of Liabilities Measured at Fair Value on Recurring Basis (Details) link:presentationLink link:calculationLink link:definitionLink 100390 - Disclosure - Fair Value Measurements - Schedule of Warrant and Earnout Share Liability Measured on Recurring Basis Using Unobservable Input (Details) link:presentationLink link:calculationLink link:definitionLink 100400 - Disclosure - Fair Value Measurements - Schedule of Assumptions Used in Determining Fair Value of Private Placement Warrants (Details) link:presentationLink link:calculationLink link:definitionLink 100410 - Disclosure - Fair Value Measurements - Schedule of Assumptions Used in Determining Fair Value of Earnout Shares (Details) link:presentationLink link:calculationLink link:definitionLink 100420 - Disclosure - Property and Equipment - Schedule of Property and Equipment, Net (Details) link:presentationLink link:calculationLink link:definitionLink 100430 - Disclosure - Prepaid Expenses - Summary of Prepaid Expenses (Details) link:presentationLink link:calculationLink link:definitionLink 100440 - Disclosure - Accrued Expenses - Schedule of Accrued Expenses (Details) link:presentationLink link:calculationLink link:definitionLink 100450 - Disclosure - License and Sponsored Research Agreements - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 100460 - Disclosure - Stockholder's Equity - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 100470 - Disclosure - Stockholder's Equity - Summary of Outstanding Warrants to Purchase Shares of Common Stock (Details) link:presentationLink link:calculationLink link:definitionLink 100480 - Disclosure - Stockholder's Equity - Schedule of Common Stock Shares Reserved for Future Issuance (Details) link:presentationLink link:calculationLink link:definitionLink 100490 - Disclosure - Stock-based Compensation - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 100500 - Disclosure - Stock-based Compensation - Schedule of Stock-based Compensation Expense (Details) link:presentationLink link:calculationLink link:definitionLink 100510 - Disclosure - Stock-based Compensation - Schedule of Assumptions Used in Determining the Fair Value of Option Awards (Details) link:presentationLink link:calculationLink link:definitionLink 100520 - Disclosure - Stock-based Compensation - Summary of Stock Option Activity (Details) link:presentationLink link:calculationLink link:definitionLink 100530 - Disclosure - Stock-based Compensation - Summary of Restricted Stock Unit Activity (Details) link:presentationLink link:calculationLink link:definitionLink 100540 - Disclosure - Related Parties - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 100550 - Disclosure - Net Income (Loss) Per Share - Net Income (Loss) Attributable to Common Stockholders of Basic and Diluted (Details) link:presentationLink link:calculationLink link:definitionLink 100560 - Disclosure - Net Income (loss) Per Share - Schedule of Potentially Antidilutive Securities Excluded from Computation of Diluted Net Loss Per Share (Detail) link:presentationLink link:calculationLink link:definitionLink 100570 - Disclosure - Subsequent Events (Additional Information) (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 10 rcor-20220331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.PRE 11 rcor-20220331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT EX-101.CAL 12 rcor-20220331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT XML 13 R1.htm IDEA: XBRL DOCUMENT v3.22.1
Document and Entity Information - shares
3 Months Ended
Mar. 31, 2022
May 12, 2022
Document Information [Line Items]    
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Mar. 31, 2022  
Document Fiscal Year Focus 2022  
Document Fiscal Period Focus Q1  
Entity Registrant Name Renovacor, Inc.  
Entity Central Index Key 0001799850  
Current Fiscal Year End Date --12-31  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Entity Ex Transition Period false  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Document Quarterly Report true  
Document Transition Report false  
Entity Common Stock, Shares Outstanding   17,267,423
Entity Shell Company false  
Entity File Number 001-39271  
Entity Tax Identification Number 83-3169838  
Entity Address, Address Line One 201 Broadway  
Entity Address, Address Line Two Suite 310  
Entity Address, City or Town Cambridge  
Entity Address, State or Province MA  
Entity Incorporation, State or Country Code DE  
Entity Address, Postal Zip Code 02139  
City Area Code 610  
Local Phone Number 424-2650  
Common Stock [Member]    
Document Information [Line Items]    
Trading Symbol RCOR  
Security Exchange Name NYSEAMER  
Title of 12(b) Security Common Stock, par value $0.0001 per share  
Warrants [Member]    
Document Information [Line Items]    
Trading Symbol RCOR.WS  
Security Exchange Name NYSEAMER  
Title of 12(b) Security Warrants to purchase common stock at an exercise price of $11.50 per share  
XML 14 R2.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 70,084 $ 78,790 [1]
Prepaid expenses 1,623 1,763 [1]
Total current assets 71,707 80,553 [1]
Property and equipment, net 362 379 [1]
Other 42 67 [1]
Total assets 72,111 80,999 [1]
Current liabilities:    
Accounts payable 1,781 1,536 [1]
Accrued expenses 1,616 2,498 [1]
Total current liabilities 3,397 4,034 [1]
Warrant liability 3,885 11,165 [1]
Share earnout liability (includes 500,000 shares of Common stock, $0.0001 par value per share, subject to forfeiture, issued and outstanding at March 31 2022 and December 31, 2021 --- Note 3) 4,090 12,256 [1]
Total liabilities 11,372 27,455 [1]
Commitments and contingencies (Note 8)  
Stockholders' equity:**    
Preferred stock, $0.0001 par value per share; 1,000,000 shares authorized; none issued or outstanding at March 31, 2022 and December 31, 2021  
Common stock, $0.0001 par value per share; 100,000,000 shares authorized; 16,756,042 shares issued and outstanding at March 31, 2022 and December 31, 2021 2 2 [1]
Additional paid-in capital 73,141 72,540 [1]
Accumulated deficit (12,404) (18,998) [1]
Total stockholders’ equity 60,739 53,544 [1]
Total liabilities and stockholders’ equity $ 72,111 $ 80,999 [1]
[1] The condensed balance sheet at December 31, 2021 has been derived from the audited financial statements at that date.
XML 15 R3.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares
Mar. 31, 2022
Dec. 31, 2021
Preferred stock, par value $ 0.0001 $ 0.0001
Preferred stock, shares authorized 1,000,000 1,000,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Common stock, par value $ 0.0001 $ 0.0001
Common stock, shares authorized 100,000,000 100,000,000
Common stock, shares issued 16,756,042 16,756,042
Common stock, shares outstanding 16,756,042 16,756,042
Shares Earnout [Member]    
Common stock, earnout shares issuable 500,000 500,000
Common stock, par value $ 0.0001 $ 0.0001
XML 16 R4.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Operating expenses:    
Research and development $ 5,930 $ 1,155
General and administrative 2,925 526
Loss from operations (8,855) (1,681)
Other income (expense):    
Interest income 4  
Change in fair value of warrant liability 7,280  
Change in fair value of share earnout liability 8,166  
Other expense (1)  
Net income (loss) $ 6,594 $ (1,681)
Net income (loss) per share    
Basic $ 0.37 $ (0.27)
Diluted $ 0.36 $ (0.27)
Weighted-average number of common shares used in computing net income (loss) per share -- (Note 13)    
Basic 17,471,266 6,274,566
Diluted 17,628,835 6,274,566
XML 17 R5.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net income (loss) $ 6,594 $ (1,681)
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Stock-based compensation 601 7
Gain on change in fair value of warrant liability (7,280)  
Gain on change in fair value of share earnout liability (8,166)  
Depreciation expense 17 1
Change in assets and liabilities:    
Prepaid expense 140 (678)
Other assets 25  
Accounts payable 298 375
Accrued expenses (522) 197
Net cash used in operating activities (8,293) (1,779)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Acquisitions of property and equipment (360)  
Net cash used in investing activities (360)  
CASH FLOWS FROM FINANCING ACTIVITIES:    
Merger-related costs (53) (80)
Net cash used in financing activities (53) (80)
Net decrease in cash and cash equivalents (8,706) (1,859)
Cash and cash equivalents at beginning of period 78,790 5,384
Cash and cash equivalents at end of period $ 70,084 3,525
SUPPLEMENTAL DISCLOSURES OF NONCASH ACTIVITIES:    
Deferred merger costs in accounts payable   $ 644
XML 18 R6.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) (Unaudited) - USD ($)
$ in Thousands
Total
Previously Reported [Member]
Retroactive Application of Reverse Recapitalization [Member]
Convertible Preferred Stock [Member]
Previously Reported [Member]
Convertible Preferred Stock [Member]
Retroactive Application of Reverse Recapitalization [Member]
Common Stock
Common Stock
Previously Reported [Member]
Common Stock
Retroactive Application of Reverse Recapitalization [Member]
Additional Paid-in Capital
Additional Paid-in Capital
Previously Reported [Member]
Additional Paid-in Capital
Retroactive Application of Reverse Recapitalization [Member]
Accumulated Equity (Deficit)
Accumulated Equity (Deficit)
Previously Reported [Member]
Balance at Dec. 31, 2020 $ 5,298 $ (4,776) $ 10,074     $ 1   $ 1 $ 10,194 $ 121 $ 10,073 $ (4,897) $ (4,897)
Balance (in Shares) at Dec. 31, 2020           6,274,566 1,953,368 4,321,198          
Temporary equity, Balance at Dec. 31, 2020       $ 10,074 $ (10,074)                
Temporary equity, Balance (in Shares) at Dec. 31, 2020       2,578,518 (2,578,518)                
Issuance of restricted common stock, shares           30,495              
Stock-based compensation 7               7        
Net income (loss) (1,681)                     (1,681)  
Balance at Mar. 31, 2021 3,624         $ 1     10,201     (6,578)  
Balance (in Shares) at Mar. 31, 2021           6,305,061              
Balance at Dec. 31, 2021 53,544 [1]         $ 2     72,540     (18,998)  
Balance (in Shares) at Dec. 31, 2021           16,756,042              
Stock-based compensation 601               601        
Net income (loss) 6,594                     6,594  
Balance at Mar. 31, 2022 $ 60,739         $ 2     $ 73,141     $ (12,404)  
Balance (in Shares) at Mar. 31, 2022           16,756,042              
[1] The condensed balance sheet at December 31, 2021 has been derived from the audited financial statements at that date.
XML 19 R7.htm IDEA: XBRL DOCUMENT v3.22.1
Business and Organization
3 Months Ended
Mar. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Business and Organization

Note 1. Business and Organization

 

Renovacor, Inc. (the “Company,” or “Renovacor”) (f/k/a Chardan Healthcare Acquisition 2 Corp. ("Chardan")), a Delaware corporation, is a biotechnology company focused on delivering innovative precision therapies to improve the lives of patients and families battling genetically-driven cardiovascular and mechanistically-related diseases. The Company’s initial focus is on the treatment of BCL2-associated athanogene 3 (BAG3) mutation-associated dilated cardiomyopathy ("DCM") ("BAG3 DCM"). BAG3 DCM is a heritable rare disease that leads to early onset, rapidly progressing heart failure and significant mortality and morbidity. The Company’s lead product candidate, REN-001, is a recombinant adeno-associated virus ("AAV") 9-based gene therapy designed to deliver a fully functional BAG3 gene to augment BAG3 protein levels in cardiomyocytes and slow or halt progression of BAG3 DCM.

 

The Company is subject to risks common to companies in the biopharmaceutical industry, including, but not limited to, risks related to the successful development and commercialization of product candidates, fluctuations in operating results and financial risks, the ability to successfully raise additional funds when needed, protection of proprietary rights and patent risks, patent litigation, compliance with government regulations, dependence on key personnel and prospective collaborative partners, and competition from competing products in the marketplace.

 

Merger Agreement

 

Prior to September 2, 2021, the Company was a special purpose acquisition company formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business transaction with one or more businesses or entities. On September 2, 2021 (the "Closing Date"), the Company consummated the business combination contemplated by that certain Agreement and Plan of Merger, dated March 22, 2021 (the “Merger Agreement”), by and among the Company, CHAQ2 Merger Sub, Inc., a wholly owned subsidiary of the Company (“Merger Sub”), and Renovacor Holdings, Inc. (f/k/a Renovacor, Inc. ("Old Renovacor")). Pursuant to the Merger Agreement, (i) Merger Sub merged with and into Old Renovacor, with Old Renovacor as the surviving company in the merger and, after giving effect to such merger, continuing as a wholly owned subsidiary of the Company (the “Merger”) and (ii) the Company’s name was changed from Chardan Healthcare Acquisition 2 Corp. to Renovacor, Inc. (the “Merger” and, together with the other transactions contemplated by the Merger Agreement, the “Business Combination”).

 

Liquidity Considerations

 

The Company has evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about its ability to continue as a going concern within one year after the date the financial statements are issued. As of March 31, 2022, the Company had an accumulated deficit of $12.4 million and a cash and cash equivalents balance of $70.1 million. The Company has incurred losses and negative cash flows from operations since inception. The Company expects to continue to incur substantial operating losses and negative cash flows for the foreseeable future and will require additional capital as it continues to advance REN-001 and/or any future product candidates through development.

 

The Company follows the provisions of Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 205-40, Presentation of Financial Statements—Going Concern, which requires management to assess the Company’s ability to continue as a going concern within one year after the date the financial statements are issued. Management currently anticipates that the Company’s balance of cash and cash equivalents, as of March 31, 2022, is sufficient to enable the Company to continue as a going concern through the one-year period subsequent to the filing date of this Quarterly Report on Form 10-Q. Management’s operating plan, which underlies the analysis of the Company’s ability to continue as a going concern, involves the estimation of the amount and timing of future cash inflows and outflows. Actual results could vary from the operating plan.

 

The Company has and will continue to evaluate available alternatives to extend its operations beyond this date, which include financing its operations through a combination of equity offerings, debt financings, collaborations, strategic alliances and licensing arrangements. However, the Company may be unable to raise additional funds or enter into such other agreements or arrangements when needed on favorable terms, or at all. If the Company fails to raise capital or enter into such agreements or arrangements as, and when, needed, it may have to significantly delay, scale back or discontinue the development and commercialization of one or more of its product candidates.

XML 20 R8.htm IDEA: XBRL DOCUMENT v3.22.1
Summary of Significant Accounting Policies
3 Months Ended
Mar. 31, 2022
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies

Note 2. Summary of Significant Accounting Policies

 

Basis of Presentation

 

The accompanying unaudited interim condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the United States Securities and Exchange Commission (“SEC”) for interim financial reporting. Accordingly, they do not include all of the information and disclosures required by U.S. GAAP for complete financial statements as certain footnotes or other financial information that are normally required by U.S. GAAP can be condensed or omitted. These condensed consolidated statements are unaudited and, in the opinion of management, include all adjustments (consisting of normal recurring adjustments and accruals) necessary to fairly present the results of the interim periods. The results of operations and cash flows for the three months ended March 31, 2022 are not necessarily indicative of the results that may be expected for the fiscal year ended December 31, 2022 or any other future period.

 

Reverse Recapitalization

 

The Business Combination was accounted for as a reverse recapitalization in accordance with U.S. GAAP (the “Reverse Recapitalization”). Under this method of accounting, the Company is treated as the “acquired” company and Old Renovacor is treated as the acquirer for financial reporting purposes. As a result, the consolidated assets, liabilities and results of operations prior to the Business Combination are those of Old Renovacor. Additionally, the shares and corresponding capital amounts and losses per share, prior to the Business Combination, have been retroactively restated based on shares reflecting the applicable exchange ratio resulting from the Common Per Share Merger Consideration and/or the Preferred Per Share Merger Consideration (each as defined by the Merger Agreement).

 

Emerging Growth Company Status

 

The Company is an "emerging growth company", as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”). Under the JOBS Act, the Company may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statement with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

 

Use of Estimates

 

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, expense, and related disclosures. The Company bases estimates and assumptions on historical experience when available and on various factors that it believes to be reasonable under the circumstances. The Company evaluates its estimates and assumptions on an ongoing basis. Estimates relied upon in preparing these financial statements relate to, but are not limited to, the fair value of financial instruments, stock-based compensation assumptions and accrued expenses (including accrued and prepaid clinical costs). Actual results may differ from these estimates under different assumptions or conditions.

 

Concentration of Credit Risk

 

Financial instruments that subject the Company to significant concentrations of credit risk consist primarily of cash primarily held at one financial institution, which, at times, may exceed federally insured limits, and cash equivalents consisting of investments in money market funds managed by a variety of financial institutions. The Company's credit risk is managed by investing in only highly rated money market instruments. As a result, no significant additional credit risk is believed by management to be inherent in the Company’s assets and the Company has not experienced any losses in such accounts and believes it is not exposed to any significant risk on such accounts.

 

Cash and Cash Equivalents

 

The Company considers all highly liquid investments with maturities of 90 days or less when purchased to be “cash equivalents.” Cash and cash equivalents at March 31, 2022 consisted of cash and money market funds.

 

Property and Equipment, net

 

Property and equipment is carried at acquisition cost less accumulated depreciation, subject to review for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable in accordance with ASC 360-10-35, Impairment or Disposal of Long-Lived Assets. The cost of normal, recurring, or periodic repairs and maintenance activities related to property and equipment, if any, are expensed as incurred. The cost for planned major maintenance activities, including the related acquisition or construction of assets, is capitalized if the repair will result in future economic benefits.

 

Depreciation and amortization are computed using the straight-line method based on the estimated useful lives of the related assets. Equipment and other long-lived assets are depreciated over three to five years. When an asset is disposed of, the associated cost and accumulated depreciation is removed from the related accounts on the Company's balance sheet with any resulting gain or loss included in the Company's condensed consolidated statement of operations.

 

Financial Instruments

 

The fair value of the Company’s financial instruments is determined and disclosed in accordance with the three-tier fair value hierarchy specified in Note 4, Fair Value Measurements. The Company is required to disclose the estimated fair values of its financial instruments. As of March 31, 2022 and December 31, 2021, the Company’s financial instruments consisted of cash equivalents and warrant and share earnout liabilities. As of March 31, 2022, the Company did not have any other derivatives, hedging instruments or other similar financial instruments.

 

Warrant Liability

 

The Company accounts for stock warrants as either equity instruments, liabilities or derivative liabilities in accordance with ASC Topic 480, Distinguishing Liabilities from Equity ("ASC 480") and/or ASC Topic 815, Derivatives and Hedging ("ASC 815"), depending on the specific terms of the warrant agreement. Liability-classified warrants are recorded at their estimated fair values at each reporting period until they are exercised, terminated, reclassified or otherwise settled. Changes in the estimated fair value of liability-classified warrants are recorded in Change in Fair Value of Warrant Liability in the Company’s condensed consolidated statements of operations. Equity-classified warrants are recorded within additional paid-in capital at the time of issuance and not subject to remeasurement.

 

Share Earnout Liability

 

The Company accounts for share earnout arrangements that represent equity-linked instruments as either liabilities or equity instruments in accordance with ASC 815, unless such arrangements are within the scope of ASC Topic 718, Compensation–Stock Compensation ("ASC 718"), depending on the specific terms of the contract. Contracts classified as liabilities are recorded at their estimated fair values at each reporting period until they are no longer outstanding. Changes in the estimated fair value of liability-classified share earnout arrangements are recorded in Change in Fair Value of Share Earnout Liability in the Company’s condensed consolidated statements of operations.

 

Research and Development Expense

 

The Company expenses research and development expenses as incurred. The Company’s research and development expenses consist primarily of personnel-related expenses such as salaries, stock-based compensation, and benefits, and external costs of outside vendors engaged to conduct preclinical development activities, including manufacturing of preclinical and clinical drug supply. The Company accrues for expenses related to development activities performed by third parties based on an evaluation of services received and efforts expended pursuant to the terms of the contractual arrangements. There may be instances in which payments made to the Company’s vendors will exceed the level of services provided and result in a prepayment of expenses. In accruing service fees, the Company estimates the time period over which services will be performed and the level of effort to be expended in each period. If the actual timing of the performance of services or the level of effort varies from the estimate, the Company will adjust the accrual or prepaid expense accordingly.

 

 

Stock-Based Compensation

 

The Company expenses stock-based compensation to employees and non-employees over the requisite service period, generally the vesting period, based on the estimated grant-date fair value of the awards. The Company accounts for forfeitures as they occur. Stock-based awards with graded-vesting schedules are recognized on a straight-line basis over the requisite service period for each separately vesting portion of the award. The Company estimates the fair value of stock option grants using the Black-Scholes option pricing model, and the assumptions used in calculating the fair value of stock-based awards represent management’s best estimates and involve inherent uncertainties and the application of management’s judgment. All stock-based compensation costs are recorded in general and administrative or research and development costs in the condensed consolidated statements of operations based upon the underlying individual’s role at the Company.

 

Income Taxes

 

In accordance with ASC 270, Interim Reporting, and ASC 740, Income Taxes, the Company is required at the end of each interim period to determine the best estimate of its annual effective tax rate and then apply that rate in providing for income taxes on a current year-to-date (interim period) basis. For the three months ended March 31, 2022 and 2021, the Company recorded no tax expense or benefit due to the expected current year loss and its historical losses. The Company has not recorded its net deferred tax asset as of either March 31, 2022 or December 31, 2021 because it maintained a full valuation allowance against all deferred tax assets as of these dates as management has determined that it is not more likely than not that the Company will realize these future tax benefits. As of March 31, 2022 and December 31, 2021, the Company had no uncertain tax positions.

 

Net Income (Loss) per Common Share

 

Basic net income (loss) per share of common stock is computed by dividing net loss applicable to common stockholders by the weighted-average number of shares of common stock outstanding during each period, which includes shares of common stock underlying the Pre-funded Warrant (as defined herein), as such warrant is exercisable, in whole or in part, for nominal cash consideration with no expiration date. Shares of common stock outstanding but subject to forfeiture and cancellation by the Company (e.g., Sponsor Earnout Shares, as defined in the Merger Agreement) are excluded from the weighted-average shares until the period in which such shares are no longer subject to forfeiture. Diluted net loss per share of common stock includes the effect, if any, from the potential exercise or conversion of securities, such as stock options, Public Warrants and Private Placement Warrants, and Sponsor Earnout Shares and Old Renovacor Earnout Shares (each as defined herein), which would result in the issuance of incremental shares of common stock, unless their effect would be anti-dilutive. See Note 13 for additional details.

 

New Accounting Pronouncements

 

From time to time, new accounting pronouncements are issued by the FASB and rules are issued by the SEC that the Company has or will adopt as of a specified date. Unless otherwise noted, management does not believe that any other recently issued accounting pronouncements issued by the FASB or guidance issued by the SEC had, or is expected to have, a material impact on the Company’s present or future consolidated financial statements.

 

Accounting Pronouncements Recently Adopted

 

In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842) ("ASU 2016-02"). ASU 2016-02 (amended by ASU 2019-10 and ASU 2020-05) is effective for non-public entities and emerging growth companies for fiscal years beginning after December 15, 2021 and interim periods within fiscal years beginning after December 15, 2022. The new standard establishes a right-of-use (ROU) model that requires a lessee to record a ROU asset and a lease liability on the balance sheet for all leases with terms longer than 12 months. Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition in the statement of operations. A modified retrospective transition approach is required at the beginning of the earliest comparative period presented in the financial statements, with certain practical expedients available. The Company adopted this standard effective January 1, 2022. The adoption did not have a material impact on the Company’s consolidated condensed financial statements as of the adoption date. However, should the Company enter into material operating leases in the future, such as real estate leases for its corporate headquarters and other office and lab space, the Company anticipates an increase in assets and liabilities due to the recognition of the required right-of use asset and corresponding lease liability for such lease obligations. See Note 14 for discussion of leasing transactions occurring after March 31, 2022.

XML 21 R9.htm IDEA: XBRL DOCUMENT v3.22.1
Merger and Recapitalization
3 Months Ended
Mar. 31, 2022
Business Combinations [Abstract]  
Merger and Recapitalization

Note 3. Merger and Recapitalization

 

Merger Agreement

 

As discussed in Note 1, on the Closing Date, the Company closed the Business Combination with Old Renovacor, as a result of which Old Renovacor became a wholly-owned subsidiary of the Company. While the Company was the legal acquirer of Old Renovacor in the business combination, for accounting purposes, the Merger is treated as a reverse recapitalization, whereby Old Renovacor is deemed to be the accounting acquirer, and the historical financial statements of Old Renovacor became the historical consolidated financial statements of the Company upon the closing of the Merger. Under this method of accounting, the Company was treated as the “acquired” company and Old Renovacor is treated as the acquirer for financial reporting purposes. Accordingly, for accounting purposes, the Merger was treated as the equivalent of Old Renovacor issuing stock for the net assets of the Company, accompanied by a recapitalization. The net assets of the Company were stated at historical cost, with no goodwill or other intangible assets recorded. Operations prior to the Merger are presented as those of Old Renovacor.

 

At the consummation of the Merger Agreement upon filing of a certificate of Merger, which occurred on the Closing Date (the "Effective Time"), an aggregate of 6,305,061 shares of the Company’s common stock, par value $0.0001 per share, plus 194,926 Exchanged Options (defined below) (the "Aggregate Merger Consideration") was issued to equityholders of Old Renovacor as of immediately prior to the Effective Time. Out of the Aggregate Merger Consideration, each holder of preferred stock of Old Renovacor, par value $0.0001 per share (the "Old Renovacor Preferred Stock") was entitled to receive a number of shares of the Company's common stock equal to the Preferred Per Share Merger Consideration (as defined in the Merger Agreement) with respect to such holder’s shares of Old Renovacor Preferred Stock. Each holder of common stock of Old Renovacor, par value $0.0001 per share (the "Old Renovacor Common Stock," and together with Old Renovacor’s preferred stock, the "Old Renovacor Capital Stock"), was entitled to receive a number of shares of the Company’s common stock equal to the Common Per Share Merger Consideration (as defined in the Merger Agreement) with respect to such holder’s shares of Old Renovacor Common Stock. In addition, pursuant to the Company's 2021 Investor Incentive Plan, a portion of the Aggregate Merger Consideration was allocated among certain Old Renovacor equityholders or their affiliates who elected to participate in the PIPE Investment on a pro rata basis based on their respective investment amounts.

 

Each option to purchase shares of Old Renovacor Common Stock ("Old Renovacor Option") outstanding as of immediately prior to the Effective Time was converted into an option to purchase a number of shares of the Company’s common stock (rounded down to the nearest whole number) equal to the product of the number of shares of Old Renovacor Common Stock subject to such Old Renovacor option and the Common Per Share Merger Consideration (an "Exchanged Option"), which Exchanged Option is subject to the same vesting terms applicable to the Old Renovacor Option as of immediately prior to the Effective Time.

 

The shares and corresponding capital amounts and loss per share related to Old Renovacor Common Stock prior to the Business Combination Transaction were retroactively restated to reflect the Common Per Share Merger Consideration and the Preferred Per Share Merger Consideration, as applicable.

 

Holders of Old Renovacor Capital Stock are entitled to receive up to an additional 1,922,816 shares of the Company’s common stock (the “Old Renovacor Earnout Shares”) as follows:

 

576,845 Old Renovacor Earnout Shares, in the aggregate, if at any time during the period beginning on the date of the Closing (the “Closing Date”) and ending on December 31, 2023 (the “First Earnout Period”), the volume-weighted average price ("VWAP") (as defined in the Merger Agreement) of the Company’s common stock over any twenty (20) Trading Days (as defined in the Merger Agreement) (which may or may not be consecutive) within any thirty (30) consecutive Trading Day period is greater than or equal to $17.50 per share of the Company’s common stock (the “First Milestone”).

 

An additional 576,845 Old Renovacor Earnout Shares, in the aggregate, if at any time during the period beginning on the Closing Date and ending on December 31, 2025 (the “Second Earnout Period”), the VWAP of the Company’s common stock over any twenty (20) Trading Days (which may or may not be consecutive) within any thirty (30) consecutive Trading Day period is greater than or equal to $25.00 per share of the Company’s common stock (the “Second Milestone”).

 

An additional 769,126 Old Renovacor Earnout Shares, in the aggregate, if at any time during the period beginning on the Closing Date and ending on December 31, 2027 (the “Third Earnout Period” and together with the First Earnout Period and the Second Earnout Period, each, an “Earnout Period” and collectively, the “Earnout Periods”), the VWAP of the Company’s common stock over any twenty (20) Trading Days (which may or may not be consecutive) within any thirty (30) consecutive Trading Day period is greater than or equal to $35.00 per share of the Company’s common stock (the “Third Milestone” and together with the First Milestone and the Second Milestone, the “Earnout Milestones”).

 

Upon the consummation of any Change in Control (as defined in the Merger Agreement) during any Earnout Period, any Earnout Milestone with respect to such Earnout Period that has not yet been achieved shall automatically be deemed to have been achieved regardless of the valuation of the Company’s common stock in such Change in Control transaction and the Company will take all actions necessary to provide for the issuance of the shares of the Company’s common stock comprising the applicable Old Renovacor Earnout Shares issuable in respect of such Earnout Milestone(s) prior to the consummation of such Change in Control.

 

Each holder of Old Renovacor's Capital Stock was entitled to such holder’s aggregate Per Share Earnout Consideration (as defined in the Merger Agreement) in respect of such shares of Old Renovacor's Capital Stock as described above. In addition, at the Effective Time, holders of Old Renovacor Options received the right to be granted an Earnout RSU Award (as defined in the Merger Agreement) in respect of such holder’s Old Renovacor Options, which entitle such holder to an aggregate number of shares of the Company's common stock equal to the aggregate Per Share Earnout Consideration in respect of the shares of Old Renovacor Capital Stock underlying such Old Renovacor Options, if any, subject to the satisfaction of the applicable vesting conditions with respect to the Exchanged Options issued in respect of such Renovacor Options at the Closing. See Note 11 for further details.

 

Further, under the terms of the Business Combination (as provided for in the Sponsor Support Agreement), certain Sponsor Shares totaling 500,000 were placed into escrow and subject to forfeiture (the "Sponsor Earnout Shares"). Such Sponsor Earnout Shares will be released from escrow if the weighted average sale price of the Company's common stock equals or exceeds the applicable Target Price (as set forth in the table below) for any 20 trading days within a 30-day trading period from the Effective Time until the applicable end date. Upon consummation of any Change in Control during any Earnout Period, any Earnout Milestone with respect to such Earnout Period that has not yet been achieved shall automatically be deemed to have been achieved regardless of the valuation of the per share common stock price in such Change in Control transaction. Any Sponsor Earnout Shares that remain unvested as of the expiration of the applicable earnout period shall be forfeited and canceled.

 

The Old Renovacor Earnout Shares and Sponsor Earnout Shares (collectively, the "Earnout Shares") are summarized, as set forth in the table below:

 

 

 

 

 

 

Old Renovacor

 

 

Sponsor

 

 

 

 

 

 

Target Price

 

 

Earnout Shares

 

 

Earnout Shares

 

 

Total

 

December 31, 2023

 

$

17.50

 

 

 

576,845

 

 

 

150,000

 

 

 

726,845

 

December 31, 2025

 

$

25.00

 

 

 

576,845

 

 

 

150,000

 

 

 

726,845

 

December 31, 2027

 

$

35.00

 

 

 

769,126

 

 

 

200,000

 

 

 

969,126

 

 

 

 

 

 

 

1,922,816

 

 

 

500,000

 

 

 

2,422,816

 

 

PIPE Investment (Private Placement)

 

Concurrently with the execution of the Merger Agreement, the Company entered into subscription agreements (the "Subscription Agreements"), with certain investors ("PIPE Investors"), including Chardan Healthcare, certain stockholders of Old Renovacor and certain other institutional and accredited investors, pursuant to which, on the Closing Date, and concurrently with the closing of the Business Combination, the PIPE Investors purchased an aggregate of 2,284,776 shares the Company's common stock, at a price of $10.00 per share, and a pre-funded warrant entitling the holder thereof to purchase 715,224 shares of the Company's common stock (the "Pre-Funded Warrant") at an initial purchase price of $9.99 per share underlying the Pre-Funded Warrant, for aggregate gross proceeds of approximately $30.0 million (the "PIPE Investment"). The Pre-Funded Warrant is immediately exercisable at an exercise price of $0.01 and is exercisable indefinitely, provided that the holder of the Pre-Funded Warrant is prohibited from exercising such Pre-Funded Warrant in an amount that would cause such holder’s beneficial ownership of our Common Stock to exceed 9.99%, which limitation may be increased up to 19.99% at the option of the holder from time to time.

 

 

The following table summarizes the elements of the net proceeds from the Merger:

 

(In thousands)

 

Amount

 

Cash – CHAQ trust and cash, net of redemptions

 

$

65,127

 

Cash – PIPE financing

 

 

29,993

 

Less: CHAQ and Old Renovacor transaction costs paid

 

 

(6,079

)

Less: Settlement of convertible note at closing

 

 

(2,500

)

   Effect of Merger, net of redemptions and transaction costs

 

$

86,541

 

 

The following table details the number of shares of common stock issued immediately following the consummation of the Merger:

 

 

 

Number of Shares

 

Common stock, outstanding prior to Merger

 

 

8,622,644

 

Less: redemption of CHAQ shares

 

 

(2,112,100

)

Common stock of CHAQ

 

 

6,510,544

 

CHAQ Founder shares

 

 

2,155,661

 

Shares issued in PIPE Financing

 

 

2,284,776

 

Merger and PIPE financing shares - common stock

 

 

10,950,981

 

Shares issued to Old Renovacor - common stock (1)

 

 

6,305,061

 

Total shares of common stock immediately after Merger (2)

 

 

17,256,042

 

____________________

(1)
The number of shares of common stock issued to Old Renovacor equityholders was determined based on (i) 1,987,636 shares of Old Renovacor Common Stock outstanding immediately prior to the closing of the Merger converted based on the Common Per Share Merger Consideration (as defined in the Merger Agreement) and (ii) 2,578,518 shares of Old Renovacor Preferred Stock outstanding immediately prior to the closing of the Merger converted based on the Preferred Per Share Merger Consideration (as defined in the Merger Agreement). All fractional shares were rounded down.
(2)
Includes 500,000 shares of common stock being held in escrow and subject to vesting or forfeiture based on satisfaction of the Earnout Milestones set forth in the Sponsor Support Agreement. Such shares are liability classified and included in the Share earnout liability as of December 31, 2021.

 

See Note 10 – Stockholders’ Equity for additional details of the Company’s capital stock.

XML 22 R10.htm IDEA: XBRL DOCUMENT v3.22.1
Fair Value Measurements
3 Months Ended
Mar. 31, 2022
Fair Value Disclosures [Abstract]  
Fair Value Measurements

Note 4. Fair Value Measurements

 

Assets and Liabilities Measured at Fair Value on a Recurring Basis

 

The Company applies the guidance in ASC 820, Fair Value Measurement, to account for financial assets and liabilities measured on a recurring basis. Fair value is measured at the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. As such, fair value is a market-based measurement that is determined based on assumptions that market participants would use in pricing an asset or liability.

 

The Company uses a fair value hierarchy, which distinguishes between assumptions based on market data (observable inputs) and an entity's own assumptions (unobservable inputs). The guidance requires that fair value measurements be classified and disclosed in one of the following three categories:

Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;
Level 2: Quoted prices in markets that are not active or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability; and
Level 3: Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e., supported by little or no market activity).

 

Determining which category an asset or liability falls within the hierarchy requires significant judgment. The Company evaluates its hierarchy disclosures each reporting period. There were no transfers between Level 1, 2 and 3 during the three months ended March 31, 2022.

 

The table below presents the liabilities measured and recorded in the financial statements at fair value on a recurring basis at March 31, 2022 and December 31, 2021 categorized by the level of inputs used in the valuation of each asset and liability.

 

 

 

March 31, 2022

 

(In thousands)

 

Total

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents – money market funds

 

$

69,089

 

 

$

69,089

 

 

$

 

 

$

 

Total assets

 

$

69,089

 

 

$

69,089

 

 

$

 

 

$

 

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

Warrant liability

 

$

3,885

 

 

$

 

 

$

 

 

$

3,885

 

Share earnout liability

 

 

4,090

 

 

 

 

 

 

 

 

 

4,090

 

Total liabilities

 

$

7,975

 

 

$

 

 

$

 

 

$

7,975

 

 

 

 

December 31, 2021

 

(In thousands)

 

Total

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents – money market funds

 

$

77,792

 

 

$

77,792

 

 

$

 

 

$

 

Total assets

 

$

77,792

 

 

$

77,792

 

 

$

 

 

$

 

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

Warrant liability

 

$

11,165

 

 

$

 

 

$

 

 

$

11,165

 

Share earnout liability

 

 

12,256

 

 

 

 

 

 

 

 

 

12,256

 

Total liabilities

 

$

23,421

 

 

$

 

 

$

 

 

$

23,421

 

 

 

 

Changes in Level 3 Liabilities Measured at Fair Value on a Recurring Basis

 

Warrant Liability and Earnout Share Liability

 

The reconciliation of the Company's warrant and earnout share liability measured at fair value on a recurring basis using unobservable inputs (Level 3) is as follows:

 

 

 

Warrant

 

 

Earnout Share

 

(In thousands)

 

Liability

 

 

Liability

 

Balance, December 31, 2021

 

$

11,165

 

 

$

12,256

 

Change in the fair value of liability

 

 

(7,280

)

 

 

(8,166

)

Balance, March 31, 2022

 

$

3,885

 

 

$

4,090

 

 

Assumptions Used in Determining Fair Value of Liability-Classified Warrants

 

The Company utilizes a Black-Scholes model to value the Private Placement Warrants at each reporting period, with changes in fair value recognized in the condensed consolidated statements of operations. The estimated fair value of the warrant liability is determined using Level 3 inputs. Inherent in an options pricing model are assumptions related to expected share-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the expected volatility of its common stock based on historical volatility of a peer group, considering the expected remaining life of the Private Placement Warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the valuation date for a maturity similar to the expected remaining life of the Private Placement Warrants. The expected life of the Private Placement Warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates to remain at zero.

 

The fair value of the Private Placement Warrants has been estimated with the following assumptions:

 

 

 

March 31,

 

 

December 31

 

 

 

2022

 

 

2021

 

Stock price

 

$

4.24

 

 

$

7.70

 

Strike price

 

$

11.50

 

 

$

11.50

 

Expected volatility

 

 

75.0

%

 

 

75.0

%

Risk-free interest rate

 

 

2.45

%

 

 

1.01

%

Expected dividend yield

 

 

 

 

 

 

Expected life (years)

 

 

3.07

 

 

 

3.31

 

Fair value per warrant

 

$

1.11

 

 

$

3.19

 

 

Assumptions Used in Determining Fair Value of Liability-Classified Earnout Shares

 

The Company utilizes a Monte Carlo simulation to value the Earnout Shares. The Company selected this model as it believes it is reflective of all significant assumptions that market participants would likely consider in negotiating the transfer of the Earnout Shares. Such assumptions include, among other inputs, expected stock price volatility, risk-free rates, and change in control assumptions. The Company estimates probability of a change in control based on both market data for the biotechnology industry and managements own assessment. The Company estimates the expected volatility of its common stock based on historical volatility of a peer group, considering the remaining term of the Earnout Shares. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the valuation date for a maturity similar to the expected remaining life of the Earnout Shares. The expected life of the Earnout Shares is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates to remain at zero.

 

The fair value of the Earnout Shares has been estimated with the following assumptions:

 

 

 

March 31,

 

 

December 31

 

 

 

2022

 

 

2021

 

Stock price

 

$

4.24

 

 

$

7.70

 

Probability of Change in Control

 

 

7.5

%

 

 

7.5

%

Expected volatility

 

 

75.0

%

 

 

75.0

%

Risk-free interest rate

 

 

2.41

%

 

 

1.35

%

Expected dividend yield

 

 

 

 

 

 

Expected life (years)

 

 

5.76

 

 

 

6.00

 

Fair value per share

 

$

1.69

 

 

$

5.06

 

 

XML 23 R11.htm IDEA: XBRL DOCUMENT v3.22.1
Property and Equipment
3 Months Ended
Mar. 31, 2022
Property, Plant and Equipment [Abstract]  
Property and Equipment

Note 5. Property and Equipment

 

Property and equipment, net, consisted of the following:

 

 

 

March 31,

 

 

December 31,

 

($ in thousands)

 

2022

 

 

2021

 

Laboratory equipment

 

$

380

 

 

$

380

 

Less: accumulated amortization

 

 

(18

)

 

 

(1

)

Property and equipment, net

 

$

362

 

 

$

379

 

XML 24 R12.htm IDEA: XBRL DOCUMENT v3.22.1
Prepaid Expenses
3 Months Ended
Mar. 31, 2022
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]  
Prepaid Expenses

Note 6. Prepaid Expenses

 

Prepaid expenses consisted of the following:

 

 

 

March 31,

 

 

December 31,

 

($ in thousands)

 

2022

 

 

2021

 

Research and development costs

 

$

483

 

 

$

209

 

Insurance

 

 

882

 

 

 

1,369

 

Other

 

 

258

 

 

 

185

 

Total prepaid expenses

 

$

1,623

 

 

$

1,763

 

XML 25 R13.htm IDEA: XBRL DOCUMENT v3.22.1
Accrued Expenses
3 Months Ended
Mar. 31, 2022
Payables and Accruals [Abstract]  
Accrued Expenses

Note 7. Accrued Expenses

 

Accrued expenses consisted of the following:

 

 

 

March 31,

 

 

December 31,

 

($ in thousands)

 

2022

 

 

2021

 

Employee compensation and benefits

 

$

688

 

 

$

1,282

 

External research and development expenses

 

 

608

 

 

 

409

 

Property and equipment

 

 

 

 

 

360

 

Professional fees

 

 

149

 

 

 

347

 

Other

 

 

171

 

 

 

100

 

Total accrued expenses

 

$

1,616

 

 

$

2,498

 

XML 26 R14.htm IDEA: XBRL DOCUMENT v3.22.1
Commitments and Contingencies
3 Months Ended
Mar. 31, 2022
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies

Note 8. Commitments and Contingencies

 

Legal Proceedings

 

The Company is not currently subject to any material legal proceedings.

 

License and Sponsored Research Agreements

 

The Company is obligated to compensate Temple pursuant to the Temple License Agreement and is committed to funding the Temple SRA as further described in Note 9.

 

Lease Commitments

 

In April 2022, the Company entered into a lease agreement relating to office space in Cambridge, Massachusetts, as more fully described in Note 14.

XML 27 R15.htm IDEA: XBRL DOCUMENT v3.22.1
License and Sponsored Research Agreements
3 Months Ended
Mar. 31, 2022
Research and Development [Abstract]  
License and Sponsored Research Agreements

Note 9. License and Sponsored Research Agreements

 

Temple University

 

In August 2019, Old Renovacor entered into an exclusive license agreement effective as of August 12, 2019 (the “Temple License Agreement”) and a sponsored research agreement, which was amended effective as of August 12, 2019, August 27, 2019 and further amended effective as of July 1, 2021 (as amended to date, the “Temple SRA”), each with Temple University (“Temple”). The Temple License Agreement was assigned to the Company in connection with the Merger. Pursuant to the Temple License Agreement, Temple granted the Company an exclusive, royalty-bearing, sublicensable, worldwide license to certain patent rights in certain inventions related to the use of BAG3 technology for the diagnosis, prevention or treatment of diseases in humans, and a non-exclusive license to use specified know-how and materials with a provision that Temple will retain the rights to practice the patent rights for non-commercial educational research purposes only and shall be free to sublicense these rights to other non-profit educational and research institutions solely for noncommercial research and educational purposes. Under the Temple SRA, Temple is primarily responsible for preclinical development activities with respect to licensed technology and know-how through the pursuit of specific investigational questions which, in the aggregate, are intended to provide important supporting data for a future IND-enabling studies and for potential future marketing efforts. The Company is responsible for all subsequent clinical development and commercialization activities with respect to the licensed technology and know-how.
 

 

Upon execution of the Temple License Agreement in 2019, Old Renovacor issued to Temple 97,879 shares of Old Renovacor Common Stock on the effective date of the transaction and agreed to issue Temple an additional 9,130 shares of Old Renovacor Common Stock upon the closing date of the second tranche of the Series A Convertible Preferred Stock, which occurred in November 2020. The Company also reimbursed Temple for the prosecution and maintenance costs incurred by Temple for the licensed patent rights prior to the Company entering into the License Agreement, and the Company is responsible for all the ongoing costs relating to the prosecution and maintenance of the Temple patent rights licensed to the Company going forward. The Company also agreed to pay Temple a minimum annual administrative fee of $20,000 per year beginning with the effective date of the Temple License Agreement and continuing each annual anniversary thereafter. Further, as required by Section 12.2 of the License Agreement, the Company was required to pay, and recorded to research and development expense during the third quarter of 2021, an assignment fee of $100,000 to Temple following closing of the Merger related to the assignment of the License Agreement from Old Renovacor to the Company.

 

The Temple License Agreement requires the Company to pay up to an aggregate of $1.25 million to Temple upon the achievement of certain developmental, regulatory and commercial milestones for the first licensed product that achieves said milestones regardless of the number of licensed products that achieve them. In addition, the Company is required to pay Temple a low single-digit royalty on net sales of any product utilizing the patent rights under the License Agreement, up to 50% of which may be reduced by payments Renovacor makes to third parties for freedom to operate. In addition, the Company must also pay a percentage of all consideration based on a percentage of sublicense consideration received by it, which percentage ranges from the mid-teens to mid-twenties depending on the stage of development at the time of the sublicense agreement.

 

The Temple License Agreement will remain effective until (i) the expiration date of the last-to-expire patents covered under the License Agreement (currently expected to occur in 2041); (ii) the termination by Temple upon (a) an uncured breach by the Company, with a 60-day notification period, (b) the Company’s filing of a voluntary petition in bankruptcy or related proceeding, providing such petition is not dismissed within 90 days after the filing thereof, (c) a failure by the Company to meet certain milestones set forth in the Licensed Agreement, or (d) non-payment of undisputed monies due to Temple, with a 30-day notification period. Additionally, the Company may terminate the entire agreement or with respect to an individual patent or patent application, if desired, subject a 90-day notification period.

 

As it relates to the Temple SRA, prior to the amendment entered into in August 2021 and effective as of July 1, 2021, Temple was to conduct certain preclinical activities for a three-year period, unless terminated sooner or extended by mutual written consent, for which the Company was obligated to fund approximately $0.9 million over the three-year initial term of the Temple SRA. The Temple SRA was further amended effective as of July 1, 2021 (the “2021 Amendment”) to, among other things, revise the period of performance, scope of work, and the budget. Following the 2021 Amendment, the Company is expected to fund up to a total of approximately $5.3 million to Temple through June 30, 2024, pursuant to the Temple SRA, of which approximately $1.5 million has been funded and/or incurred since inception of the Temple SRA through March 31, 2022.

 

During the three months ended March 31, 2022 and 2021, the Company recorded research and development expenses of approximately $0.2 million and $0.1 million, respectively, related to the Temple SRA.

XML 28 R16.htm IDEA: XBRL DOCUMENT v3.22.1
Stockholder's Equity
3 Months Ended
Mar. 31, 2022
Stockholders' Equity Note [Abstract]  
Stockholder's Equity

Note 10. Stockholder’s Equity

 

Common Stock

 

Upon closing of the Merger, pursuant to the terms of the Second Amended and Restated Certificate of Incorporation, the Company was authorized to issue up to 100,000,000 shares of common stock, par value $0.0001 per share (the "Common Stock").

 

As discussed in Note 3, the Company has retroactively adjusted the shares issued and outstanding prior to September 2, 2021 to give effect to the Common Per Share Merger Consideration (as defined in the Merger Agreement) to determine the number of shares of common stock into which they were converted.

 

Prior to the Merger, the Company was authorized to issue up to 6,000,000 shares of common stock, of which 1,987,636 were issued and outstanding immediately prior to the Closing Date. See Note 3.

 

Preferred Stock

 

Upon closing of the Merger, pursuant to the terms of the Second Amended and Restated Certificate of Incorporation, the Company was authorized to issue up to 1,000,000 shares of undesignated preferred stock, par value $0.0001 (the "Undesignated Preferred Stock"). The Company's board of directors or any committee thereof is expressly authorized, to the fullest extent permitted by law, to provide by resolution or resolutions for, out of the unissued shares of Undesignated Preferred Stock, the issuance of the shares of Undesignated Preferred Stock in one or more series, and by filing a certificate of designations pursuant to the General Corporate Law of the State of Delaware, to establish or change from time to time the number of shares of each such series, and to fix the designations, powers, including voting powers, full or limited, or no voting powers, preferences and the relative, participating, optional or other special rights of the shares of each series and any qualifications, limitations and restrictions thereof.

 

As discussed in Note 3, the Company has retroactively adjusted the shares issued and outstanding prior to September 2, 2021 to give effect to the Preferred Per Share Merger Consideration (as defined in the Merger Agreement) to determine the number of shares of common stock into which they were converted.

 

Prior to the Merger, the Company was authorized to issue up to 3,333,283 shares of its Series A convertible preferred stock, par value $0.0001 ("Series A Preferred Stock"), of which 2,578,518 were issued and outstanding immediately prior to the Closing Date. See Note 3. The Series A Preferred Stock, prior to consummation of the Business Combination, was convertible into common stock at the option of the holder at any time and without payment of any additional consideration. Each share of Series A Preferred Stock was convertible into a number of fully paid shares of common stock as is determined by dividing the Series A Preferred Stock original issuance price ($4.065063) by the Series A Preferred Stock conversion price (initially equal to $4.065063). Provided, however, shares of Series A Preferred Stock would automatically be converted into shares of common stock upon either (a) the closing of an underwritten public offering at a price of at least $12.20 per share resulting in at least $60 million of gross proceeds, prior to deductions for underwriting discounts, commission, and expenses, or (b) the date and time, or occurrence of an event, specified by a vote of at least a majority of the holders of the Series A Preferred Stock then outstanding. The Series A Preferred Stock was subject to redemption under certain deemed liquidation events and the holders were entitled to a liquidation preference in the event of a voluntary or involuntary liquidation, dissolution or winding-up of the Company, or deemed liquidation event of the Company (which includes certain mergers and asset transfers). The liquidation preference was an amount equal $4.065063, plus cumulative accrued dividends to date on such shares.

 

Assumed Public Warrants

 

Prior to the Merger, the Company had outstanding 8,622,644 warrants (the "Public Warrants") which were issued in connection with the Company's initial public offering in April 2020 (the "Chardan IPO"). Each Public Warrant entitles the holder to purchase one-half of one share of the Company's common stock at an exercise price of $11.50 per whole share, subject to adjustment. No fractional shares will be issued upon exercise of the Public Warrants. Therefore, the Public Warrants must be exercised in multiples of two Public Warrants for one share of the Company's common stock. The Public Warrants became exercisable upon the closing of the Business Combination; provided the Company has an effective and current registration statement covering the shares of Company common stock issuable upon the exercise of the Public Warrants and a current prospectus relating to such shares of common stock. The Public Warrants will expire five years following the Closing Date or earlier upon redemption or liquidation.

 

 

The Company may redeem the Public Warrants:

in whole and not in part;
at a price of $0.01 per Public Warrant;
at any time during the exercise period;
upon a minimum of 30 days’ prior written notice of redemption;
if, and only if, the last sale price of the Company’s common stock equals or exceeds $16.00 per share for any 10 trading days within a 30-trading day period ending on the third business day prior to the date on which the Company sends the notice of redemption to the warrant holders; and
if, and only if, there is a current registration statement in effect with respect to the shares of common stock underlying such Public Warrants at the time of redemption and for the entire 30-day trading period referred to above and continuing each day thereafter until the date of redemption.

 

To date, certain of the above conditions have not been met to redeem the Public Warrants. If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement.

 

The exercise price and number of shares of Common Stock issuable upon exercise of the Public Warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. Additionally, in no event will the Company be required to net cash settle the Public Warrants.

 

The Company determined that the Public Warrants met all of the criteria for equity classification. Accordingly, upon closing of the Merger, the Public Warrants were recorded as a component of additional paid-in capital.

 

Assumed Private Placement Warrants

 

Prior to the Merger, the Company had outstanding 3,500,000 warrants (the "Private Placement Warrants") which were issued simultaneously with the closing of the Chardan IPO, pursuant to a private placement transaction. Each Private Placement Warrant is exercisable to purchase one share of common stock at an exercise price of $11.50. The Private Placement Warrants are identical to the Public Warrants except that the Private Placement Warrants (i) will be exercisable for cash (even if a registration statement covering the shares of common stock issuable upon exercise of such warrants is not effective) or on a cashless basis, at the holder’s option, and (ii) will not be non-redeemable by the Company, in each case, so long as they are held by the initial purchasers or their permitted transferees. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants. The Private Placement Warrants purchased by Chardan will not be exercisable more than five years from the effective date of the Chardan IPO, in accordance with FINRA Rule 5110(f)(2)(G)(i), as long as Chardan Capital Markets or any of its related persons beneficially own these Private Placement Warrants.

 

The Private Placement Warrants are not indexed to the Company’s common stock in the manner contemplated by ASC 815-40-15 because the holder of the instrument is not an input into the pricing of a fixed-for-fixed option on equity shares. The Company classifies the Private Placement Warrants as derivative liabilities in its condensed consolidated balance sheets. The Company measures the fair value of the warrants at the end of each reporting period and recognizes changes in the fair value from the prior period in the Company’s operating results for the current period. Refer to Note 4 for discussion of fair value measurement of the warrant liabilities.

 

 

The following table summarizes outstanding warrants to purchase shares of the Company’s common stock as of March 31, 2022 and December 31, 2021:

 

 

 

Number of Warrants

 

 

 

 

 

 

 

 

 

March 31,

 

 

December 31

 

 

Weighted-Average

 

 

 

 

 

 

2022

 

 

2021

 

 

Exercise Price

 

 

Expiration Date

 

Liability-classified Warrants

 

 

 

 

 

 

 

 

 

 

 

 

 

April 2020 Private Placement Warrants

 

 

3,500,000

 

 

 

3,500,000

 

 

 

$

11.50

 

 

4/23/2025

 

 

 

 

3,500,000

 

 

 

3,500,000

 

 

 

 

 

 

 

 

Equity-classified Warrants

 

 

 

 

 

 

 

 

 

 

 

 

 

April 2020 Public Warrants (1)

 

 

8,622,644

 

 

 

8,622,644

 

 

 

$

11.50

 

 

9/2/2026

 

September 2021 Pre-Funded Warrants (2)

 

 

715,224

 

 

 

715,224

 

 

 

$

0.01

 

 

 

 

 

 

 

9,337,868

 

 

 

9,337,868

 

 

 

 

 

 

 

 

Total outstanding

 

 

12,837,868

 

 

 

12,837,868

 

 

 

 

 

 

 

 

———————

(1)
Public Warrants assumed in the Merger. Each warrant share is exercisable for one-half share of common stock, provided, however, each warrant must be exercised in multiples of two.
(2)
Pre-Funded Warrant issued in connection with PIPE Investment (Note 3). Each warrant share is exercisable indefinitely for one share of common stock.

 

Capital Stock Reserves

 

As of March 31, 2022, the Company reserved the following shares of common stock for future issuance:

 

 

 

Amount

 

Shares issuable upon exercise of pre-funded warrants outstanding

 

 

715,224

 

Shares issuable upon exercise of warrants outstanding

 

 

7,811,322

 

Shares issuable upon issuance of contingent consideration (Earnout Shares and Earnout RSUs)

 

 

1,994,338

 

Shares issuable upon exercise of outstanding stock options

 

 

1,941,099

 

Shares issuable upon vesting of time-based restricted stock units

 

 

163,350

 

Shares reserved for future issuance under 2021 Incentive Plan

 

 

1,025,170

 

Total

 

 

13,650,503

 

XML 29 R17.htm IDEA: XBRL DOCUMENT v3.22.1
Stock-based Compensation
3 Months Ended
Mar. 31, 2022
Share-based Payment Arrangement [Abstract]  
Stock-based Compensation

Note 11. Stock-based Compensation

 

Equity Incentive Plans

 

As of March 31, 2022, the only equity compensation plan from which the Company may currently issue new awards is the Company’s 2021 Omnibus Incentive Plan (the “2021 Plan”), as more fully described below.

 

2018 Stock Option and Grant Plan

 

Prior to the Merger, Old Renovacor maintained its 2018 Stock Option and Grant Plan (the "2018 Plan"), under which Old Renovacor granted incentive stock options, non-qualified stock options and restricted stock awards to its employees and certain non-employees, including consultants, advisors and directors. The maximum aggregate shares of common stock that was subject to awards and issuable under the 2018 Plan was 1,118,869 prior to the Merger.

 

As more fully described in Note 3, in connection with the Merger, each Old Renovacor Option that was outstanding and unexercised immediately prior to the Effective Time (whether vested or unvested) was assumed by the Company and converted into an option to purchase an adjusted number of shares of the Company's common stock at an adjusted exercise price per share, based on the Per Common Share Merger Consideration, and will continue to be governed by substantially the same terms and conditions, including vesting, as were applicable to the former option. Each Exchanged Option is exercisable for a number of whole shares of common stock equal to the product of the number of shares of Old Renovacor Common Stock underlying such Old Renovacor Options multiplied by the Per Common Share Merger Consideration, and the per share exercise price of such Exchanged Option is equal to the quotient determined by dividing the exercise price per share of the Old Renovacor Option by the Per Common Share Merger Consideration. Following the closing of the Merger, no new awards may be made under the 2018 Plan.

 

Upon the closing of the Merger, the outstanding and unexercised Old Renovacor Options became options to purchase an aggregate 194,926 shares of the Company’s common stock at an average exercise price of $5.66 per share. The Company accounted for the Exchanged Options as a modification of the existing options. Incremental compensation costs, measured as the excess, if any, of the fair value of the modified options over the fair value of the original options immediately before its terms are modified, is measured based on the fair value of the underlying shares and other pertinent factors at the modification date. The impact of the option modifications were de minimis.

 

2021 Omnibus Incentive Plan

 

At the Effective Time, the Company adopted the 2021 Plan which permits the granting of incentive stock options, non-qualified options, stock appreciation rights, restricted stock, restricted stock units and other stock-based award, and performance awards to employees, directors, and non-employee consultants and/or advisors. As of March 31, 2022, 3,008,803 shares of Common Stock are authorized for issuance pursuant to awards under the 2021 Plan. The pool of available shares will be automatically increased on the first day of each calendar year, beginning January 1, 2022 and ending January 1, 2031, by an amount equal to the lesser of (i) 4% of the outstanding shares of our Common Stock determined on a fully-diluted basis as of the immediately preceding December 31 and (ii) such smaller number of shares as determined by the Company's board of directors.

 

In addition, any awards outstanding under the 2018 Plan upon the closing of the Business Combination, after adjustment for the Business Combination, remain outstanding. If any of those awards subsequently expire, terminate, or are surrendered or forfeited for any reason without issuance of shares after the closing of the Business Combination, the shares of the Company's common stock underlying those awards will automatically become available for issuance under the 2021 Plan. No new awards may be made under the 2018 Plan.

 

The exercise prices, vesting and other restrictions of the awards to be granted under the 2021 Plan are determined by the board of directors, except that no stock option may be issued with an exercise price less than the fair market value of the common stock at the date of the grant or have a term in excess of ten years. Options granted under the 2021 Plan are exercisable in whole or in part at any time subsequent to vesting.

 

As of March 31, 2022, options exercisable for 1,748,761 shares of common stock and 234,872 restricted stock units (including 71,522 Earnout RSUs) were outstanding, and 1,025,170 shares of common stock units remain available for future issuance under the 2021 Plan.

 

 

Accounting for Stock-based Compensation

 

The Company recognizes non-cash compensation expense for stock-based awards under the Company’s equity incentive plans over an award’s requisite service period, or vesting period, using the straight-line attribution method, based on their grant date fair value, determined using the Black-Scholes option-pricing model. Generally, the Company issues awards with only service-based vesting conditions and records the expense for these awards using the straight-line method. The Company recognizes forfeitures related to stock-based compensation awards as they occur and reverses any previously recognized compensation cost associated with forfeited awards in the period the forfeiture occurs.

 

The Company classifies stock-based compensation expense in the statement of operations in the same manner in which the award recipients’ payroll costs are classified or in which the award recipients’ service payments are classified. Total stock-based compensation expense attributable to stock-based payments made to employees, consultants and directors included in operating expenses in the Company's condensed consolidated statements of operations for the three months ended March 31, 2022 and 2021 was as follows:


 

 

 

Three months ended

 

 

 

March 31,

 

($ in thousands)

 

2022

 

 

2021

 

Research and development

 

$

345

 

 

$

3

 

General and administrative

 

 

256

 

 

 

4

 

Total stock-based compensation expense

 

$

601

 

 

$

7

 

 

Stock Option Awards

 

Assumptions Used in Determining Fair Value of Stock Options

 

Inherent in the Black-Scholes option-pricing model are the following assumptions:

 

Volatility. The Company lacks company-specific historical and implied volatility information. Therefore, the Company estimates the expected stock volatility based on the historical volatility of a publicly traded set of peer companies over a period of time commensurate with the expected term of the stock options. The Company expects to continue to do so until it has adequate historical data regarding the volatility of the Company's traded stock price.

 

Expected term. The Company uses the simplified method described in the SEC’s Staff Accounting Bulletin No. 107, Share-Based Payment (“SAB 107”), to determine the expected life of the option grants.

 

Risk-free interest rate. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant commensurate with the expected term assumption.

 

Dividend rate. The dividend rate is based on the historical rate, which the Company anticipates will remain at zero.

 

Forfeitures. The Company accounts for forfeitures when they occur. Ultimately, the actual expense recognized over the vesting period will be for only those shares that vest.

 

 

Prior to the Business Combination, the grant date fair value of the shares of Old Renovacor common stock was determined by the Old Renovacor's board of directors with the assistance of management using valuation methodologies which utilize certain assumptions including probability weighting of events, volatility, time to liquidation, a risk-free interest rate, and an assumption for a discount for lack of marketability. In determining the fair value of the shares of Old Renovacor's common stock, the methodologies used to estimate the enterprise value were performed using methodologies, approaches, and assumptions consistent with the American Institute of Certified Public Accountants Accounting and Valuation Guide, Valuation of Privately-Held-Company Equity Securities Issued as Compensation. Subsequent to the Business Combination, the Company utilizes the price of its publicly-traded common stock to determine the grant date fair value of awards.

 

The fair value of each option award at the date of grant was estimated using the Black-Scholes option pricing model. All options granted during the three months ended March 31, 2022 and 2021 were granted at exercise prices equal to the fair market value of the common stock on the dates of grant.

 

The following table provides the weighted-average assumptions used in determining the fair value of option awards to purchase 587,650 and 32,808 shares of common stock granted during the three months ended March 31, 2022 and 2021, respectively:

 

 

 

Three months ended

 

 

 

March 31,

 

 

 

2022

 

 

2021

 

Expected volatility

 

 

76.2

%

 

 

73.6

%

Risk-free interest rate

 

 

1.92

%

 

 

0.59

%

Expected dividend yield

 

 

 

 

 

 

Expected term (years)

 

 

6.08

 

 

 

6.08

 

 

The weighted average fair value of the options granted was $3.87 and $2.32 per share for the three months ended March 31, 2022 and 2021, respectively.

 

Stock Option Activity

 

The following table summarizes stock option activity for the three months ended March 31,2022:

 

($ in thousands, except share and per share data)

 

Stock
Options

 

 

Weighted-Average
Exercise Price

 

 

Weighted-Average
Remaining
Contractual Life
(in years)

 

 

Aggregate
Intrinsic
Value

 

Outstanding at December 31, 2021

 

 

1,376,937

 

 

$

7.61

 

 

 

9.5

 

 

$

676

 

Granted

 

 

587,650

 

 

 

5.76

 

 

 

 

 

 

 

Exercised

 

 

 

 

 

 

 

 

 

 

 

 

Forfeited

 

 

(23,488

)

 

 

7.54

 

 

 

 

 

 

 

Expired

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding at March 31, 2022 (1)

 

 

1,941,099

 

 

$

7.05

 

 

 

9.4

 

 

$

308

 

Exercisable at March 31, 2022

 

 

211,780

 

 

$

6.73

 

 

 

8.2

 

 

$

249

 

 

_____________________________________

(1)
Includes both vested stock options as well as unvested stock options for which the requisite service period has not been rendered but that are expected to vest based on achievement of a service condition.

 

The fair value of options that vested during the three months ended March 31, 2022 was less than $0.3 million. As of March 31, 2022, there was approximately $7.4 million of unrecognized stock-based compensation expense related to unvested stock options, which the Company expects to recognize over a weighted average period of 3.5 years.

 

 

Restricted Stock Awards

 

In connection with the closing of the Merger, all unvested restricted stock awards outstanding immediately prior to the Effective Time became fully vested, resulting in the recognition of less than $0.1 million in stock-based compensation expense. Additionally, pursuant to the provisions of the Merger Agreement, the Company issued 72,546 Earnout RSUs during the fourth quarter of 2021 which remain unvested at March 31, 2022, representing holders of Old Renovacor Options aggregate Per Share Earnout Consideration (as defined in the Merger Agreement) in respect of such shares of Old Renovacor Options. See Note 3 for details.

 

Restricted Stock Unit Activity

 

The following table summarizes restricted stock unit activity for the three months ended March 31, 2022:

 

 

 

Time-based Awards

 

 

Market-based Awards

 

($ in thousands, except per share data)

 

Number of Shares

 

 

Weighted-Average
Grant Date
Fair Value

 

 

Number of Shares

 

 

Weighted-Average
Grant Date
Fair Value

 

Nonvested shares at December 31, 2021

 

 

 

 

$

 

 

 

72,546

 

 

$

6.42

 

Granted

 

 

163,350

 

 

 

6.45

 

 

 

 

 

 

 

Forfeited

 

 

 

 

 

 

 

 

(1,024

)

 

 

6.42

 

Vested

 

 

 

 

 

 

 

 

 

 

 

 

Nonvested shares at March 31, 2022

 

 

163,350

 

 

$

6.45

 

 

 

71,522

 

 

$

6.42

 

 

As of March 31, 2022, there was $1.0 million of unrecognized compensation cost related to the time-based awards and $0.5 million of unrecognized compensation cost related to the market-based awards, which is expected to be recognized over a weighted average period of 3.8 and 5.76 years, respectively.

XML 30 R18.htm IDEA: XBRL DOCUMENT v3.22.1
Related Parties
3 Months Ended
Mar. 31, 2022
Related Party Transactions [Abstract]  
Related Parties

Note 12. Related Parties

 

Sponsor Ownership

 

Jonas Grossman, a member of the Company's board of directors since 2018, is a managing member of Chardan Capital Markets, LLC ("Chardan CM"), an affiliate of the Sponsor. Additionally, Gbola Amusa, a member of the Company's board of directors since June 2018, is a partner of Chardan CM. As of March 31, 2022, the Sponsor beneficially owned 1,605,661 shares of the Company’s common stock, excluding the Sponsor Earnout Shares being held in escrow and subject to vesting or forfeiture based on satisfaction of the Earnout Milestones set forth in that certain Sponsor Support Agreement, representing approximately 9.6% of the Company's outstanding common stock. An affiliate of the Sponsor, Chardan Healthcare Investments LLC, also owns 250,000 shares of the Company’s common stock.

 

In February 2022, Chardan Healthcare, an affiliate of the Sponsor, distributed 250,000 shares of the Company's stock for no consideration to certain of its members and employees representing each individual's pro-rata contributions to Chardan Healthcare, including 40,000 shares each to Messrs. Grossman and Amusa.

 

In April 2022, Chardan Investments 2, LLC, an affiliate of the Sponsor, distributed 1,605,661 shares of the Company's stock for no consideration to certain of its members representing each individual's pro-rata contributions to Chardan Investments 2, LLC, including 354,657 shares to Mr. Grossman and 238,588 shares to Mr. Amusa.

 

Prior to the Merger, in December 2018, the Sponsor and certain of its employees purchased 5,000,000 shares of the Company's Common Stock for an aggregate purchase price of $25,000 and, in April 2020, canceled 2,556,250 of their shares, resulting in 2,443,750 remaining shares owned by the Sponsor and certain of its employees ("Sponsor Shares"). In June 2020, an additional 288,089 Sponsor Shares were canceled, and 500,000 shares became Sponsor Earnout Shares pursuant to the Sponsor Support Agreement upon the closing of the Business Combination.

 

Further, in April 2020, the Sponsor purchased 3,500,000 Private Placement Warrants at $0.40 per warrant (for a total purchase price of $1.4 million), as more fully described in Note 10.

 

 

Convertible Note

 

On July 20, 2021, in accordance with the Merger Agreement and the Note Purchase Agreement, Old Renovacor issued a $2.5 million Convertible Promissory Note in exchange for $2.5 million in cash to be used to finance Old Renovacor’s operations through the consummation of the Merger. In connection with the consummation of the Merger, the total principal of $2.5 million converted automatically into shares of the Company’s common stock, at a price per share equal to $10.00. All accrued and unpaid interest was cash settled following the Closing Date.

 

PIPE Investment (Private Placement)

 

Concurrently with the execution of the Merger Agreement, the Company entered into Subscription Agreements with the PIPE Investors, including Chardan Healthcare Investments, LLC, an affiliate of the Sponsor, certain stockholders of Old Renovacor and certain other institutional and accredited investors, pursuant to which, on September 2, 2021, in connection with the consummation of the Business Combination, the PIPE Investors purchased an aggregate of 2,284,776 shares of the Company's common stock and the Pre-Funded Warrant to purchase 715,224 shares of the Company's Common Stock, as more fully described in Note 3.

 

Agreements with Dr. Arthur Feldman

 

In August 2019, Old Renovacor entered into a consulting agreement (the "Feldman Consulting Agreement") with its founder and 5% or greater stockholder, Dr. Arthur Feldman, pursuant to which Dr. Feldman agreed to perform certain consulting services for Old Renovacor in exchange for a consulting fee of $8,333 per calendar month. The Feldman Consulting Agreement has a term of three years, subject to automatic renewal for successive one-year terms unless earlier terminated. The Company amended the Feldman Consulting Agreement on September 2, 2021, to appoint Dr. Feldman as the Company's Chief Scientific Advisor.

 

The Company incurred consulting fees with Dr. Arthur Feldman, the founder and prior director Old Renovacor, of less than $0.1 million during each of the three months ended March 31, 2022 and 2021. As of March 31, 2022, no amounts were due to Dr. Feldman.

 

Agreements with Temple

 

Dr. Arthur Feldman, the Company's founder, 5% or greater stockholder and current Chief Scientific Advisor, is an employee of Temple. During the three months ended March 31, 2022 and 2021, the Company recorded research and development expenses of approximately $0.2 million and $0.1 million, respectively, related to the Temple SRA. See Note 8 for further information on the Temple SRA.

XML 31 R19.htm IDEA: XBRL DOCUMENT v3.22.1
Net Income (Loss) Per Share
3 Months Ended
Mar. 31, 2022
Earnings Per Share [Abstract]  
Net Income (Loss) Per Share

Note 13. Net Income (Loss) Per Share

 

Basic net income (loss) per share of common stock is computed by dividing net income (loss) by the weighted-average number of shares of common stock, which includes the shares underlying the outstanding Pre-Funded Warrant, as such warrant is exercisable, in whole or in part, for nominal cash consideration with no expiration date. Shares of common stock outstanding but subject to forfeiture and cancellation by the Company (e.g., Sponsor Earnout Shares – see Note 3) are excluded from the weighted-average number of shares until the period in which such shares are no longer subject to forfeiture.

 

The Company used the two-class method to compute net income per common share for the three months ended March 31, 2022 as the Company realized net income and has securities outstanding (Sponsor Earnout Shares) that entitle the holders to participate in cash dividends and earnings of the Company. Under this method, earnings are allocated to common stock and participating securities based on their respective rights to receive dividends, as if all undistributed earnings for the period were distributed. The holders of the Sponsor Earnout Shares, which are subject to forfeiture, are entitled to receive nonforfeitable cash dividends during the Earnout Periods on a basis equivalent to the dividend paid to holders of common stock, and therefore, these unvested shares subject to forfeiture and cancellation meet the definition of participating securities. The two-class method is not applicable during periods with a net loss.

 

Diluted net loss per share of common stock includes the effect, if any, from the potential exercise or conversion of securities, such as stock options, Public Warrants and Private Placement Warrants, and Sponsor Earnout Shares and Old Renovacor Earnout Shares, which would result in the issuance of incremental shares of common stock, unless their effect would be anti-dilutive.

 

 

 

Three months ended

 

 

 

March 31,

 

($ in thousands except per share data)

 

2022

 

 

2021

 

Net income (loss) per share — Basic:

 

 

 

 

 

 

Net income (loss)

 

$

6,594

 

 

$

(1,681

)

Less: Undistributed earnings to participating securities

 

 

(183

)

 

 

 

Net income (loss) attributable to common stockholders

 

$

6,411

 

 

$

(1,681

)

 

 

 

 

 

 

 

Net income (loss)

 

$

6,411

 

 

$

(1,681

)

Denominator for basic net income (loss) per share

 

 

17,471,266

 

 

 

6,274,566

 

Basic net income (loss) per common share

 

$

0.37

 

 

$

(0.27

)

 

 

 

 

 

 

 

Net income (loss) per share — Diluted:

 

 

 

 

 

 

Net income (loss)

 

$

6,594

 

 

$

(1,681

)

Less: Undistributed earnings to participating securities

 

 

(183

)

 

 

 

Numerator for diluted net income (loss) per share

 

$

6,411

 

 

$

(1,681

)

 

 

 

 

 

 

 

Denominator for basic net income (loss) per share

 

 

17,471,266

 

 

 

6,274,566

 

Plus: Incremental shares underlying “in the money” options outstanding

 

 

78,306

 

 

 

 

Plus: Incremental shares underlying time-based restricted stock units

 

 

79,263

 

 

 

 

Denominator for diluted net income (loss) per share

 

 

17,628,835

 

 

 

6,274,566

 

Diluted net income (loss) per common share

 

$

0.36

 

 

$

(0.27

)

 

The following outstanding potentially dilutive securities have been excluded from the calculation of diluted net loss per share for the three months ended March 31, 2022 and 2021, as their effect is anti-dilutive:

 

 

 

Three months ended

 

 

 

March 31,

 

 

 

2022

 

 

2021

 

Stock options

 

 

1,627,127

 

 

 

73,127

 

Restricted stock units

 

 

71,522

 

 

 

 

Common stock warrants

 

 

12,122,644

 

 

 

 

Earnout shares

 

 

2,422,816

 

 

 

 

Total

 

 

16,244,109

 

 

 

73,127

 

XML 32 R20.htm IDEA: XBRL DOCUMENT v3.22.1
Subsequent Events
3 Months Ended
Mar. 31, 2022
Subsequent Events [Abstract]  
Subsequent Events

Note 14. Subsequent Events

 

The Company considers events or transactions that occur after the balance sheet date but prior to the issuance of the financial statements to provide additional evidence relative to certain estimates or to identify matters that require additional disclosure.

 

Lease Commitments

 

In April 2022, the Company entered into a sublease agreement (the “Sublease Agreement”) with Certara USA, Inc. (“Sublandlord"), pursuant to which the Company will sublease 3,815 rentable square feet of space located at 201 Broadway, Cambridge, Massachusetts 02139, known as Suite 310 (the “Suite 310 Space”) commencing on April 15, 2022 and expiring on April 14, 2024 (the “Sublease Term”), unless earlier terminated or extended in accordance with the provisions of the Sublease Agreement. The Suite 310 Space shall serve as the Company's headquarters. The Company shall have the option to extend the Sublease Term from April 15, 2024 through November 30, 2026 upon all of the same terms, conditions, covenants and agreements contained in the Sublease Agreement, subject to the conditions set forth therein.

 

The Company will pay an escalating base rent over the life of the Sublease Agreement of approximately $19,711 to $20,347 per month (or up to $20,983 per month in the event the Sublease Term is extended through November 30, 2026). In addition, the Company will pay its pro rata portion of property expenses and operating expenses for the property.

 

In accordance with ASC 842, the Company will record a right-of-use asset and corresponding lease liability related to the Sublease Agreement. The lease liability will be recorded and subsequently measured as the present value of the remaining lease payments using a discount rate determined at inception.

XML 33 R21.htm IDEA: XBRL DOCUMENT v3.22.1
Summary of Significant Accounting Policies (Policies)
3 Months Ended
Mar. 31, 2022
Accounting Policies [Abstract]  
Basis of Presentation

Basis of Presentation

 

The accompanying unaudited interim condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the United States Securities and Exchange Commission (“SEC”) for interim financial reporting. Accordingly, they do not include all of the information and disclosures required by U.S. GAAP for complete financial statements as certain footnotes or other financial information that are normally required by U.S. GAAP can be condensed or omitted. These condensed consolidated statements are unaudited and, in the opinion of management, include all adjustments (consisting of normal recurring adjustments and accruals) necessary to fairly present the results of the interim periods. The results of operations and cash flows for the three months ended March 31, 2022 are not necessarily indicative of the results that may be expected for the fiscal year ended December 31, 2022 or any other future period.
Reverse Recapitalization

Reverse Recapitalization

 

The Business Combination was accounted for as a reverse recapitalization in accordance with U.S. GAAP (the “Reverse Recapitalization”). Under this method of accounting, the Company is treated as the “acquired” company and Old Renovacor is treated as the acquirer for financial reporting purposes. As a result, the consolidated assets, liabilities and results of operations prior to the Business Combination are those of Old Renovacor. Additionally, the shares and corresponding capital amounts and losses per share, prior to the Business Combination, have been retroactively restated based on shares reflecting the applicable exchange ratio resulting from the Common Per Share Merger Consideration and/or the Preferred Per Share Merger Consideration (each as defined by the Merger Agreement).

Emerging Growth Company Status

Emerging Growth Company Status

 

The Company is an "emerging growth company", as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”). Under the JOBS Act, the Company may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statement with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Use of Estimates

Use of Estimates

 

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, expense, and related disclosures. The Company bases estimates and assumptions on historical experience when available and on various factors that it believes to be reasonable under the circumstances. The Company evaluates its estimates and assumptions on an ongoing basis. Estimates relied upon in preparing these financial statements relate to, but are not limited to, the fair value of financial instruments, stock-based compensation assumptions and accrued expenses (including accrued and prepaid clinical costs). Actual results may differ from these estimates under different assumptions or conditions.

Concentration of Credit Risk

Concentration of Credit Risk

 

Financial instruments that subject the Company to significant concentrations of credit risk consist primarily of cash primarily held at one financial institution, which, at times, may exceed federally insured limits, and cash equivalents consisting of investments in money market funds managed by a variety of financial institutions. The Company's credit risk is managed by investing in only highly rated money market instruments. As a result, no significant additional credit risk is believed by management to be inherent in the Company’s assets and the Company has not experienced any losses in such accounts and believes it is not exposed to any significant risk on such accounts.

Cash and Cash Equivalents

Cash and Cash Equivalents

 

The Company considers all highly liquid investments with maturities of 90 days or less when purchased to be “cash equivalents.” Cash and cash equivalents at March 31, 2022 consisted of cash and money market funds.

Property and Equipment, net

Property and Equipment, net

 

Property and equipment is carried at acquisition cost less accumulated depreciation, subject to review for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable in accordance with ASC 360-10-35, Impairment or Disposal of Long-Lived Assets. The cost of normal, recurring, or periodic repairs and maintenance activities related to property and equipment, if any, are expensed as incurred. The cost for planned major maintenance activities, including the related acquisition or construction of assets, is capitalized if the repair will result in future economic benefits.

 

Depreciation and amortization are computed using the straight-line method based on the estimated useful lives of the related assets. Equipment and other long-lived assets are depreciated over three to five years. When an asset is disposed of, the associated cost and accumulated depreciation is removed from the related accounts on the Company's balance sheet with any resulting gain or loss included in the Company's condensed consolidated statement of operations.

Financial Instruments

Financial Instruments

 

The fair value of the Company’s financial instruments is determined and disclosed in accordance with the three-tier fair value hierarchy specified in Note 4, Fair Value Measurements. The Company is required to disclose the estimated fair values of its financial instruments. As of March 31, 2022 and December 31, 2021, the Company’s financial instruments consisted of cash equivalents and warrant and share earnout liabilities. As of March 31, 2022, the Company did not have any other derivatives, hedging instruments or other similar financial instruments.

Warrant Liability

Warrant Liability

 

The Company accounts for stock warrants as either equity instruments, liabilities or derivative liabilities in accordance with ASC Topic 480, Distinguishing Liabilities from Equity ("ASC 480") and/or ASC Topic 815, Derivatives and Hedging ("ASC 815"), depending on the specific terms of the warrant agreement. Liability-classified warrants are recorded at their estimated fair values at each reporting period until they are exercised, terminated, reclassified or otherwise settled. Changes in the estimated fair value of liability-classified warrants are recorded in Change in Fair Value of Warrant Liability in the Company’s condensed consolidated statements of operations. Equity-classified warrants are recorded within additional paid-in capital at the time of issuance and not subject to remeasurement.

Share Earnout Liability

Share Earnout Liability

 

The Company accounts for share earnout arrangements that represent equity-linked instruments as either liabilities or equity instruments in accordance with ASC 815, unless such arrangements are within the scope of ASC Topic 718, Compensation–Stock Compensation ("ASC 718"), depending on the specific terms of the contract. Contracts classified as liabilities are recorded at their estimated fair values at each reporting period until they are no longer outstanding. Changes in the estimated fair value of liability-classified share earnout arrangements are recorded in Change in Fair Value of Share Earnout Liability in the Company’s condensed consolidated statements of operations.

Research and Development Expense

Research and Development Expense

 

The Company expenses research and development expenses as incurred. The Company’s research and development expenses consist primarily of personnel-related expenses such as salaries, stock-based compensation, and benefits, and external costs of outside vendors engaged to conduct preclinical development activities, including manufacturing of preclinical and clinical drug supply. The Company accrues for expenses related to development activities performed by third parties based on an evaluation of services received and efforts expended pursuant to the terms of the contractual arrangements. There may be instances in which payments made to the Company’s vendors will exceed the level of services provided and result in a prepayment of expenses. In accruing service fees, the Company estimates the time period over which services will be performed and the level of effort to be expended in each period. If the actual timing of the performance of services or the level of effort varies from the estimate, the Company will adjust the accrual or prepaid expense accordingly.

Stock-Based Compensation

Stock-Based Compensation

 

The Company expenses stock-based compensation to employees and non-employees over the requisite service period, generally the vesting period, based on the estimated grant-date fair value of the awards. The Company accounts for forfeitures as they occur. Stock-based awards with graded-vesting schedules are recognized on a straight-line basis over the requisite service period for each separately vesting portion of the award. The Company estimates the fair value of stock option grants using the Black-Scholes option pricing model, and the assumptions used in calculating the fair value of stock-based awards represent management’s best estimates and involve inherent uncertainties and the application of management’s judgment. All stock-based compensation costs are recorded in general and administrative or research and development costs in the condensed consolidated statements of operations based upon the underlying individual’s role at the Company.

Income Taxes

Income Taxes

 

In accordance with ASC 270, Interim Reporting, and ASC 740, Income Taxes, the Company is required at the end of each interim period to determine the best estimate of its annual effective tax rate and then apply that rate in providing for income taxes on a current year-to-date (interim period) basis. For the three months ended March 31, 2022 and 2021, the Company recorded no tax expense or benefit due to the expected current year loss and its historical losses. The Company has not recorded its net deferred tax asset as of either March 31, 2022 or December 31, 2021 because it maintained a full valuation allowance against all deferred tax assets as of these dates as management has determined that it is not more likely than not that the Company will realize these future tax benefits. As of March 31, 2022 and December 31, 2021, the Company had no uncertain tax positions.

Net Income (Loss) per Common Share

Net Income (Loss) per Common Share

 

Basic net income (loss) per share of common stock is computed by dividing net loss applicable to common stockholders by the weighted-average number of shares of common stock outstanding during each period, which includes shares of common stock underlying the Pre-funded Warrant (as defined herein), as such warrant is exercisable, in whole or in part, for nominal cash consideration with no expiration date. Shares of common stock outstanding but subject to forfeiture and cancellation by the Company (e.g., Sponsor Earnout Shares, as defined in the Merger Agreement) are excluded from the weighted-average shares until the period in which such shares are no longer subject to forfeiture. Diluted net loss per share of common stock includes the effect, if any, from the potential exercise or conversion of securities, such as stock options, Public Warrants and Private Placement Warrants, and Sponsor Earnout Shares and Old Renovacor Earnout Shares (each as defined herein), which would result in the issuance of incremental shares of common stock, unless their effect would be anti-dilutive. See Note 13 for additional details.

New Accounting Pronouncements

New Accounting Pronouncements

 

From time to time, new accounting pronouncements are issued by the FASB and rules are issued by the SEC that the Company has or will adopt as of a specified date. Unless otherwise noted, management does not believe that any other recently issued accounting pronouncements issued by the FASB or guidance issued by the SEC had, or is expected to have, a material impact on the Company’s present or future consolidated financial statements.

 

Accounting Pronouncements Recently Adopted

 

In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842) ("ASU 2016-02"). ASU 2016-02 (amended by ASU 2019-10 and ASU 2020-05) is effective for non-public entities and emerging growth companies for fiscal years beginning after December 15, 2021 and interim periods within fiscal years beginning after December 15, 2022. The new standard establishes a right-of-use (ROU) model that requires a lessee to record a ROU asset and a lease liability on the balance sheet for all leases with terms longer than 12 months. Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition in the statement of operations. A modified retrospective transition approach is required at the beginning of the earliest comparative period presented in the financial statements, with certain practical expedients available. The Company adopted this standard effective January 1, 2022. The adoption did not have a material impact on the Company’s consolidated condensed financial statements as of the adoption date. However, should the Company enter into material operating leases in the future, such as real estate leases for its corporate headquarters and other office and lab space, the Company anticipates an increase in assets and liabilities due to the recognition of the required right-of use asset and corresponding lease liability for such lease obligations. See Note 14 for discussion of leasing transactions occurring after March 31, 2022.

XML 34 R22.htm IDEA: XBRL DOCUMENT v3.22.1
Merger and Recapitalization (Tables)
3 Months Ended
Mar. 31, 2022
Business Combinations [Abstract]  
Summary of Earnout Shares

The Old Renovacor Earnout Shares and Sponsor Earnout Shares (collectively, the "Earnout Shares") are summarized, as set forth in the table below:

 

 

 

 

 

 

Old Renovacor

 

 

Sponsor

 

 

 

 

 

 

Target Price

 

 

Earnout Shares

 

 

Earnout Shares

 

 

Total

 

December 31, 2023

 

$

17.50

 

 

 

576,845

 

 

 

150,000

 

 

 

726,845

 

December 31, 2025

 

$

25.00

 

 

 

576,845

 

 

 

150,000

 

 

 

726,845

 

December 31, 2027

 

$

35.00

 

 

 

769,126

 

 

 

200,000

 

 

 

969,126

 

 

 

 

 

 

 

1,922,816

 

 

 

500,000

 

 

 

2,422,816

 

Summary of Elements of Net Proceeds From Merger

The following table summarizes the elements of the net proceeds from the Merger:

 

(In thousands)

 

Amount

 

Cash – CHAQ trust and cash, net of redemptions

 

$

65,127

 

Cash – PIPE financing

 

 

29,993

 

Less: CHAQ and Old Renovacor transaction costs paid

 

 

(6,079

)

Less: Settlement of convertible note at closing

 

 

(2,500

)

   Effect of Merger, net of redemptions and transaction costs

 

$

86,541

 

 

Summary of Number of Shares Common Stock Issued Immediately Following Consummation of Merger

The following table details the number of shares of common stock issued immediately following the consummation of the Merger:

 

 

 

Number of Shares

 

Common stock, outstanding prior to Merger

 

 

8,622,644

 

Less: redemption of CHAQ shares

 

 

(2,112,100

)

Common stock of CHAQ

 

 

6,510,544

 

CHAQ Founder shares

 

 

2,155,661

 

Shares issued in PIPE Financing

 

 

2,284,776

 

Merger and PIPE financing shares - common stock

 

 

10,950,981

 

Shares issued to Old Renovacor - common stock (1)

 

 

6,305,061

 

Total shares of common stock immediately after Merger (2)

 

 

17,256,042

 

____________________

(1)
The number of shares of common stock issued to Old Renovacor equityholders was determined based on (i) 1,987,636 shares of Old Renovacor Common Stock outstanding immediately prior to the closing of the Merger converted based on the Common Per Share Merger Consideration (as defined in the Merger Agreement) and (ii) 2,578,518 shares of Old Renovacor Preferred Stock outstanding immediately prior to the closing of the Merger converted based on the Preferred Per Share Merger Consideration (as defined in the Merger Agreement). All fractional shares were rounded down.
(2)
Includes 500,000 shares of common stock being held in escrow and subject to vesting or forfeiture based on satisfaction of the Earnout Milestones set forth in the Sponsor Support Agreement. Such shares are liability classified and included in the Share earnout liability as of December 31, 2021.
XML 35 R23.htm IDEA: XBRL DOCUMENT v3.22.1
Fair Value Measurements (Tables)
3 Months Ended
Mar. 31, 2022
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]  
Schedule of Liabilities Measured at Fair Value on Recurring Basis

The table below presents the liabilities measured and recorded in the financial statements at fair value on a recurring basis at March 31, 2022 and December 31, 2021 categorized by the level of inputs used in the valuation of each asset and liability.

 

 

 

March 31, 2022

 

(In thousands)

 

Total

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents – money market funds

 

$

69,089

 

 

$

69,089

 

 

$

 

 

$

 

Total assets

 

$

69,089

 

 

$

69,089

 

 

$

 

 

$

 

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

Warrant liability

 

$

3,885

 

 

$

 

 

$

 

 

$

3,885

 

Share earnout liability

 

 

4,090

 

 

 

 

 

 

 

 

 

4,090

 

Total liabilities

 

$

7,975

 

 

$

 

 

$

 

 

$

7,975

 

 

 

 

December 31, 2021

 

(In thousands)

 

Total

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents – money market funds

 

$

77,792

 

 

$

77,792

 

 

$

 

 

$

 

Total assets

 

$

77,792

 

 

$

77,792

 

 

$

 

 

$

 

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

Warrant liability

 

$

11,165

 

 

$

 

 

$

 

 

$

11,165

 

Share earnout liability

 

 

12,256

 

 

 

 

 

 

 

 

 

12,256

 

Total liabilities

 

$

23,421

 

 

$

 

 

$

 

 

$

23,421

 

Schedule of Warrant and Earnout Share Liability Measured on Recurring Basis Using Unobservable Inputs

The reconciliation of the Company's warrant and earnout share liability measured at fair value on a recurring basis using unobservable inputs (Level 3) is as follows:

 

 

 

Warrant

 

 

Earnout Share

 

(In thousands)

 

Liability

 

 

Liability

 

Balance, December 31, 2021

 

$

11,165

 

 

$

12,256

 

Change in the fair value of liability

 

 

(7,280

)

 

 

(8,166

)

Balance, March 31, 2022

 

$

3,885

 

 

$

4,090

 

Private Placement Warrants [Member]  
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]  
Schedule of Assumptions Used in Determining Fair Value of Private Placement Warrants and Earnout Shares

The fair value of the Private Placement Warrants has been estimated with the following assumptions:

 

 

 

March 31,

 

 

December 31

 

 

 

2022

 

 

2021

 

Stock price

 

$

4.24

 

 

$

7.70

 

Strike price

 

$

11.50

 

 

$

11.50

 

Expected volatility

 

 

75.0

%

 

 

75.0

%

Risk-free interest rate

 

 

2.45

%

 

 

1.01

%

Expected dividend yield

 

 

 

 

 

 

Expected life (years)

 

 

3.07

 

 

 

3.31

 

Fair value per warrant

 

$

1.11

 

 

$

3.19

 

Earnout Shares [Member]  
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]  
Schedule of Assumptions Used in Determining Fair Value of Private Placement Warrants and Earnout Shares

The fair value of the Earnout Shares has been estimated with the following assumptions:

 

 

 

March 31,

 

 

December 31

 

 

 

2022

 

 

2021

 

Stock price

 

$

4.24

 

 

$

7.70

 

Probability of Change in Control

 

 

7.5

%

 

 

7.5

%

Expected volatility

 

 

75.0

%

 

 

75.0

%

Risk-free interest rate

 

 

2.41

%

 

 

1.35

%

Expected dividend yield

 

 

 

 

 

 

Expected life (years)

 

 

5.76

 

 

 

6.00

 

Fair value per share

 

$

1.69

 

 

$

5.06

 

 

XML 36 R24.htm IDEA: XBRL DOCUMENT v3.22.1
Property and Equipment (Tables)
3 Months Ended
Mar. 31, 2022
Property, Plant and Equipment [Abstract]  
Schedule of Property and Equipment, Net

Property and equipment, net, consisted of the following:

 

 

 

March 31,

 

 

December 31,

 

($ in thousands)

 

2022

 

 

2021

 

Laboratory equipment

 

$

380

 

 

$

380

 

Less: accumulated amortization

 

 

(18

)

 

 

(1

)

Property and equipment, net

 

$

362

 

 

$

379

 

XML 37 R25.htm IDEA: XBRL DOCUMENT v3.22.1
Prepaid Expenses and Other Current Assets (Tables)
3 Months Ended
Mar. 31, 2022
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]  
Summary of Prepaid Expenses and Other Current Assets

Prepaid expenses consisted of the following:

 

 

 

March 31,

 

 

December 31,

 

($ in thousands)

 

2022

 

 

2021

 

Research and development costs

 

$

483

 

 

$

209

 

Insurance

 

 

882

 

 

 

1,369

 

Other

 

 

258

 

 

 

185

 

Total prepaid expenses

 

$

1,623

 

 

$

1,763

 

XML 38 R26.htm IDEA: XBRL DOCUMENT v3.22.1
Accrued Expenses (Tables)
3 Months Ended
Mar. 31, 2022
Payables and Accruals [Abstract]  
Schedule of Accrued Expenses

Accrued expenses consisted of the following:

 

 

 

March 31,

 

 

December 31,

 

($ in thousands)

 

2022

 

 

2021

 

Employee compensation and benefits

 

$

688

 

 

$

1,282

 

External research and development expenses

 

 

608

 

 

 

409

 

Property and equipment

 

 

 

 

 

360

 

Professional fees

 

 

149

 

 

 

347

 

Other

 

 

171

 

 

 

100

 

Total accrued expenses

 

$

1,616

 

 

$

2,498

 

XML 39 R27.htm IDEA: XBRL DOCUMENT v3.22.1
Stockholder's Equity (Tables)
3 Months Ended
Mar. 31, 2022
Stockholders' Equity Note [Abstract]  
Summary of Outstanding Warrants to Purchase Shares of Common Stock

The following table summarizes outstanding warrants to purchase shares of the Company’s common stock as of March 31, 2022 and December 31, 2021:

 

 

 

Number of Warrants

 

 

 

 

 

 

 

 

 

March 31,

 

 

December 31

 

 

Weighted-Average

 

 

 

 

 

 

2022

 

 

2021

 

 

Exercise Price

 

 

Expiration Date

 

Liability-classified Warrants

 

 

 

 

 

 

 

 

 

 

 

 

 

April 2020 Private Placement Warrants

 

 

3,500,000

 

 

 

3,500,000

 

 

 

$

11.50

 

 

4/23/2025

 

 

 

 

3,500,000

 

 

 

3,500,000

 

 

 

 

 

 

 

 

Equity-classified Warrants

 

 

 

 

 

 

 

 

 

 

 

 

 

April 2020 Public Warrants (1)

 

 

8,622,644

 

 

 

8,622,644

 

 

 

$

11.50

 

 

9/2/2026

 

September 2021 Pre-Funded Warrants (2)

 

 

715,224

 

 

 

715,224

 

 

 

$

0.01

 

 

 

 

 

 

 

9,337,868

 

 

 

9,337,868

 

 

 

 

 

 

 

 

Total outstanding

 

 

12,837,868

 

 

 

12,837,868

 

 

 

 

 

 

 

 

———————

(1)
Public Warrants assumed in the Merger. Each warrant share is exercisable for one-half share of common stock, provided, however, each warrant must be exercised in multiples of two.
(2)
Pre-Funded Warrant issued in connection with PIPE Investment (Note 3). Each warrant share is exercisable indefinitely for one share of common stock.
Schedule of Common Stock Shares Reserved for Future Issuance

As of March 31, 2022, the Company reserved the following shares of common stock for future issuance:

 

 

 

Amount

 

Shares issuable upon exercise of pre-funded warrants outstanding

 

 

715,224

 

Shares issuable upon exercise of warrants outstanding

 

 

7,811,322

 

Shares issuable upon issuance of contingent consideration (Earnout Shares and Earnout RSUs)

 

 

1,994,338

 

Shares issuable upon exercise of outstanding stock options

 

 

1,941,099

 

Shares issuable upon vesting of time-based restricted stock units

 

 

163,350

 

Shares reserved for future issuance under 2021 Incentive Plan

 

 

1,025,170

 

Total

 

 

13,650,503

 

XML 40 R28.htm IDEA: XBRL DOCUMENT v3.22.1
Stock-based Compensation (Tables)
3 Months Ended
Mar. 31, 2022
Share-based Payment Arrangement [Abstract]  
Schedule of Stock-based Compensation Expense Total stock-based compensation expense attributable to stock-based payments made to employees, consultants and directors included in operating expenses in the Company's condensed consolidated statements of operations for the three months ended March 31, 2022 and 2021 was as follows:


 

 

Three months ended

 

 

 

March 31,

 

($ in thousands)

 

2022

 

 

2021

 

Research and development

 

$

345

 

 

$

3

 

General and administrative

 

 

256

 

 

 

4

 

Total stock-based compensation expense

 

$

601

 

 

$

7

 

Schedule of Assumptions Used in Determining the Fair Value of Option Awards

The following table provides the weighted-average assumptions used in determining the fair value of option awards to purchase 587,650 and 32,808 shares of common stock granted during the three months ended March 31, 2022 and 2021, respectively:

 

 

 

Three months ended

 

 

 

March 31,

 

 

 

2022

 

 

2021

 

Expected volatility

 

 

76.2

%

 

 

73.6

%

Risk-free interest rate

 

 

1.92

%

 

 

0.59

%

Expected dividend yield

 

 

 

 

 

 

Expected term (years)

 

 

6.08

 

 

 

6.08

 

Summary of Stock Option Activity

The following table summarizes stock option activity for the three months ended March 31,2022:

 

($ in thousands, except share and per share data)

 

Stock
Options

 

 

Weighted-Average
Exercise Price

 

 

Weighted-Average
Remaining
Contractual Life
(in years)

 

 

Aggregate
Intrinsic
Value

 

Outstanding at December 31, 2021

 

 

1,376,937

 

 

$

7.61

 

 

 

9.5

 

 

$

676

 

Granted

 

 

587,650

 

 

 

5.76

 

 

 

 

 

 

 

Exercised

 

 

 

 

 

 

 

 

 

 

 

 

Forfeited

 

 

(23,488

)

 

 

7.54

 

 

 

 

 

 

 

Expired

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding at March 31, 2022 (1)

 

 

1,941,099

 

 

$

7.05

 

 

 

9.4

 

 

$

308

 

Exercisable at March 31, 2022

 

 

211,780

 

 

$

6.73

 

 

 

8.2

 

 

$

249

 

 

_____________________________________

(1)
Includes both vested stock options as well as unvested stock options for which the requisite service period has not been rendered but that are expected to vest based on achievement of a service condition.
Summary of Restricted Stock Unit Activity

The following table summarizes restricted stock unit activity for the three months ended March 31, 2022:

 

 

 

Time-based Awards

 

 

Market-based Awards

 

($ in thousands, except per share data)

 

Number of Shares

 

 

Weighted-Average
Grant Date
Fair Value

 

 

Number of Shares

 

 

Weighted-Average
Grant Date
Fair Value

 

Nonvested shares at December 31, 2021

 

 

 

 

$

 

 

 

72,546

 

 

$

6.42

 

Granted

 

 

163,350

 

 

 

6.45

 

 

 

 

 

 

 

Forfeited

 

 

 

 

 

 

 

 

(1,024

)

 

 

6.42

 

Vested

 

 

 

 

 

 

 

 

 

 

 

 

Nonvested shares at March 31, 2022

 

 

163,350

 

 

$

6.45

 

 

 

71,522

 

 

$

6.42

 

XML 41 R29.htm IDEA: XBRL DOCUMENT v3.22.1
Net Income (Loss) Per Share (Tables)
3 Months Ended
Mar. 31, 2022
Earnings Per Share [Abstract]  
Net Income (Loss) Attributable to Common Stockholders of Basic and Diluted

 

 

Three months ended

 

 

 

March 31,

 

($ in thousands except per share data)

 

2022

 

 

2021

 

Net income (loss) per share — Basic:

 

 

 

 

 

 

Net income (loss)

 

$

6,594

 

 

$

(1,681

)

Less: Undistributed earnings to participating securities

 

 

(183

)

 

 

 

Net income (loss) attributable to common stockholders

 

$

6,411

 

 

$

(1,681

)

 

 

 

 

 

 

 

Net income (loss)

 

$

6,411

 

 

$

(1,681

)

Denominator for basic net income (loss) per share

 

 

17,471,266

 

 

 

6,274,566

 

Basic net income (loss) per common share

 

$

0.37

 

 

$

(0.27

)

 

 

 

 

 

 

 

Net income (loss) per share — Diluted:

 

 

 

 

 

 

Net income (loss)

 

$

6,594

 

 

$

(1,681

)

Less: Undistributed earnings to participating securities

 

 

(183

)

 

 

 

Numerator for diluted net income (loss) per share

 

$

6,411

 

 

$

(1,681

)

 

 

 

 

 

 

 

Denominator for basic net income (loss) per share

 

 

17,471,266

 

 

 

6,274,566

 

Plus: Incremental shares underlying “in the money” options outstanding

 

 

78,306

 

 

 

 

Plus: Incremental shares underlying time-based restricted stock units

 

 

79,263

 

 

 

 

Denominator for diluted net income (loss) per share

 

 

17,628,835

 

 

 

6,274,566

 

Diluted net income (loss) per common share

 

$

0.36

 

 

$

(0.27

)

Schedule of Potentially Antidilutive Securities Excluded from Computation of Diluted Net Loss Per Share

The following outstanding potentially dilutive securities have been excluded from the calculation of diluted net loss per share for the three months ended March 31, 2022 and 2021, as their effect is anti-dilutive:

 

 

 

Three months ended

 

 

 

March 31,

 

 

 

2022

 

 

2021

 

Stock options

 

 

1,627,127

 

 

 

73,127

 

Restricted stock units

 

 

71,522

 

 

 

 

Common stock warrants

 

 

12,122,644

 

 

 

 

Earnout shares

 

 

2,422,816

 

 

 

 

Total

 

 

16,244,109

 

 

 

73,127

 

XML 42 R30.htm IDEA: XBRL DOCUMENT v3.22.1
Business and Organization - Additional Information (Details) - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
[1]
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Accumulated deficit $ 12,404 $ 18,998
Cash and cash equivalents $ 70,084 $ 78,790
[1] The condensed balance sheet at December 31, 2021 has been derived from the audited financial statements at that date.
XML 43 R31.htm IDEA: XBRL DOCUMENT v3.22.1
Summary of Significant Accounting Policies - Additional Information (Details) - USD ($)
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Dec. 31, 2021
Significant Accounting Policies Table [Line Items]      
Tax expense or benefit due to expected current year loss and its historical losses $ 0 $ 0  
Net deferred tax asset 0   $ 0
Uncertain tax positions $ 0   $ 0
Accounting Standards Update 2016-02 [Member]      
Significant Accounting Policies Table [Line Items]      
Accounting standards update, adopted [true false] true    
Accounting standards update, adoption date Jan. 01, 2022    
Accounting standards update, immaterial effect true    
Equipment and Other Long-lived Assets [Member] | Minimum [Member]      
Significant Accounting Policies Table [Line Items]      
Useful life 3 years    
Equipment and Other Long-lived Assets [Member] | Maximum [Member]      
Significant Accounting Policies Table [Line Items]      
Useful life 5 years    
XML 44 R32.htm IDEA: XBRL DOCUMENT v3.22.1
Merger and Recapitalization - Additional Information (Details)
$ / shares in Units, $ in Thousands
3 Months Ended
Mar. 31, 2022
USD ($)
TradingDay
$ / shares
shares
Dec. 31, 2021
$ / shares
Business Acquisition [Line Items]    
Common stock, par value $ 0.0001 $ 0.0001
Preferred stock, par value $ 0.0001 $ 0.0001
Sponsor Support Agreement [Member]    
Business Acquisition [Line Items]    
Sponsor shares placed into escrow subject to forfeiture | shares 500,000  
PIPE Investors [Member]    
Business Acquisition [Line Items]    
Number of shares issue and sell to investors (in Shares) | shares 2,284,776  
Share price (in Dollars per share) $ 10.00  
Gross proceeds from issuance of shares to investors | $ $ 30,000  
Initial purchase price per share (in Dollars per share) $ 9.99  
Pre-Funded Warrants [Member]    
Business Acquisition [Line Items]    
Number of shares issue and sell to investors (in Shares) | shares 715,224  
Warrants exercise price (in Dollars per share) $ 0.01  
Percentage of beneficial ownership limitation 9.99%  
Pre-Funded Warrants [Member] | Maximum [Member]    
Business Acquisition [Line Items]    
Percentage of beneficial ownership limitation 19.99%  
First Earnout Period [Member]    
Business Acquisition [Line Items]    
Earn out period end date Dec. 31, 2023  
Second Earnout Period [Member]    
Business Acquisition [Line Items]    
Earn out period end date Dec. 31, 2025  
Third Earnout Period [Member]    
Business Acquisition [Line Items]    
Earn out period end date Dec. 31, 2027  
Old Renovacor [Member]    
Business Acquisition [Line Items]    
Goodwill | $ $ 0  
Common stock, par value $ 0.0001  
Old Renovacor [Member] | Earnout Shares [Member]    
Business Acquisition [Line Items]    
Maximum number of additional shares entitled to receive | shares 1,922,816  
Old Renovacor [Member] | First Earnout Period [Member]    
Business Acquisition [Line Items]    
Maximum number of additional shares entitled to receive | shares 576,845  
Earn out period end date Dec. 31, 2023  
Price per share $ 17.50  
Number of trading days | TradingDay 20  
Number of consecutive trading days | TradingDay 30  
Old Renovacor [Member] | Second Earnout Period [Member]    
Business Acquisition [Line Items]    
Maximum number of additional shares entitled to receive | shares 576,845  
Earn out period end date Dec. 31, 2025  
Price per share $ 25.00  
Number of trading days | TradingDay 20  
Number of consecutive trading days | TradingDay 30  
Old Renovacor [Member] | Third Earnout Period [Member]    
Business Acquisition [Line Items]    
Maximum number of additional shares entitled to receive | shares 769,126  
Earn out period end date Dec. 31, 2027  
Price per share $ 35.00  
Number of trading days | TradingDay 20  
Number of consecutive trading days | TradingDay 30  
Old Renovacor [Member] | Common Stock [Member]    
Business Acquisition [Line Items]    
Shares issued | shares 6,305,061  
XML 45 R33.htm IDEA: XBRL DOCUMENT v3.22.1
Merger and Recapitalization - Summary of Earnout Shares (Details)
3 Months Ended
Mar. 31, 2022
$ / shares
shares
Targeted Or Tracking Stock Stock [Line Items]  
Earnout shares 2,422,816
Sponsor [Member]  
Targeted Or Tracking Stock Stock [Line Items]  
Earnout shares 500,000
Old Renovacor [Member]  
Targeted Or Tracking Stock Stock [Line Items]  
Earnout shares 1,922,816
First Earnout Period [Member]  
Targeted Or Tracking Stock Stock [Line Items]  
Earn out period end date Dec. 31, 2023
Target price | $ / shares $ 17.50
Earnout shares 726,845
First Earnout Period [Member] | Sponsor [Member]  
Targeted Or Tracking Stock Stock [Line Items]  
Earnout shares 150,000
First Earnout Period [Member] | Old Renovacor [Member]  
Targeted Or Tracking Stock Stock [Line Items]  
Earn out period end date Dec. 31, 2023
Earnout shares 576,845
Second Earnout Period [Member]  
Targeted Or Tracking Stock Stock [Line Items]  
Earn out period end date Dec. 31, 2025
Target price | $ / shares $ 25.00
Earnout shares 726,845
Second Earnout Period [Member] | Sponsor [Member]  
Targeted Or Tracking Stock Stock [Line Items]  
Earnout shares 150,000
Second Earnout Period [Member] | Old Renovacor [Member]  
Targeted Or Tracking Stock Stock [Line Items]  
Earn out period end date Dec. 31, 2025
Earnout shares 576,845
Third Earnout Period [Member]  
Targeted Or Tracking Stock Stock [Line Items]  
Earn out period end date Dec. 31, 2027
Target price | $ / shares $ 35.00
Earnout shares 969,126
Third Earnout Period [Member] | Sponsor [Member]  
Targeted Or Tracking Stock Stock [Line Items]  
Earnout shares 200,000
Third Earnout Period [Member] | Old Renovacor [Member]  
Targeted Or Tracking Stock Stock [Line Items]  
Earn out period end date Dec. 31, 2027
Earnout shares 769,126
XML 46 R34.htm IDEA: XBRL DOCUMENT v3.22.1
Merger and Recapitalization - Summary of Elements of Net Proceeds From Merger (Details)
$ in Thousands
3 Months Ended
Mar. 31, 2022
USD ($)
Business Acquisition [Line Items]  
Less: Settlement of convertible note at closing $ (2,500)
Effect of Merger, net of redemptions and transaction costs 86,541
CHAQ [Member]  
Business Acquisition [Line Items]  
Cash – net of redemptions 65,127
PIPE Investment [Member]  
Business Acquisition [Line Items]  
Cash – net of redemptions 29,993
CHAQ and Old Renovacor [Member]  
Business Acquisition [Line Items]  
Less: transaction costs paid $ (6,079)
XML 47 R35.htm IDEA: XBRL DOCUMENT v3.22.1
Merger and Recapitalization - Summary of Number of Shares Common Stock Issued Immediately Following Consummation of Merger (Details) - shares
Mar. 31, 2022
Dec. 31, 2021
Sep. 01, 2021
Business Acquisition [Line Items]      
Common stock, outstanding 16,756,042 16,756,042 1,987,636
Common stock, shares issued 16,756,042 16,756,042 1,987,636
Total shares of common stock immediately after Merger 17,256,042    
CHAQ [Member]      
Business Acquisition [Line Items]      
Common stock, outstanding prior to Merger 8,622,644    
Less: redemption of CHAQ shares (2,112,100)    
Common stock, outstanding 6,510,544    
CHAQ Founder shares 2,155,661    
PIPE Investment [Member]      
Business Acquisition [Line Items]      
Shares issued 2,284,776    
Old Renovacor [Member]      
Business Acquisition [Line Items]      
Common stock, outstanding prior to Merger 1,987,636    
Common stock, shares issued 6,305,061    
Merger and PIPE Financing [Member]      
Business Acquisition [Line Items]      
Common stock, outstanding 10,950,981    
XML 48 R36.htm IDEA: XBRL DOCUMENT v3.22.1
Merger and Recapitalization - Summary of Number of Shares Common Stock Issued Immediately Following Consummation of Merger (Parenthetical) (Detail)
3 Months Ended
Mar. 31, 2022
shares
Sponsor Support Agreement [Member]  
Business Acquisition [Line Items]  
Common stock held in escrow and subject to vesting or forfeiture 500,000
Old Renovacor [Member]  
Business Acquisition [Line Items]  
Preferred stock outstanding prior to Merger 2,578,518
Common stock outstanding prior to Merger 1,987,636
XML 49 R37.htm IDEA: XBRL DOCUMENT v3.22.1
Fair Value Measurements - Schedule of Liabilities Measured at Fair Value on Recurring Basis (Details) - Fair Value, Recurring [Member] - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Assets    
Asset fair value $ 69,089 $ 77,792
Liabilities    
Liabilities fair value 7,975 23,421
Level 1 [Member]    
Assets    
Asset fair value 69,089 77,792
Level 3 [Member]    
Liabilities    
Liabilities fair value 7,975 23,421
Warrant Liability [Member]    
Liabilities    
Liabilities fair value 3,885 11,165
Warrant Liability [Member] | Level 3 [Member]    
Liabilities    
Liabilities fair value 3,885 11,165
Share Earnout Liability [Member]    
Liabilities    
Liabilities fair value 4,090 12,256
Share Earnout Liability [Member] | Level 3 [Member]    
Liabilities    
Liabilities fair value 4,090 12,256
Money Market Funds [Member]    
Assets    
Asset fair value 69,089 77,792
Money Market Funds [Member] | Level 1 [Member]    
Assets    
Asset fair value $ 69,089 $ 77,792
XML 50 R38.htm IDEA: XBRL DOCUMENT v3.22.1
Fair Value Measurements - Schedule of Warrant and Earnout Share Liability Measured on Recurring Basis Using Unobservable Input (Details) - Level 3 [Member]
$ in Thousands
3 Months Ended
Mar. 31, 2022
USD ($)
Warrant Liability [Member]  
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]  
Balance $ 11,165
Change in the fair value of liability (7,280)
Balance 3,885
Earnout Share Liability [Member]  
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]  
Balance 12,256
Change in the fair value of liability (8,166)
Balance $ 4,090
XML 51 R39.htm IDEA: XBRL DOCUMENT v3.22.1
Fair Value Measurements - Schedule of Assumptions Used in Determining Fair Value of Private Placement Warrants (Details) - Private Placement Warrants [Member]
3 Months Ended 12 Months Ended
Mar. 31, 2022
$ / shares
Dec. 31, 2021
$ / shares
Stock Price [Member]    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Derivative Liability, Measurement Input 4.24 7.70
Strike Price [Member]    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Derivative Liability, Measurement Input 11.50 11.50
Expected Volatility [Member]    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Derivative Liability, Measurement Input 75.0 75.0
Risk-Free Interest Rate [Member]    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Derivative Liability, Measurement Input 2.45 1.01
Expected Life (Years) [Member]    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Derivative, Term of Contract 3 years 25 days 3 years 3 months 21 days
Fair Value Per Warrant [Member]    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Derivative Liability, Measurement Input 1.11 3.19
XML 52 R40.htm IDEA: XBRL DOCUMENT v3.22.1
Fair Value Measurements - Schedule of Assumptions Used in Determining Fair Value of Earnout Shares (Details) - Earnout Shares [Member]
3 Months Ended 12 Months Ended
Mar. 31, 2022
$ / shares
Dec. 31, 2021
$ / shares
Stock Price [Member]    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Derivative Liability, Measurement Input 4.24 7.70
Probability of Change in Control [Member]    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Derivative Liability, Measurement Input 7.5 7.5
Expected Volatility [Member]    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Derivative Liability, Measurement Input 75.0 75.0
Risk-Free Interest Rate [Member]    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Derivative Liability, Measurement Input 2.41 1.35
Expected Life (Years) [Member]    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Derivative, Term of Contract 5 years 9 months 3 days 6 years
Fair Value Per Share [Member]    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Derivative Liability, Measurement Input 1.69 5.06
XML 53 R41.htm IDEA: XBRL DOCUMENT v3.22.1
Property and Equipment - Schedule of Property and Equipment, Net (Details) - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Property, Plant and Equipment [Abstract]    
Laboratory equipment $ 380 $ 380
Less: accumulated amortization (18) (1)
Property and equipment, net $ 362 $ 379 [1]
[1] The condensed balance sheet at December 31, 2021 has been derived from the audited financial statements at that date.
XML 54 R42.htm IDEA: XBRL DOCUMENT v3.22.1
Prepaid Expenses - Summary of Prepaid Expenses (Details) - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Prepaid Expense and Other Assets, Current [Abstract]    
Research and development costs $ 483 $ 209
Insurance 882 1,369
Other 258 185
Total prepaid expense $ 1,623 $ 1,763 [1]
[1] The condensed balance sheet at December 31, 2021 has been derived from the audited financial statements at that date.
XML 55 R43.htm IDEA: XBRL DOCUMENT v3.22.1
Accrued Expenses - Schedule of Accrued Expenses (Details) - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Payables and Accruals [Abstract]    
Employee compensation and benefits $ 688 $ 1,282
External research and development expenses 608 409
Property and equipment   360
Professional fees 149 347
Other 171 100
Total accrued expenses $ 1,616 $ 2,498 [1]
[1] The condensed balance sheet at December 31, 2021 has been derived from the audited financial statements at that date.
XML 56 R44.htm IDEA: XBRL DOCUMENT v3.22.1
License and Sponsored Research Agreements - Additional Information (Details) - USD ($)
1 Months Ended 3 Months Ended
Jul. 01, 2021
Nov. 30, 2020
Aug. 31, 2019
Mar. 31, 2022
Mar. 31, 2021
Research And Development Arrangement Contract To Perform For Others [Line Items]          
Research and development expenses       $ 5,930,000 $ 1,155,000
Temple License Agreement [Member]          
Research And Development Arrangement Contract To Perform For Others [Line Items]          
Agreement effective date     Aug. 12, 2019    
Assignment fees     $ 100,000    
Development regulatory and commercial milestone payment     $ 1,250,000    
Royalty percentage     50.00%    
Agreement expiration description       The Temple License Agreement will remain effective until (i) the expiration date of the last-to-expire patents covered under the License Agreement (currently expected to occur in 2041); (ii) the termination by Temple upon (a) an uncured breach by the Company, with a 60-day notification period, (b) the Company’s filing of a voluntary petition in bankruptcy or related proceeding, providing such petition is not dismissed within 90 days after the filing thereof, (c) a failure by the Company to meet certain milestones set forth in the Licensed Agreement, or (d) non-payment of undisputed monies due to Temple, with a 30-day notification period. Additionally, the Company may terminate the entire agreement or with respect to an individual patent or patent application, if desired, subject a 90-day notification period.  
Preclinical term 3 years        
Sponsored research agreement fund $ 900,000        
Sponsored research agreement fund, net $ 5,300,000        
Sponsor research agreement funded and/or incurred from inception       $ 1,500,000  
Research and development expenses       $ 200,000 $ 100,000
Temple License Agreement [Member] | Minimum [Member]          
Research And Development Arrangement Contract To Perform For Others [Line Items]          
Annual administrative fee     $ 20,000    
Temple License Agreement [Member] | Common Stock [Member]          
Research And Development Arrangement Contract To Perform For Others [Line Items]          
Common stock, shares issued     97,879    
Additional shares issued upon closing of Series A convertible preferred stock   9,130      
XML 57 R45.htm IDEA: XBRL DOCUMENT v3.22.1
Stockholder's Equity - Additional Information (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended
Sep. 01, 2021
Mar. 31, 2022
Dec. 31, 2021
Class Of Stock [Line Items]      
Common stock, shares authorized 6,000,000 100,000,000 100,000,000
Common stock, par value   $ 0.0001 $ 0.0001
Common stock, shares issued 1,987,636 16,756,042 16,756,042
Common stock, shares outstanding 1,987,636 16,756,042 16,756,042
Preferred stock, shares authorized   1,000,000 1,000,000
Preferred stock, par value   $ 0.0001 $ 0.0001
Number of voting rights   no  
Public Warrants [Member]      
Class Of Stock [Line Items]      
Number of warrants outstanding 8,622,644    
Exercise price $ 11.50    
Warrant price per share 0.01    
Warrant or Right, Reason for Issuance, Description   The Company may redeem the Public Warrants:•in whole and not in part;•at a price of $0.01 per Public Warrant;•at any time during the exercise period;•upon a minimum of 30 days’ prior written notice of redemption;•if, and only if, the last sale price of the Company’s common stock equals or exceeds $16.00 per share for any 10 trading days within a 30-trading day period ending on the third business day prior to the date on which the Company sends the notice of redemption to the warrant holders; and•if, and only if, there is a current registration statement in effect with respect to the shares of common stock underlying such Public Warrants at the time of redemption and for the entire 30-day trading period referred to above and continuing each day thereafter until the date of redemption.  
Redemption written notice period   30 days  
Common stock exceeds price per share $ 16.00    
Private Placement Warrants [Member]      
Class Of Stock [Line Items]      
Number of warrants outstanding 3,500,000    
Exercise price $ 11.50    
Warrant exercisable term   5 years  
Series A Redeemable Convertible Preferred Stock [Member]      
Class Of Stock [Line Items]      
Temporary equity, authorized 3,333,283    
Temporary equity, par value $ 0.0001    
Temporary equity, issued 2,578,518    
Temporary equity, outstanding 2,578,518    
Temporary equity shares issued price per share $ 4.065063    
Price per share $ 12.20    
Proceeds from initial public offer $ 60    
Temporary Equity Conversion Into Permanent Equity Conversion Price Per $ 4.065063    
XML 58 R46.htm IDEA: XBRL DOCUMENT v3.22.1
Stockholder's Equity - Summary of Outstanding Warrants to Purchase Shares of Common Stock (Details) - $ / shares
Mar. 31, 2022
Dec. 31, 2021
Class of Warrant Or Right [Line Items]    
Number of Warrants Outstanding 12,837,868 12,837,868
Liability Classified Warrants [Member]    
Class of Warrant Or Right [Line Items]    
Number of Warrants Outstanding 3,500,000 3,500,000
Liability Classified Warrants [Member] | April 2020 Private Placement Warrants [Member]    
Class of Warrant Or Right [Line Items]    
Number of Warrants Outstanding 3,500,000 3,500,000
Weighted-Average Exercise Price $ 11.50  
Expiration Date Apr. 23, 2025  
Equity Classified Warrants [Member]    
Class of Warrant Or Right [Line Items]    
Number of Warrants Outstanding 9,337,868 9,337,868
Equity Classified Warrants [Member] | April 2020 Public Warrants [Member]    
Class of Warrant Or Right [Line Items]    
Number of Warrants Outstanding [1] 8,622,644 8,622,644
Weighted-Average Exercise Price [1] $ 11.50  
Expiration Date [1] Sep. 02, 2026  
Equity Classified Warrants [Member] | September 2021 Pre-Funded Warrants [Member]    
Class of Warrant Or Right [Line Items]    
Number of Warrants Outstanding [2] 715,224 715,224
Weighted-Average Exercise Price [2] $ 0.01  
[1] Public Warrants assumed in the Merger. Each warrant share is exercisable for one-half share of common stock, provided, however, each warrant must be exercised in multiples of two.
[2] Pre-Funded Warrant issued in connection with PIPE Investment (Note 3). Each warrant share is exercisable indefinitely for one share of common stock.
XML 59 R47.htm IDEA: XBRL DOCUMENT v3.22.1
Stockholder's Equity - Schedule of Common Stock Shares Reserved for Future Issuance (Details)
Mar. 31, 2022
shares
Class Of Stock [Line Items]  
Common stock, capital shares reserved for future issuance 13,650,503
Pre-Funded Warrants [Member]  
Class Of Stock [Line Items]  
Common stock, capital shares reserved for future issuance 715,224
Warrants [Member]  
Class Of Stock [Line Items]  
Common stock, capital shares reserved for future issuance 7,811,322
Earnout Shares [Member]  
Class Of Stock [Line Items]  
Common stock, capital shares reserved for future issuance 1,994,338
Stock Options Outstanding [Member]  
Class Of Stock [Line Items]  
Common stock, capital shares reserved for future issuance 1,941,099
Time-based Restricted Stock Units [Member]  
Class Of Stock [Line Items]  
Common stock, capital shares reserved for future issuance 163,350
2021 Incentive Plan [Member]  
Class Of Stock [Line Items]  
Common stock, capital shares reserved for future issuance 1,025,170
XML 60 R48.htm IDEA: XBRL DOCUMENT v3.22.1
Stock-based Compensation - Additional Information (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended
Mar. 31, 2022
Dec. 31, 2021
Mar. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Weighted average fair value of options granted $ 3.87   $ 2.32
Fair value of options, vested in period $ 300    
Stock-based compensation expense $ 601   $ 7
2018 Stock Option and Grant Plan [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of shares authorized for issuance 1,118,869    
Exchanged options issued 194,926    
Purchase price per share $ 5.66    
2021 Omnibus Incentive Plan [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of shares authorized for issuance 3,008,803    
Percentage of outstanding shares 4.00%    
Number of shares, options outstanding 1,748,761    
Remain available for future issuance 1,025,170    
Common Stock [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of shares purchased for issuance under share-based payment arrangement 587,650   32,808
Earnout RSU [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Committed share issuance   72,546  
Earnout RSU [Member] | 2021 Omnibus Incentive Plan [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of shares, RSUs outstanding 71,522    
Stock Options [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of shares, options outstanding 1,941,099 [1] 1,376,937  
Options granted 587,650    
Unrecognized stock-based expense $ 7,400    
Vesting period 3 years 6 months    
Restricted Stock [Member] | Maximum [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Stock-based compensation expense $ 100    
Restricted Stock Units [Member] | 2021 Omnibus Incentive Plan [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of shares, RSUs outstanding 234,872    
Time-based Awards [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of shares, RSUs outstanding 163,350    
Unrecognized stock-based expense $ 1,000    
Unrecognized compensation cost, weighted average expected to be recognized period 3 years 9 months 18 days    
Market-based Awards [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of shares, RSUs outstanding 71,522 72,546  
Unrecognized stock-based expense $ 500    
Unrecognized compensation cost, weighted average expected to be recognized period 5 years 9 months 3 days    
[1] Includes both vested stock options as well as unvested stock options for which the requisite service period has not been rendered but that are expected to vest based on achievement of a service condition.
XML 61 R49.htm IDEA: XBRL DOCUMENT v3.22.1
Stock-based Compensation - Schedule of Stock-based Compensation Expense (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Stock-based compensation expense $ 601 $ 7
Research and Development [Member]    
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Stock-based compensation expense 345 3
General and Administrative [Member]    
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Stock-based compensation expense $ 256 $ 4
XML 62 R50.htm IDEA: XBRL DOCUMENT v3.22.1
Stock-based Compensation - Schedule of Assumptions Used in Determining the Fair Value of Option Awards (Details) - Stock Options [Member]
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]    
Expected volatility 76.20% 73.60%
Risk-free interest rate 1.92% 0.59%
Expected dividend yield 0.00% 0.00%
Expected term (years) 6 years 29 days 6 years 29 days
XML 63 R51.htm IDEA: XBRL DOCUMENT v3.22.1
Stock-based Compensation - Summary of Stock Option Activity (Details) - Stock Options [Member] - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2022
Dec. 31, 2021
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]    
Stock Options Outstanding, Beginning balance 1,376,937  
Stock Options, Granted 587,650  
Stock Options, Forfeited (23,488)  
Stock Options Outstanding, Ending Balance 1,941,099 [1] 1,376,937
Stock Options, Exercisable 211,780  
Weighted-Average Exercise Price, Outstanding $ 7.61  
Weighted-Average Exercise Price, Granted 5.76  
Weighted-Average Exercise Price, Forfeited 7.54  
Weighted-Average Exercise Price, Outstanding, Ending Balance 7.05 [1] $ 7.61
Weighted-Average Exercise Price, Exercisable $ 6.73  
Weighted-Average Remaining Contractual Life, Outstanding 9 years 4 months 24 days [1] 9 years 6 months
Weighted-Average Remaining Contractual Life, Exercisable 8 years 2 months 12 days  
Aggregate Intrinsic Value, Outstanding $ 308 [1] $ 676
Aggregate Intrinsic Value, Exercisable $ 249  
[1] Includes both vested stock options as well as unvested stock options for which the requisite service period has not been rendered but that are expected to vest based on achievement of a service condition.
XML 64 R52.htm IDEA: XBRL DOCUMENT v3.22.1
Stock-based Compensation - Summary of Restricted Stock Unit Activity (Details)
3 Months Ended
Mar. 31, 2022
$ / shares
shares
Time-based Awards [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Number of shares, Granted | shares 163,350
Number of shares, Nonvested, Ending Balance | shares 163,350
Weighted-Average Grant Date Fair Value, Granted | $ / shares $ 6.45
Weighted-Average Grant Date Fair Value, Nonvested Shares, Ending Balance | $ / shares $ 6.45
Market-based Awards [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Number of shares, Nonvested, Beginning Balance | shares 72,546
Number of shares, Forfeited | shares (1,024)
Number of shares, Nonvested, Ending Balance | shares 71,522
Weighted-Average Grant Date Fair Value, Nonvested Shares, Beginning Balance | $ / shares $ 6.42
Weighted-Average Grant Date Fair Value, Forfeited | $ / shares 6.42
Weighted-Average Grant Date Fair Value, Nonvested Shares, Ending Balance | $ / shares $ 6.42
XML 65 R53.htm IDEA: XBRL DOCUMENT v3.22.1
Related Parties - Additional Information (Details) - USD ($)
1 Months Ended 3 Months Ended
Sep. 02, 2021
Jul. 20, 2021
Apr. 30, 2022
Feb. 28, 2022
Jun. 30, 2020
Apr. 30, 2020
Aug. 31, 2019
Dec. 31, 2018
Mar. 31, 2022
Mar. 31, 2021
Dec. 31, 2021
Sep. 01, 2021
Related Party Transaction [Line Items]                        
Common stock, shares outstanding                 16,756,042   16,756,042 1,987,636
Research and development                 $ 5,930,000 $ 1,155,000    
Temple License Agreement [Member]                        
Related Party Transaction [Line Items]                        
Minimum percentage of ownership held by Founder                 5.00%      
Research and development                 $ 200,000 100,000    
Feldman Consulting Agreement [Member]                        
Related Party Transaction [Line Items]                        
Minimum percentage of ownership held by Founder             5.00%          
Consulting fee amount per calendar month             $ 8,333          
Long term service commitment period             3 years          
Service commitment renewal term             1 year          
Consulting Fees                 100,000 $ 100,000    
Due to related party                 $ 0      
Merger Agreement and Note Purchase Agreement [Member] | Convertible Promissory Note [Member]                        
Related Party Transaction [Line Items]                        
Issued amount   $ 2,500,000                    
Proceeds from convertible debt   $ 2,500,000                    
Conversion price per share   $ 10.00                    
Private Placement Warrants [Member]                        
Related Party Transaction [Line Items]                        
Stock Issued During Period, Shares, New Issues           3,500,000            
Exercise price           $ 0.40            
Purchase price of warrants           $ 1,400,000            
Private Placement [Member] | Merger Agreement [Member]                        
Related Party Transaction [Line Items]                        
Common stock purchased 2,284,776                      
Pre - funded warrants to purchase common stock 715,224                      
Sponsor Ownership [Member]                        
Related Party Transaction [Line Items]                        
Common stock, shares outstanding                 1,605,661      
Percentage of outstanding shares                 9.60%      
Chardan Healthcare Investments LLC [Member]                        
Related Party Transaction [Line Items]                        
Common stock, shares outstanding                 250,000      
Number of shares distributed to members and employees       250,000                
Sponsor Shares [Member]                        
Related Party Transaction [Line Items]                        
Stock Issued During Period, Shares, New Issues               5,000,000        
Aggregate purchase price               $ 25,000        
Sponsor cancelled shares (in shares)         288,089 2,556,250            
Remaining shares owned by sponsor (in Shares)           2,443,750            
Sponsor earnout shares         500,000              
Chardan Investments 2 [Member] | Subsequent Event [Member]                        
Related Party Transaction [Line Items]                        
Number of shares distributed to members and employees     1,605,661                  
Amusa [Member]                        
Related Party Transaction [Line Items]                        
Number of shares distributed to related parties       40,000                
Amusa [Member] | Subsequent Event [Member]                        
Related Party Transaction [Line Items]                        
Number of shares distributed to related parties     238,588                  
Grossman [Member] | Subsequent Event [Member]                        
Related Party Transaction [Line Items]                        
Number of shares distributed to related parties     354,657                  
XML 66 R54.htm IDEA: XBRL DOCUMENT v3.22.1
Net Income (Loss) Per Share - Net Income (Loss) Attributable to Common Stockholders of Basic and Diluted (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Net income (loss) per share - Basic:    
Net income (loss) $ 6,594 $ (1,681)
Less: Undistributed earnings to participating securities (183)  
Net income (loss) attributable to common stockholders $ 6,411 $ (1,681)
Denominator for basic net income (loss) per share 17,471,266 6,274,566
Basic net income (loss) per common share $ 0.37 $ (0.27)
Net income (loss) per share - Diluted:    
Net income (loss) $ 6,594 $ (1,681)
Less: Undistributed earnings to participating securities (183)  
Numerator for diluted net income (loss) per share $ 6,411 $ (1,681)
Denominator for basic net income (loss) per share 17,471,266 6,274,566
Plus: Incremental shares underlying "in the money" options outstanding 78,306  
Plus: Incremental shares underlying time-based restricted stock units 79,263  
Denominator for diluted net income (loss) per share 17,628,835 6,274,566
Diluted net income (loss) per common share $ 0.36 $ (0.27)
XML 67 R55.htm IDEA: XBRL DOCUMENT v3.22.1
Net Income (loss) Per Share - Schedule of Potentially Antidilutive Securities Excluded from Computation of Diluted Net Loss Per Share (Detail) - shares
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]    
Anti-dilutive Securities 16,244,109 73,127
Stock Options [Member]    
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]    
Anti-dilutive Securities 1,627,127 73,127
Restricted Stock Units [Member]    
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]    
Anti-dilutive Securities 71,522  
Common Stock Warrants [Member]    
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]    
Anti-dilutive Securities 12,122,644  
Earnout Shares [Member]    
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]    
Anti-dilutive Securities 2,422,816  
XML 68 R56.htm IDEA: XBRL DOCUMENT v3.22.1
Subsequent Events (Additional Information) (Details) - Subsequent Event [Member]
1 Months Ended
Apr. 30, 2022
USD ($)
ft²
Subsequent Event [Line Items]  
Sublease rentable space | ft² 3,815
Sublease commencing date Apr. 15, 2022
Sublease expiring date Apr. 14, 2024
Lessee, Operating Sublease, Existence of Option to Extend [true false] true
Lessee, Operating Sublease, Option to Extend Company shall have the option to extend the Sublease Term from April 15, 2024 through November 30, 2026 upon all of the same terms, conditions, covenants and agreements contained in the Sublease Agreement, subject to the conditions set forth therein.
Maximum [Member]  
Subsequent Event [Line Items]  
Sublease base rent $ 20,347,000
Extended sublease base rent 20,983,000
Minimum [Member]  
Subsequent Event [Line Items]  
Sublease base rent $ 19,711
XML 69 rcor-20220331_htm.xml IDEA: XBRL DOCUMENT 0001799850 srt:ScenarioPreviouslyReportedMember us-gaap:ConvertiblePreferredStockMember 2020-12-31 0001799850 rcor:PublicWarrantsMember 2022-01-01 2022-03-31 0001799850 rcor:EarnoutRsuMember rcor:TwoThousandTwentyOneOmnibusIncentivePlanMember 2022-03-31 0001799850 rcor:PreFundedWarrantsMember 2022-03-31 0001799850 rcor:PrivatePlacementWarrantsMember 2020-04-01 2020-04-30 0001799850 rcor:SecondMilestoneMember rcor:OldRenovacorMember 2022-01-01 2022-03-31 0001799850 srt:RestatementAdjustmentMember 2020-12-31 0001799850 rcor:LiabilityClassifiedWarrantsMember 2021-12-31 0001799850 rcor:TwoThousandEighteenStockOptionAndGrantPlanMember 2022-03-31 0001799850 rcor:ChardanHealthcareAcquisitionCorporationMember 2022-01-01 2022-03-31 0001799850 rcor:FeldmanConsultingAgreementMember 2022-03-31 0001799850 rcor:EarnoutShareLiabilityMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001799850 rcor:OldRenovacorMember us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001799850 rcor:PrivatePlacementWarrantsMember 2020-04-30 0001799850 us-gaap:EmployeeStockOptionMember 2022-03-31 0001799850 2022-05-12 0001799850 rcor:SecondMilestoneMember 2022-01-01 2022-03-31 0001799850 us-gaap:CommonStockMember 2020-12-31 0001799850 rcor:AmusaMember us-gaap:SubsequentEventMember 2022-04-01 2022-04-30 0001799850 srt:ScenarioPreviouslyReportedMember us-gaap:CommonStockMember 2020-12-31 0001799850 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-03-31 0001799850 rcor:PrivatePlacementWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2022-03-31 0001799850 rcor:PIPEInvestmentMember 2022-01-01 2022-03-31 0001799850 rcor:TwoThousandTwentyOneOmnibusIncentivePlanMember 2022-03-31 0001799850 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001799850 us-gaap:RestrictedStockUnitsRSUMember rcor:TwoThousandTwentyOneOmnibusIncentivePlanMember 2022-03-31 0001799850 us-gaap:SubsequentEventMember 2022-04-30 0001799850 rcor:ConvertiblePromissoryNoteMember rcor:MergerAgreementAndNotePurchaseAgreementMember 2021-07-20 2021-07-20 0001799850 srt:ScenarioPreviouslyReportedMember us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001799850 rcor:PrivatePlacementWarrantsMember 2021-09-01 0001799850 rcor:EarnoutSharesMember us-gaap:MeasurementInputPriceVolatilityMember 2022-03-31 0001799850 rcor:PrivatePlacementWarrantsMember 2022-01-01 2022-03-31 0001799850 rcor:ConvertiblePromissoryNoteMember rcor:MergerAgreementAndNotePurchaseAgreementMember 2021-07-20 0001799850 us-gaap:RetainedEarningsMember 2020-12-31 0001799850 rcor:ThirdMilestoneMember rcor:OldRenovacorMember 2022-03-31 0001799850 rcor:LiabilityClassifiedWarrantsMember rcor:April2020PrivatePlacementWarrantsMember 2021-12-31 0001799850 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001799850 us-gaap:GeneralAndAdministrativeExpenseMember 2021-01-01 2021-03-31 0001799850 srt:RestatementAdjustmentMember us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001799850 srt:MinimumMember us-gaap:OtherMachineryAndEquipmentMember 2022-01-01 2022-03-31 0001799850 rcor:PrivatePlacementWarrantsMember us-gaap:MeasurementInputPriceVolatilityMember 2022-03-31 0001799850 rcor:EarnoutSharesMember 2022-01-01 2022-03-31 0001799850 rcor:WarrantLiabilityMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001799850 rcor:EarnoutSharesMember us-gaap:MeasurementInputSharePriceMember 2021-12-31 0001799850 rcor:EarnoutSharesMember rcor:MeasurementInputFairValuePerShareMember 2022-03-31 0001799850 rcor:PublicWarrantsMember 2021-09-01 2021-09-01 0001799850 srt:MinimumMember rcor:TempleLicenseAgreementMember 2019-08-01 2019-08-31 0001799850 rcor:OldRenovacorMember 2022-01-01 2022-03-31 0001799850 us-gaap:GeneralAndAdministrativeExpenseMember 2022-01-01 2022-03-31 0001799850 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001799850 us-gaap:FairValueInputsLevel3Member rcor:WarrantLiabilityMember 2022-03-31 0001799850 rcor:MarketBasedRestrictedStockUnitsMember 2022-03-31 0001799850 us-gaap:FairValueInputsLevel3Member rcor:EarnoutShareLiabilityMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001799850 rcor:GrossmanMember us-gaap:SubsequentEventMember 2022-04-01 2022-04-30 0001799850 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001799850 us-gaap:FairValueInputsLevel3Member rcor:WarrantLiabilityMember 2021-12-31 0001799850 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-03-31 0001799850 rcor:FeldmanConsultingAgreementMember 2019-08-01 2019-08-31 0001799850 us-gaap:WarrantMember 2022-01-01 2022-03-31 0001799850 rcor:EarnoutSharesMember us-gaap:MeasurementInputExpectedTermMember 2021-01-01 2021-12-31 0001799850 srt:MaximumMember us-gaap:OtherMachineryAndEquipmentMember 2022-01-01 2022-03-31 0001799850 rcor:EquityClassifiedWarrantsMember 2021-12-31 0001799850 rcor:FirstMilestoneMember rcor:OldRenovacorMember 2022-03-31 0001799850 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001799850 us-gaap:FairValueInputsLevel3Member rcor:EarnoutShareLiabilityMember us-gaap:FairValueMeasurementsRecurringMember 2022-03-31 0001799850 us-gaap:ResearchAndDevelopmentExpenseMember 2022-01-01 2022-03-31 0001799850 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001799850 rcor:SecondMilestoneMember rcor:SponsorMember 2022-01-01 2022-03-31 0001799850 srt:RestatementAdjustmentMember us-gaap:CommonStockMember 2020-12-31 0001799850 rcor:EquityClassifiedWarrantsMember rcor:September2021PreFundedWarrantsMember 2022-03-31 0001799850 us-gaap:FairValueInputsLevel3Member rcor:EarnoutShareLiabilityMember 2022-03-31 0001799850 rcor:PIPEInvestmentMember 2022-03-31 0001799850 rcor:EarnoutSharesMember us-gaap:MeasurementInputSharePriceMember 2022-03-31 0001799850 rcor:SponsorSharesMember 2020-06-01 2020-06-30 0001799850 us-gaap:RetainedEarningsMember 2022-03-31 0001799850 rcor:MergerAgreementMember us-gaap:PrivatePlacementMember 2021-09-02 0001799850 rcor:TempleLicenseAgreementMember 2021-07-01 0001799850 us-gaap:EmployeeStockOptionMember 2021-01-01 2021-12-31 0001799850 rcor:SeriesARedeemableConvertiblePreferredStockMember 2021-09-01 2021-09-01 0001799850 rcor:MergerAndPipeFinancingMember 2022-03-31 0001799850 srt:MinimumMember us-gaap:SubsequentEventMember 2022-04-01 2022-04-30 0001799850 2022-01-01 2022-03-31 0001799850 rcor:PrivatePlacementWarrantsMember us-gaap:MeasurementInputExpectedTermMember 2022-01-01 2022-03-31 0001799850 rcor:ChardanHealthcareInvestmentsLimitedLiabilityCompanyMember 2022-02-01 2022-02-28 0001799850 rcor:ChardanInvestments2LimitedLiabilityCompanyMember us-gaap:SubsequentEventMember 2022-04-01 2022-04-30 0001799850 rcor:AmusaMember 2022-02-01 2022-02-28 0001799850 us-gaap:FairValueMeasurementsRecurringMember 2022-03-31 0001799850 us-gaap:CommonStockMember 2021-12-31 0001799850 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-03-31 0001799850 rcor:TempleLicenseAgreementMember 2021-01-01 2021-03-31 0001799850 rcor:OldRenovacorMember 2022-03-31 0001799850 rcor:PrivatePlacementWarrantsMember rcor:MeasurementInputFairValuePerWarrantMember 2021-12-31 0001799850 srt:ScenarioPreviouslyReportedMember 2020-12-31 0001799850 rcor:PreFundedWarrantsMember 2022-01-01 2022-03-31 0001799850 rcor:ChardanHealthcareAcquisitionCorporationAndOldRenovacorMember 2022-01-01 2022-03-31 0001799850 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-03-31 0001799850 rcor:ChardanHealthcareInvestmentsLimitedLiabilityCompanyMember 2022-03-31 0001799850 rcor:EarnoutSharesMember 2022-01-01 2022-03-31 0001799850 us-gaap:CommonStockMember 2021-03-31 0001799850 rcor:EarnoutSharesMember rcor:MeasurementInputProbabilityOfChangeInControlMember 2022-03-31 0001799850 srt:MaximumMember rcor:PreFundedWarrantsMember 2022-01-01 2022-03-31 0001799850 rcor:EarnoutShareLiabilityMember us-gaap:FairValueMeasurementsRecurringMember 2022-03-31 0001799850 rcor:PrivatePlacementWarrantsMember us-gaap:MeasurementInputSharePriceMember 2022-03-31 0001799850 rcor:MarketBasedRestrictedStockUnitsMember 2022-01-01 2022-03-31 0001799850 rcor:TwoThousandTwentyOneOmnibusIncentivePlanMember 2022-01-01 2022-03-31 0001799850 rcor:PipeInvestorsMember 2022-01-01 2022-03-31 0001799850 us-gaap:FairValueInputsLevel3Member rcor:WarrantLiabilityMember us-gaap:FairValueMeasurementsRecurringMember 2022-03-31 0001799850 rcor:PipeInvestorsMember 2022-03-31 0001799850 2021-12-31 0001799850 rcor:FeldmanConsultingAgreementMember 2021-01-01 2021-03-31 0001799850 rcor:SecondMilestoneMember rcor:OldRenovacorMember 2022-03-31 0001799850 rcor:StockOptionsMember 2022-01-01 2022-03-31 0001799850 rcor:PrivatePlacementWarrantsMember us-gaap:MeasurementInputExercisePriceMember 2021-12-31 0001799850 rcor:SharesEarnoutMember 2022-03-31 0001799850 rcor:EarnoutSharesMember rcor:MeasurementInputFairValuePerShareMember 2021-12-31 0001799850 rcor:ThirdMilestoneMember 2022-01-01 2022-03-31 0001799850 us-gaap:AccountingStandardsUpdate201602Member 2022-03-31 0001799850 us-gaap:WarrantMember 2022-03-31 0001799850 us-gaap:RetainedEarningsMember 2021-03-31 0001799850 rcor:EarnoutSharesMember us-gaap:MeasurementInputPriceVolatilityMember 2021-12-31 0001799850 rcor:SponsorOwnershipMember 2022-03-31 0001799850 rcor:PrivatePlacementWarrantsMember us-gaap:MeasurementInputExpectedTermMember 2021-01-01 2021-12-31 0001799850 rcor:TimeBasedRestrictedStockUnitsMember 2022-01-01 2022-03-31 0001799850 rcor:PreFundedWarrantsMember 2022-03-31 0001799850 rcor:EquityClassifiedWarrantsMember rcor:September2021PreFundedWarrantsMember 2021-12-31 0001799850 us-gaap:CommonStockMember 2022-03-31 0001799850 2021-03-31 0001799850 rcor:SharesEarnoutMember 2021-12-31 0001799850 us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001799850 rcor:TwoThousandEighteenStockOptionAndGrantPlanMember 2022-01-01 2022-03-31 0001799850 us-gaap:FairValueInputsLevel3Member rcor:EarnoutShareLiabilityMember 2022-01-01 2022-03-31 0001799850 rcor:SponsorSupportAgreementMember 2022-01-01 2022-03-31 0001799850 rcor:PrivatePlacementWarrantsMember 2022-01-01 2022-03-31 0001799850 2021-09-01 0001799850 rcor:SponsorSharesMember 2018-12-01 2018-12-31 0001799850 rcor:MarketBasedRestrictedStockUnitsMember 2021-12-31 0001799850 rcor:FirstMilestoneMember 2022-01-01 2022-03-31 0001799850 rcor:WarrantLiabilityMember us-gaap:FairValueMeasurementsRecurringMember 2022-03-31 0001799850 srt:ScenarioPreviouslyReportedMember us-gaap:RetainedEarningsMember 2020-12-31 0001799850 rcor:LiabilityClassifiedWarrantsMember rcor:April2020PrivatePlacementWarrantsMember 2022-03-31 0001799850 rcor:CommonStockWarrantsMember 2022-01-01 2022-03-31 0001799850 2020-12-31 0001799850 rcor:TempleLicenseAgreementMember 2022-03-31 0001799850 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001799850 rcor:PrivatePlacementWarrantsMember us-gaap:MeasurementInputExercisePriceMember 2022-03-31 0001799850 rcor:TempleLicenseAgreementMember 2019-08-01 2019-08-31 0001799850 rcor:FirstMilestoneMember rcor:OldRenovacorMember 2022-01-01 2022-03-31 0001799850 srt:MaximumMember us-gaap:SubsequentEventMember 2022-04-01 2022-04-30 0001799850 rcor:EquityClassifiedWarrantsMember rcor:April2020PublicWarrantsMember 2022-03-31 0001799850 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001799850 rcor:EarnoutSharesMember rcor:OldRenovacorMember 2022-01-01 2022-03-31 0001799850 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001799850 rcor:TempleLicenseAgreementMember us-gaap:CommonStockMember 2019-08-01 2019-08-31 0001799850 rcor:ThirdMilestoneMember rcor:OldRenovacorMember 2022-01-01 2022-03-31 0001799850 2021-01-01 2021-03-31 0001799850 us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember 2022-03-31 0001799850 us-gaap:FairValueInputsLevel3Member rcor:WarrantLiabilityMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001799850 srt:MaximumMember us-gaap:RestrictedStockMember 2022-01-01 2022-03-31 0001799850 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001799850 us-gaap:RetainedEarningsMember 2021-12-31 0001799850 rcor:LiabilityClassifiedWarrantsMember 2022-03-31 0001799850 rcor:PrivatePlacementWarrantsMember rcor:MeasurementInputFairValuePerWarrantMember 2022-03-31 0001799850 rcor:FirstMilestoneMember rcor:SponsorMember 2022-01-01 2022-03-31 0001799850 rcor:PrivatePlacementWarrantsMember us-gaap:MeasurementInputSharePriceMember 2021-12-31 0001799850 srt:RestatementAdjustmentMember us-gaap:ConvertiblePreferredStockMember 2020-12-31 0001799850 2022-03-31 0001799850 rcor:ChardanHealthcareAcquisitionCorporationMember 2022-03-31 0001799850 us-gaap:FairValueInputsLevel3Member rcor:EarnoutShareLiabilityMember 2021-12-31 0001799850 rcor:TempleLicenseAgreementMember 2022-01-01 2022-03-31 0001799850 us-gaap:ResearchAndDevelopmentExpenseMember 2021-01-01 2021-03-31 0001799850 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001799850 us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001799850 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-03-31 0001799850 us-gaap:SubsequentEventMember 2022-04-01 2022-04-30 0001799850 rcor:EarnoutSharesMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2022-03-31 0001799850 rcor:SponsorSharesMember 2020-04-01 2020-04-30 0001799850 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001799850 rcor:PublicWarrantsMember 2022-03-31 0001799850 rcor:EarnoutSharesMember 2022-03-31 0001799850 rcor:StockOptionsMember 2021-01-01 2021-03-31 0001799850 rcor:PrivatePlacementWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2021-12-31 0001799850 rcor:ThirdMilestoneMember rcor:SponsorMember 2022-01-01 2022-03-31 0001799850 rcor:SponsorMember 2022-01-01 2022-03-31 0001799850 us-gaap:EmployeeStockOptionMember 2021-01-01 2021-03-31 0001799850 rcor:MergerAgreementMember us-gaap:PrivatePlacementMember 2021-09-02 2021-09-02 0001799850 rcor:EquityClassifiedWarrantsMember 2022-03-31 0001799850 rcor:EquityClassifiedWarrantsMember rcor:April2020PublicWarrantsMember 2021-12-31 0001799850 rcor:SeriesARedeemableConvertiblePreferredStockMember 2021-09-01 0001799850 rcor:TimeBasedRestrictedStockUnitsMember 2022-03-31 0001799850 rcor:PublicWarrantsMember 2021-09-01 0001799850 rcor:EarnoutSharesMember us-gaap:MeasurementInputExpectedTermMember 2022-01-01 2022-03-31 0001799850 rcor:TempleLicenseAgreementMember us-gaap:CommonStockMember 2020-11-01 2020-11-30 0001799850 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001799850 rcor:FeldmanConsultingAgreementMember 2022-01-01 2022-03-31 0001799850 rcor:EarnoutSharesMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2021-12-31 0001799850 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001799850 us-gaap:EmployeeStockOptionMember 2021-12-31 0001799850 us-gaap:FairValueInputsLevel3Member rcor:WarrantLiabilityMember 2022-01-01 2022-03-31 0001799850 rcor:PrivatePlacementWarrantsMember us-gaap:MeasurementInputPriceVolatilityMember 2021-12-31 0001799850 rcor:TempleLicenseAgreementMember 2021-07-01 2021-07-01 0001799850 rcor:EarnoutRsuMember 2021-10-01 2021-12-31 0001799850 rcor:EarnoutSharesMember rcor:MeasurementInputProbabilityOfChangeInControlMember 2021-12-31 iso4217:USD shares pure utr:sqft shares rcor:TradingDay iso4217:USD P3Y Q1 0001799850 false --12-31 10-Q true 2022-03-31 2022 false 001-39271 Renovacor, Inc. DE 83-3169838 201 Broadway Suite 310 Cambridge MA 02139 610 424-2650 Common Stock, par value $0.0001 per share RCOR NYSEAMER Warrants to purchase common stock at an exercise price of $11.50 per share RCOR.WS NYSEAMER Yes Yes Non-accelerated Filer true true false false 17267423 70084000 78790000 1623000 1763000 71707000 80553000 362000 379000 42000 67000 72111000 80999000 1781000 1536000 1616000 2498000 3397000 4034000 3885000 11165000 500000 500000 0.0001 0.0001 4090000 12256000 11372000 27455000 0.0001 0.0001 1000000 1000000 0 0 0 0 0.0001 0.0001 100000000 100000000 16756042 16756042 16756042 16756042 2000 2000 73141000 72540000 -12404000 -18998000 60739000 53544000 72111000 80999000 5930000 1155000 2925000 526000 -8855000 -1681000 4000 -7280000 -8166000 1000 6594000 -1681000 0.37 -0.27 0.36 -0.27 17471266 6274566 17628835 6274566 6594000 -1681000 601000 7000 -7280000 -8166000 17000 1000 -140000 678000 -25000 298000 375000 -522000 197000 -8293000 -1779000 360000 -360000 53000 80000 -53000 -80000 -8706000 -1859000 78790000 5384000 70084000 3525000 644000 16756042 2000 72540000 -18998000 53544000 601000 601000 6594000 6594000 16756042 2000 73141000 -12404000 60739000 2578518 10074000 1953368 121000 -4897000 -4776000 -2578518 -10074000 4321198 1000 10073000 10074000 6274566 1000 10194000 -4897000 5298000 30495 7000 7000 -1681000 -1681000 6305061 1000 10201000 -6578000 3624000 <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Note 1. Business and Organization</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Renovacor, Inc. (the “Company,” or “Renovacor”) (f/k/a Chardan Healthcare Acquisition 2 Corp. ("Chardan")), a Delaware corporation, is a biotechnology company focused on delivering innovative precision therapies to improve the lives of patients and families battling genetically-driven cardiovascular and mechanistically-related diseases. The Company’s initial focus is on the treatment of </span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">BCL2-associated athanogene 3 (</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">BAG3) </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">mutation</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">associated dilated cardiomyopathy ("DCM") ("BAG3 DCM"). BAG3 DCM is a heritable rare disease that leads to early onset, rapidly progressing heart failure and significant mortality and morbidity. The Company’s lead product candidate, REN-001, is a recombinant </span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">adeno-associated virus ("AAV") 9-based </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">gene therapy designed to deliver a fully functional </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">BAG3 </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">gene to augment BAG3 protein levels in cardiomyocytes and slow or halt progression of BAG3 DCM.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The Company is subject to risks common to companies in the biopharmaceutical industry, including, but not limited to, risks related to the successful development and commercialization of product candidates, fluctuations in operating results and financial risks, the ability to successfully raise additional funds when needed, protection of proprietary rights and patent risks, patent litigation, compliance with government regulations, dependence on key personnel and prospective collaborative partners, and competition from competing products in the marketplace.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Merger Agreement</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span> </p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Prior to September 2, 2021, the Company was a special purpose acquisition company formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business transaction with one or more businesses or entities. On September 2, 2021 (the "Closing Date"), the Company consummated the business combination contemplated by that certain Agreement and Plan of Merger, dated March 22, 2021 (the “Merger Agreement”), by and among the Company, CHAQ2 Merger Sub, Inc., a wholly owned subsidiary of the Company (“Merger Sub”), and Renovacor Holdings, Inc. (f/k/a Renovacor, Inc. ("Old Renovacor")). Pursuant to the Merger Agreement, (i) Merger Sub merged with and into Old Renovacor, with Old Renovacor as the surviving company in the merger and, after giving effect to such merger, continuing as a wholly owned subsidiary of the Company (the “Merger”) and (ii) the Company’s name was changed from Chardan Healthcare Acquisition 2 Corp. to Renovacor, Inc. (the “Merger”</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> and, together with the other transactions contemplated by the Merger Agreement, the “Business Combination”).</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Liquidity Considerations</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The Company has evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about its ability to continue as a going concern within one year after the date the financial statements are issued. As of March 31, 2022, the Company had an accumulated deficit of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">12.4</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> and a cash and cash equivalents balance of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">70.1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">. The Company has incurred losses and negative cash flows from operations since inception. The Company expects to continue to incur substantial operating losses and negative cash flows for the foreseeable future and will require additional capital as it continues to advance REN-001 and/or any future product candidates through development.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The Company follows the provisions of Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 205-40, Presentation of Financial Statements—Going Concern, which requires management to assess the Company’s ability to continue as a going concern within one year after the date the financial statements are issued. Management currently anticipates that the Company’s balance of cash and cash equivalents, as of March 31, 2022, is sufficient to enable the Company to continue as a going concern through the one-year period subsequent to the filing date of this Quarterly Report on Form 10-Q. Management’s operating plan, which underlies the analysis of the Company’s ability to continue as a going concern, involves the estimation of the amount and timing of future cash inflows and outflows. Actual results could vary from the operating plan.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The Company has and will continue to evaluate available alternatives to extend its operations beyond this date, which include financing its operations through a combination of equity offerings, debt financings, collaborations, strategic alliances and licensing arrangements. However, the Company may be unable to raise additional funds or enter into such other agreements or arrangements when needed on favorable terms, or at all. If the Company fails to raise capital or enter into such agreements or arrangements as, and when, needed, it may have to significantly delay, scale back or discontinue the development and commercialization of one or more of its product candidates.</span></p> -12400000 70100000 <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Note 2. Summary of Significant Accounting Policies</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Basis of Presentation</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The accompanying unaudited interim condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the United States Securities and Exchange Commission (“SEC”) for interim financial reporting. Accordingly, they do not include all of the information and disclosures required by U.S. GAAP for complete financial statements as certain footnotes or other financial information that are normally required by U.S. GAAP can be condensed or omitted. These condensed consolidated statements are unaudited and, in the opinion of management, include all adjustments (consisting of normal recurring adjustments and accruals) necessary to fairly present the results of the interim periods. The results of operations and cash flows for the three months ended March 31, 2022 are not necessarily indicative of the results that may be expected for the fiscal year ended December 31, 2022 or any other future period.</span></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Reverse Recapitalization</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The Business Combination was accounted for as a reverse recapitalization in accordance with U.S. GAAP (the “Reverse Recapitalization”). Under this method of accounting, the Company is treated as the “acquired” company and Old Renovacor is treated as the acquirer for financial reporting purposes. As a result, the consolidated assets, liabilities and results of operations prior to the Business Combination are those of Old Renovacor. Additionally, the shares and corresponding capital amounts and losses per share, prior to the Business Combination, have been retroactively restated based on shares reflecting the applicable exchange ratio resulting from the Common Per Share Merger Consideration and/or the Preferred Per Share Merger Consideration (each as defined by the Merger Agreement).</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Emerging Growth Company Status</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The Company is an "emerging growth company", as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”). Under the JOBS Act, the Company may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statement with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.</span></p></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, expense, and related disclosures. The Company bases estimates and assumptions on historical experience when available and on various factors that it believes to be reasonable under the circumstances. The Company evaluates its estimates and assumptions on an ongoing basis. Estimates relied upon in preparing these financial statements relate to, but are not limited to, the fair value of financial instruments, stock-based compensation assumptions and accrued expenses (including accrued and prepaid clinical costs). Actual results may differ from these estimates under different assumptions or conditions.</span></p></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Concentration of Credit Risk</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Financial instruments that subject the Company to significant concentrations of credit risk consist primarily of cash primarily held at one financial institution, which, at times, may exceed federally insured limits, and cash equivalents consisting of investments in money market funds managed by a variety of financial institutions. The Company's credit risk is managed by investing in only highly rated money market instruments. As a result, no significant additional credit risk is believed by management to be inherent in the Company’s assets and the Company has not experienced any losses in such accounts and believes it is not exposed to any significant risk on such accounts</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">.</span></p></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Cash and Cash Equivalents</span></p><p style="text-indent:5.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Arial;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The Company considers all highly liquid investments with maturities of 90 days or less when purchased to be “cash equivalents.” Cash and cash equivalents at March 31, 2022 consisted of cash and money market funds.</span></p></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Property and Equipment, net</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Property and equipment is carried at acquisition cost less accumulated depreciation, subject to review for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable in accordance with ASC 360-10-35, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Impairment or Disposal of Long-Lived Assets.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> The cost of normal, recurring, or periodic repairs and maintenance activities related to property and equipment, if any, are expensed as incurred. The cost for planned major maintenance activities, including the related acquisition or construction of assets, is capitalized if the repair will result in future economic benefits.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Depreciation and amortization are computed using the straight-line method based on the estimated useful lives of the related assets. Equipment and other long-lived assets are depreciated over </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_2a7308d1-e1af-4913-b7f2-d4df74436427;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">three</span></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> to </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">five years</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">. When an asset is disposed of, the associated cost and accumulated depreciation is removed from the related accounts on the Company's balance sheet with any resulting gain or loss included in the Company's condensed consolidated statement of operations.</span></p></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Financial Instruments</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The fair value of the Company’s financial instruments is determined and disclosed in accordance with the three-tier fair value hierarchy specified in Note 4, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Fair Value Measurements</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">. The Company is required to disclose the estimated fair values of its financial instruments. As of March 31, 2022 and December 31, 2021, the Company’s financial instruments consisted of cash equivalents and warrant and share earnout liabilities. As of March 31, 2022, the Company did not have any other derivatives, hedging instruments or other similar financial instruments.</span></p></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Warrant Liability</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The Company accounts for stock warrants as either equity instruments, liabilities or derivative liabilities in accordance with ASC Topic 480, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Distinguishing Liabilities from Equity</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> ("ASC 480") and/or ASC Topic 815, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Derivatives and Hedging</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> ("ASC 815"), depending on the specific terms of the warrant agreement. Liability-classified warrants are recorded at their estimated fair values at each reporting period until they are exercised, terminated, reclassified or otherwise settled. Changes in the estimated fair value of liability-classified warrants are recorded in Change in Fair Value of Warrant Liability in the Company’s condensed consolidated statements of operations. Equity-classified warrants are recorded within additional paid-in capital at the time of issuance and not subject to remeasurement.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Share Earnout Liability</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The Company accounts for share earnout arrangements that represent equity-linked instruments as either liabilities or equity instruments in accordance with ASC 815, unless such arrangements are within the scope of ASC Topic 718, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Compensation–Stock Compensation</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> ("ASC 718"), depending on the specific terms of the contract. Contracts classified as liabilities are recorded at their estimated fair values at each reporting period until they are no longer outstanding. Changes in the estimated fair value of liability-classified share earnout arrangements are recorded in Change in Fair Value of Share Earnout Liability in the Company’s condensed consolidated statements of operations.</span></p></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Research and Development Expense</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The Company expenses research and development expenses as incurred. The Company’s research and development expenses consist primarily of personnel-related expenses such as salaries, stock-based compensation, and benefits, and external costs of outside vendors engaged to conduct preclinical development activities, including manufacturing of preclinical and clinical drug supply. The Company accrues for expenses related to development activities performed by third parties based on an evaluation of services received and efforts expended pursuant to the terms of the contractual arrangements. There may be instances in which payments made to the Company’s vendors will exceed the level of services provided and result in a prepayment of expenses. In accruing service fees, the Company estimates the time period over which services will be performed and the level of effort to be expended in each period. If the actual timing of the performance of services or the level of effort varies from the estimate, the Company will adjust the accrual or prepaid expense accordingly</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">.</span></p></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Stock-Based Compensation</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The Company expenses stock-based compensation to employees and non-employees over the requisite service period, generally the vesting period, based on the estimated grant-date fair value of the awards. The Company accounts for forfeitures as they occur. Stock-based awards with graded-vesting schedules are recognized on a straight-line basis over the requisite service period for each separately vesting portion of the award. The Company estimates the fair value of stock option grants using the Black-Scholes option pricing model, and the assumptions used in calculating the fair value of stock-based awards represent management’s best estimates and involve inherent uncertainties and the application of management’s judgment. All stock-based compensation costs are recorded in general and administrative or research and development costs in the condensed consolidated statements of operations based upon the underlying individual’s role at the Company.</span></p></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Income Taxes</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">In accordance with ASC 270, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Interim Reporting</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">, and ASC 740, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Income Taxes</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">, the Company is required at the end of each interim period to determine the best estimate of its annual effective tax rate and then apply that rate in providing for income taxes on a current year-to-date (interim period) basis. For the three months ended March 31, 2022 and 2021, the Company recorded </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> tax expense or benefit due to the expected current year loss and its historical losses. The Company has </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">t recorded its net deferred tax asset as of either March 31, 2022 or December 31, 2021 because it maintained a full valuation allowance against all deferred tax assets as of these dates as management has determined that it is not more likely than not that the Company will realize these future tax benefits. As of March 31, 2022 and December 31, 2021, the Company had </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> uncertain tax positions.</span></p></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Net Income (Loss) per Common Share</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Basic net income (loss) per share of common stock is computed by dividing net loss applicable to common stockholders by the weighted-average number of shares of common stock outstanding during each period, which includes shares of common stock underlying the Pre-funded Warrant (as defined herein), as such warrant is exercisable, in whole or in part, for nominal cash consideration with no expiration date. Shares of common stock outstanding but subject to forfeiture and cancellation by the Company (e.g., Sponsor Earnout Shares, as defined in the Merger Agreement) are excluded from the weighted-average shares until the period in which such shares are no longer subject to forfeiture. Diluted net loss per share of common stock includes the effect, if any, from the potential exercise or conversion of securities, such as stock options, Public Warrants and Private Placement Warrants, and Sponsor Earnout Shares and Old Renovacor</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> Earnout Shares (each as defined herein), which would result in the issuance of incremental shares of common stock, unless their effect would be anti-dilutive. See Note 13 for additional details.</span></p></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">New Accounting Pronouncements</span></p><p style="text-indent:3.333%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">From time to time, new accounting pronouncements are issued by the FASB and rules are issued by the SEC that the Company has or will adopt as of a specified date. Unless otherwise noted, management does not believe that any other recently issued accounting pronouncements issued by the FASB or guidance issued by the SEC had, or is expected to have, a material impact on the Company’s present or future consolidated financial statements.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Accounting Pronouncements Recently Adopted</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">In February 2016, the FASB issued ASU No. 2016-02, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Leases (Topic 842) </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">("ASU 2016-02"). ASU 2016-02 (amended by ASU 2019-10 and ASU 2020-05) is effective for non-public entities and emerging growth companies for fiscal years beginning after December 15, 2021 and interim periods within fiscal years beginning after December 15, 2022. The new standard establishes a right-of-use (ROU) model that requires a lessee to record a ROU asset and a lease liability on the balance sheet for all leases with terms longer than 12 months. Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition in the statement of operations. A modified retrospective transition approach is required at the beginning of the earliest comparative period presented in the financial statements, with certain practical expedients available</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">. The Company </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">adopted</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> this standard effective </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">January 1, 2022</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">. The adoption did </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">no</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">t have a material impact on the Company’s consolidated condensed financial statements as of the adoption date. However, should the Company enter into material operating leases in the future, such as real estate leases for its corporate headquarters and other office and lab space, the Company anticipates an increase in assets and liabilities due to the recognition of the required right-of use asset and corresponding lease liability for such lease obligations. See Note 14 for discussion of leasing transactions occurring after March 31, 2022.</span></p></div> <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Basis of Presentation</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The accompanying unaudited interim condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the United States Securities and Exchange Commission (“SEC”) for interim financial reporting. Accordingly, they do not include all of the information and disclosures required by U.S. GAAP for complete financial statements as certain footnotes or other financial information that are normally required by U.S. GAAP can be condensed or omitted. These condensed consolidated statements are unaudited and, in the opinion of management, include all adjustments (consisting of normal recurring adjustments and accruals) necessary to fairly present the results of the interim periods. The results of operations and cash flows for the three months ended March 31, 2022 are not necessarily indicative of the results that may be expected for the fiscal year ended December 31, 2022 or any other future period.</span> <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Reverse Recapitalization</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The Business Combination was accounted for as a reverse recapitalization in accordance with U.S. GAAP (the “Reverse Recapitalization”). Under this method of accounting, the Company is treated as the “acquired” company and Old Renovacor is treated as the acquirer for financial reporting purposes. As a result, the consolidated assets, liabilities and results of operations prior to the Business Combination are those of Old Renovacor. Additionally, the shares and corresponding capital amounts and losses per share, prior to the Business Combination, have been retroactively restated based on shares reflecting the applicable exchange ratio resulting from the Common Per Share Merger Consideration and/or the Preferred Per Share Merger Consideration (each as defined by the Merger Agreement).</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Emerging Growth Company Status</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The Company is an "emerging growth company", as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”). Under the JOBS Act, the Company may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statement with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.</span></p> <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, expense, and related disclosures. The Company bases estimates and assumptions on historical experience when available and on various factors that it believes to be reasonable under the circumstances. The Company evaluates its estimates and assumptions on an ongoing basis. Estimates relied upon in preparing these financial statements relate to, but are not limited to, the fair value of financial instruments, stock-based compensation assumptions and accrued expenses (including accrued and prepaid clinical costs). Actual results may differ from these estimates under different assumptions or conditions.</span></p> <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Concentration of Credit Risk</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Financial instruments that subject the Company to significant concentrations of credit risk consist primarily of cash primarily held at one financial institution, which, at times, may exceed federally insured limits, and cash equivalents consisting of investments in money market funds managed by a variety of financial institutions. The Company's credit risk is managed by investing in only highly rated money market instruments. As a result, no significant additional credit risk is believed by management to be inherent in the Company’s assets and the Company has not experienced any losses in such accounts and believes it is not exposed to any significant risk on such accounts</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">.</span></p> <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Cash and Cash Equivalents</span></p><p style="text-indent:5.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Arial;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The Company considers all highly liquid investments with maturities of 90 days or less when purchased to be “cash equivalents.” Cash and cash equivalents at March 31, 2022 consisted of cash and money market funds.</span></p> <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Property and Equipment, net</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Property and equipment is carried at acquisition cost less accumulated depreciation, subject to review for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable in accordance with ASC 360-10-35, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Impairment or Disposal of Long-Lived Assets.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> The cost of normal, recurring, or periodic repairs and maintenance activities related to property and equipment, if any, are expensed as incurred. The cost for planned major maintenance activities, including the related acquisition or construction of assets, is capitalized if the repair will result in future economic benefits.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Depreciation and amortization are computed using the straight-line method based on the estimated useful lives of the related assets. Equipment and other long-lived assets are depreciated over </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_2a7308d1-e1af-4913-b7f2-d4df74436427;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">three</span></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> to </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">five years</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">. When an asset is disposed of, the associated cost and accumulated depreciation is removed from the related accounts on the Company's balance sheet with any resulting gain or loss included in the Company's condensed consolidated statement of operations.</span></p> P5Y <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Financial Instruments</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The fair value of the Company’s financial instruments is determined and disclosed in accordance with the three-tier fair value hierarchy specified in Note 4, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Fair Value Measurements</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">. The Company is required to disclose the estimated fair values of its financial instruments. As of March 31, 2022 and December 31, 2021, the Company’s financial instruments consisted of cash equivalents and warrant and share earnout liabilities. As of March 31, 2022, the Company did not have any other derivatives, hedging instruments or other similar financial instruments.</span></p> <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Warrant Liability</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The Company accounts for stock warrants as either equity instruments, liabilities or derivative liabilities in accordance with ASC Topic 480, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Distinguishing Liabilities from Equity</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> ("ASC 480") and/or ASC Topic 815, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Derivatives and Hedging</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> ("ASC 815"), depending on the specific terms of the warrant agreement. Liability-classified warrants are recorded at their estimated fair values at each reporting period until they are exercised, terminated, reclassified or otherwise settled. Changes in the estimated fair value of liability-classified warrants are recorded in Change in Fair Value of Warrant Liability in the Company’s condensed consolidated statements of operations. Equity-classified warrants are recorded within additional paid-in capital at the time of issuance and not subject to remeasurement.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Share Earnout Liability</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The Company accounts for share earnout arrangements that represent equity-linked instruments as either liabilities or equity instruments in accordance with ASC 815, unless such arrangements are within the scope of ASC Topic 718, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Compensation–Stock Compensation</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> ("ASC 718"), depending on the specific terms of the contract. Contracts classified as liabilities are recorded at their estimated fair values at each reporting period until they are no longer outstanding. Changes in the estimated fair value of liability-classified share earnout arrangements are recorded in Change in Fair Value of Share Earnout Liability in the Company’s condensed consolidated statements of operations.</span></p> <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Research and Development Expense</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The Company expenses research and development expenses as incurred. The Company’s research and development expenses consist primarily of personnel-related expenses such as salaries, stock-based compensation, and benefits, and external costs of outside vendors engaged to conduct preclinical development activities, including manufacturing of preclinical and clinical drug supply. The Company accrues for expenses related to development activities performed by third parties based on an evaluation of services received and efforts expended pursuant to the terms of the contractual arrangements. There may be instances in which payments made to the Company’s vendors will exceed the level of services provided and result in a prepayment of expenses. In accruing service fees, the Company estimates the time period over which services will be performed and the level of effort to be expended in each period. If the actual timing of the performance of services or the level of effort varies from the estimate, the Company will adjust the accrual or prepaid expense accordingly</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">.</span></p> <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Stock-Based Compensation</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The Company expenses stock-based compensation to employees and non-employees over the requisite service period, generally the vesting period, based on the estimated grant-date fair value of the awards. The Company accounts for forfeitures as they occur. Stock-based awards with graded-vesting schedules are recognized on a straight-line basis over the requisite service period for each separately vesting portion of the award. The Company estimates the fair value of stock option grants using the Black-Scholes option pricing model, and the assumptions used in calculating the fair value of stock-based awards represent management’s best estimates and involve inherent uncertainties and the application of management’s judgment. All stock-based compensation costs are recorded in general and administrative or research and development costs in the condensed consolidated statements of operations based upon the underlying individual’s role at the Company.</span></p> <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Income Taxes</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">In accordance with ASC 270, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Interim Reporting</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">, and ASC 740, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Income Taxes</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">, the Company is required at the end of each interim period to determine the best estimate of its annual effective tax rate and then apply that rate in providing for income taxes on a current year-to-date (interim period) basis. For the three months ended March 31, 2022 and 2021, the Company recorded </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> tax expense or benefit due to the expected current year loss and its historical losses. The Company has </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">t recorded its net deferred tax asset as of either March 31, 2022 or December 31, 2021 because it maintained a full valuation allowance against all deferred tax assets as of these dates as management has determined that it is not more likely than not that the Company will realize these future tax benefits. As of March 31, 2022 and December 31, 2021, the Company had </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> uncertain tax positions.</span></p> 0 0 0 0 0 0 <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Net Income (Loss) per Common Share</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Basic net income (loss) per share of common stock is computed by dividing net loss applicable to common stockholders by the weighted-average number of shares of common stock outstanding during each period, which includes shares of common stock underlying the Pre-funded Warrant (as defined herein), as such warrant is exercisable, in whole or in part, for nominal cash consideration with no expiration date. Shares of common stock outstanding but subject to forfeiture and cancellation by the Company (e.g., Sponsor Earnout Shares, as defined in the Merger Agreement) are excluded from the weighted-average shares until the period in which such shares are no longer subject to forfeiture. Diluted net loss per share of common stock includes the effect, if any, from the potential exercise or conversion of securities, such as stock options, Public Warrants and Private Placement Warrants, and Sponsor Earnout Shares and Old Renovacor</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> Earnout Shares (each as defined herein), which would result in the issuance of incremental shares of common stock, unless their effect would be anti-dilutive. See Note 13 for additional details.</span></p> <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">New Accounting Pronouncements</span></p><p style="text-indent:3.333%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">From time to time, new accounting pronouncements are issued by the FASB and rules are issued by the SEC that the Company has or will adopt as of a specified date. Unless otherwise noted, management does not believe that any other recently issued accounting pronouncements issued by the FASB or guidance issued by the SEC had, or is expected to have, a material impact on the Company’s present or future consolidated financial statements.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Accounting Pronouncements Recently Adopted</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">In February 2016, the FASB issued ASU No. 2016-02, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Leases (Topic 842) </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">("ASU 2016-02"). ASU 2016-02 (amended by ASU 2019-10 and ASU 2020-05) is effective for non-public entities and emerging growth companies for fiscal years beginning after December 15, 2021 and interim periods within fiscal years beginning after December 15, 2022. The new standard establishes a right-of-use (ROU) model that requires a lessee to record a ROU asset and a lease liability on the balance sheet for all leases with terms longer than 12 months. Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition in the statement of operations. A modified retrospective transition approach is required at the beginning of the earliest comparative period presented in the financial statements, with certain practical expedients available</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">. The Company </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">adopted</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> this standard effective </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">January 1, 2022</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">. The adoption did </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">no</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">t have a material impact on the Company’s consolidated condensed financial statements as of the adoption date. However, should the Company enter into material operating leases in the future, such as real estate leases for its corporate headquarters and other office and lab space, the Company anticipates an increase in assets and liabilities due to the recognition of the required right-of use asset and corresponding lease liability for such lease obligations. See Note 14 for discussion of leasing transactions occurring after March 31, 2022.</span></p> true 2022-01-01 true <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Note 3. Merger and Recapitalization</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Merger Agreement</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">As discussed in Note 1, on the Closing Date, the Company closed the Business Combination with Old Renovacor, as a result of which Old Renovacor became a wholly-owned subsidiary of the Company. While the Company was the legal acquirer of Old Renovacor in the business combination, for accounting purposes, the Merger is treated as a reverse recapitalization, whereby Old Renovacor is deemed to be the accounting acquirer, and the historical financial statements of Old Renovacor became the historical consolidated financial statements of the Company upon the closing of the Merger. Under this method of accounting, the Company was treated as the “acquired” company and Old Renovacor is treated as the acquirer for financial reporting purposes. Accordingly, for accounting purposes, the Merger was treated as the equivalent of Old Renovacor issuing stock for the net assets of the Company, accompanied by a recapitalization. The net assets of the Company were stated at historical cost, with </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> goodwill or other intangible assets recorded. Operations prior to the Merger are presented as those of Old Renovacor.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">At the consummation of the Merger Agreement upon filing of a certificate of Merger, which occurred on the Closing Date (the "Effective Time"), an aggregate of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">6,305,061</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> shares of the Company’s common stock, par value $0.0001 per share, plus 194,926 Exchanged Options (defined below) (the "Aggregate Merger Consideration") was issued to equityholders of Old Renovacor as of immediately prior to the Effective Time. Out of the Aggregate Merger Consideration, each holder of preferred stock of Old Renovacor, par value $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">0.0001</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> per share (the "Old Renovacor Preferred Stock") was entitled to receive a number of shares of the Company's common stock equal to the Preferred Per Share Merger Consideration (as defined in the Merger Agreement) with respect to such holder’s shares of Old Renovacor Preferred Stock. Each holder of common stock of Old Renovacor, par value $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">0.0001</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> per share (the "Old Renovacor Common Stock," and together with Old Renovacor’s preferred stock, the "Old Renovacor Capital Stock"), was entitled to receive a number of shares of the Company’s common stock equal to the Common Per Share Merger Consideration (as defined in the Merger Agreement) with respect to such holder’s shares of Old Renovacor Common Stock. In addition, pursuant to the Company's 2021 Investor Incentive Plan, a portion of the Aggregate Merger Consideration was allocated among certain Old Renovacor equityholders or their affiliates who elected to participate in the PIPE Investment on a pro rata basis based on their respective investment amounts.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Each option to purchase shares of Old Renovacor Common Stock ("Old Renovacor Option") outstanding as of immediately prior to the Effective Time was converted into an option to purchase a number of shares of the Company’s common stock (rounded down to the nearest whole number) equal to the product of the number of shares of Old Renovacor Common Stock subject to such Old Renovacor option and the Common Per Share Merger Consideration (an "Exchanged Option"), which Exchanged Option is subject to the same vesting terms applicable to the Old Renovacor Option as of immediately prior to the Effective Time.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">T</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">he shares and corresponding capital amounts and loss per share related to Old Renovacor Common Stock prior to the Business Combination Transaction were retroactively restated to reflect the </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Common Per Share Merger Consideration and the Preferred Per Share Merger Consideration, as applicable.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Holders of Old Renovacor Capital Stock are entitled to receive up to an additional </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,922,816</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> shares of the Company’s common stock (the “Old Renovacor Earnout Shares”) as follows:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;min-width:fit-content;"> </span> </p><div style="margin-left:2.0%;text-indent:0.0%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.0%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.0408163265306123%;">•</span><div style="display:inline;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">576,845</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> Old Renovacor Earnout Shares, in the aggregate, if at any time during the period beginning on the date of the Closing (the “Closing Date”) and ending on</span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> December 31, 2023</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> (the “First Earnout Period”), the volume-weighted average price ("VWAP") (as defined in the Merger Agreement) of the Company’s common stock over any twenty (</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">20</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">) Trading Days (as defined in the Merger Agreement) (which may or may not be consecutive) within any thirty (</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">30</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">) consecutive Trading Day period is greater than or equal to $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">17.50</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> per share of the Company’s common stock (the “First Milestone”).</span></div></div><p style="margin-left:2.0%;text-indent:-2.041%;padding-left:2.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="margin-left:2.0%;text-indent:0.0%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.0%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.0408163265306123%;">•</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">An additional </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">576,845</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> Old Renovacor Earnout Shares, in the aggregate, if at any time during the period beginning on the Closing Date and ending on </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">December 31, 2025</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> (the “Second Earnout Period”), the VWAP of the Company’s common stock over any twenty (</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">20</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">) Trading Days (which may or may not be consecutive) within any thirty (</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">30</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">) consecutive Trading Day period is greater than or equal to $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">25.00</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> per share of the Company’s common stock (the “Second Milestone”).</span></div></div><p style="margin-left:2.0%;text-indent:-2.041%;padding-left:2.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="margin-left:2.0%;text-indent:0.0%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.0%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.0408163265306123%;">•</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">An additional </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">769,126</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> Old Renovacor Earnout Shares, in the aggregate, if at any time during the period beginning on the Closing Date and ending on </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">December 31, 2027</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> (the “Third Earnout Period” and together with the First Earnout Period and the Second Earnout Period, each, an “Earnout Period” and collectively, the “Earnout Periods”), the VWAP of the Company’s common stock over any twenty (</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">20</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">) Trading Days (which may or may not be consecutive) within any thirty (</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">30</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">) consecutive Trading Day period is greater than or equal to $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">35.00</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> per share of the Company’s common stock (the “Third Milestone” and together with the First Milestone and the Second Milestone, the “Earnout Milestones”).</span></div></div><p style="margin-left:2.0%;text-indent:-2.041%;padding-left:2.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="margin-left:2.0%;text-indent:0.0%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.0%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.0408163265306123%;">•</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Upon the consummation of any Change in Control (as defined in the Merger Agreement) during any Earnout Period, any Earnout Milestone with respect to such Earnout Period that has not yet been achieved shall automatically be deemed to have been achieved regardless of the valuation of the Company’s common stock in such Change in Control transaction and the Company will take all actions necessary to provide for the issuance of the shares of the Company’s common stock comprising the applicable Old Renovacor Earnout Shares issuable in respect of such Earnout Milestone(s) prior to the consummation of such Change in Control.</span></div></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Times New Roman;min-width:fit-content;"> </span> </p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Each holder of Old Renovacor's Capital Stock was entitled to such holder’s aggregate Per Share Earnout Consideration (as defined in the Merger Agreement) in respect of such shares of Old Renovacor's Capital Stock as described above. In addition, at the Effective Time, holders of Old Renovacor Options received the right to be granted an Earnout RSU Award (as defined in the Merger Agreement) in respect of such holder’s Old Renovacor Options, which entitle such holder to an aggregate number of shares of the Company's common stock equal to the aggregate Per Share Earnout Consideration in respect of the shares of Old Renovacor Capital Stock underlying such Old Renovacor Options, if any, subject to the satisfaction of the applicable vesting conditions with respect to the Exchanged Options issued in respect of such Renovacor Options at the Closing. See Note 11 for further details.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Further, under the terms of the Business Combination (as provided for in the Sponsor Support Agreement), certain Sponsor Shares totaling </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">500,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> were placed into escrow and subject to forfeiture (the "Sponsor Earnout Shares"). Such Sponsor Earnout Shares will be released from escrow if the weighted average sale price of the Company's common stock equals or exceeds the applicable Target Price (as set forth in the table below) for any 20 trading days within a 30-day trading period from the Effective Time until the applicable end date. Upon consummation of any Change in Control during any Earnout Period, any Earnout Milestone with respect to such Earnout Period that has not yet been achieved shall automatically be deemed to have been achieved regardless of the valuation of the per share common stock price in such Change in Control transaction. Any Sponsor Earnout Shares that remain unvested as of the expiration of the applicable earnout period shall be forfeited and canceled.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:11.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The Old Renovacor Earnout Shares and Sponsor Earnout Shares (collectively, the "Earnout Shares") are summarized, as set forth in the table below:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span> </p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:29.004%;"/> <td style="width:1.058%;"/> <td style="width:1.206%;"/> <td style="width:15.717%;"/> <td style="width:0.594%;"/> <td style="width:1.058%;"/> <td style="width:0.594%;"/> <td style="width:15.235%;"/> <td style="width:0.594%;"/> <td style="width:1.058%;"/> <td style="width:0.594%;"/> <td style="width:15.216%;"/> <td style="width:0.594%;"/> <td style="width:1.058%;"/> <td style="width:0.594%;"/> <td style="width:15.235%;"/> <td style="width:0.594%;"/> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Old Renovacor</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Sponsor</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Target Price</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Earnout Shares</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Earnout Shares</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Total</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">December 31, 2023</span></span></p></td> <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:middle;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">17.50</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:middle;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">576,845</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:middle;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">150,000</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:middle;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">726,845</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">December 31, 2025</span></span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">25.00</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">576,845</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">150,000</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">726,845</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">December 31, 2027</span></span></p></td> <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:middle;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">35.00</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:middle;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">769,126</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">200,000</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">969,126</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,922,816</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">500,000</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2,422,816</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> </table></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">PIPE Investment (Private Placement)</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Concurrently with the execution of the Merger Agreement, the Company entered into subscription agreements (the "Subscription Agreements"), with certain investors ("PIPE Investors"), including Chardan Healthcare, certain stockholders of Old Renovacor and certain other institutional and accredited investors, pursuant to which, on the Closing Date, and concurrently with the closing of the Business Combination, the PIPE Investors purchased an aggregate of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2,284,776</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> shares the Company's common stock, at a price of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">10.00</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> per share, and a pre-funded warrant entitling the holder thereof to purchase </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">715,224</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> shares of the Company's common stock (the "Pre-Funded Warrant") at an initial purchase price of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">9.99</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> per share underlying the Pre-Funded Warrant, for aggregate gross proceeds of approximately $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">30.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> million (the "PIPE Investment"). The Pre-Funded Warrant is immediately exercisable at an exercise price of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">0.01</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> and is exercisable indefinitely, provided that the holder of the Pre-Funded Warrant is prohibited from exercising such Pre-Funded Warrant in an amount that would cause such holder’s beneficial ownership of our Common Stock to exceed </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">9.99</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">%, which limitation may be increased up to </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">19.99</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">% at the option of the holder from time to time.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Times New Roman;min-width:fit-content;"> </span> </p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:12.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The following table summarizes the elements of the net proceeds from the Merger:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Times New Roman;min-width:fit-content;"> </span> </p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:78.562%;"/> <td style="width:4.638%;"/> <td style="width:1.197%;"/> <td style="width:14.814%;"/> <td style="width:0.788%;"/> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">(In thousands)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Amount</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Cash – CHAQ trust and cash, net of redemptions</span></p></td> <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:middle;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">65,127</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Cash – PIPE financing</span></p></td> <td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:middle;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">29,993</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Less: CHAQ and Old Renovacor transaction costs paid</span></p></td> <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:middle;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">6,079</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Less: Settlement of convertible note at closing</span></p></td> <td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:middle;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2,500</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">   Effect of Merger, net of redemptions and transaction costs</span></p></td> <td style="background-color:rgba(207,240,252,1);text-indent:25.0pt;word-break:break-word;vertical-align:middle;"><p style="margin-left:25.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">86,541</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span> </p></div><div style="font-size:12.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The following table details the number of shares of common stock issued immediately following the consummation of the Merger:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:78.987%;"/> <td style="width:4.639%;"/> <td style="width:0.584%;"/> <td style="width:15.001%;"/> <td style="width:0.789%;"/> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Number of Shares</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Common stock, outstanding prior to Merger</span></p></td> <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:middle;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">8,622,644</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Less: redemption of CHAQ shares</span></p></td> <td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:middle;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2,112,100</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Common stock of CHAQ</span></p></td> <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:middle;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">6,510,544</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">CHAQ Founder shares</span></p></td> <td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:middle;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2,155,661</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Shares issued in PIPE Financing</span></p></td> <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:middle;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2,284,776</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Merger and PIPE financing shares - common stock</span></p></td> <td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:middle;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">10,950,981</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Shares issued to Old Renovacor - common stock </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:Times New Roman;position:relative;min-width:fit-content;">(1)</span></p></td> <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:middle;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">6,305,061</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Total shares of common stock immediately after Merger </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:bold;font-size:6.7pt;font-family:Times New Roman;position:relative;min-width:fit-content;">(2)</span></p></td> <td style="background-color:rgba(0,0,0,0);text-indent:25.0pt;word-break:break-word;vertical-align:middle;"><p style="margin-left:25.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">17,256,042</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> </table><p style="margin-left:1.333%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Times New Roman;min-width:fit-content;"> ____________________</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><div style="margin-left:2.667%;text-indent:0.0%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:9.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.7400778769790306%;">(1)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;min-width:fit-content;">The number of shares of common stock issued to Old Renovacor equityholders was determined based on (i) </span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;min-width:fit-content;">1,987,636</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;min-width:fit-content;"> shares of Old Renovacor Common Stock outstanding immediately prior to the closing of the Merger converted based on the Common Per Share Merger Consideration (as defined in the Merger Agreement) and (ii) </span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;min-width:fit-content;">2,578,518</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;min-width:fit-content;"> shares of Old Renovacor Preferred Stock outstanding immediately prior to the closing of the Merger converted based on the Preferred Per Share Merger Consideration (as defined in the Merger Agreement). All fractional shares were rounded down.</span></div></div><div style="margin-left:2.667%;text-indent:0.0%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:9.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.7400778769790306%;">(2)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;min-width:fit-content;">Includes </span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;min-width:fit-content;">500,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;min-width:fit-content;"> shares of common stock being held in escrow and subject to vesting or forfeiture based on satisfaction of the Earnout Milestones set forth in the Sponsor Support Agreement. Such shares are liability classified and included in the Share earnout liability as of December 31, 2021.</span></div></div></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Times New Roman;min-width:fit-content;"> </span> </p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">See Note 10 –</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> Stockholders’ Equity</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> for additional details of the Company’s capital stock.</span></p> 0 6305061 0.0001 0.0001 1922816 576845 2023-12-31 20 30 17.50 576845 2025-12-31 20 30 25.00 769126 2027-12-31 20 30 35.00 500000 <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The Old Renovacor Earnout Shares and Sponsor Earnout Shares (collectively, the "Earnout Shares") are summarized, as set forth in the table below:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span> </p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:29.004%;"/> <td style="width:1.058%;"/> <td style="width:1.206%;"/> <td style="width:15.717%;"/> <td style="width:0.594%;"/> <td style="width:1.058%;"/> <td style="width:0.594%;"/> <td style="width:15.235%;"/> <td style="width:0.594%;"/> <td style="width:1.058%;"/> <td style="width:0.594%;"/> <td style="width:15.216%;"/> <td style="width:0.594%;"/> <td style="width:1.058%;"/> <td style="width:0.594%;"/> <td style="width:15.235%;"/> <td style="width:0.594%;"/> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Old Renovacor</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Sponsor</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Target Price</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Earnout Shares</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Earnout Shares</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Total</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">December 31, 2023</span></span></p></td> <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:middle;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">17.50</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:middle;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">576,845</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:middle;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">150,000</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:middle;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">726,845</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">December 31, 2025</span></span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">25.00</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">576,845</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">150,000</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">726,845</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">December 31, 2027</span></span></p></td> <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:middle;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">35.00</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:middle;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">769,126</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">200,000</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">969,126</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,922,816</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">500,000</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2,422,816</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> </table> 2023-12-31 17.50 576845 150000 726845 2025-12-31 25.00 576845 150000 726845 2027-12-31 35.00 769126 200000 969126 1922816 500000 2422816 2284776 10.00 715224 9.99 30000000.0 0.01 0.0999 0.1999 <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The following table summarizes the elements of the net proceeds from the Merger:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Times New Roman;min-width:fit-content;"> </span> </p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:78.562%;"/> <td style="width:4.638%;"/> <td style="width:1.197%;"/> <td style="width:14.814%;"/> <td style="width:0.788%;"/> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">(In thousands)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Amount</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Cash – CHAQ trust and cash, net of redemptions</span></p></td> <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:middle;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">65,127</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Cash – PIPE financing</span></p></td> <td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:middle;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">29,993</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Less: CHAQ and Old Renovacor transaction costs paid</span></p></td> <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:middle;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">6,079</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Less: Settlement of convertible note at closing</span></p></td> <td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:middle;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2,500</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">   Effect of Merger, net of redemptions and transaction costs</span></p></td> <td style="background-color:rgba(207,240,252,1);text-indent:25.0pt;word-break:break-word;vertical-align:middle;"><p style="margin-left:25.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">86,541</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span> </p> 65127000 29993000 6079000 2500000 86541000 <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The following table details the number of shares of common stock issued immediately following the consummation of the Merger:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:78.987%;"/> <td style="width:4.639%;"/> <td style="width:0.584%;"/> <td style="width:15.001%;"/> <td style="width:0.789%;"/> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Number of Shares</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Common stock, outstanding prior to Merger</span></p></td> <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:middle;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">8,622,644</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Less: redemption of CHAQ shares</span></p></td> <td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:middle;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2,112,100</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Common stock of CHAQ</span></p></td> <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:middle;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">6,510,544</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">CHAQ Founder shares</span></p></td> <td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:middle;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2,155,661</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Shares issued in PIPE Financing</span></p></td> <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:middle;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2,284,776</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Merger and PIPE financing shares - common stock</span></p></td> <td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:middle;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">10,950,981</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Shares issued to Old Renovacor - common stock </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:Times New Roman;position:relative;min-width:fit-content;">(1)</span></p></td> <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:middle;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">6,305,061</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Total shares of common stock immediately after Merger </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:bold;font-size:6.7pt;font-family:Times New Roman;position:relative;min-width:fit-content;">(2)</span></p></td> <td style="background-color:rgba(0,0,0,0);text-indent:25.0pt;word-break:break-word;vertical-align:middle;"><p style="margin-left:25.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">17,256,042</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> </table><p style="margin-left:1.333%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Times New Roman;min-width:fit-content;"> ____________________</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><div style="margin-left:2.667%;text-indent:0.0%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:9.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.7400778769790306%;">(1)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;min-width:fit-content;">The number of shares of common stock issued to Old Renovacor equityholders was determined based on (i) </span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;min-width:fit-content;">1,987,636</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;min-width:fit-content;"> shares of Old Renovacor Common Stock outstanding immediately prior to the closing of the Merger converted based on the Common Per Share Merger Consideration (as defined in the Merger Agreement) and (ii) </span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;min-width:fit-content;">2,578,518</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;min-width:fit-content;"> shares of Old Renovacor Preferred Stock outstanding immediately prior to the closing of the Merger converted based on the Preferred Per Share Merger Consideration (as defined in the Merger Agreement). All fractional shares were rounded down.</span></div></div><div style="margin-left:2.667%;text-indent:0.0%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:9.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.7400778769790306%;">(2)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;min-width:fit-content;">Includes </span><span style="font-size:9.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;min-width:fit-content;">500,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;min-width:fit-content;"> shares of common stock being held in escrow and subject to vesting or forfeiture based on satisfaction of the Earnout Milestones set forth in the Sponsor Support Agreement. Such shares are liability classified and included in the Share earnout liability as of December 31, 2021.</span></div></div> 8622644 2112100 6510544 2155661 2284776 10950981 6305061 17256042 1987636 2578518 500000 <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Note 4. Fair Value Measurements</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Arial;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Assets and Liabilities Measured at Fair Value on a Recurring Basis</span></p><p style="text-indent:5.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The Company applies the guidance in ASC 820, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Fair Value Measurement</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">, to account for financial assets and liabilities measured on a recurring basis. Fair value is measured at the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. As such, fair value is a market-based measurement that is determined based on assumptions that market participants would use in pricing an asset or liability.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The Company uses a fair value hierarchy, which distinguishes between assumptions based on market data (observable inputs) and an entity's own assumptions (unobservable inputs). The guidance requires that fair value measurements be classified and disclosed in one of the following three categories:</span></p><div style="margin-left:2.0%;text-indent:0.0%;display:flex;margin-top:9.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.0%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.0408163265306123%;">•</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;</span></div></div><div style="margin-left:2.0%;text-indent:0.0%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.0%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.0408163265306123%;">•</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Level 2: Quoted prices in markets that are not active or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability; and</span></div></div><div style="margin-left:2.0%;text-indent:0.0%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.0%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.0408163265306123%;">•</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Level 3: Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e., supported by little or no market activity).</span></div></div><p style="text-indent:5.067%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Determining which category an asset or liability falls within the hierarchy requires significant judgment. The Company evaluates its hierarchy disclosures each reporting period. There were no transfers between Level 1, 2 and 3 during the three months ended March 31, 2022.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The table below presents the liabilities measured and recorded in the financial statements at fair value on a recurring basis at March 31, 2022 and December 31, 2021 categorized by the level of inputs used in the valuation of each asset and liability.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:49.824%;"/> <td style="width:1.206%;"/> <td style="width:1.206%;"/> <td style="width:9.555%;"/> <td style="width:0.594%;"/> <td style="width:1.206%;"/> <td style="width:1.206%;"/> <td style="width:9.555%;"/> <td style="width:0.594%;"/> <td style="width:1.206%;"/> <td style="width:1.206%;"/> <td style="width:9.508%;"/> <td style="width:0.594%;"/> <td style="width:1.206%;"/> <td style="width:1.206%;"/> <td style="width:9.536%;"/> <td style="width:0.594%;"/> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="14" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">March 31, 2022</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">(In thousands)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Total</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Level 1</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Level 2</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Level 3</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Assets</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Cash equivalents – money market funds</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">69,089</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">69,089</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Total assets</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">69,089</span></p></td> <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">69,089</span></p></td> <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Liabilities</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Warrant liability</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">3,885</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">3,885</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Share earnout liability</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">4,090</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">4,090</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Total liabilities</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">7,975</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">7,975</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:49.81%;"/> <td style="width:1.206%;"/> <td style="width:1.206%;"/> <td style="width:9.554%;"/> <td style="width:0.594%;"/> <td style="width:1.206%;"/> <td style="width:1.206%;"/> <td style="width:9.554%;"/> <td style="width:0.594%;"/> <td style="width:1.206%;"/> <td style="width:1.206%;"/> <td style="width:9.507%;"/> <td style="width:0.594%;"/> <td style="width:1.206%;"/> <td style="width:1.206%;"/> <td style="width:9.554%;"/> <td style="width:0.594%;"/> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="14" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">December 31, 2021</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">(In thousands)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Total</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Level 1</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Level 2</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Level 3</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Assets</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Cash equivalents – money market funds</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">77,792</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">77,792</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Total assets</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">77,792</span></p></td> <td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">77,792</span></p></td> <td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Liabilities</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Warrant liability</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">11,165</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">11,165</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Share earnout liability</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">12,256</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">12,256</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Total liabilities</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">23,421</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">23,421</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> </table></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Changes in Level 3 Liabilities Measured at Fair Value on a Recurring Basis</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Warrant Liability and Earnout Share Liability</span></p><p style="text-indent:5.067%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:12.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The reconciliation of the Company's warrant and earnout share liability measured at fair value on a recurring basis using unobservable inputs (Level 3) is as follows:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:61.921%;"/> <td style="width:1.742%;"/> <td style="width:1.433%;"/> <td style="width:14.906%;"/> <td style="width:0.959%;"/> <td style="width:1.742%;"/> <td style="width:1.433%;"/> <td style="width:14.906%;"/> <td style="width:0.959%;"/> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Warrant</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Earnout Share</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">(In thousands)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Liability</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Liability</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Balance, December 31, 2021</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">11,165</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">12,256</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Change in the fair value of liability</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">7,280</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">8,166</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Balance, March 31, 2022</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">3,885</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">4,090</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> </table></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:3.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Assumptions Used in Determining Fair Value of Liability-Classified Warrants</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The Company utilizes a Black-Scholes model to value the Private Placement Warrants at each reporting period, with changes in fair value recognized in the condensed consolidated statements of operations. The estimated fair value of the warrant liability is determined using Level 3 inputs. Inherent in an options pricing model are assumptions related to expected share-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the expected volatility of its common stock based on historical volatility of a peer group, considering the expected remaining life of the Private Placement Warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the valuation date for a maturity similar to the expected remaining life of the Private Placement Warrants. The expected life of the Private Placement Warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates to remain at zero</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:11.0pt;font-family:Calibri;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The fair value of the Private Placement Warrants has been estimated with the following assumptions:</span></p><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:56.042%;"/> <td style="width:1.072%;"/> <td style="width:1.423%;"/> <td style="width:16.704%;"/> <td style="width:2.361%;"/> <td style="width:1.691%;"/> <td style="width:1.423%;"/> <td style="width:16.921%;"/> <td style="width:2.361%;"/> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">March 31,</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">December 31</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2022</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2021</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Stock price</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">4.24</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">7.70</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Strike price</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">11.50</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">11.50</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Expected volatility</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">75.0</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">75.0</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Risk-free interest rate</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2.45</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1.01</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Expected dividend yield</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Expected life (years)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">3.07</span></span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">3.31</span></span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Fair value per warrant</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1.11</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">3.19</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> </table></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Assumptions Used in Determining Fair Value of Liability-Classified Earnout Shares</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The Company utilizes a Monte Carlo simulation to value the Earnout Shares. The Company selected this model as it believes it is reflective of all significant assumptions that market participants would likely consider in negotiating the transfer of the Earnout Shares. Such assumptions include, among other inputs, expected stock price volatility, risk-free rates, and change in control assumptions. The Company estimates probability of a change in control based on both market data for the biotechnology industry and managements own assessment. The Company estimates the expected volatility of its common stock based on historical volatility of a peer group, considering the remaining term of the Earnout Shares. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the valuation date for a maturity similar to the expected remaining life of the Earnout Shares. The expected life of the Earnout Shares is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates to remain at zero.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:11.0pt;font-family:Calibri;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The fair value of the Earnout Shares has been estimated with the following assumptions:</span></p><p style="text-indent:5.067%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:56.202%;"/> <td style="width:1.072%;"/> <td style="width:1.423%;"/> <td style="width:16.558%;"/> <td style="width:2.361%;"/> <td style="width:1.691%;"/> <td style="width:1.423%;"/> <td style="width:16.909%;"/> <td style="width:2.361%;"/> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">March 31,</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">December 31</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2022</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2021</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Stock price</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">4.24</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">7.70</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Probability of Change in Control</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">7.5</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">7.5</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Expected volatility</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">75.0</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">75.0</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Risk-free interest rate</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2.41</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1.35</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Expected dividend yield</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Expected life (years)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">5.76</span></span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">6.00</span></span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Fair value per share</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1.69</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">5.06</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></div> <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The table below presents the liabilities measured and recorded in the financial statements at fair value on a recurring basis at March 31, 2022 and December 31, 2021 categorized by the level of inputs used in the valuation of each asset and liability.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:49.824%;"/> <td style="width:1.206%;"/> <td style="width:1.206%;"/> <td style="width:9.555%;"/> <td style="width:0.594%;"/> <td style="width:1.206%;"/> <td style="width:1.206%;"/> <td style="width:9.555%;"/> <td style="width:0.594%;"/> <td style="width:1.206%;"/> <td style="width:1.206%;"/> <td style="width:9.508%;"/> <td style="width:0.594%;"/> <td style="width:1.206%;"/> <td style="width:1.206%;"/> <td style="width:9.536%;"/> <td style="width:0.594%;"/> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="14" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">March 31, 2022</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">(In thousands)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Total</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Level 1</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Level 2</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Level 3</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Assets</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Cash equivalents – money market funds</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">69,089</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">69,089</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Total assets</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">69,089</span></p></td> <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">69,089</span></p></td> <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Liabilities</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Warrant liability</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">3,885</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">3,885</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Share earnout liability</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">4,090</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">4,090</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Total liabilities</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">7,975</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">7,975</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:49.81%;"/> <td style="width:1.206%;"/> <td style="width:1.206%;"/> <td style="width:9.554%;"/> <td style="width:0.594%;"/> <td style="width:1.206%;"/> <td style="width:1.206%;"/> <td style="width:9.554%;"/> <td style="width:0.594%;"/> <td style="width:1.206%;"/> <td style="width:1.206%;"/> <td style="width:9.507%;"/> <td style="width:0.594%;"/> <td style="width:1.206%;"/> <td style="width:1.206%;"/> <td style="width:9.554%;"/> <td style="width:0.594%;"/> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="14" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">December 31, 2021</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">(In thousands)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Total</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Level 1</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Level 2</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Level 3</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Assets</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Cash equivalents – money market funds</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">77,792</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">77,792</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Total assets</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">77,792</span></p></td> <td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">77,792</span></p></td> <td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Liabilities</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Warrant liability</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">11,165</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">11,165</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Share earnout liability</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">12,256</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">12,256</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Total liabilities</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">23,421</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">23,421</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> </table> 69089000 69089000 69089000 69089000 3885000 3885000 4090000 4090000 7975000 7975000 77792000 77792000 77792000 77792000 11165000 11165000 12256000 12256000 23421000 23421000 <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The reconciliation of the Company's warrant and earnout share liability measured at fair value on a recurring basis using unobservable inputs (Level 3) is as follows:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:61.921%;"/> <td style="width:1.742%;"/> <td style="width:1.433%;"/> <td style="width:14.906%;"/> <td style="width:0.959%;"/> <td style="width:1.742%;"/> <td style="width:1.433%;"/> <td style="width:14.906%;"/> <td style="width:0.959%;"/> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Warrant</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Earnout Share</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">(In thousands)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Liability</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Liability</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Balance, December 31, 2021</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">11,165</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">12,256</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Change in the fair value of liability</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">7,280</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">8,166</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Balance, March 31, 2022</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">3,885</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">4,090</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> </table> 11165000 12256000 -7280000 -8166000 3885000 4090000 <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The fair value of the Private Placement Warrants has been estimated with the following assumptions:</span></p><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:56.042%;"/> <td style="width:1.072%;"/> <td style="width:1.423%;"/> <td style="width:16.704%;"/> <td style="width:2.361%;"/> <td style="width:1.691%;"/> <td style="width:1.423%;"/> <td style="width:16.921%;"/> <td style="width:2.361%;"/> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">March 31,</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">December 31</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2022</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2021</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Stock price</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">4.24</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">7.70</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Strike price</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">11.50</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">11.50</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Expected volatility</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">75.0</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">75.0</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Risk-free interest rate</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2.45</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1.01</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Expected dividend yield</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Expected life (years)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">3.07</span></span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">3.31</span></span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Fair value per warrant</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1.11</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">3.19</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> </table> 4.24 7.70 11.50 11.50 75.0 75.0 2.45 1.01 P3Y25D P3Y3M21D 1.11 3.19 <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The fair value of the Earnout Shares has been estimated with the following assumptions:</span></p><p style="text-indent:5.067%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:56.202%;"/> <td style="width:1.072%;"/> <td style="width:1.423%;"/> <td style="width:16.558%;"/> <td style="width:2.361%;"/> <td style="width:1.691%;"/> <td style="width:1.423%;"/> <td style="width:16.909%;"/> <td style="width:2.361%;"/> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">March 31,</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">December 31</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2022</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2021</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Stock price</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">4.24</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">7.70</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Probability of Change in Control</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">7.5</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">7.5</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Expected volatility</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">75.0</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">75.0</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Risk-free interest rate</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2.41</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1.35</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Expected dividend yield</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Expected life (years)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">5.76</span></span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">6.00</span></span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Fair value per share</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1.69</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">5.06</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> 4.24 7.70 7.5 7.5 75.0 75.0 2.41 1.35 P5Y9M3D P6Y 1.69 5.06 <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Note 5. Property and Equipment</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Property and equipment, net, consisted of the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:85.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:57.832%;"/> <td style="width:2.019%;"/> <td style="width:1.561%;"/> <td style="width:16.155%;"/> <td style="width:1.037%;"/> <td style="width:2.15%;"/> <td style="width:1.561%;"/> <td style="width:16.647%;"/> <td style="width:1.037%;"/> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">March 31,</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">December 31,</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">($ in thousands)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2022</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2021</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Laboratory equipment</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">380</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">380</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Less: accumulated amortization</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">18</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Property and equipment, net</span></p></td> <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">362</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">379</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> </table></div> <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Property and equipment, net, consisted of the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:85.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:57.832%;"/> <td style="width:2.019%;"/> <td style="width:1.561%;"/> <td style="width:16.155%;"/> <td style="width:1.037%;"/> <td style="width:2.15%;"/> <td style="width:1.561%;"/> <td style="width:16.647%;"/> <td style="width:1.037%;"/> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">March 31,</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">December 31,</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">($ in thousands)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2022</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2021</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Laboratory equipment</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">380</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">380</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Less: accumulated amortization</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">18</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Property and equipment, net</span></p></td> <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">362</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">379</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> </table> 380000 380000 18000 1000 362000 379000 <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Note 6. Prepaid Expenses</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:12.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Prepaid expenses consisted of the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:85.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:66.288%;"/> <td style="width:1.397%;"/> <td style="width:1.561%;"/> <td style="width:13.046%;"/> <td style="width:0.71%;"/> <td style="width:1.397%;"/> <td style="width:1.561%;"/> <td style="width:13.33%;"/> <td style="width:0.71%;"/> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">March 31,</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">December 31,</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">($ in thousands)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2022</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2021</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Research and development costs</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">483</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">209</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Insurance</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">882</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,369</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Other</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">258</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">185</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Total prepaid expenses</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,623</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,763</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> </table></div> <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Prepaid expenses consisted of the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:85.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:66.288%;"/> <td style="width:1.397%;"/> <td style="width:1.561%;"/> <td style="width:13.046%;"/> <td style="width:0.71%;"/> <td style="width:1.397%;"/> <td style="width:1.561%;"/> <td style="width:13.33%;"/> <td style="width:0.71%;"/> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">March 31,</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">December 31,</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">($ in thousands)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2022</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2021</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Research and development costs</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">483</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">209</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Insurance</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">882</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,369</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Other</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">258</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">185</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Total prepaid expenses</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,623</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,763</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> </table> 483000 209000 882000 1369000 258000 185000 1623000 1763000 <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Note 7. Accrued Expenses</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:12.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Accrued expenses consisted of the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:85.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:66.161%;"/> <td style="width:1.386%;"/> <td style="width:1.561%;"/> <td style="width:13.099%;"/> <td style="width:0.71%;"/> <td style="width:1.419%;"/> <td style="width:1.561%;"/> <td style="width:13.394%;"/> <td style="width:0.71%;"/> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">March 31,</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">December 31,</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">($ in thousands)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2022</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2021</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Employee compensation and benefits</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">688</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,282</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">External research and development expenses</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">608</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">409</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Property and equipment</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">360</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Professional fees</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">149</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">347</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Other</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">171</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">100</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Total accrued expenses</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,616</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2,498</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> </table></div> <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Accrued expenses consisted of the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:85.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:66.161%;"/> <td style="width:1.386%;"/> <td style="width:1.561%;"/> <td style="width:13.099%;"/> <td style="width:0.71%;"/> <td style="width:1.419%;"/> <td style="width:1.561%;"/> <td style="width:13.394%;"/> <td style="width:0.71%;"/> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">March 31,</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">December 31,</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">($ in thousands)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2022</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2021</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Employee compensation and benefits</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">688</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,282</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">External research and development expenses</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">608</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">409</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Property and equipment</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">360</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Professional fees</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">149</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">347</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Other</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">171</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">100</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Total accrued expenses</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,616</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2,498</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> </table> 688000 1282000 608000 409000 360000 149000 347000 171000 100000 1616000 2498000 <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Note 8. Commitments and Contingencies</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Legal Proceedings</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The Company is not currently subject to any material legal proceedings.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">License and Sponsored Research Agreements</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The Company is obligated to compensate Temple pursuant to the Temple License Agreement and is committed to funding the Temple SRA as further described in Note 9.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Lease Commitments</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">In April 2022, the Company entered into a lease agreement relating to office space in Cambridge, Massachusetts, as more fully described in Note 14.</span></p> <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Note 9. License and Sponsored Research Agreements</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Temple University</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">In August 2019, Old Renovacor entered into an exclusive license agreement effective as of </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">August 12, 2019</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> (the “Temple License Agreement”) and a sponsored research agreement, which was amended effective as of August 12, 2019, August 27, 2019 and further amended effective as of July 1, 2021 (as amended to date, the “Temple SRA”), each with Temple University (“Temple”). The Temple License Agreement was assigned to the Company in connection with the Merger. Pursuant to the Temple License Agreement, Temple granted the Company an exclusive, royalty-bearing, sublicensable, worldwide license to certain patent rights in certain inventions related to the use of BAG3 technology for the diagnosis, prevention or treatment of diseases in humans, and a non-exclusive license to use specified know-how and materials with a provision that Temple will retain the rights to practice the patent rights for non-commercial educational research purposes only and shall be free to sublicense these rights to other non-profit educational and research institutions solely for noncommercial research and educational purposes. Under the Temple SRA, Temple is primarily responsible for preclinical development activities with respect to licensed technology and know-how through the pursuit of specific investigational questions which, in the aggregate, are intended to provide important supporting data for a future IND-enabling studies and for potential future marketing efforts. The Company is responsible for all subsequent clinical development and commercialization activities with respect to the licensed technology and know-how.<br/></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Upon execution of the Temple License Agreement in 2019, Old Renovacor issued to Temple </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">97,879</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> shares of Old Renovacor Common Stock on the effective date of the transaction and agreed to issue Temple an additional </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">9,130</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> shares of Old Renovacor Common Stock upon the closing date of the second tranche of the Series A Convertible Preferred Stock, which occurred in November 2020. The Company also reimbursed Temple for the prosecution and maintenance costs incurred by Temple for the licensed patent rights prior to the Company entering into the License Agreement, and the Company is responsible for all the ongoing costs relating to the prosecution and maintenance of the Temple patent rights licensed to the Company going forward. The Company also agreed to pay Temple a minimum annual administrative fee of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">20,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> per year beginning with the effective date of the Temple License Agreement and continuing each annual anniversary thereafter. Further, as required by Section 12.2 of the License Agreement, the Company was required to pay, and recorded to research and development expense during the third quarter of 2021, an assignment fee of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">100,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> to Temple following closing of the Merger related to the assignment of the License Agreement from Old Renovacor to the Company.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The Temple License Agreement requires the Company to pay up to an aggregate of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1.25</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> million to Temple upon the achievement of certain developmental, regulatory and commercial milestones for the first licensed product that achieves said milestones regardless of the number of licensed products that achieve them. In addition, the Company is required to pay Temple a low single-digit royalty on net sales of any product utilizing the patent rights under the License Agreement, up to </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">50</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">% of which may be reduced by payments Renovacor makes to third parties for freedom to operate. In addition, the Company must also pay a percentage of all consideration based on a percentage of sublicense consideration received by it, which percentage ranges from the mid-teens to mid-twenties depending on the stage of development at the time of the sublicense agreement.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The Temple License Agreement will remain effective until (i) the expiration date of the last-to-expire patents covered under the License Agreement (currently expected to occur in 2041); (ii) the termination by Temple upon (a) an uncured breach by the Company, with a 60-day notification period, (b) the Company’s filing of a voluntary petition in bankruptcy or related proceeding, providing such petition is not dismissed within 90 days after the filing thereof, (c) a failure by the Company to meet certain milestones set forth in the Licensed Agreement, or (d) non-payment of undisputed monies due to Temple, with a 30-day notification period. Additionally, the Company may terminate the entire agreement or with respect to an individual patent or patent application, if desired, subject a 90-day notification period.</span></span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">As it relates to the Temple SRA, prior to the amendment entered into in August 2021 and effective as of July 1, 2021, Temple was to conduct certain preclinical activities for a three-year period, unless terminated sooner or extended by mutual written consent, for which the Company was obligated to fund approximately $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">0.9</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> million over the </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">three-year</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> initial term of the Temple SRA. The Temple SRA was further amended effective as of July 1, 2021 (the “2021 Amendment”) to, among other things, revise the period of performance, scope of work, and the budget. Following the 2021 Amendment, the Company is expected to fund up to a total of approximately $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">5.3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> million to Temple through June 30, 2024, pursuant to the Temple SRA, of which approximately $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1.5</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> million has been funded and/or incurred since inception of the Temple SRA through March 31, 2022.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">During the three months ended March 31, 2022 and 2021, the Company recorded research and development expenses of approximately $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">0.2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> million and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">0.1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> million, respectively, related to the Temple SRA.<br/><br/></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> 2019-08-12 97879 9130 20000 100000 1250000 0.50 The Temple License Agreement will remain effective until (i) the expiration date of the last-to-expire patents covered under the License Agreement (currently expected to occur in 2041); (ii) the termination by Temple upon (a) an uncured breach by the Company, with a 60-day notification period, (b) the Company’s filing of a voluntary petition in bankruptcy or related proceeding, providing such petition is not dismissed within 90 days after the filing thereof, (c) a failure by the Company to meet certain milestones set forth in the Licensed Agreement, or (d) non-payment of undisputed monies due to Temple, with a 30-day notification period. Additionally, the Company may terminate the entire agreement or with respect to an individual patent or patent application, if desired, subject a 90-day notification period. 900000 P3Y 5300000 1500000 200000 100000 <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Note 10. Stockholder’s Equity</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Common Stock</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(37,37,37,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Upon closing of the Merger, pursuant to the terms of the Second Amended and Restated Certificate of Incorporation, the Company was authorized to issue up to </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(37,37,37,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">100,000,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(37,37,37,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> shares of common stock, par value $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(37,37,37,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">0.0001</span><span style="background-color:rgba(0,0,0,0);color:rgba(37,37,37,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> per share (the "Common Stock").</span><span style="color:rgba(37,37,37,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(37,37,37,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">As discussed in Note 3, the Company has retroactively adjusted the shares issued and outstanding prior to September 2, 2021 to give effect to the Common Per Share Merger Consideration </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(as defined in the Merger Agreement) </span><span style="background-color:rgba(0,0,0,0);color:rgba(37,37,37,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">to determine the number of shares of common stock into which they were converted.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Prior to the Merger, the Company was authorized to issue up to </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">6,000,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> shares of common stock, of which </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,987,636</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> were issued and outstanding immediately prior to the Closing Date. See Note 3.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Preferred Stock</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Upon closing of the Merger, pursuant to the terms of the Second Amended and Restated Certificate of Incorporation, the Company was authorized to issue up to </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,000,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> shares of undesignated preferred stock, par value $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">0.0001</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> (the "Undesignated Preferred Stock"). The Company's board of directors or any committee thereof is expressly authorized, to the fullest extent permitted by law, to provide by resolution or resolutions for, out of the unissued shares of Undesignated Preferred Stock, the issuance of the shares of Undesignated Preferred Stock in one or more series, and by filing a certificate of designations pursuant to the General Corporate Law of the State of Delaware, to establish or change from time to time the number of shares of each such series, and to fix the designations, powers, including voting powers, full or limited, or </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">no</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> voting powers, preferences and the relative, participating, optional or other special rights of the shares of each series and any qualifications, limitations and restrictions thereof.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">As discussed in Note 3, the Company has retroactively adjusted the shares issued and outstanding prior to September 2, 2021 to give effect to the Preferred Per Share Merger Consideration (as defined in the Merger Agreement) to determine the number of shares of common stock into which they were converted.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Prior to the Merger, the Company was authorized to issue up to </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">3,333,283</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> shares of its Series A convertible preferred stock, par value $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">0.0001</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> ("Series A Preferred Stock"), of which </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2,578,518</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> were issued and outstanding immediately prior to the Closing Date. See Note 3. The Series A Preferred Stock, prior to consummation of the Business Combination, was convertible into common stock at the option of the holder at any time and without payment of any additional consideration. Each share of Series A Preferred Stock was convertible into a number of fully paid shares of common stock as is determined by dividing the Series A Preferred Stock original issuance price ($</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">4.065063</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">) by the Series A Preferred Stock conversion price (initially equal to $4.065063). Provided, however, shares of Series A Preferred Stock would automatically be converted into shares of common stock upon either (a) the closing of an underwritten public offering at a price of at least $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">12.20</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> per share resulting in at least $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">60</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> million of gross proceeds, prior to deductions for underwriting discounts, commission, and expenses, or (b) the date and time, or occurrence of an event, specified by a vote of at least a majority of the holders of the Series A Preferred Stock then outstanding. The Series A Preferred Stock was subject to redemption under certain deemed liquidation events and the holders were entitled to a liquidation preference in the event of a voluntary or involuntary liquidation, dissolution or winding-up of the Company, or deemed liquidation event of the Company (which includes certain mergers and asset transfers). The liquidation preference was an amount equal $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">4.065063</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">, plus cumulative accrued dividends to date on such shares.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Assumed Public Warrants</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Prior to the Merger, the Company had outstanding </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">8,622,644</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> warrants (the "Public Warrants") which were issued in connection with the Company's initial public offering in April 2020 (the "Chardan IPO"). </span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Each Public Warrant entitles the holder to purchase </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">one-half of one share</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> of the Company's common stock at an exercise price of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">11.50</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> per whole share, subject to adjustment. No fractional shares will be issued upon exercise of the Public Warrants. Therefore, the Public Warrants must be exercised in multiples of two Public Warrants for one share of the Company's common stock. The Public Warrants became exercisable upon the closing of the Business Combination; provided the Company has an effective and current registration statement covering the shares of Company common stock issuable upon the exercise of the Public Warrants and a current prospectus relating to such shares of common stock. The Public Warrants will expire five years following the Closing Date or earlier upon redemption or liquidation.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The Company may redeem the Public Warrants:</span></span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><div style="margin-left:2.0%;text-indent:0.0%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.0%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.0408163265306123%;">•</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">in whole and not in part;</span></div></div><div style="margin-left:2.0%;text-indent:0.0%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.0%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.0408163265306123%;">•</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">at a price of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">0.01</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> per Public Warrant;</span></div></div><div style="margin-left:2.0%;text-indent:0.0%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.0%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.0408163265306123%;">•</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">at any time during the exercise period;</span></div></div><div style="margin-left:2.0%;text-indent:0.0%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.0%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.0408163265306123%;">•</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">upon a minimum of </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">30 days</span></span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">’ prior written notice of redemption;</span></div></div><div style="margin-left:2.0%;text-indent:0.0%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.0%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.0408163265306123%;">•</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">if, and only if, the last sale price of the Company’s common stock equals or exceeds $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">16.00</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> per share for any 10 trading days within a 30-trading day period ending on the third business day prior to the date on which the Company sends the notice of redemption to the warrant holders; and</span></div></div><div style="margin-left:2.0%;text-indent:0.0%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.0%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.0408163265306123%;">•</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">if, and only if, there is a current registration statement in effect with respect to the shares of common stock underlying such Public Warrants at the time of redemption and for the entire 30-day trading period referred to above and continuing each day thereafter until the date of redemption.</span></div></div></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">To date, certain of the above conditions have not been met to redeem the Public Warrants. If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The exercise price and number of shares of Common Stock issuable upon exercise of the Public Warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. Additionally, in no event will the Company be required to net cash settle the Public Warrants.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The Company determined that the Public Warrants met </span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">all of the criteria for equity classification. Accordingly, upon closing of the Merger, the Public Warrants were recorded as a component of additional paid-in capital.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Assumed Private Placement Warrants</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Prior to the Merger, the Company had outstanding </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">3,500,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> warrants (the "Private Placement Warrants") which were issued simultaneously with the closing of the Chardan IPO, pursuant to a private placement transaction. Each Private Placement Warrant is exercisable to purchase one share of common stock at an exercise price of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">11.50</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">. The Private Placement Warrants are identical to the Public Warrants except that the Private Placement Warrants (i) will be exercisable for cash (even if a registration statement covering the shares of common stock issuable upon exercise of such warrants is not effective) or on a cashless basis, at the holder’s option, and (ii) will not be non-redeemable by the Company, in each case, so long as they are held by the initial purchasers or their permitted transferees. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants. The Private Placement Warrants purchased by Chardan will not be exercisable more than </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">five years</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> from the effective date of the Chardan IPO, in accordance with FINRA Rule 5110(f)(2)(G)(i), as long as Chardan Capital Markets or any of its related persons beneficially own these Private Placement Warrants.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The Private Placement Warrants are not indexed to the Company’s common stock in the manner contemplated by ASC 815-40-15 because the holder of the instrument is not an input into the pricing of a fixed-for-fixed option on equity shares. The Company classifies the Private Placement Warrants as derivative liabilities in its condensed consolidated balance sheets. The Company measures the fair value of the warrants at the end of each reporting period and recognizes changes in the fair value from the prior period in the Company’s operating results for the current period. Refer to Note 4 for discussion of fair value measurement of the warrant liabilities.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:12.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The following table summarizes outstanding warrants to purchase shares of the Company’s common stock as of March 31, 2022 and December 31, 2021:</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:92.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:36.278%;"/> <td style="width:1.644%;"/> <td style="width:0.656%;"/> <td style="width:12.769%;"/> <td style="width:0.656%;"/> <td style="width:1.775%;"/> <td style="width:0.656%;"/> <td style="width:12.769%;"/> <td style="width:0.656%;"/> <td style="width:1.644%;"/> <td style="width:5.174%;"/> <td style="width:1.422%;"/> <td style="width:7.554%;"/> <td style="width:0.656%;"/> <td style="width:1.644%;"/> <td style="width:0.696%;"/> <td style="width:12.698%;"/> <td style="width:0.656%;"/> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Number of Warrants</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">March 31,</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">December 31</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Weighted-Average</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2022</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2021</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Exercise Price</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Expiration Date</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Liability-classified Warrants</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">April 2020 Private Placement Warrants</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">3,500,000</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">3,500,000</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">11.50</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">4/23/2025</span></span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">3,500,000</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">3,500,000</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Equity-classified Warrants</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:11.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">April 2020 Public Warrants </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-5.159pt;white-space:pre-wrap;font-weight:normal;font-size:7.37pt;font-family:Times New Roman;position:relative;min-width:fit-content;">(1)</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">8,622,644</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">8,622,644</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">11.50</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">9/2/2026</span></span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:11.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">September 2021 Pre-Funded Warrants </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-5.159pt;white-space:pre-wrap;font-weight:normal;font-size:7.37pt;font-family:Times New Roman;position:relative;min-width:fit-content;">(2)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">715,224</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">715,224</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">0.01</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">9,337,868</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">9,337,868</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Total outstanding</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">12,837,868</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">12,837,868</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> </table><p style="margin-left:1.333%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">———————</span></p><div style="margin-left:2.667%;text-indent:0.0%;display:flex;margin-top:3.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:9.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.7400778769790306%;">(1)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;min-width:fit-content;">Public Warrants assumed in the Merger. Each warrant share is exercisable for one-half share of common stock, provided, however, each warrant must be exercised in multiples of two.</span></div></div><div style="margin-left:2.667%;text-indent:0.0%;display:flex;margin-top:3.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:9.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.7400778769790306%;">(2)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;min-width:fit-content;">Pre-Funded Warrant issued in connection with PIPE Investment (Note 3). Each warrant share is exercisable indefinitely for one share of common stock.</span></div></div></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Capital Stock Reserves</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:12.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">As of March 31, 2022, the Company reserved the following shares of common stock for future issuance:</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:83.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:75.369%;"/> <td style="width:5.59%;"/> <td style="width:0.693%;"/> <td style="width:17.654%;"/> <td style="width:0.693%;"/> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Amount</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Shares issuable upon exercise of pre-funded warrants outstanding</span></p></td> <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:middle;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">715,224</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Shares issuable upon exercise of warrants outstanding</span></p></td> <td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:middle;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">7,811,322</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Shares issuable upon issuance of contingent consideration (Earnout Shares and Earnout RSUs)</span></p></td> <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:middle;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,994,338</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Shares issuable upon exercise of outstanding stock options</span></p></td> <td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:middle;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,941,099</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Shares issuable upon vesting of time-based restricted stock units</span></p></td> <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:middle;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">163,350</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Shares reserved for future issuance under 2021 Incentive Plan</span></p></td> <td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:middle;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,025,170</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Total</span></p></td> <td style="background-color:rgba(207,240,252,1);text-indent:25.0pt;word-break:break-word;vertical-align:middle;"><p style="margin-left:25.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">13,650,503</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> </table></div> 100000000 0.0001 6000000 1987636 1987636 1000000 0.0001 no 3333283 0.0001 2578518 2578518 4.065063 12.20 60000000 4.065063 8622644 11.50 The Company may redeem the Public Warrants:•in whole and not in part;•at a price of $0.01 per Public Warrant;•at any time during the exercise period;•upon a minimum of 30 days’ prior written notice of redemption;•if, and only if, the last sale price of the Company’s common stock equals or exceeds $16.00 per share for any 10 trading days within a 30-trading day period ending on the third business day prior to the date on which the Company sends the notice of redemption to the warrant holders; and•if, and only if, there is a current registration statement in effect with respect to the shares of common stock underlying such Public Warrants at the time of redemption and for the entire 30-day trading period referred to above and continuing each day thereafter until the date of redemption. 0.01 P30D 16.00 3500000 11.50 P5Y <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The following table summarizes outstanding warrants to purchase shares of the Company’s common stock as of March 31, 2022 and December 31, 2021:</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:92.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:36.278%;"/> <td style="width:1.644%;"/> <td style="width:0.656%;"/> <td style="width:12.769%;"/> <td style="width:0.656%;"/> <td style="width:1.775%;"/> <td style="width:0.656%;"/> <td style="width:12.769%;"/> <td style="width:0.656%;"/> <td style="width:1.644%;"/> <td style="width:5.174%;"/> <td style="width:1.422%;"/> <td style="width:7.554%;"/> <td style="width:0.656%;"/> <td style="width:1.644%;"/> <td style="width:0.696%;"/> <td style="width:12.698%;"/> <td style="width:0.656%;"/> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Number of Warrants</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">March 31,</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">December 31</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Weighted-Average</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2022</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2021</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Exercise Price</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Expiration Date</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Liability-classified Warrants</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">April 2020 Private Placement Warrants</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">3,500,000</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">3,500,000</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">11.50</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">4/23/2025</span></span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">3,500,000</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">3,500,000</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Equity-classified Warrants</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:11.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">April 2020 Public Warrants </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-5.159pt;white-space:pre-wrap;font-weight:normal;font-size:7.37pt;font-family:Times New Roman;position:relative;min-width:fit-content;">(1)</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">8,622,644</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">8,622,644</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">11.50</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">9/2/2026</span></span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:11.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">September 2021 Pre-Funded Warrants </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-5.159pt;white-space:pre-wrap;font-weight:normal;font-size:7.37pt;font-family:Times New Roman;position:relative;min-width:fit-content;">(2)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">715,224</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">715,224</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">0.01</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">9,337,868</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">9,337,868</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Total outstanding</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">12,837,868</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">12,837,868</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> </table><p style="margin-left:1.333%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">———————</span></p><div style="margin-left:2.667%;text-indent:0.0%;display:flex;margin-top:3.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:9.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.7400778769790306%;">(1)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;min-width:fit-content;">Public Warrants assumed in the Merger. Each warrant share is exercisable for one-half share of common stock, provided, however, each warrant must be exercised in multiples of two.</span></div></div><div style="margin-left:2.667%;text-indent:0.0%;display:flex;margin-top:3.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:9.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.7400778769790306%;">(2)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;min-width:fit-content;">Pre-Funded Warrant issued in connection with PIPE Investment (Note 3). Each warrant share is exercisable indefinitely for one share of common stock.</span></div></div> 3500000 3500000 11.50 2025-04-23 3500000 3500000 8622644 8622644 11.50 2026-09-02 715224 715224 0.01 9337868 9337868 12837868 12837868 <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">As of March 31, 2022, the Company reserved the following shares of common stock for future issuance:</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:83.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:75.369%;"/> <td style="width:5.59%;"/> <td style="width:0.693%;"/> <td style="width:17.654%;"/> <td style="width:0.693%;"/> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Amount</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Shares issuable upon exercise of pre-funded warrants outstanding</span></p></td> <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:middle;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">715,224</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Shares issuable upon exercise of warrants outstanding</span></p></td> <td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:middle;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">7,811,322</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Shares issuable upon issuance of contingent consideration (Earnout Shares and Earnout RSUs)</span></p></td> <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:middle;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,994,338</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Shares issuable upon exercise of outstanding stock options</span></p></td> <td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:middle;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,941,099</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Shares issuable upon vesting of time-based restricted stock units</span></p></td> <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:middle;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">163,350</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Shares reserved for future issuance under 2021 Incentive Plan</span></p></td> <td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:middle;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,025,170</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Total</span></p></td> <td style="background-color:rgba(207,240,252,1);text-indent:25.0pt;word-break:break-word;vertical-align:middle;"><p style="margin-left:25.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">13,650,503</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> </table> 715224 7811322 1994338 1941099 163350 1025170 13650503 <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Note 11. Stock-based Compensation</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Equity Incentive Plans</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">As of March 31, 2022, the only equity compensation plan from which the Company may currently issue new awards is the Company’s 2021 Omnibus Incentive Plan (the “2021 Plan”), as more fully described below.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">2018 Stock Option and Grant Plan</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Prior to the Merger, Old Renovacor maintained its 2018 Stock Option and Grant Plan (the "2018 Plan"), under which Old Renovacor granted incentive stock options, non-qualified stock options and restricted stock awards to its employees and certain non-employees, including consultants, advisors and directors. The maximum aggregate shares of common stock that was subject to awards and issuable under the 2018 Plan was </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,118,869</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> prior to the Merger.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">As more fully described in Note 3, in connection with the Merger, each Old Renovacor Option that was outstanding and unexercised immediately prior to the Effective Time (whether vested or unvested) was assumed by the Company and converted into an option to purchase an adjusted number of shares of the Company's common stock at an adjusted exercise price per share, based on the Per Common Share Merger Consideration, and will continue to be governed by substantially the same terms and conditions, including vesting, as were applicable to the former option. Each Exchanged Option is exercisable for a number of whole shares of common stock equal to the product of the number of shares of Old Renovacor Common Stock underlying such Old Renovacor Options multiplied by the Per Common Share Merger Consideration, and the per share exercise price of such Exchanged Option is equal to the quotient determined by dividing the exercise price per share of the Old Renovacor Option by the Per Common Share Merger Consideration. Following the closing of the Merger, no new awards may be made under the 2018 Plan.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Upon the closing of the Merger, the outstanding and unexercised Old Renovacor Options became options to purchase an aggregate </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">194,926</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> shares of the Company’s common stock at an average exercise price of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">5.66</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> per share. The Company accounted for the Exchanged Options as a modification of the existing options. Incremental compensation costs, measured as the excess, if any, of the fair value of the modified options over the fair value of the original options immediately before its terms are modified, is measured based on the fair value of the underlying shares and other pertinent factors at the modification date. The impact of the option modifications were de minimis.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">2021 Omnibus Incentive Plan</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">At the Effective Time, the Company adopted the 2021 Plan which permits the granting of incentive stock options, non-qualified options, stock appreciation rights, restricted stock, restricted stock units and other stock-based award, and performance awards to employees, directors, and non-employee consultants and/or advisors. As of March 31, 2022, </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">3,008,803</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> shares of Common Stock are authorized for issuance pursuant to awards under the 2021 Plan. The pool of available shares will be automatically increased on the first day of each calendar year, beginning January 1, 2022 and ending January 1, 2031, by an amount equal to the lesser of (i) </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">4</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">% of the outstanding shares of our Common Stock determined on a fully-diluted basis as of the immediately preceding December 31 and (ii) such smaller number of shares as determined by the Company's board of directors.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">In addition, any awards outstanding under the 2018 Plan upon the closing of the Business Combination, after adjustment for the Business Combination, remain outstanding. If any of those awards subsequently expire, terminate, or are surrendered or forfeited for any reason without issuance of shares after the closing of the Business Combination, the shares of the Company's common stock underlying those awards will automatically become available for issuance under the 2021 Plan. No new awards may be made under the 2018 Plan.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The exercise prices, vesting and other restrictions of the awards to be granted under the 2021 Plan are determined by the board of directors, except that no stock option may be issued with an exercise price less than the fair market value of the common stock at the date of the grant or have a term in excess of ten years. Options granted under the 2021 Plan are exercisable in whole or in part at any time subsequent to vesting.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">As of March 31, 2022, options exercisable for </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,748,761</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> shares of common stock and </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">234,872</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> restricted stock units (including </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">71,522</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> Earnout RSUs) were outstanding, and </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,025,170</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> shares of common stock units remain available for future issuance under the 2021 Plan.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Accounting for Stock-based Compensation</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The Company recognizes non-cash compensation expense for stock-based awards under the Company’s equity incentive plans over an award’s requisite service period, or vesting period, using the straight-line attribution method, based on their grant date fair value, determined using the Black-Scholes option-pricing model. Generally, the Company issues awards with only service-based vesting conditions and records the expense for these awards using the straight-line method. The Company recognizes forfeitures related to stock-based compensation awards as they occur and reverses any previously recognized compensation cost associated with forfeited awards in the period the forfeiture occurs.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The Company classifies stock-based compensation expense in the statement of operations in the same manner in which the award recipients’ payroll costs are classified or in which the award recipients’ service payments are classified. </span><span style="font-size:12.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Total stock-based compensation expense attributable to stock-based payments made to employees, consultants and directors included in operating expenses in the Company's condensed consolidated statements of operations for the three months ended March 31, 2022 and 2021 was as follows:<br/><br/><br/></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:66.337%;"/> <td style="width:1.577%;"/> <td style="width:1.433%;"/> <td style="width:13.228%;"/> <td style="width:0.65%;"/> <td style="width:1.577%;"/> <td style="width:1.433%;"/> <td style="width:13.115%;"/> <td style="width:0.65%;"/> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Three months ended</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">March 31,</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">($ in thousands)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2022</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2021</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Research and development</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">345</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">3</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">General and administrative</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">256</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">4</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Total stock-based compensation expense</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">601</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">7</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> </table></div><p style="text-indent:4.133%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:3.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Stock Option Awards</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Assumptions Used in Determining Fair Value of Stock Options</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span> </p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Inherent in the Black-Scholes option-pricing model are the following assumptions:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span> </p><p style="margin-left:2.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Volatility</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">. The Company lacks company-specific historical and implied volatility information. Therefore, the Company estimates the expected stock volatility based on the historical volatility of a publicly traded set of peer companies over a period of time commensurate with the expected term of the stock options. The Company expects to continue to do so until it has adequate historical data regarding the volatility of the Company's traded stock price.</span></p><p style="margin-left:2.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span> </p><p style="margin-left:2.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Expected term</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">. The Company uses the simplified method described in the SEC’s Staff Accounting Bulletin No. 107, Share-Based Payment (“</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">SAB 107</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">”), to determine the expected life of the option grants.</span></p><p style="margin-left:2.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="margin-left:2.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Risk-free interest rate</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant commensurate with the expected term assumption.</span></p><p style="margin-left:2.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span> </p><p style="margin-left:2.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Dividend rate</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">. The dividend rate is based on the historical rate, which the Company anticipates will remain at zero.</span></p><p style="margin-left:2.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span> </p><p style="margin-left:2.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Forfeitures</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">. The Company accounts for forfeitures when they occur. Ultimately, the actual expense recognized over the vesting period will be for only those shares that vest.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span> </p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Prior to the Business Combination, the grant date fair value of the shares of Old Renovacor common stock was determined by the Old Renovacor's board of directors with the assistance of management using valuation methodologies which utilize certain assumptions including probability weighting of events, volatility, time to liquidation, a risk-free interest rate, and an assumption for a discount for lack of marketability. In determining the fair value of the shares of Old Renovacor's common stock, the methodologies used to estimate the enterprise value were performed using methodologies, approaches, and assumptions consistent with the American Institute of Certified Public Accountants Accounting and Valuation Guide, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Valuation of Privately-Held-Company Equity Securities Issued as Compensation</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">. Subsequent to the Business Combination, the Company utilizes the price of its publicly-traded common stock to determine the grant date fair value of awards.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The fair value of each option award at the date of grant was estimated using the Black-Scholes option pricing model. All options granted during the three months ended March 31, 2022 and 2021 were granted at exercise prices equal to the fair market value of the common stock on the dates of grant.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:12.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The following table provides the weighted-average assumptions used in determining the fair value of option awards to purchase </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">587,650</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> and </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">32,808</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> shares of common stock granted during the three months ended March 31, 2022 and 2021, respectively:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:64.143%;"/> <td style="width:1.366%;"/> <td style="width:0.862%;"/> <td style="width:12.293%;"/> <td style="width:3.408%;"/> <td style="width:1.366%;"/> <td style="width:0.862%;"/> <td style="width:12.293%;"/> <td style="width:3.408%;"/> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Three months ended</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">March 31,</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2022</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2021</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Expected volatility</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">76.2</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">73.6</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Risk-free interest rate</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1.92</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">0.59</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Expected dividend yield</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Expected term (years)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">6.08</span></span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">6.08</span></span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> </table></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The weighted average fair value of the options granted was $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">3.87</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2.32</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> per share for the three months ended March 31, 2022 and 2021, respectively.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Stock Option Activity</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:12.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The following table summarizes stock option activity for the three months ended March 31,2022:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;"> <tr style="visibility:collapse;"> <td style="width:49.731%;"/> <td style="width:1.206%;"/> <td style="width:0.594%;"/> <td style="width:10.093%;"/> <td style="width:0.798%;"/> <td style="width:1.206%;"/> <td style="width:1.197%;"/> <td style="width:9.545%;"/> <td style="width:0.594%;"/> <td style="width:1.206%;"/> <td style="width:0.603%;"/> <td style="width:10.093%;"/> <td style="width:0.594%;"/> <td style="width:1.206%;"/> <td style="width:1.197%;"/> <td style="width:9.545%;"/> <td style="width:0.594%;"/> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">($ in thousands, except share and per share data)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Stock<br/>Options</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Weighted-Average<br/>Exercise Price</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Weighted-Average<br/>Remaining<br/>Contractual Life<br/>(in years)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Aggregate<br/>Intrinsic <br/>Value</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Outstanding at December 31, 2021</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,376,937</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">7.61</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">9.5</span></span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">676</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Granted</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">587,650</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">5.76</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Exercised</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Forfeited</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">23,488</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">7.54</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Expired</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Outstanding at March 31, 2022 </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:bold;font-size:6.7pt;font-family:Times New Roman;position:relative;min-width:fit-content;">(1)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,941,099</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">7.05</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">9.4</span></span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">308</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Exercisable at March 31, 2022</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">211,780</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">6.73</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">8.2</span></span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">249</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> </table><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="margin-left:1.333%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:6.0pt;font-family:Times New Roman;min-width:fit-content;">_____________________________________</span></p><div style="margin-left:2.667%;text-indent:0.0%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:9.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.7400778769790306%;">(1)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;min-width:fit-content;">Includes both vested stock options as well as unvested stock options for which the requisite service period has not been rendered but that are expected to vest based on achievement of a service condition.</span></div></div></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The fair value of options that vested during the three months ended March 31, 2022 was less than $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">0.3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> million. As of March 31, 2022, there was approximately $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">7.4</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> million of unrecognized stock-based compensation expense related to unvested stock options, which the Company expects to recognize over a weighted average period of </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">3.5</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> years.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Restricted Stock Awards</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">In connection with the closing of the Merger, all unvested restricted stock awards outstanding immediately prior to the Effective Time became fully vested, resulting in the recognition of less than $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">0.1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> million in stock-based compensation expense. </span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Additionally, pursuant to the provisions of the Merger Agreement, the Company issued </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">72,546</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> Earnout RSUs during the fourth quarter of 2021 which remain unvested at March 31, 2022, representing holders of Old Renovacor Options aggregate Per Share Earnout Consideration (as defined in the Merger Agreement) in respect of such shares of Old Renovacor Options</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">. See Note 3 for details.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Restricted Stock Unit Activity</span></p><p style="text-indent:3.333%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The following table summarizes restricted stock unit activity for the three months ended March 31, 2022:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;"> <tr style="visibility:collapse;"> <td style="width:44.151%;"/> <td style="width:1.345%;"/> <td style="width:0.594%;"/> <td style="width:11.393%;"/> <td style="width:0.594%;"/> <td style="width:1.345%;"/> <td style="width:1.206%;"/> <td style="width:10.845%;"/> <td style="width:0.594%;"/> <td style="width:1.345%;"/> <td style="width:0.603%;"/> <td style="width:11.198%;"/> <td style="width:0.798%;"/> <td style="width:1.345%;"/> <td style="width:1.206%;"/> <td style="width:10.845%;"/> <td style="width:0.594%;"/> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Time-based Awards</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Market-based Awards</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">($ in thousands, except per share data)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Number of Shares</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Weighted-Average<br/>Grant Date <br/>Fair Value</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Number of Shares</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Weighted-Average<br/>Grant Date <br/>Fair Value</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Nonvested shares at December 31, 2021</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">72,546</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">6.42</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Granted</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">163,350</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">6.45</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Forfeited</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,024</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">6.42</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Vested</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Nonvested shares at March 31, 2022</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">163,350</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">6.45</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">71,522</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">6.42</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> </table></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">As of March 31, 2022, there was $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1.0</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> million of unrecognized compensation cost related to the time-based awards and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">0.5</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> million of unrecognized compensation cost related to the market-based awards, which is expected to be recognized over a weighted average period of </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">3.8</span></span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> and </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">5.76</span></span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> years, respectively.</span></p> 1118869 194926 5.66 3008803 0.04 1748761 234872 71522 1025170 <span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Total stock-based compensation expense attributable to stock-based payments made to employees, consultants and directors included in operating expenses in the Company's condensed consolidated statements of operations for the three months ended March 31, 2022 and 2021 was as follows:<br/><br/><br/></span> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:66.337%;"/> <td style="width:1.577%;"/> <td style="width:1.433%;"/> <td style="width:13.228%;"/> <td style="width:0.65%;"/> <td style="width:1.577%;"/> <td style="width:1.433%;"/> <td style="width:13.115%;"/> <td style="width:0.65%;"/> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Three months ended</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">March 31,</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">($ in thousands)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2022</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2021</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Research and development</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">345</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">3</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">General and administrative</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">256</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">4</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Total stock-based compensation expense</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">601</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">7</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> </table> 345000 3000 256000 4000 601000 7000 <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The following table provides the weighted-average assumptions used in determining the fair value of option awards to purchase </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">587,650</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> and </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">32,808</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> shares of common stock granted during the three months ended March 31, 2022 and 2021, respectively:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:64.143%;"/> <td style="width:1.366%;"/> <td style="width:0.862%;"/> <td style="width:12.293%;"/> <td style="width:3.408%;"/> <td style="width:1.366%;"/> <td style="width:0.862%;"/> <td style="width:12.293%;"/> <td style="width:3.408%;"/> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Three months ended</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">March 31,</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2022</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2021</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Expected volatility</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">76.2</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">73.6</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Risk-free interest rate</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1.92</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">0.59</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Expected dividend yield</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Expected term (years)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">6.08</span></span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">6.08</span></span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> </table> 587650 32808 0.762 0.736 0.0192 0.0059 0 0 P6Y29D P6Y29D 3.87 2.32 <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The following table summarizes stock option activity for the three months ended March 31,2022:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;"> <tr style="visibility:collapse;"> <td style="width:49.731%;"/> <td style="width:1.206%;"/> <td style="width:0.594%;"/> <td style="width:10.093%;"/> <td style="width:0.798%;"/> <td style="width:1.206%;"/> <td style="width:1.197%;"/> <td style="width:9.545%;"/> <td style="width:0.594%;"/> <td style="width:1.206%;"/> <td style="width:0.603%;"/> <td style="width:10.093%;"/> <td style="width:0.594%;"/> <td style="width:1.206%;"/> <td style="width:1.197%;"/> <td style="width:9.545%;"/> <td style="width:0.594%;"/> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">($ in thousands, except share and per share data)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Stock<br/>Options</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Weighted-Average<br/>Exercise Price</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Weighted-Average<br/>Remaining<br/>Contractual Life<br/>(in years)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Aggregate<br/>Intrinsic <br/>Value</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Outstanding at December 31, 2021</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,376,937</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">7.61</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">9.5</span></span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">676</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Granted</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">587,650</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">5.76</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Exercised</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Forfeited</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">23,488</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">7.54</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Expired</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Outstanding at March 31, 2022 </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:bold;font-size:6.7pt;font-family:Times New Roman;position:relative;min-width:fit-content;">(1)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,941,099</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">7.05</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">9.4</span></span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">308</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Exercisable at March 31, 2022</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">211,780</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">6.73</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">8.2</span></span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">249</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> </table><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="margin-left:1.333%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:6.0pt;font-family:Times New Roman;min-width:fit-content;">_____________________________________</span></p><div style="margin-left:2.667%;text-indent:0.0%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:9.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.7400778769790306%;">(1)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;min-width:fit-content;">Includes both vested stock options as well as unvested stock options for which the requisite service period has not been rendered but that are expected to vest based on achievement of a service condition.</span></div></div> 1376937 7.61 P9Y6M 676000 587650 5.76 23488 7.54 1941099 7.05 P9Y4M24D 308000 211780 6.73 P8Y2M12D 249000 300000 7400000 P3Y6M 100000 72546 <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The following table summarizes restricted stock unit activity for the three months ended March 31, 2022:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;"> <tr style="visibility:collapse;"> <td style="width:44.151%;"/> <td style="width:1.345%;"/> <td style="width:0.594%;"/> <td style="width:11.393%;"/> <td style="width:0.594%;"/> <td style="width:1.345%;"/> <td style="width:1.206%;"/> <td style="width:10.845%;"/> <td style="width:0.594%;"/> <td style="width:1.345%;"/> <td style="width:0.603%;"/> <td style="width:11.198%;"/> <td style="width:0.798%;"/> <td style="width:1.345%;"/> <td style="width:1.206%;"/> <td style="width:10.845%;"/> <td style="width:0.594%;"/> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Time-based Awards</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Market-based Awards</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">($ in thousands, except per share data)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Number of Shares</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Weighted-Average<br/>Grant Date <br/>Fair Value</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Number of Shares</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Weighted-Average<br/>Grant Date <br/>Fair Value</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Nonvested shares at December 31, 2021</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">72,546</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">6.42</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Granted</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">163,350</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">6.45</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Forfeited</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,024</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">6.42</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Vested</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Nonvested shares at March 31, 2022</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">163,350</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">6.45</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">71,522</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">6.42</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> </table> 72546 6.42 163350 6.45 1024 6.42 163350 6.45 71522 6.42 1000000.0 500000 P3Y9M18D P5Y9M3D <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Note 12. Related Parties</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Sponsor Ownership</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Jonas Grossman, a member of the Company's board of directors since 2018, is a managing member of Chardan Capital Markets, LLC ("Chardan CM"), an affiliate of the Sponsor. Additionally, Gbola Amusa, a member of the Company's board of directors since June 2018, is a partner of Chardan CM. As of March 31, 2022, the Sponsor beneficially owned </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,605,661</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> shares of the Company’s common stock, excluding the Sponsor Earnout Shares being held in escrow and subject to vesting or forfeiture based on satisfaction of the Earnout Milestones set forth in that certain Sponsor Support Agreement, representing approximately </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">9.6</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">% of the Company's outstanding common stock. An affiliate of the Sponsor, Chardan Healthcare Investments LLC, also owns </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">250,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> shares of the Company’s common stock.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">In February 2022, Chardan Healthcare, an affiliate of the Sponsor, distributed </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">250,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> shares of the Company's stock for no consideration to certain of its members and employees representing each individual's pro-rata contributions to Chardan Healthcare, including </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">40,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> shares each to Messrs. Grossman and Amusa.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">In April 2022, Chardan Investments 2, LLC, an affiliate of the Sponsor, distributed </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,605,661</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> shares of the Company's stock for no consideration to certain of its members representing each individual's pro-rata contributions to Chardan Investments 2, LLC, including </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">354,657</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> shares to Mr. Grossman and </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">238,588</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> shares to Mr. Amusa.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Prior to the Merger, in December 2018, the Sponsor and certain of its employees purchased </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">5,000,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> shares of the Company's Common Stock for an aggregate purchase price of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">25,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> and, in April 2020, canceled </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2,556,250</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> of their shares, resulting in </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2,443,750</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> remaining shares owned by the Sponsor and certain of its employees ("Sponsor Shares"). In June 2020, an additional </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">288,089</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> Sponsor Shares were canceled, and </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">500,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> shares became Sponsor Earnout Shares pursuant to the Sponsor Support Agreement upon the closing of the Business Combination.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Further, in April 2020, the Sponsor purchased </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">3,500,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> Private Placement Warrants at $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">0.40</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> per warrant (for a total purchase price of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1.4</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> million), as more fully described in Note 10.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Convertible Note</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">On July 20, 2021, in accordance with the Merger Agreement and the Note Purchase Agreement, Old Renovacor issued a $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2.5</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> million Convertible Promissory Note in exchange for $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2.5</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> million in cash to be used to finance Old Renovacor’s operations through the consummation of the Merger. In connection with the consummation of the Merger, the total principal of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2.5</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> million converted automatically into shares of the Company’s common stock, at a price per share equal to $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">10.00</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">. All accrued and unpaid interest was cash settled following the Closing Date.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span> </p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">PIPE Investment (Private Placement)</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span> </p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Concurrently with the execution of the Merger Agreement, the Company entered into Subscription Agreements with the PIPE Investors, including Chardan Healthcare Investments, LLC, an affiliate of the Sponsor, certain stockholders of Old Renovacor and certain other institutional and accredited investors, pursuant to which, on September 2, 2021, in connection with the consummation of the Business Combination, the PIPE Investors purchased an aggregate of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2,284,776</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> shares of the Company's common stock and the Pre-Funded Warrant to purchase </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">715,224</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> shares of the Company's Common Stock, as more fully described in Note 3.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Agreements with Dr. Arthur Feldman</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">In August 2019, Old Renovacor entered into a consulting agreement (the "Feldman Consulting Agreement") with its founder and </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">5</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">% or greater stockholder, Dr. Arthur Feldman, pursuant to which Dr. Feldman agreed to perform certain consulting services for Old Renovacor in exchange for a consulting fee of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">8,333</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> per calendar month. The Feldman Consulting Agreement has a term of </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">three years</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">, subject to automatic renewal for successive </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">one-year</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> terms unless earlier terminated. The Company amended the Feldman Consulting Agreement on September 2, 2021, to appoint Dr. Feldman as the Company's Chief Scientific Advisor.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The Company incurred consulting fees with Dr. Arthur Feldman, the founder and prior director Old Renovacor, of less than $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">0.1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> million during each of the three months ended March 31, 2022 and 2021. As of March 31, 2022, </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> amounts were due to Dr. Feldman.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Agreements with Temple</span></p><p style="text-indent:3.333%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Dr. Arthur Feldman, the Company's founder, </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">5</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">% or greater stockholder and current Chief Scientific Advisor, is an employee of Temple. During the three months ended March 31, 2022 and 2021, the Company recorded research and development expenses of approximately $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">0.2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> million and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">0.1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> million, respectively, related to the Temple SRA. See Note 8 for further information on the Temple SRA.</span></p> 1605661 0.096 250000 250000 40000 1605661 354657 238588 5000000 25000 2556250 2443750 288089 500000 3500000 0.40 1400000 2500000 2500000 2500000 10.00 2284776 715224 0.05 8333 P3Y P1Y 100000 100000 0 0.05 200000 100000 <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Note 13. Net Income (Loss) Per Share</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Basic net income (loss) per share of common stock is computed by dividing net income (loss) by the weighted-average number of shares of common stock</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">, which includes the shares underlying the outstanding Pre-Funded Warrant, as such warrant is exercisable, in whole or in part, for nominal cash consideration with no expiration date</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">. Shares of common stock outstanding but subject to forfeiture </span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">and cancellation by the Company (e.g., Sponsor Earnout Shares – see Note 3) </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">are excluded from the weighted-average number of shares until the period in which such shares are no longer subject to forfeiture.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The Company used the two-class method to compute net income per common share for the three months ended March 31, 2022 as the Company realized net income and has securities outstanding (Sponsor Earnout Shares) that entitle the holders to participate in cash dividends and earnings of the Company. Under this method, earnings are allocated to common stock and participating securities based on their respective rights to receive dividends, as if all undistributed earnings for the period were distributed. The holders of the Sponsor Earnout Shares, which are subject to forfeiture, are entitled to receive nonforfeitable cash dividends during the </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Earnout Periods on a basis equivalent to the dividend paid to holders of common stock, and therefore, these unvested shares </span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">subject to forfeiture and cancellation meet the definition of participating securities. The two-class method is not applicable during periods with a net loss.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Diluted net loss per share of common stock includes the effect, if any, from the potential exercise or conversion of securities, such as stock options, </span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Public Warrants and Private Placement Warrants</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">, and Sponsor Earnout Shares and Old Renovacor Earnout Shares, which would result in the issuance of incremental shares of common stock, unless their effect would be anti-dilutive.</span></p><p style="text-indent:3.333%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"> </p><div style="font-size:10.0pt;font-family:Times New Roman;"> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:62.551%;"/> <td style="width:2.403%;"/> <td style="width:1.206%;"/> <td style="width:14.147%;"/> <td style="width:0.798%;"/> <td style="width:2.755%;"/> <td style="width:1.206%;"/> <td style="width:14.137%;"/> <td style="width:0.798%;"/> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Three months ended</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">March 31,</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">($ in thousands except per share data)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2022</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2021</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Net income (loss) per share — Basic:</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Net income (loss)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">6,594</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,681</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Less: Undistributed earnings to participating securities</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">183</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Net income (loss) attributable to common stockholders</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">6,411</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,681</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> </tr> <tr> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Net income (loss)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">6,411</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,681</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Denominator for basic net income (loss) per share</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">17,471,266</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">6,274,566</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Basic net income (loss) per common share</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">0.37</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">0.27</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> </tr> <tr> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Net income (loss) per share — Diluted:</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Net income (loss)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">6,594</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,681</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Less: Undistributed earnings to participating securities</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">183</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Numerator for diluted net income (loss) per share</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">6,411</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,681</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> </tr> <tr> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Denominator for basic net income (loss) per share</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">17,471,266</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">6,274,566</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Plus: Incremental shares underlying “in the money” options outstanding</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">78,306</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Plus: Incremental shares underlying time-based restricted stock units</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">79,263</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Denominator for diluted net income (loss) per share</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">17,628,835</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">6,274,566</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Diluted net income (loss) per common share</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">0.36</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">0.27</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> </tr> </table></div><p style="text-indent:3.333%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The following outstanding potentially dilutive securities have been excluded from the calculation of diluted net loss per share for the three months ended March 31, 2022 and 2021, as their effect is anti-dilutive:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:61.584%;"/> <td style="width:2.476%;"/> <td style="width:0.603%;"/> <td style="width:15.35%;"/> <td style="width:0.603%;"/> <td style="width:2.847%;"/> <td style="width:0.603%;"/> <td style="width:15.331%;"/> <td style="width:0.603%;"/> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Three months ended</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">March 31,</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2022</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2021</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Stock options</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,627,127</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">73,127</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Restricted stock units</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">71,522</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Common stock warrants</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">12,122,644</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Earnout shares</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2,422,816</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Total</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">16,244,109</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">73,127</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> </table></div> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:62.551%;"/> <td style="width:2.403%;"/> <td style="width:1.206%;"/> <td style="width:14.147%;"/> <td style="width:0.798%;"/> <td style="width:2.755%;"/> <td style="width:1.206%;"/> <td style="width:14.137%;"/> <td style="width:0.798%;"/> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Three months ended</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">March 31,</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">($ in thousands except per share data)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2022</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2021</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Net income (loss) per share — Basic:</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Net income (loss)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">6,594</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,681</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Less: Undistributed earnings to participating securities</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">183</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Net income (loss) attributable to common stockholders</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">6,411</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,681</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> </tr> <tr> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Net income (loss)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">6,411</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,681</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Denominator for basic net income (loss) per share</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">17,471,266</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">6,274,566</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Basic net income (loss) per common share</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">0.37</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">0.27</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> </tr> <tr> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Net income (loss) per share — Diluted:</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Net income (loss)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">6,594</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,681</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Less: Undistributed earnings to participating securities</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">183</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Numerator for diluted net income (loss) per share</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">6,411</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,681</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> </tr> <tr> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Denominator for basic net income (loss) per share</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">17,471,266</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">6,274,566</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Plus: Incremental shares underlying “in the money” options outstanding</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">78,306</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Plus: Incremental shares underlying time-based restricted stock units</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">79,263</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Denominator for diluted net income (loss) per share</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">17,628,835</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">6,274,566</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Diluted net income (loss) per common share</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">0.36</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">0.27</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> </tr> </table> 6594000 -1681000 183000 6411000 -1681000 6411000 -1681000 17471266 6274566 0.37 -0.27 6594000 -1681000 183000 6411000 -1681000 17471266 6274566 78306 79263 17628835 6274566 0.36 -0.27 <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The following outstanding potentially dilutive securities have been excluded from the calculation of diluted net loss per share for the three months ended March 31, 2022 and 2021, as their effect is anti-dilutive:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:61.584%;"/> <td style="width:2.476%;"/> <td style="width:0.603%;"/> <td style="width:15.35%;"/> <td style="width:0.603%;"/> <td style="width:2.847%;"/> <td style="width:0.603%;"/> <td style="width:15.331%;"/> <td style="width:0.603%;"/> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Three months ended</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">March 31,</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2022</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2021</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Stock options</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,627,127</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">73,127</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Restricted stock units</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">71,522</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Common stock warrants</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">12,122,644</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Earnout shares</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2,422,816</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Total</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">16,244,109</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">73,127</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td> </tr> </table> 1627127 73127 71522 12122644 2422816 16244109 73127 <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Note 14. Subsequent Events</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The Company considers events or transactions that occur after the balance sheet date but prior to the issuance of the financial statements to provide additional evidence relative to certain estimates or to identify matters that require additional disclosure.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Lease Commitments</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">In April 2022, the Company entered into a sublease agreement (the “Sublease Agreement”) with Certara USA, Inc. (“Sublandlord"), pursuant to which the Company will sublease </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">3,815</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> rentable square feet of space located at 201 Broadway, Cambridge, Massachusetts 02139, known as Suite 310 (the “Suite 310 Space”) commencing on </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">April 15, 2022</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> and expiring on </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">April 14, 2024</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> (the “Sublease Term”), unless earlier terminated or extended in accordance with the provisions of the Sublease Agreement. The Suite 310 Space shall serve as the Company's headquarters. The </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Company shall have the </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">option</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> to extend the Sublease Term from April 15, 2024 through November 30, 2026 upon all of the same terms, conditions, covenants and agreements contained in the Sublease Agreement, subject to the conditions set forth therein.</span></span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The Company will pay an escalating base rent over the life of the Sublease Agreement of approximately $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">19,711</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> to $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">20,347</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> per month (or up to $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">20,983</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> per month in the event the Sublease Term is extended through November 30, 2026). In addition, the Company will pay its pro rata portion of property expenses and operating expenses for the property.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">In accordance with ASC 842, the Company will record a right-of-use asset and corresponding lease liability related to the Sublease Agreement. The lease liability will be recorded and subsequently measured as the present value of the remaining lease payments using a discount rate determined at inception.</span></p> 3815 2022-04-15 2024-04-14 Company shall have the option to extend the Sublease Term from April 15, 2024 through November 30, 2026 upon all of the same terms, conditions, covenants and agreements contained in the Sublease Agreement, subject to the conditions set forth therein. true 19711 20347000 20983000 The condensed balance sheet at December 31, 2021 has been derived from the audited financial statements at that date. Public Warrants assumed in the Merger. Each warrant share is exercisable for one-half share of common stock, provided, however, each warrant must be exercised in multiples of two. Pre-Funded Warrant issued in connection with PIPE Investment (Note 3). Each warrant share is exercisable indefinitely for one share of common stock. Includes both vested stock options as well as unvested stock options for which the requisite service period has not been rendered but that are expected to vest based on achievement of a service condition. EXCEL 70 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( $^!K%0'04UB@0 +$ 0 9&]C4')O<',O87!P+GAM M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGDK7A.YNJQ<&4GPZ4A!0W_J=0U[R;UEA_6\#MI7E!+ P04 M " !/@:Q4W_6&M^X K @ $0 &1O8U!R;W!S+V-O&ULS9+! M:@,A$(9?I7C?'=?0'&3CI:6G! H-M/0F.DFDZZ[HE-V\?5V;;"CM Q2\.//[ MS3=@:X(T0\3G. 2,Y##=3;[KDS1APTY$00(DAN@UY6L\0M#F M0Q\1!.=K\$C::M(P ZNP$)EJK9$FHJ8A7O#6+/CP&;L"LP:P0X\])6CJ!IB: M)X;SU+5P \PPPNC3=P'M0BS5/[&E ^R2G));4N,XUN.JY/(.#;SMMB]EW621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X M8-DOV]:[MR_>X%#BVR]*+ M41B1%G\@M MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7 MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V< M/!T3$LV4"P9!AI@S M&L%&KQMUAVC2/'K^!?F<-0HACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0' MHYI9";V$5FJ?JH,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RSTS0LS0[=R2^JVE+ZU)CA* M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D* MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-# MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P MOFH]M!5.S_Y9KF4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2 MD 83 >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+ M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5 M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0 ( M $^!K%37&L9&PO=V]R:W-H965T&UL MM9E=;]LV%(:ONU]!&+W8@-B62'\6C@''3;I@39K:V8JNV 4MT;902=1(*H[_ M_4C*%IU /E(Q]":Q/LZK1T='[R&IR8Z+[W++F$+/29S*R]96J>Q=MRN#+4NH M[/",I?K(FHN$*KTI-EV9"49#&Y3$7>QY@VY"H[0UG=A]#V(ZX;F*HY0]""3S M)*%B?\5BOKML^:WCCD6TV2JSHSN=9'3#EDS]F3T(O=4M5<(H8:F,>(H$6U^V M9OZ[><\&V#/^BMA.GOQ&YE96G'\W&[?A9D\5G4X$WR%ASM9JYH?-C8W6=Q.EYC$NE=!'(QVGIN]YD.NGHA!-0W2= MJDCMT6U:E(=)%[Y&/JZ)?T) R<<3*D;K$G6;KVT=]%KI5 M+)'_ -?HE=?HV6OTZJ[QN,]8U1. PWVO_1F@Z)<4?5!FIA%"BW$3TTT5!AR_ MIK%D ,>@Y!@TR\8#$Q$WU1HB7?.5B8&5CI7TRYLW-=4P+-F&S=AN(AG0&'UE M5* ;O;/RQ8&U:I!&)=+HAY .63L+!:M]]@&D<8DT!D4._K)@FT@J037;/4TJ MGQ^LLV I?Z(!%Q?Z[0LZ )GO.1_TFK#-=<:$SM:M-JUG] ?;5QH?+.5YGC\< MCT=]#R([<6@?E)OG0KPN+:CV:^3:;1^W"?0X?>S0<).DW40Q$VBN>39<5&<, MUKGG:9L&@6[N0HN$A2!$Z%S:)TT(EPF-8W252WU85C)'/(PWUFZ#YOR M >@Z86(3I1OT02NH+9KS)*-I=>Y@P3HR9_,^[--'LF?TJ-]-&=F.5KA&)=;_ M:MD@K7J"LRYOP_;MAO.N/H"J&"Q MNOK"SOEQ,^?G2:*!EHH'WR_0THYZT:=<2:6'QKK<*D>5<'\,V?32NK9[A0.Y0(U.;)N?UN+'7H_L\6;TVZ ,.+*([8YN, M\1!J/]B9.VYD[H_T&=V&NK"B=104 W$ $)8<$=T;!^,1&4&$SNUQ([>?A:&N M)GEQ_('L/.%36MF_:R2QYZ,KP6FXHWN(T?D^;N3[U8R/.U[)"$LN\T@Q/<*& M!D#8-0#GVB<,_36ZYB) M,LKTU-&N,4+#K:MY6=8(-2C+GC/"'NQA/U"6-4IEH2B.LESH>Y0,!46M2NMJU"R* M(_;,1!#I8YF( GOIM[[?Z7MPW79/5N3-3-]^J)!:7[?<8G&^W%M^#)G93P!= M=WKQ)>6.FH4"B6*VUJ%>QWQ)$,7'B6)#\,ADR8$_3Q->?J MN&$N4'XBFOX'4$L#!!0 ( $^!K%0,F'MNU@4 )T7 8 >&PO=V]R M:W-H965T&ULI5C;!5BJV9Q)I.^]#6 M$R?-0ZW OY5>6,:?10 M%I6ZG.1:;Q>SF4IS5E)U+K:L@C<;(4NJX5;>SM16,IHU2F4Q(YX7S4K*J\GR MHGEV+9<7HM8%K]BU1*HN2RH?/[!"W%].\.3IP4=^FVOS8+:\V-);=L/TY^VU MA+O9WDK&2U8I+BHDV>9R\AXO5B0T"HW$GYS=JX-K9*"LA?AJ;G[-+B>>\8@5 M+-7&!(6_.W;%BL)8 C^^M48G^S6-XN'UD_6?&_ 9DT5NQ+%%Y[I_'*23%#& M-K0N]$=Q_PMK 34.IJ)0S2^Z;V6]"4IKI479*H,'):]V__2A#<0I"J15(#T% M'!Q1\%L%OZ_@'U$(6H6@B2'%/9)&&JR9BR:8C3; YY7Y[C=: MPEL.>GIY):H,OB++$%PI4?",:KCY0 M:I0S=&,,*G:'/-ROT^M4;] KQ"GW* M1:UHE:F+F08?C*59VJ[W8;<>.;+>;U2>(Q]/$?$(L:A?N=57+-VKX^?J,T"^ MAT_V\$ECSS\&OY:251I1I0#GPF'1WUOT&XO!,8M4Y0AB@U)SP;[5_(X6L(0U M5CM346/*9.C=,O:\)+B8W1V&Q"*5Q'/ON=3*[=9?^&\'N& /+G!:N99L2WF& MV,/6;!HKIIV%\,!;'!&_!\DB%$<]H97;%S>B<(\H=%KY)#0M(-$.MX$-53AP M.,:Q%_=@#:42+PS[N-P>N7%%>US1R)>"UB#U8[,5S2[<0K'64U0Q;8,7#1SW M(](#9Y&)YSUH;J?>^1[/_*0R6G"ZY@77G#EK*?:Z[N0Y MW7N?IJ*&XHFV])&N"V9M.)ZEF"3]8-FD0C_J!6O$'7>T\$'3Q6.P9,W<=;0U M\;R0XJ@/:RA%@GG2A^5V9P16UTPQ>4$Q/=@,5GQD6$_\>;^B6J0"SP_Z^-Q^ MC>#K6CMV-]$O5$IZ@.S1BLL?XDJ2L(]K* 4)'H5]8-_3U7'7UK&[E][D5#+$ MJ*S@:-#!0Z]YE19UQA0*/6_J>1Y21E(AL0&^6)9 W(&AIE^GZ)5W#J\QY*E$ M0'AJAJ#][*2G<*A8_P,\'VF!X*2R85S7YC%7RB2!Z5"PK-)PP:M;1#4"EICF MP/,:EM@( /%CY1I,/I$_='9VAGX7FB'_C?4S#"E&X/5)TY5%"A,2#LK"]U 1 MW'$1? H9&T[7KD-FV/Q0FUIRBXG<.Y53-ZQR1*Y?.YH!HZ=3>W&[.Q< M%!F3ZJ>&0^G'Q=NW+MM=_\?NM@M$>L.@3&8GY,\[A$WJ':8?K74N)/^79>]0 M)2KVE$I"'LNDJ2.5K+O,Z?__"'M')?!\=*N<5%<@+KNH'(L,CJ9Q&$V]@#R] M':\X+X[3?)AF_4P<%5F-A,2=A:1C4V2$3649-],6*#+F&'<&1_F4;CD4'1LT M,F1,L8^#/K&RB9$PZ!]/1UP;@=@Q*S+*K.JR+IHA1L8V/.76\PX9TJ8S3 *O M?_2VRB7S <$:\6H$W<&TXA2"I0X*TX\_) 3'[]KR9(4Z9%"1%_OS/M*A6.B' M09]IC3@X K1C6L1-; :=L,G(%P*WS$TLIRB+F.T8->+P"'##Q)X_Z4@!>6$+ M;M&-4(FD4SE5:,U8!5DC^1WH;*0H$1RUH:1"U3 / M> 5&>+,!(;_:9@ZL+H^PHM5 M,V[M/7]/@L6*!)8W$(NGT?.L6V(WN(:Z?LLKA0JV@>6\\QC")G>SX-V-%MMF M.KH66HNRN&PO=V]R:W-H965T&ULG9;?;]HP$,?_ M%2O:PR9UY <_0BN(M-)-VT,E5+3M8=J#20YBU;&9;:#;7[]S$M*D!1+* [&= M^YX_9Y_CF^RE>M0I@"%/&1=ZZJ3&;&Y<5\06/QCL=:U-;"A+*1]M MYULR=3Q+!!QB8UU0?.Q@!IQ;3\CQIW3J5'-:8;U]\/XE#QZ#65(-,\E_LL2D M4V?LD 16=,O-@]Q_A3*@H?472Z[S?[(O;$>A0^*M-C(KQ4B0,5$\Z5.Y$#6! M/S@A"$I!T%70+P7]/-""+ _KCAH:393<$V6MT9MMY&N3JS$:)NPV+HS"MPQU M)II)D>"F0$*PI25G"378N:6%G,&)^:\IZI'^OX5";P@."*?G9??05S)_:;BK)0BJ)0AR M?X,3_N:8.* 41HVK'3]>D0U59$?Y%HZ%5O@*G1 U/)>"K5.UBV: >5]3CRZE/9^KX-<ZXKV^G++\1H55$2%1TC-WE5L90&:Y2\F6(9"CP P \ P !@ !X;"]W;W)KWO] M;(@A5A,[9SNP_?]]7NX)61,U$33G\LQ>R(AJV\N"K6E*26Z6J],,@2/R*,.ZME_;L2:Z7HM$E MX_1)(M54%9'?'V@I3BL/>^\'S^Q0:'/@KYPO.G6R@8=VC=*BZI2!0<5X^R1O72 N% !G7"'L%,)KA?D-A:A3B*RC+3/K MUB/19+V4XH2DD08TL["QL=K@#>,FC2]:PK\,]/1Z(W@.2:$Y@I42)(P&6>9]"P3)\L_A5)H+T6%1'_7 MQ_@E ]/3+(NO"8Y(X23#XQ33GF+JOD.ZH!+J;"S1QW:.L1\Z#<"8.?HJ0*(BF"2N/P&G03ZRQ<,LMPC9W, MVM1W*1^UBT=NW VKX=EJZ+3ZA>K^NI50'Y-1R^&@9R3Q8GY5$"-2CHK Y[:* MW7UU0!%!];8)<]0%/C=8[.ZP#T2QW:C;K5YVX5 PB])KMX=2TV 6IC?5[0VV&:=\8C,[?BXQ$[R(SF9,6!..QVF+];TA,Y.-^Q=6H5UI)Z8[D@K(<<+*^[$S@Q10%6L%(_*#D M*,Z>@0[EB;%?>C!/+SN>1D0RDDAM JN_9S(E6:8M*1R_3T8[I4^M>/[\:OW& M!*^"><*"3%GVDZ9R>]F).B E:WS(Y#T[?B>G@ ;:7L(R87[!\23K=4!R$)+M M3LH*P8[FQ3_^,KR5!6%I$ ]"9;1%$LUB*7Z4]62 K UF&*Q M!3>JX@)\?LSQ(:5*Y@OH@L?X&GS^] 5\ C0'#UMV$#A/Q:@G%3)MOY><4%P5 M*% +"A_0A8\TX^K0P<< MO\RR;^SY;5F>Q-_!S>WR9PQN[I=W8+F:W4\>YHMO8#)]F/^8/\QG\87#3[_T MTS=^^BU^%FK?TSQA.P(^9TR(+[92%"8"8T+O\N=Q,!CV1[WG\_PTA;HPB& I M]0;>H(0W<*9ADOZK5G2QK"13+)"P/*$9 7D=MWZM)Q.]\@YZ>:H%IKB+8TGS M3;'YJ:1$N+(6E+ "9]9BR9)?74T&*5 8%$,*K#G&EKS"TN \>1ZLY:XI$]KS M%I8 0R? ;UA'GX-DB_,-T:E88\K!,\X.1._/(^8^:J.:64%-.0/[H MTA*;\V'#.0QK5;6(V+%!K^)>STT+9=:P$$1M"L6>99+>6=SPC.&A,P!-?W:@FP"'6#,&I) JK@(2>\I=P2?DJ %1MJN$6#%J<5'T/?Z722 M).R@:6B/7_!39D^*WW0\C.I):0KY81N\BL:AF\<5/'X@9>DWRS'0S>XM MOJ84'+;0$:QX' [>[3/O4K,5],"RR]'0KZ.VB,$P'+;@KH@>!G_5A^>+'[/X M+_HPK!@;NBE[DOP^4$$U[Y@CU)[K%,D7L\6)>K?7;=":(@M1^T$+3\.*J*&; MJ1LEH_DS$1\IF868V_%4Q R'?U6*F_EBLIA^O!2H8EGD.2._(WQ#>)>3S!QM M$R;L1',R\W9#U5>F3:BMB:**HI&;HAO%6=,!NY M>5MC3DFB[H["M#"#7Z]N\Z"7N#H%Z*.>%7>3U+M1Z 5UY!8Q& U:> !5](_< M]#]MPPJP!$]D0_-_&WCS>AYX7U2\!J-D\_$%;\T55]T#N:T#\N%K=SNYFBX?)+;B>Q]/;9?QX M/XO!\@8LE@O##!\D@8KYD?N,?TW6A'.UN7:�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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 72 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 73 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.1 html 202 282 1 true 82 0 false 6 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://renovacor.com/20220331/taxonomy/role/Role_DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 100010 - Statement - Condensed Consolidated Balance Sheets Sheet http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1 Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 100040 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 100050 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Sheet http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsUnaudited Condensed Consolidated Statements of Operations (Unaudited) Statements 4 false false R5.htm 100060 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 5 false false R6.htm 100070 - Statement - Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) (Unaudited) Sheet http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) (Unaudited) Statements 6 false false R7.htm 100080 - Disclosure - Business and Organization Sheet http://renovacor.com/20220331/taxonomy/role/Role_DisclosureBusinessAndOrganization Business and Organization Notes 7 false false R8.htm 100090 - Disclosure - Summary of Significant Accounting Policies Sheet http://renovacor.com/20220331/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 8 false false R9.htm 100100 - Disclosure - Merger and Recapitalization Sheet http://renovacor.com/20220331/taxonomy/role/Role_DisclosureMergerAndRecapitalization Merger and Recapitalization Notes 9 false false R10.htm 100110 - Disclosure - Fair Value Measurements Sheet http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurements Fair Value Measurements Notes 10 false false R11.htm 100120 - Disclosure - Property and Equipment Sheet http://renovacor.com/20220331/taxonomy/role/DisclosurePropertyAndEquipment Property and Equipment Notes 11 false false R12.htm 100130 - Disclosure - Prepaid Expenses Sheet http://renovacor.com/20220331/taxonomy/role/DisclosurePrepaidExpenses1 Prepaid Expenses Notes 12 false false R13.htm 100140 - Disclosure - Accrued Expenses Sheet http://renovacor.com/20220331/taxonomy/role/Role_DisclosureAccruedExpenses Accrued Expenses Notes 13 false false R14.htm 100150 - Disclosure - Commitments and Contingencies Sheet http://renovacor.com/20220331/taxonomy/role/Role_DisclosureCommitmentsAndContingencies Commitments and Contingencies Notes 14 false false R15.htm 100160 - Disclosure - License and Sponsored Research Agreements Sheet http://renovacor.com/20220331/taxonomy/role/Role_DisclosureLicenseAndSponsoredResearchAgreements License and Sponsored Research Agreements Notes 15 false false R16.htm 100170 - Disclosure - Stockholder's Equity Sheet http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockholderSEquity Stockholder's Equity Notes 16 false false R17.htm 100180 - Disclosure - Stock-based Compensation Sheet http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensation Stock-based Compensation Notes 17 false false R18.htm 100190 - Disclosure - Related Parties Sheet http://renovacor.com/20220331/taxonomy/role/Role_DisclosureRelatedParties Related Parties Notes 18 false false R19.htm 100200 - Disclosure - Net Income (Loss) Per Share Sheet http://renovacor.com/20220331/taxonomy/role/DisclosureNetIncomeLossPerShare Net Income (Loss) Per Share Notes 19 false false R20.htm 100210 - Disclosure - Subsequent Events Sheet http://renovacor.com/20220331/taxonomy/role/Role_DisclosureSubsequentEvents Subsequent Events Notes 20 false false R21.htm 100220 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://renovacor.com/20220331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://renovacor.com/20220331/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies 21 false false R22.htm 100230 - Disclosure - Merger and Recapitalization (Tables) Sheet http://renovacor.com/20220331/taxonomy/role/DisclosureMergerAndRecapitalizationTables Merger and Recapitalization (Tables) Tables http://renovacor.com/20220331/taxonomy/role/Role_DisclosureMergerAndRecapitalization 22 false false R23.htm 100240 - Disclosure - Fair Value Measurements (Tables) Sheet http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurements 23 false false R24.htm 100250 - Disclosure - Property and Equipment (Tables) Sheet http://renovacor.com/20220331/taxonomy/role/DisclosurePropertyAndEquipmentTables Property and Equipment (Tables) Tables http://renovacor.com/20220331/taxonomy/role/DisclosurePropertyAndEquipment 24 false false R25.htm 100260 - Disclosure - Prepaid Expenses and Other Current Assets (Tables) Sheet http://renovacor.com/20220331/taxonomy/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsTables Prepaid Expenses and Other Current Assets (Tables) Tables 25 false false R26.htm 100270 - Disclosure - Accrued Expenses (Tables) Sheet http://renovacor.com/20220331/taxonomy/role/Role_DisclosureAccruedExpensesTables Accrued Expenses (Tables) Tables http://renovacor.com/20220331/taxonomy/role/Role_DisclosureAccruedExpenses 26 false false R27.htm 100280 - Disclosure - Stockholder's Equity (Tables) Sheet http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockholderSEquityTables Stockholder's Equity (Tables) Tables http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockholderSEquity 27 false false R28.htm 100290 - Disclosure - Stock-based Compensation (Tables) Sheet http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensationTables Stock-based Compensation (Tables) Tables http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensation 28 false false R29.htm 100300 - Disclosure - Net Income (Loss) Per Share (Tables) Sheet http://renovacor.com/20220331/taxonomy/role/DisclosureNetIncomeLossPerShareTables Net Income (Loss) Per Share (Tables) Tables http://renovacor.com/20220331/taxonomy/role/DisclosureNetIncomeLossPerShare 29 false false R30.htm 100310 - Disclosure - Business and Organization - Additional Information (Details) Sheet http://renovacor.com/20220331/taxonomy/role/DisclosureBusinessAndOrganizationAdditionalInformationDetails Business and Organization - Additional Information (Details) Details 30 false false R31.htm 100320 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details) Sheet http://renovacor.com/20220331/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails Summary of Significant Accounting Policies - Additional Information (Details) Details 31 false false R32.htm 100330 - Disclosure - Merger and Recapitalization - Additional Information (Details) Sheet http://renovacor.com/20220331/taxonomy/role/Role_DisclosureMergerAndRecapitalizationAdditionalInformationDetails Merger and Recapitalization - Additional Information (Details) Details 32 false false R33.htm 100340 - Disclosure - Merger and Recapitalization - Summary of Earnout Shares (Details) Sheet http://renovacor.com/20220331/taxonomy/role/Role_DisclosureMergerAndRecapitalizationSummaryOfEarnoutSharesDetails Merger and Recapitalization - Summary of Earnout Shares (Details) Details 33 false false R34.htm 100350 - Disclosure - Merger and Recapitalization - Summary of Elements of Net Proceeds From Merger (Details) Sheet http://renovacor.com/20220331/taxonomy/role/DisclosureMergerAndRecapitalizationSummaryOfElementsOfNetProceedsFromMergerDetails Merger and Recapitalization - Summary of Elements of Net Proceeds From Merger (Details) Details 34 false false R35.htm 100360 - Disclosure - Merger and Recapitalization - Summary of Number of Shares Common Stock Issued Immediately Following Consummation of Merger (Details) Sheet http://renovacor.com/20220331/taxonomy/role/DisclosureMergerAndRecapitalizationSummaryOfNumberOfSharesCommonStockIssuedImmediatelyFollowingConsummationOfMergerDetails Merger and Recapitalization - Summary of Number of Shares Common Stock Issued Immediately Following Consummation of Merger (Details) Details 35 false false R36.htm 100370 - Disclosure - Merger and Recapitalization - Summary of Number of Shares Common Stock Issued Immediately Following Consummation of Merger (Parenthetical) (Detail) Sheet http://renovacor.com/20220331/taxonomy/role/DisclosureMergerAndRecapitalizationSummaryOfNumberOfSharesCommonStockIssuedImmediatelyFollowingConsummationOfMergerParentheticalDetail Merger and Recapitalization - Summary of Number of Shares Common Stock Issued Immediately Following Consummation of Merger (Parenthetical) (Detail) Details 36 false false R37.htm 100380 - Disclosure - Fair Value Measurements - Schedule of Liabilities Measured at Fair Value on Recurring Basis (Details) Sheet http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails Fair Value Measurements - Schedule of Liabilities Measured at Fair Value on Recurring Basis (Details) Details 37 false false R38.htm 100390 - Disclosure - Fair Value Measurements - Schedule of Warrant and Earnout Share Liability Measured on Recurring Basis Using Unobservable Input (Details) Sheet http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfWarrantAndEarnoutShareLiabilityMeasuredOnRecurringBasisUsingUnobservableInputDetails Fair Value Measurements - Schedule of Warrant and Earnout Share Liability Measured on Recurring Basis Using Unobservable Input (Details) Details 38 false false R39.htm 100400 - Disclosure - Fair Value Measurements - Schedule of Assumptions Used in Determining Fair Value of Private Placement Warrants (Details) Sheet http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssumptionsUsedInDeterminingFairValueOfPrivatePlacementWarrantsDetails Fair Value Measurements - Schedule of Assumptions Used in Determining Fair Value of Private Placement Warrants (Details) Details 39 false false R40.htm 100410 - Disclosure - Fair Value Measurements - Schedule of Assumptions Used in Determining Fair Value of Earnout Shares (Details) Sheet http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssumptionsUsedInDeterminingFairValueOfEarnoutSharesDetails Fair Value Measurements - Schedule of Assumptions Used in Determining Fair Value of Earnout Shares (Details) Details 40 false false R41.htm 100420 - Disclosure - Property and Equipment - Schedule of Property and Equipment, Net (Details) Sheet http://renovacor.com/20220331/taxonomy/role/DisclosurePropertyAndEquipmentScheduleOfPropertyAndEquipmentNetDetails Property and Equipment - Schedule of Property and Equipment, Net (Details) Details 41 false false R42.htm 100430 - Disclosure - Prepaid Expenses - Summary of Prepaid Expenses (Details) Sheet http://renovacor.com/20220331/taxonomy/role/DisclosurePrepaidExpensesSummaryOfPrepaidExpensesDetails Prepaid Expenses - Summary of Prepaid Expenses (Details) Details 42 false false R43.htm 100440 - Disclosure - Accrued Expenses - Schedule of Accrued Expenses (Details) Sheet http://renovacor.com/20220331/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails Accrued Expenses - Schedule of Accrued Expenses (Details) Details 43 false false R44.htm 100450 - Disclosure - License and Sponsored Research Agreements - Additional Information (Details) Sheet http://renovacor.com/20220331/taxonomy/role/Role_DisclosureLicenseAndSponsoredResearchAgreementsAdditionalInformationDetails License and Sponsored Research Agreements - Additional Information (Details) Details 44 false false R45.htm 100460 - Disclosure - Stockholder's Equity - Additional Information (Details) Sheet http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockholderSEquityAdditionalInformationDetails Stockholder's Equity - Additional Information (Details) Details 45 false false R46.htm 100470 - Disclosure - Stockholder's Equity - Summary of Outstanding Warrants to Purchase Shares of Common Stock (Details) Sheet http://renovacor.com/20220331/taxonomy/role/DisclosureStockholdersEquitySummaryOfOutstandingWarrantsToPurchaseSharesOfCommonStockDetails Stockholder's Equity - Summary of Outstanding Warrants to Purchase Shares of Common Stock (Details) Details 46 false false R47.htm 100480 - Disclosure - Stockholder's Equity - Schedule of Common Stock Shares Reserved for Future Issuance (Details) Sheet http://renovacor.com/20220331/taxonomy/role/DisclosureStockholdersEquityScheduleOfCommonStockSharesReservedForFutureIssuanceDetails Stockholder's Equity - Schedule of Common Stock Shares Reserved for Future Issuance (Details) Details 47 false false R48.htm 100490 - Disclosure - Stock-based Compensation - Additional Information (Details) Sheet http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails Stock-based Compensation - Additional Information (Details) Details 48 false false R49.htm 100500 - Disclosure - Stock-based Compensation - Schedule of Stock-based Compensation Expense (Details) Sheet http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfStockBasedCompensationExpenseDetails Stock-based Compensation - Schedule of Stock-based Compensation Expense (Details) Details 49 false false R50.htm 100510 - Disclosure - Stock-based Compensation - Schedule of Assumptions Used in Determining the Fair Value of Option Awards (Details) Sheet http://renovacor.com/20220331/taxonomy/role/DisclosureStockbasedCompensationScheduleOfAssumptionsUsedInDeterminingTheFairValueOfOptionAwardsDetails Stock-based Compensation - Schedule of Assumptions Used in Determining the Fair Value of Option Awards (Details) Details 50 false false R51.htm 100520 - Disclosure - Stock-based Compensation - Summary of Stock Option Activity (Details) Sheet http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails Stock-based Compensation - Summary of Stock Option Activity (Details) Details 51 false false R52.htm 100530 - Disclosure - Stock-based Compensation - Summary of Restricted Stock Unit Activity (Details) Sheet http://renovacor.com/20220331/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitActivityDetails Stock-based Compensation - Summary of Restricted Stock Unit Activity (Details) Details 52 false false R53.htm 100540 - Disclosure - Related Parties - Additional Information (Details) Sheet http://renovacor.com/20220331/taxonomy/role/Role_DisclosureRelatedPartiesAdditionalInformationDetails Related Parties - Additional Information (Details) Details 53 false false R54.htm 100550 - Disclosure - Net Income (Loss) Per Share - Net Income (Loss) Attributable to Common Stockholders of Basic and Diluted (Details) Sheet http://renovacor.com/20220331/taxonomy/role/DisclosureNetIncomeLossPerShareNetIncomeLossAttributableToCommonStockholdersOfBasicAndDilutedDetails3 Net Income (Loss) Per Share - Net Income (Loss) Attributable to Common Stockholders of Basic and Diluted (Details) Details http://renovacor.com/20220331/taxonomy/role/DisclosureNetIncomeLossPerShareTables 54 false false R55.htm 100560 - Disclosure - Net Income (loss) Per Share - Schedule of Potentially Antidilutive Securities Excluded from Computation of Diluted Net Loss Per Share (Detail) Sheet http://renovacor.com/20220331/taxonomy/role/DisclosureNetIncomeLossPerShareScheduleOfPotentiallyAntidilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetail Net Income (loss) Per Share - Schedule of Potentially Antidilutive Securities Excluded from Computation of Diluted Net Loss Per Share (Detail) Details http://renovacor.com/20220331/taxonomy/role/DisclosureNetIncomeLossPerShareTables 55 false false R56.htm 100570 - Disclosure - Subsequent Events (Additional Information) (Details) Sheet http://renovacor.com/20220331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails Subsequent Events (Additional Information) (Details) Details http://renovacor.com/20220331/taxonomy/role/Role_DisclosureSubsequentEvents 56 false false All Reports Book All Reports rcor-20220331.htm rcor-20220331.xsd rcor-20220331_cal.xml rcor-20220331_def.xml rcor-20220331_lab.xml rcor-20220331_pre.xml rcor-ex31_1.htm rcor-ex31_2.htm rcor-ex32_1.htm rcor-ex32_2.htm img88120184_0.jpg img88120184_1.jpg http://fasb.org/us-gaap/2021-01-31 http://xbrl.sec.gov/dei/2021q4 true true JSON 76 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "rcor-20220331.htm": { "axisCustom": 0, "axisStandard": 26, "contextCount": 202, "dts": { "calculationLink": { "local": [ "rcor-20220331_cal.xml" ] }, "definitionLink": { "local": [ "rcor-20220331_def.xml" ] }, "inline": { "local": [ "rcor-20220331.htm" ] }, "labelLink": { "local": [ "rcor-20220331_lab.xml" ] }, "presentationLink": { "local": [ "rcor-20220331_pre.xml" ] }, "schema": { "local": [ "rcor-20220331.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" ] } }, "elementCount": 494, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2021-01-31": 3, "http://xbrl.sec.gov/dei/2021q4": 4, "total": 7 }, "keyCustom": 70, "keyStandard": 212, "memberCustom": 45, "memberStandard": 27, "nsprefix": "rcor", "nsuri": "http://renovacor.com/20220331", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "p", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_29cdc283-0d61-407e-9e5c-5b8d4b11220d", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document and Entity Information", "role": "http://renovacor.com/20220331/taxonomy/role/Role_DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_29cdc283-0d61-407e-9e5c-5b8d4b11220d", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_29cdc283-0d61-407e-9e5c-5b8d4b11220d", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100110 - Disclosure - Fair Value Measurements", "role": "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurements", "shortName": "Fair Value Measurements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_29cdc283-0d61-407e-9e5c-5b8d4b11220d", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_29cdc283-0d61-407e-9e5c-5b8d4b11220d", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100120 - Disclosure - Property and Equipment", "role": "http://renovacor.com/20220331/taxonomy/role/DisclosurePropertyAndEquipment", "shortName": "Property and Equipment", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_29cdc283-0d61-407e-9e5c-5b8d4b11220d", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_29cdc283-0d61-407e-9e5c-5b8d4b11220d", "decimals": null, "first": true, "lang": "en-US", "name": "rcor:DisclosureOfPrepaidExpensesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100130 - Disclosure - Prepaid Expenses", "role": "http://renovacor.com/20220331/taxonomy/role/DisclosurePrepaidExpenses1", "shortName": "Prepaid Expenses", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_29cdc283-0d61-407e-9e5c-5b8d4b11220d", "decimals": null, "first": true, "lang": "en-US", "name": "rcor:DisclosureOfPrepaidExpensesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_29cdc283-0d61-407e-9e5c-5b8d4b11220d", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100140 - Disclosure - Accrued Expenses", "role": "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureAccruedExpenses", "shortName": "Accrued Expenses", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_29cdc283-0d61-407e-9e5c-5b8d4b11220d", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_29cdc283-0d61-407e-9e5c-5b8d4b11220d", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100150 - Disclosure - Commitments and Contingencies", "role": "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureCommitmentsAndContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_29cdc283-0d61-407e-9e5c-5b8d4b11220d", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_29cdc283-0d61-407e-9e5c-5b8d4b11220d", "decimals": null, "first": true, "lang": "en-US", "name": "rcor:LicenseAndSponsoredResearchAgreementsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100160 - Disclosure - License and Sponsored Research Agreements", "role": "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureLicenseAndSponsoredResearchAgreements", "shortName": "License and Sponsored Research Agreements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_29cdc283-0d61-407e-9e5c-5b8d4b11220d", "decimals": null, "first": true, "lang": "en-US", "name": "rcor:LicenseAndSponsoredResearchAgreementsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_29cdc283-0d61-407e-9e5c-5b8d4b11220d", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100170 - Disclosure - Stockholder's Equity", "role": "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockholderSEquity", "shortName": "Stockholder's Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_29cdc283-0d61-407e-9e5c-5b8d4b11220d", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_29cdc283-0d61-407e-9e5c-5b8d4b11220d", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100180 - Disclosure - Stock-based Compensation", "role": "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensation", "shortName": "Stock-based Compensation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_29cdc283-0d61-407e-9e5c-5b8d4b11220d", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_29cdc283-0d61-407e-9e5c-5b8d4b11220d", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100190 - Disclosure - Related Parties", "role": "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureRelatedParties", "shortName": "Related Parties", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_29cdc283-0d61-407e-9e5c-5b8d4b11220d", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_29cdc283-0d61-407e-9e5c-5b8d4b11220d", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100200 - Disclosure - Net Income (Loss) Per Share", "role": "http://renovacor.com/20220331/taxonomy/role/DisclosureNetIncomeLossPerShare", "shortName": "Net Income (Loss) Per Share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_29cdc283-0d61-407e-9e5c-5b8d4b11220d", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_98e42dd4-bd29-4bb2-bdf5-21a29c87e1e1", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100010 - Statement - Condensed Consolidated Balance Sheets", "role": "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1", "shortName": "Condensed Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_98e42dd4-bd29-4bb2-bdf5-21a29c87e1e1", "decimals": "-3", "lang": null, "name": "us-gaap:AssetsCurrent", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_29cdc283-0d61-407e-9e5c-5b8d4b11220d", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100210 - Disclosure - Subsequent Events", "role": "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureSubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_29cdc283-0d61-407e-9e5c-5b8d4b11220d", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "div", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_29cdc283-0d61-407e-9e5c-5b8d4b11220d", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100220 - Disclosure - Summary of Significant Accounting Policies (Policies)", "role": "http://renovacor.com/20220331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies", "shortName": "Summary of Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_29cdc283-0d61-407e-9e5c-5b8d4b11220d", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "div", "rcor:MergerAndRecapitalizationDisclosureTextBlock", "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_29cdc283-0d61-407e-9e5c-5b8d4b11220d", "decimals": null, "first": true, "lang": "en-US", "name": "rcor:SummaryOfEarnoutSharesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100230 - Disclosure - Merger and Recapitalization (Tables)", "role": "http://renovacor.com/20220331/taxonomy/role/DisclosureMergerAndRecapitalizationTables", "shortName": "Merger and Recapitalization (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "rcor:MergerAndRecapitalizationDisclosureTextBlock", "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_29cdc283-0d61-407e-9e5c-5b8d4b11220d", "decimals": null, "first": true, "lang": "en-US", "name": "rcor:SummaryOfEarnoutSharesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "div", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_29cdc283-0d61-407e-9e5c-5b8d4b11220d", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100240 - Disclosure - Fair Value Measurements (Tables)", "role": "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsTables", "shortName": "Fair Value Measurements (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_29cdc283-0d61-407e-9e5c-5b8d4b11220d", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "div", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_29cdc283-0d61-407e-9e5c-5b8d4b11220d", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100250 - Disclosure - Property and Equipment (Tables)", "role": "http://renovacor.com/20220331/taxonomy/role/DisclosurePropertyAndEquipmentTables", "shortName": "Property and Equipment (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_29cdc283-0d61-407e-9e5c-5b8d4b11220d", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "div", "rcor:DisclosureOfPrepaidExpensesTextBlock", "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_29cdc283-0d61-407e-9e5c-5b8d4b11220d", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100260 - Disclosure - Prepaid Expenses and Other Current Assets (Tables)", "role": "http://renovacor.com/20220331/taxonomy/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsTables", "shortName": "Prepaid Expenses and Other Current Assets (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "rcor:DisclosureOfPrepaidExpensesTextBlock", "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_29cdc283-0d61-407e-9e5c-5b8d4b11220d", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "div", "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_29cdc283-0d61-407e-9e5c-5b8d4b11220d", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100270 - Disclosure - Accrued Expenses (Tables)", "role": "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureAccruedExpensesTables", "shortName": "Accrued Expenses (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_29cdc283-0d61-407e-9e5c-5b8d4b11220d", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "div", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_29cdc283-0d61-407e-9e5c-5b8d4b11220d", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100280 - Disclosure - Stockholder's Equity (Tables)", "role": "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockholderSEquityTables", "shortName": "Stockholder's Equity (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_29cdc283-0d61-407e-9e5c-5b8d4b11220d", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_29cdc283-0d61-407e-9e5c-5b8d4b11220d", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100290 - Disclosure - Stock-based Compensation (Tables)", "role": "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensationTables", "shortName": "Stock-based Compensation (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_29cdc283-0d61-407e-9e5c-5b8d4b11220d", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "div", "us-gaap:EarningsPerShareTextBlock", "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_29cdc283-0d61-407e-9e5c-5b8d4b11220d", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100300 - Disclosure - Net Income (Loss) Per Share (Tables)", "role": "http://renovacor.com/20220331/taxonomy/role/DisclosureNetIncomeLossPerShareTables", "shortName": "Net Income (Loss) Per Share (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:EarningsPerShareTextBlock", "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_29cdc283-0d61-407e-9e5c-5b8d4b11220d", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_98e42dd4-bd29-4bb2-bdf5-21a29c87e1e1", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "U_UnitedStatesOfAmericaDollarsShare", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100040 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)", "role": "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical", "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_98e42dd4-bd29-4bb2-bdf5-21a29c87e1e1", "decimals": "INF", "lang": null, "name": "us-gaap:PreferredStockSharesIssued", "reportCount": 1, "unique": true, "unitRef": "U_shares", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_98e42dd4-bd29-4bb2-bdf5-21a29c87e1e1", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RetainedEarningsAccumulatedDeficit", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100310 - Disclosure - Business and Organization - Additional Information (Details)", "role": "http://renovacor.com/20220331/taxonomy/role/DisclosureBusinessAndOrganizationAdditionalInformationDetails", "shortName": "Business and Organization - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R31": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:IncomeTaxPolicyTextBlock", "div", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_29cdc283-0d61-407e-9e5c-5b8d4b11220d", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CurrentIncomeTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100320 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details)", "role": "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails", "shortName": "Summary of Significant Accounting Policies - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:IncomeTaxPolicyTextBlock", "div", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_29cdc283-0d61-407e-9e5c-5b8d4b11220d", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CurrentIncomeTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_98e42dd4-bd29-4bb2-bdf5-21a29c87e1e1", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "U_UnitedStatesOfAmericaDollarsShare", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100330 - Disclosure - Merger and Recapitalization - Additional Information (Details)", "role": "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureMergerAndRecapitalizationAdditionalInformationDetails", "shortName": "Merger and Recapitalization - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "rcor:MergerAndRecapitalizationDisclosureTextBlock", "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_6822d8d9-bc2b-45d8-a945-aaf2b0807434", "decimals": "INF", "lang": null, "name": "us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction", "reportCount": 1, "unique": true, "unitRef": "U_shares", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "rcor:SummaryOfEarnoutSharesTableTextBlock", "div", "rcor:MergerAndRecapitalizationDisclosureTextBlock", "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_29cdc283-0d61-407e-9e5c-5b8d4b11220d", "decimals": "0", "first": true, "lang": null, "name": "rcor:EarnoutShares", "reportCount": 1, "unique": true, "unitRef": "U_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100340 - Disclosure - Merger and Recapitalization - Summary of Earnout Shares (Details)", "role": "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureMergerAndRecapitalizationSummaryOfEarnoutSharesDetails", "shortName": "Merger and Recapitalization - Summary of Earnout Shares (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "rcor:SummaryOfEarnoutSharesTableTextBlock", "div", "rcor:MergerAndRecapitalizationDisclosureTextBlock", "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_29cdc283-0d61-407e-9e5c-5b8d4b11220d", "decimals": "0", "first": true, "lang": null, "name": "rcor:EarnoutShares", "reportCount": 1, "unique": true, "unitRef": "U_shares", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "rcor:SummaryOfElementsOfNetProceedsFromMergerTableTextBlock", "div", "rcor:MergerAndRecapitalizationDisclosureTextBlock", "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_29cdc283-0d61-407e-9e5c-5b8d4b11220d", "decimals": "-3", "first": true, "lang": null, "name": "rcor:SettlementOfConvertibleNoteAtClosing", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100350 - Disclosure - Merger and Recapitalization - Summary of Elements of Net Proceeds From Merger (Details)", "role": "http://renovacor.com/20220331/taxonomy/role/DisclosureMergerAndRecapitalizationSummaryOfElementsOfNetProceedsFromMergerDetails", "shortName": "Merger and Recapitalization - Summary of Elements of Net Proceeds From Merger (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "rcor:SummaryOfElementsOfNetProceedsFromMergerTableTextBlock", "div", "rcor:MergerAndRecapitalizationDisclosureTextBlock", "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_29cdc283-0d61-407e-9e5c-5b8d4b11220d", "decimals": "-3", "first": true, "lang": null, "name": "rcor:SettlementOfConvertibleNoteAtClosing", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "us-gaap:CommonStockSharesIssued", "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_98e42dd4-bd29-4bb2-bdf5-21a29c87e1e1", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesOutstanding", "reportCount": 1, "unitRef": "U_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100360 - Disclosure - Merger and Recapitalization - Summary of Number of Shares Common Stock Issued Immediately Following Consummation of Merger (Details)", "role": "http://renovacor.com/20220331/taxonomy/role/DisclosureMergerAndRecapitalizationSummaryOfNumberOfSharesCommonStockIssuedImmediatelyFollowingConsummationOfMergerDetails", "shortName": "Merger and Recapitalization - Summary of Number of Shares Common Stock Issued Immediately Following Consummation of Merger (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "rcor:SummaryOfNumberOfSharesCommonStockIssuedImmediatelyFollowingConsummationOfMergerTableTextBlock", "div", "rcor:MergerAndRecapitalizationDisclosureTextBlock", "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_98e42dd4-bd29-4bb2-bdf5-21a29c87e1e1", "decimals": "INF", "lang": null, "name": "rcor:SharesOfCommonStockImmediatelyAfterMerger", "reportCount": 1, "unique": true, "unitRef": "U_shares", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "span", "div", "div", "rcor:SummaryOfNumberOfSharesCommonStockIssuedImmediatelyFollowingConsummationOfMergerTableTextBlock", "div", "rcor:MergerAndRecapitalizationDisclosureTextBlock", "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_d84c1d68-9e83-4482-81e8-454032bad633", "decimals": "INF", "first": true, "lang": null, "name": "rcor:CommonStockHeldInEscrowAndSubjectToVestingOrForfeiture", "reportCount": 1, "unitRef": "U_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100370 - Disclosure - Merger and Recapitalization - Summary of Number of Shares Common Stock Issued Immediately Following Consummation of Merger (Parenthetical) (Detail)", "role": "http://renovacor.com/20220331/taxonomy/role/DisclosureMergerAndRecapitalizationSummaryOfNumberOfSharesCommonStockIssuedImmediatelyFollowingConsummationOfMergerParentheticalDetail", "shortName": "Merger and Recapitalization - Summary of Number of Shares Common Stock Issued Immediately Following Consummation of Merger (Parenthetical) (Detail)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "rcor:SummaryOfNumberOfSharesCommonStockIssuedImmediatelyFollowingConsummationOfMergerTableTextBlock", "div", "rcor:MergerAndRecapitalizationDisclosureTextBlock", "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_998018f9-c5c7-4d92-a01e-c9db2f2a6c65", "decimals": "INF", "lang": null, "name": "rcor:PreferredStockOutstandingPriorToMerger", "reportCount": 1, "unique": true, "unitRef": "U_shares", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "div", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_78def07c-15ab-48f4-9dc6-b6df230b00f8", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AssetsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100380 - Disclosure - Fair Value Measurements - Schedule of Liabilities Measured at Fair Value on Recurring Basis (Details)", "role": "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails", "shortName": "Fair Value Measurements - Schedule of Liabilities Measured at Fair Value on Recurring Basis (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "div", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_78def07c-15ab-48f4-9dc6-b6df230b00f8", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AssetsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "rcor:ScheduleOfWarrantAndEarnoutShareLiabilityMeasuredOnRecurringBasisUsingUnobservableInputTableTextBlock", "div", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_e149a3de-6e6e-45b5-830d-0d0d9631167e", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100390 - Disclosure - Fair Value Measurements - Schedule of Warrant and Earnout Share Liability Measured on Recurring Basis Using Unobservable Input (Details)", "role": "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfWarrantAndEarnoutShareLiabilityMeasuredOnRecurringBasisUsingUnobservableInputDetails", "shortName": "Fair Value Measurements - Schedule of Warrant and Earnout Share Liability Measured on Recurring Basis Using Unobservable Input (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "rcor:ScheduleOfWarrantAndEarnoutShareLiabilityMeasuredOnRecurringBasisUsingUnobservableInputTableTextBlock", "div", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_e149a3de-6e6e-45b5-830d-0d0d9631167e", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "div", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_70b857cc-9796-4192-928c-fd6bd1a27830", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:DerivativeLiabilityMeasurementInput", "reportCount": 1, "unique": true, "unitRef": "U_UnitedStatesOfAmericaDollarsShare", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100400 - Disclosure - Fair Value Measurements - Schedule of Assumptions Used in Determining Fair Value of Private Placement Warrants (Details)", "role": "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssumptionsUsedInDeterminingFairValueOfPrivatePlacementWarrantsDetails", "shortName": "Fair Value Measurements - Schedule of Assumptions Used in Determining Fair Value of Private Placement Warrants (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "div", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_70b857cc-9796-4192-928c-fd6bd1a27830", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:DerivativeLiabilityMeasurementInput", "reportCount": 1, "unique": true, "unitRef": "U_UnitedStatesOfAmericaDollarsShare", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_29cdc283-0d61-407e-9e5c-5b8d4b11220d", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ResearchAndDevelopmentExpense", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100050 - Statement - Condensed Consolidated Statements of Operations (Unaudited)", "role": "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsUnaudited", "shortName": "Condensed Consolidated Statements of Operations (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_29cdc283-0d61-407e-9e5c-5b8d4b11220d", "decimals": "-3", "lang": null, "name": "us-gaap:GeneralAndAdministrativeExpense", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "div", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_7e439bf0-22f1-45e7-b21c-3b1d312e7f73", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:DerivativeLiabilityMeasurementInput", "reportCount": 1, "unique": true, "unitRef": "U_UnitedStatesOfAmericaDollarsShare", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100410 - Disclosure - Fair Value Measurements - Schedule of Assumptions Used in Determining Fair Value of Earnout Shares (Details)", "role": "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssumptionsUsedInDeterminingFairValueOfEarnoutSharesDetails", "shortName": "Fair Value Measurements - Schedule of Assumptions Used in Determining Fair Value of Earnout Shares (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "div", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_7e439bf0-22f1-45e7-b21c-3b1d312e7f73", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:DerivativeLiabilityMeasurementInput", "reportCount": 1, "unique": true, "unitRef": "U_UnitedStatesOfAmericaDollarsShare", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "div", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_98e42dd4-bd29-4bb2-bdf5-21a29c87e1e1", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100420 - Disclosure - Property and Equipment - Schedule of Property and Equipment, Net (Details)", "role": "http://renovacor.com/20220331/taxonomy/role/DisclosurePropertyAndEquipmentScheduleOfPropertyAndEquipmentNetDetails", "shortName": "Property and Equipment - Schedule of Property and Equipment, Net (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "div", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_98e42dd4-bd29-4bb2-bdf5-21a29c87e1e1", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "div", "rcor:DisclosureOfPrepaidExpensesTextBlock", "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_98e42dd4-bd29-4bb2-bdf5-21a29c87e1e1", "decimals": "-3", "first": true, "lang": null, "name": "rcor:PrepaidResearchAndDevelopmentCosts", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100430 - Disclosure - Prepaid Expenses - Summary of Prepaid Expenses (Details)", "role": "http://renovacor.com/20220331/taxonomy/role/DisclosurePrepaidExpensesSummaryOfPrepaidExpensesDetails", "shortName": "Prepaid Expenses - Summary of Prepaid Expenses (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "div", "rcor:DisclosureOfPrepaidExpensesTextBlock", "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_98e42dd4-bd29-4bb2-bdf5-21a29c87e1e1", "decimals": "-3", "first": true, "lang": null, "name": "rcor:PrepaidResearchAndDevelopmentCosts", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "div", "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_98e42dd4-bd29-4bb2-bdf5-21a29c87e1e1", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100440 - Disclosure - Accrued Expenses - Schedule of Accrued Expenses (Details)", "role": "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails", "shortName": "Accrued Expenses - Schedule of Accrued Expenses (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "div", "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_98e42dd4-bd29-4bb2-bdf5-21a29c87e1e1", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_29cdc283-0d61-407e-9e5c-5b8d4b11220d", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ResearchAndDevelopmentExpense", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100450 - Disclosure - License and Sponsored Research Agreements - Additional Information (Details)", "role": "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureLicenseAndSponsoredResearchAgreementsAdditionalInformationDetails", "shortName": "License and Sponsored Research Agreements - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "rcor:LicenseAndSponsoredResearchAgreementsTextBlock", "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_64ed6a0e-25dc-4c2c-8de7-df83db5682e3", "decimals": null, "lang": "en-US", "name": "rcor:TempleLicenseAgreementEffectiveDate", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_beae4db1-90d7-48f7-ba22-9514397b2e9e", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesAuthorized", "reportCount": 1, "unique": true, "unitRef": "U_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100460 - Disclosure - Stockholder's Equity - Additional Information (Details)", "role": "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockholderSEquityAdditionalInformationDetails", "shortName": "Stockholder's Equity - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_beae4db1-90d7-48f7-ba22-9514397b2e9e", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesAuthorized", "reportCount": 1, "unique": true, "unitRef": "U_shares", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "div", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_98e42dd4-bd29-4bb2-bdf5-21a29c87e1e1", "decimals": "INF", "first": true, "lang": null, "name": "rcor:WarrantsOutstanding", "reportCount": 1, "unique": true, "unitRef": "U_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100470 - Disclosure - Stockholder's Equity - Summary of Outstanding Warrants to Purchase Shares of Common Stock (Details)", "role": "http://renovacor.com/20220331/taxonomy/role/DisclosureStockholdersEquitySummaryOfOutstandingWarrantsToPurchaseSharesOfCommonStockDetails", "shortName": "Stockholder's Equity - Summary of Outstanding Warrants to Purchase Shares of Common Stock (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "div", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_98e42dd4-bd29-4bb2-bdf5-21a29c87e1e1", "decimals": "INF", "first": true, "lang": null, "name": "rcor:WarrantsOutstanding", "reportCount": 1, "unique": true, "unitRef": "U_shares", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "rcor:CommonStockSharesReservedForFutureIssuanceTableTextBlock", "div", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_98e42dd4-bd29-4bb2-bdf5-21a29c87e1e1", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance", "reportCount": 1, "unique": true, "unitRef": "U_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100480 - Disclosure - Stockholder's Equity - Schedule of Common Stock Shares Reserved for Future Issuance (Details)", "role": "http://renovacor.com/20220331/taxonomy/role/DisclosureStockholdersEquityScheduleOfCommonStockSharesReservedForFutureIssuanceDetails", "shortName": "Stockholder's Equity - Schedule of Common Stock Shares Reserved for Future Issuance (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "rcor:CommonStockSharesReservedForFutureIssuanceTableTextBlock", "div", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_98e42dd4-bd29-4bb2-bdf5-21a29c87e1e1", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance", "reportCount": 1, "unique": true, "unitRef": "U_shares", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_29cdc283-0d61-407e-9e5c-5b8d4b11220d", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "reportCount": 1, "unique": true, "unitRef": "U_UnitedStatesOfAmericaDollarsShare", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100490 - Disclosure - Stock-based Compensation - Additional Information (Details)", "role": "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails", "shortName": "Stock-based Compensation - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_29cdc283-0d61-407e-9e5c-5b8d4b11220d", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "reportCount": 1, "unique": true, "unitRef": "U_UnitedStatesOfAmericaDollarsShare", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "ix:continuation", "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_29cdc283-0d61-407e-9e5c-5b8d4b11220d", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100500 - Disclosure - Stock-based Compensation - Schedule of Stock-based Compensation Expense (Details)", "role": "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfStockBasedCompensationExpenseDetails", "shortName": "Stock-based Compensation - Schedule of Stock-based Compensation Expense (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "ix:continuation", "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_dad0e9a2-f08c-4dc9-a279-2697b0ae46f0", "decimals": "-3", "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_29cdc283-0d61-407e-9e5c-5b8d4b11220d", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100060 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)", "role": "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited", "shortName": "Condensed Consolidated Statements of Cash Flows (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_29cdc283-0d61-407e-9e5c-5b8d4b11220d", "decimals": "-3", "lang": null, "name": "us-gaap:ShareBasedCompensation", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_7d84b43d-d10f-4446-b4d6-1e3f3ffeaabb", "decimals": "3", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "reportCount": 1, "unique": true, "unitRef": "U_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100510 - Disclosure - Stock-based Compensation - Schedule of Assumptions Used in Determining the Fair Value of Option Awards (Details)", "role": "http://renovacor.com/20220331/taxonomy/role/DisclosureStockbasedCompensationScheduleOfAssumptionsUsedInDeterminingTheFairValueOfOptionAwardsDetails", "shortName": "Stock-based Compensation - Schedule of Assumptions Used in Determining the Fair Value of Option Awards (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_7d84b43d-d10f-4446-b4d6-1e3f3ffeaabb", "decimals": "3", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "reportCount": 1, "unique": true, "unitRef": "U_pure", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_fad36411-cd4f-42d4-897b-06a48a89ab52", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unitRef": "U_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100520 - Disclosure - Stock-based Compensation - Summary of Stock Option Activity (Details)", "role": "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails", "shortName": "Stock-based Compensation - Summary of Stock Option Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_7d84b43d-d10f-4446-b4d6-1e3f3ffeaabb", "decimals": "0", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "reportCount": 1, "unique": true, "unitRef": "U_shares", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock", "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_9852f122-ad95-420e-87d3-0f6dd0d65db8", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "reportCount": 1, "unique": true, "unitRef": "U_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100530 - Disclosure - Stock-based Compensation - Summary of Restricted Stock Unit Activity (Details)", "role": "http://renovacor.com/20220331/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitActivityDetails", "shortName": "Stock-based Compensation - Summary of Restricted Stock Unit Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock", "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_9852f122-ad95-420e-87d3-0f6dd0d65db8", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "reportCount": 1, "unique": true, "unitRef": "U_shares", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "us-gaap:CommonStockSharesIssued", "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_98e42dd4-bd29-4bb2-bdf5-21a29c87e1e1", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesOutstanding", "reportCount": 1, "unitRef": "U_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100540 - Disclosure - Related Parties - Additional Information (Details)", "role": "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureRelatedPartiesAdditionalInformationDetails", "shortName": "Related Parties - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_cb4f4f53-0efc-4f10-8342-fcd77f92c5b1", "decimals": "INF", "lang": null, "name": "rcor:MinimumPercentageOfOwnershipHeldByFounder", "reportCount": 1, "unique": true, "unitRef": "U_pure", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_29cdc283-0d61-407e-9e5c-5b8d4b11220d", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100550 - Disclosure - Net Income (Loss) Per Share - Net Income (Loss) Attributable to Common Stockholders of Basic and Diluted (Details)", "role": "http://renovacor.com/20220331/taxonomy/role/DisclosureNetIncomeLossPerShareNetIncomeLossAttributableToCommonStockholdersOfBasicAndDilutedDetails3", "shortName": "Net Income (Loss) Per Share - Net Income (Loss) Attributable to Common Stockholders of Basic and Diluted (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "div", "us-gaap:EarningsPerShareTextBlock", "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_29cdc283-0d61-407e-9e5c-5b8d4b11220d", "decimals": "-3", "lang": null, "name": "us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "div", "us-gaap:EarningsPerShareTextBlock", "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_29cdc283-0d61-407e-9e5c-5b8d4b11220d", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "U_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100560 - Disclosure - Net Income (loss) Per Share - Schedule of Potentially Antidilutive Securities Excluded from Computation of Diluted Net Loss Per Share (Detail)", "role": "http://renovacor.com/20220331/taxonomy/role/DisclosureNetIncomeLossPerShareScheduleOfPotentiallyAntidilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetail", "shortName": "Net Income (loss) Per Share - Schedule of Potentially Antidilutive Securities Excluded from Computation of Diluted Net Loss Per Share (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "div", "us-gaap:EarningsPerShareTextBlock", "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_29cdc283-0d61-407e-9e5c-5b8d4b11220d", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "U_shares", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:SubsequentEventsTextBlock", "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_34dedae5-37cf-47a8-afe1-3185d15ecab8", "decimals": "INF", "first": true, "lang": null, "name": "rcor:SubleaseRentableSpace", "reportCount": 1, "unique": true, "unitRef": "U_sqft", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100570 - Disclosure - Subsequent Events (Additional Information) (Details)", "role": "http://renovacor.com/20220331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails", "shortName": "Subsequent Events (Additional Information) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:SubsequentEventsTextBlock", "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_34dedae5-37cf-47a8-afe1-3185d15ecab8", "decimals": "INF", "first": true, "lang": null, "name": "rcor:SubleaseRentableSpace", "reportCount": 1, "unique": true, "unitRef": "U_sqft", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_617c0105-f9d5-44bb-a481-a6d447201155", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100070 - Statement - Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) (Unaudited)", "role": "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited", "shortName": "Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_617c0105-f9d5-44bb-a481-a6d447201155", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_29cdc283-0d61-407e-9e5c-5b8d4b11220d", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100080 - Disclosure - Business and Organization", "role": "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureBusinessAndOrganization", "shortName": "Business and Organization", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_29cdc283-0d61-407e-9e5c-5b8d4b11220d", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_29cdc283-0d61-407e-9e5c-5b8d4b11220d", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100090 - Disclosure - Summary of Significant Accounting Policies", "role": "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies", "shortName": "Summary of Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_29cdc283-0d61-407e-9e5c-5b8d4b11220d", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_29cdc283-0d61-407e-9e5c-5b8d4b11220d", "decimals": null, "first": true, "lang": "en-US", "name": "rcor:MergerAndRecapitalizationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100100 - Disclosure - Merger and Recapitalization", "role": "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureMergerAndRecapitalization", "shortName": "Merger and Recapitalization", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rcor-20220331.htm", "contextRef": "C_29cdc283-0d61-407e-9e5c-5b8d4b11220d", "decimals": null, "first": true, "lang": "en-US", "name": "rcor:MergerAndRecapitalizationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 82, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]", "terseLabel": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]", "terseLabel": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r495" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report", "terseLabel": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r496" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r493" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r493" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r499" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period", "terseLabel": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r493" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r498" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r493" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r493" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r493" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r493" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r492" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r494" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "rcor_AccruedPropertyAndEquipmentCurrent": { "auth_ref": [], "calculation": { "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails": { "order": 2.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accrued property and equipment current.", "label": "Accrued Property and Equipment Current", "terseLabel": "Property and equipment" } } }, "localname": "AccruedPropertyAndEquipmentCurrent", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "rcor_AdditionalSharesIssuedUponClosingOfSecondTrancheOfConvertiblePreferredStock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Additional shares issued upon closing of second tranche of convertible preferred stock.", "label": "Additional Shares Issued Upon Closing Of Second Tranche of Convertible Preferred Stock", "terseLabel": "Additional shares issued upon closing of Series A convertible preferred stock" } } }, "localname": "AdditionalSharesIssuedUponClosingOfSecondTrancheOfConvertiblePreferredStock", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureLicenseAndSponsoredResearchAgreementsAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "rcor_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationVestingOfRestrictedCommonStock": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Adjustments to additional paid in capital share based compensation vesting of restricted common stock.", "label": "Adjustments to Additional Paid In Capital Share Based Compensation Vesting Of Restricted Common Stock", "terseLabel": "Vesting of restricted common stock" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationVestingOfRestrictedCommonStock", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited" ], "xbrltype": "monetaryItemType" }, "rcor_AmusaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amusa.", "label": "Amusa [Member]", "terseLabel": "Amusa [Member]" } } }, "localname": "AmusaMember", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureRelatedPartiesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "rcor_April2020PrivatePlacementWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "April 2020 Private Placement Warrants.", "label": "April2020 Private Placement Warrants [Member]", "terseLabel": "April 2020 Private Placement Warrants [Member]" } } }, "localname": "April2020PrivatePlacementWarrantsMember", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureStockholdersEquitySummaryOfOutstandingWarrantsToPurchaseSharesOfCommonStockDetails" ], "xbrltype": "domainItemType" }, "rcor_April2020PublicWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "April 2020 Public Warrants.", "label": "April2020 Public Warrants [Member]", "terseLabel": "April 2020 Public Warrants [Member]" } } }, "localname": "April2020PublicWarrantsMember", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureStockholdersEquitySummaryOfOutstandingWarrantsToPurchaseSharesOfCommonStockDetails" ], "xbrltype": "domainItemType" }, "rcor_AssignmentFees": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Assignment fees.", "label": "Assignment Fees", "terseLabel": "Assignment fees" } } }, "localname": "AssignmentFees", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureLicenseAndSponsoredResearchAgreementsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "rcor_BeneficialOwnershipLimitationPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of beneficial ownership limitation.", "label": "Beneficial Ownership Limitation Percentage", "terseLabel": "Percentage of beneficial ownership limitation" } } }, "localname": "BeneficialOwnershipLimitationPercentage", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureMergerAndRecapitalizationAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "rcor_BusinessCombinationExchangedOptionsIssued": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Business combination exchanged options issued.", "label": "Business Combination Exchanged Options Issued", "terseLabel": "Exchanged options issued" } } }, "localname": "BusinessCombinationExchangedOptionsIssued", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureMergerAndRecapitalizationAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "rcor_CashNetOfRedemptions": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cash, Net of Redemptions.", "label": "Cash Net Of Redemptions", "terseLabel": "Cash \u2013 net of redemptions", "verboseLabel": "Cash - trust and cash, net of redemptions" } } }, "localname": "CashNetOfRedemptions", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureMergerAndRecapitalizationSummaryOfElementsOfNetProceedsFromMergerDetails" ], "xbrltype": "monetaryItemType" }, "rcor_ChardanHealthcareAcquisitionCorporationAndOldRenovacorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Chardan Healthcare Acquisition Corporation and Old Renovacor [Member]", "label": "Chardan Healthcare Acquisition Corporation and Old Renovacor [Member]", "terseLabel": "CHAQ and Old Renovacor [Member]" } } }, "localname": "ChardanHealthcareAcquisitionCorporationAndOldRenovacorMember", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureMergerAndRecapitalizationSummaryOfElementsOfNetProceedsFromMergerDetails" ], "xbrltype": "domainItemType" }, "rcor_ChardanHealthcareAcquisitionCorporationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Chardan Healthcare Acquisition Corporation.", "label": "Chardan Healthcare Acquisition Corporation [Member]", "terseLabel": "CHAQ [Member]" } } }, "localname": "ChardanHealthcareAcquisitionCorporationMember", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureMergerAndRecapitalizationSummaryOfElementsOfNetProceedsFromMergerDetails", "http://renovacor.com/20220331/taxonomy/role/DisclosureMergerAndRecapitalizationSummaryOfNumberOfSharesCommonStockIssuedImmediatelyFollowingConsummationOfMergerDetails" ], "xbrltype": "domainItemType" }, "rcor_ChardanHealthcareInvestmentsLimitedLiabilityCompanyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Chardan Healthcare Investments Limited Liability Company.", "label": "Chardan Healthcare Investments Limited Liability Company [Member]", "terseLabel": "Chardan Healthcare Investments LLC [Member]" } } }, "localname": "ChardanHealthcareInvestmentsLimitedLiabilityCompanyMember", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureRelatedPartiesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "rcor_ChardanInvestments2LimitedLiabilityCompanyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Chardan Investments 2 Limited Liability Company Member.", "label": "Chardan Investments 2 Limited Liability Company Member", "terseLabel": "Chardan Investments 2 [Member]" } } }, "localname": "ChardanInvestments2LimitedLiabilityCompanyMember", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureRelatedPartiesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "rcor_CommittedShareIssuance": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Committed share issuance", "label": "Committed Share Issuance", "terseLabel": "Committed share issuance" } } }, "localname": "CommittedShareIssuance", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "rcor_CommonStockAndPreFundedWarrantsIssuedPursuantToPIPEFinancingNetOfIssuanceCosts": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Common stock and pre-funded warrants issued pursuant to PIPE financing, net of issuance costs.", "label": "Common Stock And Pre Funded Warrants Issued Pursuant To P I P E Financing Net Of Issuance Costs", "terseLabel": "Common stock and pre-funded warrants issued pursuant to PIPE financing" } } }, "localname": "CommonStockAndPreFundedWarrantsIssuedPursuantToPIPEFinancingNetOfIssuanceCosts", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited" ], "xbrltype": "monetaryItemType" }, "rcor_CommonStockAndPreFundedWarrantsIssuedPursuantToPIPEFinancingNetOfIssuanceCostsShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common stock and pre funded warrants issued pursuant to PIPE financing net of issuance costs shares.", "label": "Common Stock And Pre Funded Warrants Issued Pursuant To P I P E Financing Net Of Issuance Costs Shares", "terseLabel": "Common stock and pre-funded warrants issued pursuant to PIPE financing, shares" } } }, "localname": "CommonStockAndPreFundedWarrantsIssuedPursuantToPIPEFinancingNetOfIssuanceCostsShares", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited" ], "xbrltype": "sharesItemType" }, "rcor_CommonStockEarnoutSharesIssuable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common stock earnout shares issuable.", "label": "Common Stock Earnout Shares Issuable", "terseLabel": "Common stock, earnout shares issuable" } } }, "localname": "CommonStockEarnoutSharesIssuable", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "rcor_CommonStockHeldInEscrowAndSubjectToVestingOrForfeiture": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common stock held in escrow and subject to vesting or forfeiture.", "label": "Common Stock Held in Escrow and Subject to Vesting or Forfeiture", "terseLabel": "Common stock held in escrow and subject to vesting or forfeiture", "verboseLabel": "Sponsor shares placed into escrow subject to forfeiture" } } }, "localname": "CommonStockHeldInEscrowAndSubjectToVestingOrForfeiture", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureMergerAndRecapitalizationSummaryOfNumberOfSharesCommonStockIssuedImmediatelyFollowingConsummationOfMergerParentheticalDetail", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureMergerAndRecapitalizationAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "rcor_CommonStockOutstandingFounderShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common Stock, Outstanding, Founder Shares.", "label": "Common Stock Outstanding Founder Shares", "terseLabel": "CHAQ Founder shares" } } }, "localname": "CommonStockOutstandingFounderShares", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureMergerAndRecapitalizationSummaryOfNumberOfSharesCommonStockIssuedImmediatelyFollowingConsummationOfMergerDetails" ], "xbrltype": "sharesItemType" }, "rcor_CommonStockOutstandingPriorToMerger": { "auth_ref": [], "calculation": { "http://renovacor.com/20220331/taxonomy/role/DisclosureMergerAndRecapitalizationSummaryOfNumberOfSharesCommonStockIssuedImmediatelyFollowingConsummationOfMergerDetails": { "order": 0.0, "parentTag": "us-gaap_CommonStockSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Common stock, outstanding prior to Merger.", "label": "Common Stock Outstanding Prior To Merger", "terseLabel": "Common stock outstanding prior to Merger", "verboseLabel": "Common stock, outstanding prior to Merger" } } }, "localname": "CommonStockOutstandingPriorToMerger", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureMergerAndRecapitalizationSummaryOfNumberOfSharesCommonStockIssuedImmediatelyFollowingConsummationOfMergerDetails", "http://renovacor.com/20220331/taxonomy/role/DisclosureMergerAndRecapitalizationSummaryOfNumberOfSharesCommonStockIssuedImmediatelyFollowingConsummationOfMergerParentheticalDetail" ], "xbrltype": "sharesItemType" }, "rcor_CommonStockSharesReservedForFutureIssuanceTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common stock shares reserved for future issuance.", "label": "Common Stock Shares Reserved For Future Issuance [Table Text Block]", "terseLabel": "Schedule of Common Stock Shares Reserved for Future Issuance" } } }, "localname": "CommonStockSharesReservedForFutureIssuanceTableTextBlock", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockholderSEquityTables" ], "xbrltype": "textBlockItemType" }, "rcor_CommonStockWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common Stock Warrants [Member]", "label": "Common Stock Warrants [Member]", "terseLabel": "Common Stock Warrants" } } }, "localname": "CommonStockWarrantsMember", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureNetIncomeLossPerShareScheduleOfPotentiallyAntidilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetail" ], "xbrltype": "domainItemType" }, "rcor_ConsultingFeeAmountPerCalendarMonth": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Consulting fee per calendar month.", "label": "Consulting Fee Amount Per Calendar Month", "terseLabel": "Consulting fee amount per calendar month" } } }, "localname": "ConsultingFeeAmountPerCalendarMonth", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureRelatedPartiesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "rcor_ConsultingFees": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Consulting Fees.", "label": "Consulting Fees", "terseLabel": "Consulting Fees" } } }, "localname": "ConsultingFees", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureRelatedPartiesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "rcor_ConvertiblePromissoryNoteMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible promissory note.", "label": "Convertible Promissory Note [Member]" } } }, "localname": "ConvertiblePromissoryNoteMember", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureRelatedPartiesAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "rcor_DeferredMergerCostsInAccountsPayable": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred Merger Costs In Accounts Payable", "label": "Deferred Merger Costs In Accounts Payable", "terseLabel": "Deferred merger costs in accounts payable" } } }, "localname": "DeferredMergerCostsInAccountsPayable", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "rcor_DevelopmentRegulatoryAndCommercialMilestonePayment": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Development regulatory and commercial milestone payment.", "label": "Development Regulatory And Commercial Milestone Payment", "terseLabel": "Development regulatory and commercial milestone payment" } } }, "localname": "DevelopmentRegulatoryAndCommercialMilestonePayment", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureLicenseAndSponsoredResearchAgreementsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "rcor_DisclosureOfPrepaidExpensesTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of prepaid expenses.", "label": "Disclosure of Prepaid Expenses [Text Block]", "terseLabel": "Prepaid Expenses" } } }, "localname": "DisclosureOfPrepaidExpensesTextBlock", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosurePrepaidExpenses1" ], "xbrltype": "textBlockItemType" }, "rcor_EarnoutRsuMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Earnout RSU.", "label": "Earnout RSU [Member]", "terseLabel": "Earnout RSUs [Member]" } } }, "localname": "EarnoutRsuMember", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "rcor_EarnoutShareLiabilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Earnout share liability.", "label": "Earnout Share Liability [Member]", "terseLabel": "Share Earnout Liability [Member]" } } }, "localname": "EarnoutShareLiabilityMember", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfWarrantAndEarnoutShareLiabilityMeasuredOnRecurringBasisUsingUnobservableInputDetails" ], "xbrltype": "domainItemType" }, "rcor_EarnoutShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Earnout shares.", "label": "Earnout Shares", "terseLabel": "Earnout shares" } } }, "localname": "EarnoutShares", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureMergerAndRecapitalizationSummaryOfEarnoutSharesDetails" ], "xbrltype": "sharesItemType" }, "rcor_EarnoutSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Earnout shares.", "label": "Earnout Shares [Member]", "terseLabel": "Earnout Shares [Member]" } } }, "localname": "EarnoutSharesMember", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureNetIncomeLossPerShareScheduleOfPotentiallyAntidilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetail", "http://renovacor.com/20220331/taxonomy/role/DisclosureStockholdersEquityScheduleOfCommonStockSharesReservedForFutureIssuanceDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssumptionsUsedInDeterminingFairValueOfEarnoutSharesDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsTables", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureMergerAndRecapitalizationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "rcor_EffectOfMergerAndRecapitalizationNetOfIssuanceCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Effect of Merger and recapitalization, net of issuance costs.", "label": "Effect Of Merger And Recapitalization Net Of Issuance Costs", "terseLabel": "Effect of Merger and recapitalization" } } }, "localname": "EffectOfMergerAndRecapitalizationNetOfIssuanceCosts", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited" ], "xbrltype": "monetaryItemType" }, "rcor_EffectOfMergerAndRecapitalizationNetOfIssuanceCostsShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Effect of merger and recapitalization net of issuance costs shares.", "label": "Effect Of Merger And Recapitalization Net Of Issuance Costs Shares", "terseLabel": "Effect of Merger and recapitalization, Shares" } } }, "localname": "EffectOfMergerAndRecapitalizationNetOfIssuanceCostsShares", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited" ], "xbrltype": "sharesItemType" }, "rcor_EffectOfMergerNetOfRedemptionsAndTransactionCostsIncludedInCashFlow": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Effect of Merger, net of Redemptions and Transaction Costs, Included in Cash Flow.", "label": "Effect Of Merger Net Of Redemptions And Transaction Costs Included In Cash Flow", "terseLabel": "Effect of Merger, net of redemptions and transaction costs", "totalLabel": "Effect of Merger, net of redemptions and transaction costs" } } }, "localname": "EffectOfMergerNetOfRedemptionsAndTransactionCostsIncludedInCashFlow", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureMergerAndRecapitalizationSummaryOfElementsOfNetProceedsFromMergerDetails" ], "xbrltype": "monetaryItemType" }, "rcor_EmergingGrowthCompanyPoliciesTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Emerging growth company.", "label": "Emerging Growth Company Policies [Text Block]", "terseLabel": "Emerging Growth Company Status" } } }, "localname": "EmergingGrowthCompanyPoliciesTextBlock", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "rcor_EquityClassifiedWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equity classified warrants.", "label": "Equity Classified Warrants [Member]", "terseLabel": "Equity Classified Warrants [Member]" } } }, "localname": "EquityClassifiedWarrantsMember", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureStockholdersEquitySummaryOfOutstandingWarrantsToPurchaseSharesOfCommonStockDetails" ], "xbrltype": "domainItemType" }, "rcor_ExtendedSubleaseBaseRent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Extended sublease base rent", "label": "Extended sublease base rent" } } }, "localname": "ExtendedSubleaseBaseRent", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "rcor_ExternalResearchAndDevelopmentExpenses": { "auth_ref": [], "calculation": { "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails": { "order": 1.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "External research and development expenses.", "label": "External Research And Development Expenses", "terseLabel": "External research and development expenses" } } }, "localname": "ExternalResearchAndDevelopmentExpenses", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "rcor_FeldmanConsultingAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Dr. Arthur Feldman consulting agreement member.", "label": "Feldman Consulting Agreement [Member]", "terseLabel": "Feldman Consulting Agreement [Member]" } } }, "localname": "FeldmanConsultingAgreementMember", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureRelatedPartiesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "rcor_FinancialInstrumentPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financial instrument policy.", "label": "Financial Instrument Policy [Text Block]", "terseLabel": "Financial Instruments" } } }, "localname": "FinancialInstrumentPolicyTextBlock", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "rcor_FirstMilestoneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First milestone member.", "label": "First Milestone [Member]", "terseLabel": "First Earnout Period [Member]" } } }, "localname": "FirstMilestoneMember", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureMergerAndRecapitalizationAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureMergerAndRecapitalizationSummaryOfEarnoutSharesDetails" ], "xbrltype": "domainItemType" }, "rcor_GrossProceedsFromIssuanceOfSharesToInvestors": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gross proceeds from issuance of shares to investors.", "label": "Gross Proceeds From Issuance Of Shares To Investors", "terseLabel": "Gross proceeds from issuance of shares to investors" } } }, "localname": "GrossProceedsFromIssuanceOfSharesToInvestors", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureMergerAndRecapitalizationAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "rcor_GrossmanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Grossman.", "label": "Grossman [Member]", "terseLabel": "Grossman [Member]" } } }, "localname": "GrossmanMember", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureRelatedPartiesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "rcor_IncrementalCommonSharesAttributableToUnderlyingInTheMoneyOptionsOutstanding": { "auth_ref": [], "calculation": { "http://renovacor.com/20220331/taxonomy/role/DisclosureNetIncomeLossPerShareNetIncomeLossAttributableToCommonStockholdersOfBasicAndDilutedDetails3": { "order": 1.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to underlying in the money options outstanding.", "label": "Incremental Common Shares Attributable To Underlying in the Money Options Outstanding", "terseLabel": "Plus: Incremental shares underlying \"in the money\" options outstanding" } } }, "localname": "IncrementalCommonSharesAttributableToUnderlyingInTheMoneyOptionsOutstanding", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureNetIncomeLossPerShareNetIncomeLossAttributableToCommonStockholdersOfBasicAndDilutedDetails3" ], "xbrltype": "sharesItemType" }, "rcor_IncrementalCommonSharesAttributableToUnderlyingTimeBasedRestrictedStockUnits": { "auth_ref": [], "calculation": { "http://renovacor.com/20220331/taxonomy/role/DisclosureNetIncomeLossPerShareNetIncomeLossAttributableToCommonStockholdersOfBasicAndDilutedDetails3": { "order": 2.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to underlying time-based restricted stock units.", "label": "Incremental Common Shares Attributable to Underlying Time-Based Restricted Stock Units", "terseLabel": "Plus: Incremental shares underlying time-based restricted stock units" } } }, "localname": "IncrementalCommonSharesAttributableToUnderlyingTimeBasedRestrictedStockUnits", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureNetIncomeLossPerShareNetIncomeLossAttributableToCommonStockholdersOfBasicAndDilutedDetails3" ], "xbrltype": "sharesItemType" }, "rcor_InitialPurchasePricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Initial purchase price per share.", "label": "Initial Purchase Price Per Share", "terseLabel": "Initial purchase price per share (in Dollars per share)" } } }, "localname": "InitialPurchasePricePerShare", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureMergerAndRecapitalizationAdditionalInformationDetails" ], "xbrltype": "perShareItemType" }, "rcor_LiabilityClassifiedWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Liability classified warrants.", "label": "Liability Classified Warrants [Member]", "terseLabel": "Liability Classified Warrants [Member]" } } }, "localname": "LiabilityClassifiedWarrantsMember", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureStockholdersEquitySummaryOfOutstandingWarrantsToPurchaseSharesOfCommonStockDetails" ], "xbrltype": "domainItemType" }, "rcor_LicenseAndSponsoredResearchAgreementsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "License and sponsored research agreements.", "label": "License And Sponsored Research Agreements [Text Block]", "terseLabel": "License and Sponsored Research Agreements" } } }, "localname": "LicenseAndSponsoredResearchAgreementsTextBlock", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureLicenseAndSponsoredResearchAgreements" ], "xbrltype": "textBlockItemType" }, "rcor_LongTermServiceCommitmentPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Long Term Service Commitment Period.", "label": "Long Term Service Commitment Period", "terseLabel": "Long term service commitment period" } } }, "localname": "LongTermServiceCommitmentPeriod", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureRelatedPartiesAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "rcor_LossOnChangeInFairValueOfShareEarnoutLiability": { "auth_ref": [], "calculation": { "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsUnaudited": { "order": 6.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Loss on change in fair value of share earnout liability.", "label": "Loss On Change In Fair Value Of Share Earnout Liability", "negatedLabel": "Change in fair value of share earnout liability", "terseLabel": "Gain on change in fair value of share earnout liability" } } }, "localname": "LossOnChangeInFairValueOfShareEarnoutLiability", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "monetaryItemType" }, "rcor_MarketBasedRestrictedStockUnitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Market-based restricted stock units.", "label": "Market-based Restricted Stock Units [Member]", "terseLabel": "Market-based Awards [Member]" } } }, "localname": "MarketBasedRestrictedStockUnitsMember", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitActivityDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "rcor_MaximumNumberOfAdditionalSharesEntitledToReceive": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Maximum number of additional shares entitled to receive.", "label": "Maximum Number of Additional Shares Entitled to Receive", "terseLabel": "Maximum number of additional shares entitled to receive" } } }, "localname": "MaximumNumberOfAdditionalSharesEntitledToReceive", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureMergerAndRecapitalizationAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "rcor_MeasurementInputFairValuePerShareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement input fair value per share.", "label": "Measurement Input Fair Value Per Share [Member]", "terseLabel": "Fair Value Per Share [Member]" } } }, "localname": "MeasurementInputFairValuePerShareMember", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssumptionsUsedInDeterminingFairValueOfEarnoutSharesDetails" ], "xbrltype": "domainItemType" }, "rcor_MeasurementInputFairValuePerWarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement input fair value per warrant .", "label": "Measurement Input Fair Value Per Warrant [Member]", "terseLabel": "Fair Value Per Warrant [Member]" } } }, "localname": "MeasurementInputFairValuePerWarrantMember", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssumptionsUsedInDeterminingFairValueOfPrivatePlacementWarrantsDetails" ], "xbrltype": "domainItemType" }, "rcor_MeasurementInputProbabilityOfChangeInControlMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement input probability of change in control.", "label": "Measurement Input Probability Of Change In Control [Member]", "terseLabel": "Probability of Change in Control [Member]" } } }, "localname": "MeasurementInputProbabilityOfChangeInControlMember", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssumptionsUsedInDeterminingFairValueOfEarnoutSharesDetails" ], "xbrltype": "domainItemType" }, "rcor_MergerAgreementAndNotePurchaseAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Merger agreement and note purchase agreement.", "label": "Merger Agreement and Note Purchase Agreement [Member]" } } }, "localname": "MergerAgreementAndNotePurchaseAgreementMember", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureRelatedPartiesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "rcor_MergerAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Merger Agreement member.", "label": "Merger Agreement [Member]", "terseLabel": "Merger Agreement [Member]" } } }, "localname": "MergerAgreementMember", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureRelatedPartiesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "rcor_MergerAndPipeFinancingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Merger and PIPE financing shares.", "label": "Merger and PIPE Financing [Member]", "terseLabel": "Merger and PIPE Financing [Member]" } } }, "localname": "MergerAndPipeFinancingMember", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureMergerAndRecapitalizationSummaryOfNumberOfSharesCommonStockIssuedImmediatelyFollowingConsummationOfMergerDetails" ], "xbrltype": "domainItemType" }, "rcor_MergerAndRecapitalizationDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Merger and Recapitalization disclosure.", "label": "Merger And Recapitalization Disclosure [Text Block]", "terseLabel": "Merger and Recapitalization" } } }, "localname": "MergerAndRecapitalizationDisclosureTextBlock", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureMergerAndRecapitalization" ], "xbrltype": "textBlockItemType" }, "rcor_MinimumPercentageOfOwnershipHeldByFounder": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Minimum percentage of ownership held by founder.", "label": "Minimum Percentage of Ownership Held by Founder", "terseLabel": "Minimum percentage of ownership held by Founder" } } }, "localname": "MinimumPercentageOfOwnershipHeldByFounder", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureRelatedPartiesAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "rcor_NumberOfSharesDistributedToMembersAndEmployees": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares distributed to members and employees.", "label": "Number of Shares Distributed to Members and Employees", "terseLabel": "Number of shares distributed to members and employees" } } }, "localname": "NumberOfSharesDistributedToMembersAndEmployees", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureRelatedPartiesAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "rcor_NumberOfSharesDistributedToRelatedParties": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares distributed to related parties.", "label": "Number of Shares Distributed to Related Parties", "terseLabel": "Number of shares distributed to related parties" } } }, "localname": "NumberOfSharesDistributedToRelatedParties", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureRelatedPartiesAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "rcor_OldRenovacorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Old renovacor member.", "label": "Old Renovacor [Member]", "terseLabel": "Old Renovacor [Member]" } } }, "localname": "OldRenovacorMember", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureMergerAndRecapitalizationSummaryOfNumberOfSharesCommonStockIssuedImmediatelyFollowingConsummationOfMergerDetails", "http://renovacor.com/20220331/taxonomy/role/DisclosureMergerAndRecapitalizationSummaryOfNumberOfSharesCommonStockIssuedImmediatelyFollowingConsummationOfMergerParentheticalDetail", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureMergerAndRecapitalizationAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureMergerAndRecapitalizationSummaryOfEarnoutSharesDetails" ], "xbrltype": "domainItemType" }, "rcor_PIPEInvestmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "PIPE investment member.", "label": "P I P E Investment [Member]", "terseLabel": "PIPE Investment [Member]" } } }, "localname": "PIPEInvestmentMember", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureMergerAndRecapitalizationSummaryOfElementsOfNetProceedsFromMergerDetails", "http://renovacor.com/20220331/taxonomy/role/DisclosureMergerAndRecapitalizationSummaryOfNumberOfSharesCommonStockIssuedImmediatelyFollowingConsummationOfMergerDetails" ], "xbrltype": "domainItemType" }, "rcor_PercentageOfOutstandingShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of outstanding shares.", "label": "Percentage Of Outstanding Shares", "terseLabel": "Percentage of outstanding shares" } } }, "localname": "PercentageOfOutstandingShares", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureRelatedPartiesAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "rcor_PipeInvestorsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "PIPE investors.", "label": "PIPE Investors [Member]", "terseLabel": "PIPE Investors [Member]" } } }, "localname": "PipeInvestorsMember", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureMergerAndRecapitalizationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "rcor_PreFundedWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Pre Funded Warrants [Member]", "label": "Pre Funded Warrants [Member]", "terseLabel": "Pre-Funded Warrants [Member]" } } }, "localname": "PreFundedWarrantsMember", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureStockholdersEquityScheduleOfCommonStockSharesReservedForFutureIssuanceDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureMergerAndRecapitalizationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "rcor_PreclinicalTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preclinical term.", "label": "Preclinical Term", "terseLabel": "Preclinical term" } } }, "localname": "PreclinicalTerm", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureLicenseAndSponsoredResearchAgreementsAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "rcor_PreferredStockOutstandingPriorToMerger": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred stock outstanding prior to merger.", "label": "Preferred Stock Outstanding Prior to Merger", "terseLabel": "Preferred stock outstanding prior to Merger" } } }, "localname": "PreferredStockOutstandingPriorToMerger", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureMergerAndRecapitalizationSummaryOfNumberOfSharesCommonStockIssuedImmediatelyFollowingConsummationOfMergerParentheticalDetail" ], "xbrltype": "sharesItemType" }, "rcor_PrepaidResearchAndDevelopmentCosts": { "auth_ref": [], "calculation": { "http://renovacor.com/20220331/taxonomy/role/DisclosurePrepaidExpensesSummaryOfPrepaidExpensesDetails": { "order": 0.0, "parentTag": "us-gaap_PrepaidExpenseCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Prepaid research and development costs.", "label": "Prepaid Research And Development Costs", "terseLabel": "Research and development costs" } } }, "localname": "PrepaidResearchAndDevelopmentCosts", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosurePrepaidExpensesSummaryOfPrepaidExpensesDetails" ], "xbrltype": "monetaryItemType" }, "rcor_PrivatePlacementWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Private placement warrants.", "label": "Private Placement Warrants [Member]", "terseLabel": "Private Placement Warrants [Member]" } } }, "localname": "PrivatePlacementWarrantsMember", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssumptionsUsedInDeterminingFairValueOfPrivatePlacementWarrantsDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsTables", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureRelatedPartiesAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockholderSEquityAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "rcor_PublicWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Public Warrants.", "label": "Public Warrants [Member]", "terseLabel": "Public Warrants" } } }, "localname": "PublicWarrantsMember", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockholderSEquityAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "rcor_PurchasePricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Purchase price per share.", "label": "Purchase Price Per Share", "terseLabel": "Purchase price per share" } } }, "localname": "PurchasePricePerShare", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "perShareItemType" }, "rcor_ReconciliationOfElementsOfMergerToCondensedConsolidatedStatementOfCashFlowsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reconciliation of elements of merger to condensed consolidated statement of cash flows.", "label": "Reconciliation of Elements of Merger to Condensed Consolidated Statement of Cash Flows [Table Text Block]", "terseLabel": "Schedule of Merger to Unaudited Condensed Consolidated Statement of Cash Flows" } } }, "localname": "ReconciliationOfElementsOfMergerToCondensedConsolidatedStatementOfCashFlowsTableTextBlock", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureMergerAndRecapitalizationTables" ], "xbrltype": "textBlockItemType" }, "rcor_ReverseRecapitalizationPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reverse Recapitalization.", "label": "Reverse Recapitalization Policy [Text Block]", "terseLabel": "Reverse Recapitalization" } } }, "localname": "ReverseRecapitalizationPolicyTextBlock", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "rcor_RoyaltyPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Royalty percentage.", "label": "Royalty Percentage", "terseLabel": "Royalty percentage" } } }, "localname": "RoyaltyPercentage", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureLicenseAndSponsoredResearchAgreementsAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "rcor_ScheduleOfMergerToUnauditedCondensedConsolidatedStatementOfChangesInStockholdersEquityDeficitTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of merger to unaudited condensed consolidated statement of changes in stockholders' equity (Deficit).", "label": "Schedule of Merger to Unaudited Condensed Consolidated Statement of Changes in Stockholders' Equity (Deficit) [Table Text Block]", "terseLabel": "Schedule of Merger to Unaudited Condensed Consolidated Statement of Changes in Stockholders' Equity (Deficit)" } } }, "localname": "ScheduleOfMergerToUnauditedCondensedConsolidatedStatementOfChangesInStockholdersEquityDeficitTableTextBlock", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureMergerAndRecapitalizationTables" ], "xbrltype": "textBlockItemType" }, "rcor_ScheduleOfWarrantAndEarnoutShareLiabilityMeasuredOnRecurringBasisUsingUnobservableInputTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of warrant and earnout share liability measured on recurring basis using unobservable input.", "label": "Schedule of Warrant and Earnout Share Liability Measured on Recurring Basis Using Unobservable Input [Table Text Block]", "terseLabel": "Schedule of Warrant and Earnout Share Liability Measured on Recurring Basis Using Unobservable Inputs" } } }, "localname": "ScheduleOfWarrantAndEarnoutShareLiabilityMeasuredOnRecurringBasisUsingUnobservableInputTableTextBlock", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "rcor_SecondMilestoneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Second milestone member.", "label": "Second Milestone [Member]", "terseLabel": "Second Earnout Period [Member]" } } }, "localname": "SecondMilestoneMember", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureMergerAndRecapitalizationAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureMergerAndRecapitalizationSummaryOfEarnoutSharesDetails" ], "xbrltype": "domainItemType" }, "rcor_September2021PreFundedWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "September 2021 Pre-Funded Warrants.", "label": "September2021 Pre Funded Warrants [Member]", "terseLabel": "September 2021 Pre-Funded Warrants [Member]" } } }, "localname": "September2021PreFundedWarrantsMember", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureStockholdersEquitySummaryOfOutstandingWarrantsToPurchaseSharesOfCommonStockDetails" ], "xbrltype": "domainItemType" }, "rcor_SeriesARedeemableConvertiblePreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series A redeemable convertible preferred stock.", "label": "Series A Redeemable Convertible Preferred Stock [Member]" } } }, "localname": "SeriesARedeemableConvertiblePreferredStockMember", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockholderSEquityAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "rcor_ServiceCommitmentRenewalTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Service Commitment Renewal Term.", "label": "Service Commitment Renewal Term", "terseLabel": "Service commitment renewal term" } } }, "localname": "ServiceCommitmentRenewalTerm", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureRelatedPartiesAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "rcor_SettlementOfConvertibleNoteAtClosing": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Settlement of convertible note at closing.", "label": "Settlement Of Convertible Note At Closing", "negatedLabel": "Less: Settlement of convertible note at closing" } } }, "localname": "SettlementOfConvertibleNoteAtClosing", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureMergerAndRecapitalizationSummaryOfElementsOfNetProceedsFromMergerDetails" ], "xbrltype": "monetaryItemType" }, "rcor_ShareEarnoutLiability": { "auth_ref": [], "calculation": { "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Share earnout liability", "label": "Share Earnout Liability", "terseLabel": "Share earnout liability (includes 500,000 shares of Common stock, $0.0001 par value per share, subject to forfeiture, issued and outstanding at March 31 2022 and December 31, 2021 --- Note 3)" } } }, "localname": "ShareEarnoutLiability", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1" ], "xbrltype": "monetaryItemType" }, "rcor_ShareEarnoutLiabilityPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share Earnout Liability.", "label": "Share Earnout Liability Policy [Text Block]", "terseLabel": "Share Earnout Liability" } } }, "localname": "ShareEarnoutLiabilityPolicyTextBlock", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "rcor_SharesEarnoutMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shares earnout.", "label": "Shares Earnout [Member]" } } }, "localname": "SharesEarnoutMember", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "domainItemType" }, "rcor_SharesOfCommonStockImmediatelyAfterMerger": { "auth_ref": [], "calculation": { "http://renovacor.com/20220331/taxonomy/role/DisclosureMergerAndRecapitalizationSummaryOfNumberOfSharesCommonStockIssuedImmediatelyFollowingConsummationOfMergerDetails2": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "Shares of common stock immediately after merger.", "label": "Shares of Common Stock Immediately After Merger", "terseLabel": "Total shares of common stock immediately after Merger", "totalLabel": "Total shares of common stock immediately after Merger" } } }, "localname": "SharesOfCommonStockImmediatelyAfterMerger", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureMergerAndRecapitalizationSummaryOfNumberOfSharesCommonStockIssuedImmediatelyFollowingConsummationOfMergerDetails" ], "xbrltype": "sharesItemType" }, "rcor_SignificantAccountingPoliciesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Significant Accounting Policies Table", "label": "Significant Accounting Policies [Table]", "terseLabel": "Significant Accounting Policies [Table]" } } }, "localname": "SignificantAccountingPoliciesTable", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "rcor_SignificantAccountingPoliciesTableLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Significant Accounting Policies Table Line Items", "label": "Significant Accounting Policies Table [Line Items]", "terseLabel": "Significant Accounting Policies Table [Line Items]" } } }, "localname": "SignificantAccountingPoliciesTableLineItems", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "rcor_SponsorCancelledShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sponsor cancelled shares.", "label": "Sponsor Cancelled Shares", "terseLabel": "Sponsor cancelled shares (in shares)" } } }, "localname": "SponsorCancelledShares", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureRelatedPartiesAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "rcor_SponsorEarnoutShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sponsor Earnout Shares.", "label": "Sponsor Earnout Shares", "terseLabel": "Sponsor earnout shares" } } }, "localname": "SponsorEarnoutShares", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureRelatedPartiesAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "rcor_SponsorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sponsor [Member]", "label": "Sponsor [Member]", "terseLabel": "Sponsor [Member]" } } }, "localname": "SponsorMember", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureMergerAndRecapitalizationSummaryOfEarnoutSharesDetails" ], "xbrltype": "domainItemType" }, "rcor_SponsorOwnershipMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sponsor Ownership [Member].", "label": "Sponsor Ownership [Member]", "terseLabel": "Sponsor Ownership [Member]" } } }, "localname": "SponsorOwnershipMember", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureRelatedPartiesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "rcor_SponsorResearchAgreementFundedAndOrIncurredFromInception": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sponsor research agreement funded and/or incurred from inception.", "label": "Sponsor Research Agreement Funded and/or Incurred From Inception", "terseLabel": "Sponsor research agreement funded and/or incurred from inception" } } }, "localname": "SponsorResearchAgreementFundedAndOrIncurredFromInception", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureLicenseAndSponsoredResearchAgreementsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "rcor_SponsorSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sponsor shares.", "label": "Sponsor Shares [Member]" } } }, "localname": "SponsorSharesMember", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureRelatedPartiesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "rcor_SponsorSupportAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sponsor support agreement member.", "label": "Sponsor Support Agreement [Member]", "terseLabel": "Sponsor Support Agreement [Member]" } } }, "localname": "SponsorSupportAgreementMember", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureMergerAndRecapitalizationSummaryOfNumberOfSharesCommonStockIssuedImmediatelyFollowingConsummationOfMergerParentheticalDetail", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureMergerAndRecapitalizationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "rcor_SponsoredResearchAgreementFund": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sponsored research agreement fund.", "label": "Sponsored Research Agreement Fund", "terseLabel": "Sponsored research agreement fund" } } }, "localname": "SponsoredResearchAgreementFund", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureLicenseAndSponsoredResearchAgreementsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "rcor_SponsoredResearchAgreementFundNet": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sponsored research agreement fund net.", "label": "Sponsored Research Agreement Fund Net", "terseLabel": "Sponsored research agreement fund, net" } } }, "localname": "SponsoredResearchAgreementFundNet", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureLicenseAndSponsoredResearchAgreementsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "rcor_StockOptionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock Options [Member]", "label": "Stock Options [Member]", "terseLabel": "Stock Options" } } }, "localname": "StockOptionsMember", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureNetIncomeLossPerShareScheduleOfPotentiallyAntidilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetail" ], "xbrltype": "domainItemType" }, "rcor_SubleaseBaseRent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sublease base rent.", "label": "Sublease base rent" } } }, "localname": "SubleaseBaseRent", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "rcor_SubleaseCommencingDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sublease commencing date", "label": "Sublease Commencing Date", "terseLabel": "Sublease commencing date" } } }, "localname": "SubleaseCommencingDate", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" ], "xbrltype": "dateItemType" }, "rcor_SubleaseExpiringDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sublease expiring date", "label": "Sublease expiring date" } } }, "localname": "SubleaseExpiringDate", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" ], "xbrltype": "dateItemType" }, "rcor_SubleaseRentableSpace": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sublease rentable space", "label": "Sublease rentable space" } } }, "localname": "SubleaseRentableSpace", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" ], "xbrltype": "areaItemType" }, "rcor_SummaryOfEarnoutSharesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Summary Of Earnout Shares Table.", "label": "Summary Of Earnout Shares Table [Text Block]", "terseLabel": "Summary of Earnout Shares" } } }, "localname": "SummaryOfEarnoutSharesTableTextBlock", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureMergerAndRecapitalizationTables" ], "xbrltype": "textBlockItemType" }, "rcor_SummaryOfElementsOfNetProceedsFromMergerTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Summary of elements of net proceeds from merger.", "label": "Summary of Elements of Net Proceeds From Merger" } } }, "localname": "SummaryOfElementsOfNetProceedsFromMergerTableTextBlock", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureMergerAndRecapitalizationTables" ], "xbrltype": "textBlockItemType" }, "rcor_SummaryOfNumberOfSharesCommonStockIssuedImmediatelyFollowingConsummationOfMergerTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Summary of number of shares common stock issued immediately following consummation of merger.", "label": "Summary of Number of Shares Common Stock Issued Immediately Following Consummation of Merger [Table Text Block]", "terseLabel": "Summary of Number of Shares Common Stock Issued Immediately Following Consummation of Merger" } } }, "localname": "SummaryOfNumberOfSharesCommonStockIssuedImmediatelyFollowingConsummationOfMergerTableTextBlock", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureMergerAndRecapitalizationTables" ], "xbrltype": "textBlockItemType" }, "rcor_TargetPricePerShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Target Price Per Shares.", "label": "Target Price Per Shares", "terseLabel": "Target price" } } }, "localname": "TargetPricePerShares", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureMergerAndRecapitalizationSummaryOfEarnoutSharesDetails" ], "xbrltype": "perShareItemType" }, "rcor_TempleLicenseAgreementEffectiveDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Temple license agreement effective date.", "label": "Temple License Agreement Effective Date", "terseLabel": "Agreement effective date" } } }, "localname": "TempleLicenseAgreementEffectiveDate", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureLicenseAndSponsoredResearchAgreementsAdditionalInformationDetails" ], "xbrltype": "dateItemType" }, "rcor_TempleLicenseAgreementExpirationDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Temple license agreement expiration description.", "label": "Temple License Agreement Expiration Description", "terseLabel": "Agreement expiration description" } } }, "localname": "TempleLicenseAgreementExpirationDescription", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureLicenseAndSponsoredResearchAgreementsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "rcor_TempleLicenseAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Temple license agreement.", "label": "Temple License Agreement [Member]", "terseLabel": "Temple License Agreement [Member]" } } }, "localname": "TempleLicenseAgreementMember", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureLicenseAndSponsoredResearchAgreementsAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureRelatedPartiesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "rcor_TemporaryEquityConversionIntoPermanentEquityConversionPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Temporary equity conversion into permanent equity conversion price per share.", "label": "Temporary Equity Conversion Into Permanent Equity Conversion Price Per Share", "terseLabel": "Temporary Equity Conversion Into Permanent Equity Conversion Price Per" } } }, "localname": "TemporaryEquityConversionIntoPermanentEquityConversionPricePerShare", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockholderSEquityAdditionalInformationDetails" ], "xbrltype": "perShareItemType" }, "rcor_TemporaryEquitySharesIssuedPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Temporary equity shares issued price per share.", "label": "Temporary Equity Shares Issued Price Per Share", "terseLabel": "Temporary equity shares issued price per share" } } }, "localname": "TemporaryEquitySharesIssuedPricePerShare", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockholderSEquityAdditionalInformationDetails" ], "xbrltype": "perShareItemType" }, "rcor_ThirdMilestoneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Third milestone member.", "label": "Third Milestone [Member]", "terseLabel": "Third Earnout Period [Member]" } } }, "localname": "ThirdMilestoneMember", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureMergerAndRecapitalizationAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureMergerAndRecapitalizationSummaryOfEarnoutSharesDetails" ], "xbrltype": "domainItemType" }, "rcor_TimeBasedRestrictedStockUnitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Time-based Restricted Stock Units [Member]", "label": "Time-based Restricted Stock Units [Member]", "terseLabel": "Time-based Awards [Member]", "verboseLabel": "Time-based Restricted Stock Units [Member]" } } }, "localname": "TimeBasedRestrictedStockUnitsMember", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitActivityDetails", "http://renovacor.com/20220331/taxonomy/role/DisclosureStockholdersEquityScheduleOfCommonStockSharesReservedForFutureIssuanceDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "rcor_TransactionFinanceCost": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Transaction finance cost.", "label": "Transaction Finance Cost", "negatedLabel": "Less: transaction costs paid" } } }, "localname": "TransactionFinanceCost", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureMergerAndRecapitalizationSummaryOfElementsOfNetProceedsFromMergerDetails" ], "xbrltype": "monetaryItemType" }, "rcor_TwoThousandEighteenStockOptionAndGrantPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2018 stock option and grant plan.", "label": "Two Thousand Eighteen Stock Option And Grant Plan [Member]", "terseLabel": "2018 Stock Option and Grant Plan [Member]" } } }, "localname": "TwoThousandEighteenStockOptionAndGrantPlanMember", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "rcor_TwoThousandTwentyOneOmnibusIncentivePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two thousand twenty one omnibus incentive plan.", "label": "Two Thousand Twenty One Omnibus Incentive Plan [Member]", "terseLabel": "2021 Omnibus Incentive Plan [Member]", "verboseLabel": "2021 Incentive Plan [Member]" } } }, "localname": "TwoThousandTwentyOneOmnibusIncentivePlanMember", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureStockholdersEquityScheduleOfCommonStockSharesReservedForFutureIssuanceDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "rcor_WarrantExercisableTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrant exercisable term.", "label": "Warrant Exercisable Term", "terseLabel": "Warrant exercisable term" } } }, "localname": "WarrantExercisableTerm", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockholderSEquityAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "rcor_WarrantLiabilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrant liability.", "label": "Warrant Liability [Member]", "terseLabel": "Warrant Liability" } } }, "localname": "WarrantLiabilityMember", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfWarrantAndEarnoutShareLiabilityMeasuredOnRecurringBasisUsingUnobservableInputDetails" ], "xbrltype": "domainItemType" }, "rcor_WarrantLiabilityPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrant Liability.", "label": "Warrant Liability Policy [Text Block]", "terseLabel": "Warrant Liability" } } }, "localname": "WarrantLiabilityPolicyTextBlock", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "rcor_WarrantOrRightsPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrant or rights price per share.", "label": "Warrant Or Rights Price Per Share", "terseLabel": "Warrant Or Rights Price Per Share", "verboseLabel": "Warrant price per share" } } }, "localname": "WarrantOrRightsPricePerShare", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockholderSEquityAdditionalInformationDetails" ], "xbrltype": "perShareItemType" }, "rcor_WarrantsOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants outstanding.", "label": "Warrants Outstanding", "terseLabel": "Number of Warrants Outstanding" } } }, "localname": "WarrantsOutstanding", "nsuri": "http://renovacor.com/20220331", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureStockholdersEquitySummaryOfOutstandingWarrantsToPurchaseSharesOfCommonStockDetails" ], "xbrltype": "sharesItemType" }, "srt_MaximumMember": { "auth_ref": [ "r198", "r225", "r260", "r263", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r456", "r457", "r489", "r490" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum [Member]", "verboseLabel": "Maximum" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureMergerAndRecapitalizationAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r198", "r225", "r260", "r263", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r456", "r457", "r489", "r490" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureLicenseAndSponsoredResearchAgreementsAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r198", "r225", "r249", "r260", "r263", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r456", "r457", "r489", "r490" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]", "terseLabel": "Statistical Measurement" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureLicenseAndSponsoredResearchAgreementsAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureMergerAndRecapitalizationAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r198", "r225", "r249", "r260", "r263", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r456", "r457", "r489", "r490" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]", "terseLabel": "Statistical Measurement" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureLicenseAndSponsoredResearchAgreementsAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureMergerAndRecapitalizationAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_RestatementAdjustmentMember": { "auth_ref": [ "r81", "r82", "r83", "r85", "r86", "r89", "r90", "r92", "r94", "r95", "r97", "r98", "r123", "r355", "r356" ], "lang": { "en-us": { "role": { "label": "Revision of Prior Period, Adjustment [Member]", "terseLabel": "Retroactive Application of Reverse Recapitalization [Member]" } } }, "localname": "RestatementAdjustmentMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited" ], "xbrltype": "domainItemType" }, "srt_RestatementAxis": { "auth_ref": [ "r3", "r81", "r82", "r83", "r85", "r86", "r89", "r90", "r91", "r92", "r94", "r95", "r96", "r97", "r98", "r100", "r123", "r160", "r161", "r306", "r328", "r351", "r355", "r356", "r357", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r503", "r504" ], "lang": { "en-us": { "role": { "label": "Revision of Prior Period [Axis]", "terseLabel": "Revision of Prior Period" } } }, "localname": "RestatementAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited" ], "xbrltype": "stringItemType" }, "srt_RestatementDomain": { "auth_ref": [ "r3", "r81", "r82", "r83", "r85", "r86", "r89", "r90", "r91", "r92", "r94", "r95", "r96", "r97", "r98", "r100", "r123", "r160", "r161", "r306", "r328", "r351", "r355", "r356", "r357", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r503", "r504" ], "lang": { "en-us": { "role": { "label": "Revision of Prior Period [Domain]", "terseLabel": "Revision of Prior Period" } } }, "localname": "RestatementDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited" ], "xbrltype": "domainItemType" }, "srt_ScenarioPreviouslyReportedMember": { "auth_ref": [ "r3", "r81", "r83", "r85", "r86", "r89", "r90", "r91", "r92", "r94", "r95", "r97", "r98", "r123", "r160", "r161", "r306", "r328", "r351", "r355", "r356", "r357", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r503", "r504" ], "lang": { "en-us": { "role": { "label": "Previously Reported [Member]", "terseLabel": "Previously Reported [Member]" } } }, "localname": "ScenarioPreviouslyReportedMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited" ], "xbrltype": "domainItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [ "r93", "r100", "r261" ], "lang": { "en-us": { "role": { "label": "Scenario [Domain]" } } }, "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureMergerAndRecapitalizationAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureMergerAndRecapitalizationSummaryOfEarnoutSharesDetails" ], "xbrltype": "domainItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r93", "r100", "r178", "r261", "r406" ], "lang": { "en-us": { "role": { "label": "Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureMergerAndRecapitalizationAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureMergerAndRecapitalizationSummaryOfEarnoutSharesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountingStandardsUpdate201602Member": { "auth_ref": [ "r389" ], "lang": { "en-us": { "role": { "documentation": "Accounting Standards Update 2016-02 Leases (Topic 842).", "label": "Accounting Standards Update 2016-02 [Member]" } } }, "localname": "AccountingStandardsUpdate201602Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.", "label": "Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]", "terseLabel": "Accrued Expenses" } } }, "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureAccruedExpenses" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r37", "r403" ], "calculation": { "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1": { "order": 0.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Current", "terseLabel": "Accounts payable", "totalLabel": "Accounts Payable, Current, Total" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r39" ], "calculation": { "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Liabilities, Current", "terseLabel": "Accrued expenses", "totalLabel": "Total accrued expenses" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails", "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedProfessionalFeesCurrent": { "auth_ref": [ "r13", "r14", "r39" ], "calculation": { "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails": { "order": 3.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Professional Fees, Current", "terseLabel": "Professional fees" } } }, "localname": "AccruedProfessionalFeesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r35", "r169" ], "calculation": { "http://renovacor.com/20220331/taxonomy/role/DisclosurePropertyAndEquipmentScheduleOfPropertyAndEquipmentNetDetails": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedLabel": "Less: accumulated amortization", "periodEndLabel": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Ending Balance", "periodStartLabel": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Beginning Balance", "totalLabel": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Total" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosurePropertyAndEquipmentScheduleOfPropertyAndEquipmentNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "auth_ref": [ "r27" ], "calculation": { "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.", "label": "Additional Paid in Capital, Common Stock", "periodEndLabel": "Additional Paid in Capital, Common Stock, Ending Balance", "periodStartLabel": "Additional Paid in Capital, Common Stock, Beginning Balance", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapitalCommonStock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r81", "r82", "r83", "r303", "r304", "r305", "r355" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-in Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": { "auth_ref": [ "r0", "r1", "r2", "r3", "r4", "r85", "r86", "r87", "r88", "r100", "r148", "r149", "r155", "r156", "r157", "r158", "r160", "r161", "r181", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r306", "r325", "r326", "r327", "r328", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r369", "r370", "r372", "r373", "r374", "r375", "r376", "r377", "r392", "r420", "r421", "r422", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r500", "r501", "r502", "r503", "r504" ], "lang": { "en-us": { "role": { "documentation": "Information by amendment to accounting standards.", "label": "Accounting Standards Update [Axis]" } } }, "localname": "AdjustmentsForNewAccountingPronouncementsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r264", "r266", "r309", "r310" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition", "terseLabel": "Stock-based compensation", "totalLabel": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition, Total" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net income (loss) to net cash used in operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_AdministrativeFeesExpense": { "auth_ref": [ "r397" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for administrative services provided to the limited liability company (LLC) or limited partnership (LP) by the managing member or general partner, affiliate of managing member or general partner, or affiliate of LLC or LP, for example, but not limited to, salaries, rent, or overhead costs.", "label": "Administrative Fees Expense", "terseLabel": "Annual administrative fee" } } }, "localname": "AdministrativeFeesExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureLicenseAndSponsoredResearchAgreementsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r266", "r296", "r308" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Share-based Payment Arrangement, Expense", "terseLabel": "Total stock-based compensation expense", "verboseLabel": "Stock-based compensation expense" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfStockBasedCompensationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r120" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Anti-dilutive Securities" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureNetIncomeLossPerShareScheduleOfPotentiallyAntidilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r120" ], "lang": { "en-us": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities [Axis]", "terseLabel": "Antidilutive Securities" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureNetIncomeLossPerShareScheduleOfPotentiallyAntidilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetail" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "terseLabel": "Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureNetIncomeLossPerShareScheduleOfPotentiallyAntidilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetail" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r120" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.", "label": "Antidilutive Securities, Name [Domain]", "terseLabel": "Antidilutive Securities, Name" } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureNetIncomeLossPerShareScheduleOfPotentiallyAntidilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetail" ], "xbrltype": "domainItemType" }, "us-gaap_AreaOfRealEstateProperty": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area of a real estate property.", "label": "Area of Real Estate Property" } } }, "localname": "AreaOfRealEstateProperty", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" ], "xbrltype": "areaItemType" }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]" } } }, "localname": "ArrangementsAndNonarrangementTransactionsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureMergerAndRecapitalizationSummaryOfNumberOfSharesCommonStockIssuedImmediatelyFollowingConsummationOfMergerParentheticalDetail", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureMergerAndRecapitalizationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r76", "r139", "r141", "r145", "r151", "r182", "r183", "r184", "r186", "r187", "r188", "r189", "r190", "r191", "r193", "r194", "r337", "r341", "r368", "r401", "r403", "r436", "r448" ], "calculation": { "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r10", "r12", "r46", "r76", "r151", "r182", "r183", "r184", "r186", "r187", "r188", "r189", "r190", "r191", "r193", "r194", "r337", "r341", "r368", "r401", "r403" ], "calculation": { "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1": { "order": 0.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsFairValueDisclosure": { "auth_ref": [ "r358" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Fair Value Disclosure", "terseLabel": "Asset fair value" } } }, "localname": "AssetsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsFairValueDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Fair Value Disclosure [Abstract]", "terseLabel": "Assets" } } }, "localname": "AssetsFairValueDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r267", "r298" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]", "terseLabel": "Award Type" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureStockbasedCompensationScheduleOfAssumptionsUsedInDeterminingTheFairValueOfOptionAwardsDetails", "http://renovacor.com/20220331/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitActivityDetails", "http://renovacor.com/20220331/taxonomy/role/DisclosureStockholdersEquityScheduleOfCommonStockSharesReservedForFutureIssuanceDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureMergerAndRecapitalizationAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Accounting, Policy [Policy Text Block]", "terseLabel": "Basis of Presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r259", "r262" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition, Acquiree [Domain]", "terseLabel": "Business Acquisition, Acquiree" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureMergerAndRecapitalizationSummaryOfElementsOfNetProceedsFromMergerDetails", "http://renovacor.com/20220331/taxonomy/role/DisclosureMergerAndRecapitalizationSummaryOfNumberOfSharesCommonStockIssuedImmediatelyFollowingConsummationOfMergerDetails", "http://renovacor.com/20220331/taxonomy/role/DisclosureMergerAndRecapitalizationSummaryOfNumberOfSharesCommonStockIssuedImmediatelyFollowingConsummationOfMergerParentheticalDetail", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureMergerAndRecapitalizationAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureMergerAndRecapitalizationSummaryOfEarnoutSharesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r259", "r262", "r332", "r333" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]", "terseLabel": "Business Acquisition" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureMergerAndRecapitalizationSummaryOfElementsOfNetProceedsFromMergerDetails", "http://renovacor.com/20220331/taxonomy/role/DisclosureMergerAndRecapitalizationSummaryOfNumberOfSharesCommonStockIssuedImmediatelyFollowingConsummationOfMergerDetails", "http://renovacor.com/20220331/taxonomy/role/DisclosureMergerAndRecapitalizationSummaryOfNumberOfSharesCommonStockIssuedImmediatelyFollowingConsummationOfMergerParentheticalDetail", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureMergerAndRecapitalizationAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureMergerAndRecapitalizationSummaryOfEarnoutSharesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": { "auth_ref": [ "r334" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of equity interests issued or issuable to acquire entity.", "label": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares", "terseLabel": "Shares issued" } } }, "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureMergerAndRecapitalizationAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_BusinessAcquisitionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Business Acquisition [Line Items]", "terseLabel": "Business Acquisition [Line Items]" } } }, "localname": "BusinessAcquisitionLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureMergerAndRecapitalizationSummaryOfElementsOfNetProceedsFromMergerDetails", "http://renovacor.com/20220331/taxonomy/role/DisclosureMergerAndRecapitalizationSummaryOfNumberOfSharesCommonStockIssuedImmediatelyFollowingConsummationOfMergerDetails", "http://renovacor.com/20220331/taxonomy/role/DisclosureMergerAndRecapitalizationSummaryOfNumberOfSharesCommonStockIssuedImmediatelyFollowingConsummationOfMergerParentheticalDetail", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureMergerAndRecapitalizationAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combinations [Abstract]" } } }, "localname": "BusinessCombinationsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": { "auth_ref": [ "r6", "r80", "r138" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Business Description and Basis of Presentation [Text Block]", "terseLabel": "Business and Organization" } } }, "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureBusinessAndOrganization" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r7", "r32", "r69" ], "calculation": { "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "periodEndLabel": "Cash and Cash Equivalents, at Carrying Value, Ending Balance", "periodStartLabel": "Cash and Cash Equivalents, at Carrying Value, Beginning Balance", "terseLabel": "Cash and cash equivalents", "totalLabel": "Cash and Cash Equivalents, at Carrying Value, Total" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureBusinessAndOrganizationAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r17", "r70" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r64", "r69", "r71" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "periodEndLabel": "Cash and cash equivalents at end of period", "periodStartLabel": "Cash and cash equivalents at beginning of period", "totalLabel": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Total" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "auth_ref": [ "r64", "r378" ], "calculation": { "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect", "totalLabel": "Net decrease in cash and cash equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]", "terseLabel": "SUPPLEMENTAL DISCLOSURES OF NONCASH ACTIVITIES:" } } }, "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted": { "auth_ref": [ "r0", "r1", "r81", "r82", "r84", "r148", "r149", "r152", "r153", "r154", "r155", "r156", "r181", "r299", "r300", "r301", "r325", "r346", "r347", "r348", "r369", "r371", "r372", "r373", "r376", "r377", "r390", "r392", "r420", "r421", "r458", "r459", "r500" ], "lang": { "en-us": { "role": { "documentation": "Indicates (true false) whether accounting standards update was adopted.", "label": "Change in Accounting Principle, Accounting Standards Update, Adopted [true false]", "terseLabel": "Accounting standards update, adopted [true false]" } } }, "localname": "ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "booleanItemType" }, "us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate": { "auth_ref": [ "r0", "r1", "r81", "r82", "r92", "r148", "r149", "r152", "r153", "r154", "r155", "r156", "r181", "r299", "r300", "r301", "r325", "r346", "r347", "r348", "r349", "r352", "r369", "r371", "r372", "r373", "r376", "r377", "r390", "r392", "r420", "r421", "r458", "r459", "r500" ], "lang": { "en-us": { "role": { "documentation": "Date accounting standards update was adopted, in YYYY-MM-DD format.", "label": "Change in Accounting Principle, Accounting Standards Update, Adoption Date", "terseLabel": "Accounting standards update, adoption date" } } }, "localname": "ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "dateItemType" }, "us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect": { "auth_ref": [ "r85", "r99", "r150", "r159", "r306", "r329" ], "lang": { "en-us": { "role": { "documentation": "Indicates (true false) whether effect from applying amendment to accounting standards is immaterial.", "label": "Change in Accounting Principle, Accounting Standards Update, Immaterial Effect [true false]", "terseLabel": "Accounting standards update, immaterial effect" } } }, "localname": "ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "booleanItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r73", "r76", "r104", "r105", "r110", "r115", "r119", "r127", "r128", "r129", "r151", "r182", "r187", "r188", "r189", "r193", "r194", "r223", "r224", "r228", "r232", "r368", "r497" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]", "terseLabel": "Class of Stock" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureMergerAndRecapitalizationAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureRelatedPartiesAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockholderSEquityAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DocumentDocumentAndEntityInformation", "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical", "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Stock [Line Items]", "terseLabel": "Class Of Stock [Line Items]" } } }, "localname": "ClassOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureStockholdersEquityScheduleOfCommonStockSharesReservedForFutureIssuanceDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockholderSEquityAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightAxis": { "auth_ref": [ "r247", "r265" ], "lang": { "en-us": { "role": { "documentation": "Information by type of warrant or right issued.", "label": "Class of Warrant or Right [Axis]" } } }, "localname": "ClassOfWarrantOrRightAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureStockholdersEquitySummaryOfOutstandingWarrantsToPurchaseSharesOfCommonStockDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockholderSEquityAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months.", "label": "Class of Warrant or Right [Domain]" } } }, "localname": "ClassOfWarrantOrRightDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureStockholdersEquitySummaryOfOutstandingWarrantsToPurchaseSharesOfCommonStockDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockholderSEquityAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r240" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Weighted-Average Exercise Price", "terseLabel": "Exercise price", "verboseLabel": "Warrants exercise price (in Dollars per share)" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureStockholdersEquitySummaryOfOutstandingWarrantsToPurchaseSharesOfCommonStockDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureMergerAndRecapitalizationAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureRelatedPartiesAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockholderSEquityAdditionalInformationDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Warrant Or Right [Line Items]" } } }, "localname": "ClassOfWarrantOrRightLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureStockholdersEquitySummaryOfOutstandingWarrantsToPurchaseSharesOfCommonStockDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": { "auth_ref": [ "r240" ], "lang": { "en-us": { "role": { "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.", "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights", "terseLabel": "Pre - funded warrants to purchase common stock" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureRelatedPartiesAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants or rights outstanding.", "label": "Class of Warrant or Right, Outstanding", "terseLabel": "Number of warrants outstanding" } } }, "localname": "ClassOfWarrantOrRightOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockholderSEquityAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of reason for issuing warrant or right.", "label": "Warrant or Right, Reason for Issuance, Description", "terseLabel": "Warrant or Right, Reason for Issuance, Description" } } }, "localname": "ClassOfWarrantOrRightReasonForIssuingToNonemployees", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockholderSEquityAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightTable": { "auth_ref": [ "r247", "r265" ], "lang": { "en-us": { "role": { "documentation": "Disclosure for warrants or rights issued, which includes the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.", "label": "Class of Warrant or Right [Table]" } } }, "localname": "ClassOfWarrantOrRightTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureStockholdersEquitySummaryOfOutstandingWarrantsToPurchaseSharesOfCommonStockDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r42", "r177", "r440", "r452" ], "calculation": { "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "terseLabel": "Commitments and contingencies (Note 8)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r174", "r175", "r176", "r179", "r485" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureCommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": { "auth_ref": [ "r44" ], "lang": { "en-us": { "role": { "documentation": "Aggregate number of common shares reserved for future issuance.", "label": "Common Stock, Capital Shares Reserved for Future Issuance", "terseLabel": "Shares available for issuance", "totalLabel": "Total", "verboseLabel": "Common stock, capital shares reserved for future issuance" } } }, "localname": "CommonStockCapitalSharesReservedForFutureIssuance", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureStockholdersEquityScheduleOfCommonStockSharesReservedForFutureIssuanceDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockConvertibleConversionPriceIncrease": { "auth_ref": [ "r240" ], "lang": { "en-us": { "role": { "documentation": "Per share increase in conversion price of convertible common stock. Excludes change due to standard antidilution provision.", "label": "Common Stock, Convertible, Conversion Price, Increase", "terseLabel": "Common stock exceeds price per share" } } }, "localname": "CommonStockConvertibleConversionPriceIncrease", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockholderSEquityAdditionalInformationDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r81", "r82", "r355" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock", "verboseLabel": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureLicenseAndSponsoredResearchAgreementsAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureMergerAndRecapitalizationAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DocumentDocumentAndEntityInformation", "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r26" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureMergerAndRecapitalizationAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockholderSEquityAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r26" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockholderSEquityAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r26" ], "calculation": { "http://renovacor.com/20220331/taxonomy/role/DisclosureMergerAndRecapitalizationSummaryOfNumberOfSharesCommonStockIssuedImmediatelyFollowingConsummationOfMergerDetails2": { "order": 1.0, "parentTag": "rcor_SharesOfCommonStockImmediatelyAfterMerger", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, shares issued", "totalLabel": "Common Stock, Shares, Issued, Total", "verboseLabel": "Shares issued - common stock" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureMergerAndRecapitalizationSummaryOfNumberOfSharesCommonStockIssuedImmediatelyFollowingConsummationOfMergerDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockholderSEquityAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r26", "r239" ], "calculation": { "http://renovacor.com/20220331/taxonomy/role/DisclosureMergerAndRecapitalizationSummaryOfNumberOfSharesCommonStockIssuedImmediatelyFollowingConsummationOfMergerDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://renovacor.com/20220331/taxonomy/role/DisclosureMergerAndRecapitalizationSummaryOfNumberOfSharesCommonStockIssuedImmediatelyFollowingConsummationOfMergerDetails2": { "order": 0.0, "parentTag": "rcor_SharesOfCommonStockImmediatelyAfterMerger", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "periodEndLabel": "Common Stock, Shares, Outstanding, Ending Balance", "periodStartLabel": "Common Stock, Shares, Outstanding, Beginning Balance", "terseLabel": "Common stock, shares outstanding", "totalLabel": "Common stock, outstanding", "verboseLabel": "Common stock, outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureMergerAndRecapitalizationSummaryOfNumberOfSharesCommonStockIssuedImmediatelyFollowingConsummationOfMergerDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureRelatedPartiesAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockholderSEquityAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r26", "r403" ], "calculation": { "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "periodEndLabel": "Common Stock, Value, Issued, Ending Balance", "periodStartLabel": "Common Stock, Value, Issued, Beginning Balance", "terseLabel": "Common stock, $0.0001 par value per share; 100,000,000 shares authorized; 16,756,042 shares issued and outstanding at March 31, 2022 and December 31, 2021", "totalLabel": "Common Stock, Value, Issued, Total" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1" ], "xbrltype": "monetaryItemType" }, "us-gaap_CompensationRelatedCostsPolicyTextBlock": { "auth_ref": [ "r271" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.", "label": "Compensation Related Costs, Policy [Policy Text Block]", "terseLabel": "Stock-Based Compensation" } } }, "localname": "CompensationRelatedCostsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskCreditRisk": { "auth_ref": [ "r132", "r446" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for credit risk.", "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]", "terseLabel": "Concentration of Credit Risk" } } }, "localname": "ConcentrationRiskCreditRisk", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConvertiblePreferredStockMember": { "auth_ref": [ "r223", "r224", "r228" ], "lang": { "en-us": { "role": { "documentation": "Preferred stock that may be exchanged into common shares or other types of securities at the owner's option.", "label": "Convertible Preferred Stock [Member]", "terseLabel": "Convertible Preferred Stock [Member]" } } }, "localname": "ConvertiblePreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_CurrentIncomeTaxExpenseBenefit": { "auth_ref": [ "r77", "r323", "r330", "r331" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.", "label": "Current Income Tax Expense (Benefit)", "terseLabel": "Tax expense or benefit due to expected current year loss and its historical losses", "totalLabel": "Current Income Tax Expense (Benefit), Total" } } }, "localname": "CurrentIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r20", "r21", "r22", "r75", "r79", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r208", "r209", "r210", "r211", "r213", "r214", "r215", "r216", "r387", "r437", "r438", "r447" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureRelatedPartiesAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentConvertibleConversionPrice1": { "auth_ref": [ "r197", "r212" ], "lang": { "en-us": { "role": { "documentation": "The price per share of the conversion feature embedded in the debt instrument.", "label": "Debt Instrument, Convertible, Conversion Price", "terseLabel": "Conversion price per share" } } }, "localname": "DebtInstrumentConvertibleConversionPrice1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureRelatedPartiesAdditionalInformationDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.", "label": "Debt Instrument, Convertible, Threshold Consecutive Trading Days", "terseLabel": "Number of consecutive trading days" } } }, "localname": "DebtInstrumentConvertibleThresholdConsecutiveTradingDays1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureMergerAndRecapitalizationAdditionalInformationDetails" ], "xbrltype": "integerItemType" }, "us-gaap_DebtInstrumentConvertibleThresholdTradingDays": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.", "label": "Debt Instrument, Convertible, Threshold Trading Days", "terseLabel": "Number of trading days" } } }, "localname": "DebtInstrumentConvertibleThresholdTradingDays", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureMergerAndRecapitalizationAdditionalInformationDetails" ], "xbrltype": "integerItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r195", "r213", "r214", "r386", "r387", "r388" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount", "terseLabel": "Principal amount", "verboseLabel": "Issued amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureRelatedPartiesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r41", "r75", "r79", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r208", "r209", "r210", "r211", "r213", "r214", "r215", "r216", "r387" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument, Name [Domain]" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureRelatedPartiesAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtPolicyTextBlock": { "auth_ref": [ "r180" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy related to debt. Includes, but is not limited to, debt issuance costs, the effects of refinancings, method of amortizing debt issuance costs and original issue discount, and classifications of debt.", "label": "Debt, Policy [Policy Text Block]", "terseLabel": "Convertible Note" } } }, "localname": "DebtPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]" } } }, "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock": { "auth_ref": [ "r36" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs.", "label": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]", "terseLabel": "Summary of Prepaid Expenses and Other Current Assets" } } }, "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DeferredTaxAssetsLiabilitiesNet": { "auth_ref": [ "r321" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.", "label": "Deferred Tax Assets, Net", "terseLabel": "Net deferred tax asset", "totalLabel": "Deferred Tax Assets, Net, Total" } } }, "localname": "DeferredTaxAssetsLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r67", "r167" ], "calculation": { "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation", "terseLabel": "Depreciation expense", "totalLabel": "Depreciation, Total" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeFairValueHedgeIncludedInEffectivenessGainLoss": { "auth_ref": [ "r345" ], "calculation": { "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsUnaudited": { "order": 3.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on derivative instrument designated and qualifying as fair value hedge included in assessment of hedge effectiveness, recognized in earnings.", "label": "Derivative, Fair Value Hedge, Included in Effectiveness, Gain (Loss)", "negatedLabel": "Gain on change in fair value of derivative liability", "terseLabel": "Change in fair value of derivative liability" } } }, "localname": "DerivativeFairValueHedgeIncludedInEffectivenessGainLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilitiesNoncurrent": { "auth_ref": [ "r47" ], "calculation": { "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability, Noncurrent", "terseLabel": "Warrant liability" } } }, "localname": "DerivativeLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilityMeasurementInput": { "auth_ref": [ "r363" ], "lang": { "en-us": { "role": { "documentation": "Value of input used to measure derivative liability.", "label": "Derivative Liability, Measurement Input", "terseLabel": "Derivative Liability, Measurement Input" } } }, "localname": "DerivativeLiabilityMeasurementInput", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssumptionsUsedInDeterminingFairValueOfEarnoutSharesDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssumptionsUsedInDeterminingFairValueOfPrivatePlacementWarrantsDetails" ], "xbrltype": "decimalItemType" }, "us-gaap_DerivativeTermOfContract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period the derivative contract is outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Derivative, Term of Contract", "terseLabel": "Derivative, Term of Contract" } } }, "localname": "DerivativeTermOfContract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssumptionsUsedInDeterminingFairValueOfEarnoutSharesDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssumptionsUsedInDeterminingFairValueOfPrivatePlacementWarrantsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r311" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "Share-based Payment Arrangement [Text Block]", "terseLabel": "Stock-based Compensation" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensation" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Payment Arrangement [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_DueToRelatedPartiesCurrent": { "auth_ref": [ "r37", "r78", "r185", "r187", "r188", "r192", "r193", "r194", "r396" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).", "label": "Due to Related Parties, Current", "terseLabel": "Due to related party", "totalLabel": "Due to Related Parties, Current, Total" } } }, "localname": "DueToRelatedPartiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureRelatedPartiesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]", "terseLabel": "Net income (loss) per share" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r55", "r89", "r90", "r92", "r93", "r94", "r101", "r104", "r115", "r118", "r119", "r123", "r124", "r356", "r357", "r442", "r454" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Basic", "totalLabel": "Earnings Per Share, Basic, Total", "verboseLabel": "Basic net income (loss) per common share" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureNetIncomeLossPerShareNetIncomeLossAttributableToCommonStockholdersOfBasicAndDilutedDetails3", "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r55", "r89", "r90", "r92", "r93", "r94", "r104", "r115", "r118", "r119", "r123", "r124", "r356", "r357", "r442", "r454" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Diluted", "totalLabel": "Diluted", "verboseLabel": "Diluted net income (loss) per common share" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureNetIncomeLossPerShareNetIncomeLossAttributableToCommonStockholdersOfBasicAndDilutedDetails3", "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r120", "r121" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings Per Share, Policy [Policy Text Block]", "terseLabel": "Net Income (Loss) per Common Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r120", "r121", "r122", "r125" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "terseLabel": "Net Income (Loss) Per Share" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureNetIncomeLossPerShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "auth_ref": [ "r39" ], "calculation": { "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails": { "order": 0.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Employee-related Liabilities, Current", "terseLabel": "Employee compensation and benefits", "totalLabel": "Employee-related Liabilities, Current, Total" } } }, "localname": "EmployeeRelatedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]" } } }, "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfStockBasedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "auth_ref": [ "r297" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.", "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount", "terseLabel": "Unrecognized stock-based expense", "totalLabel": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "auth_ref": [ "r297" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition", "terseLabel": "Unrecognized compensation cost, weighted average expected to be recognized period" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [ "r294" ], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.", "label": "Share-based Payment Arrangement, Option [Member]", "terseLabel": "Stock Options Outstanding [Member]", "verboseLabel": "Stock Options [Member]" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureStockbasedCompensationScheduleOfAssumptionsUsedInDeterminingTheFairValueOfOptionAwardsDetails", "http://renovacor.com/20220331/taxonomy/role/DisclosureStockholdersEquityScheduleOfCommonStockSharesReservedForFutureIssuanceDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EmployeeTrustAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Employee Trust [Abstract]" } } }, "localname": "EmployeeTrustAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r2", "r51", "r52", "r53", "r81", "r82", "r83", "r86", "r95", "r98", "r126", "r158", "r239", "r246", "r303", "r304", "r305", "r327", "r328", "r355", "r379", "r380", "r381", "r382", "r383", "r384", "r460", "r461", "r462", "r504" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureStockholdersEquityScheduleOfCommonStockSharesReservedForFutureIssuanceDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureLicenseAndSponsoredResearchAgreementsAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAdjustmentOfWarrants": { "auth_ref": [ "r67", "r217" ], "calculation": { "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsUnaudited": { "order": 4.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability.", "label": "Fair Value Adjustment of Warrants", "negatedLabel": "Change in fair value of warrant liability", "terseLabel": "Gain on change in fair value of warrant liability" } } }, "localname": "FairValueAdjustmentOfWarrants", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "terseLabel": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssumptionsUsedInDeterminingFairValueOfEarnoutSharesDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssumptionsUsedInDeterminingFairValueOfPrivatePlacementWarrantsDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfWarrantAndEarnoutShareLiabilityMeasuredOnRecurringBasisUsingUnobservableInputDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r358", "r359", "r360", "r366" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value, Recurring and Nonrecurring [Table]", "terseLabel": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssumptionsUsedInDeterminingFairValueOfEarnoutSharesDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssumptionsUsedInDeterminingFairValueOfPrivatePlacementWarrantsDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfWarrantAndEarnoutShareLiabilityMeasuredOnRecurringBasisUsingUnobservableInputDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": { "auth_ref": [ "r364" ], "lang": { "en-us": { "role": { "documentation": "Class of asset.", "label": "Asset Class [Domain]" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueByAssetClassAxis": { "auth_ref": [ "r358", "r366" ], "lang": { "en-us": { "role": { "documentation": "Information by class of asset.", "label": "Asset Class [Axis]" } } }, "localname": "FairValueByAssetClassAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r204", "r213", "r214", "r250", "r251", "r252", "r253", "r254", "r255", "r256", "r258", "r359", "r408", "r409", "r410" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]", "terseLabel": "Fair Value Hierarchy and NAV" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfWarrantAndEarnoutShareLiabilityMeasuredOnRecurringBasisUsingUnobservableInputDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByLiabilityClassAxis": { "auth_ref": [ "r365", "r366" ], "lang": { "en-us": { "role": { "documentation": "Information by class of liability.", "label": "Liability Class [Axis]", "terseLabel": "Liability Class" } } }, "localname": "FairValueByLiabilityClassAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssumptionsUsedInDeterminingFairValueOfEarnoutSharesDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssumptionsUsedInDeterminingFairValueOfPrivatePlacementWarrantsDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfWarrantAndEarnoutShareLiabilityMeasuredOnRecurringBasisUsingUnobservableInputDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsTables" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "auth_ref": [ "r358", "r359", "r362", "r363", "r367" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement frequency.", "label": "Measurement Frequency [Axis]", "terseLabel": "Measurement Frequency" } } }, "localname": "FairValueByMeasurementFrequencyAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r365" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "terseLabel": "Fair Value Measurements" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurements" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r204", "r250", "r251", "r256", "r258", "r359", "r408" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]", "terseLabel": "Level 1 [Member]" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r204", "r213", "r214", "r250", "r251", "r256", "r258", "r359", "r409" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]", "terseLabel": "Level 2 [Member]" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r204", "r213", "r214", "r250", "r251", "r252", "r253", "r254", "r255", "r256", "r258", "r359", "r410" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]", "terseLabel": "Level 3 [Member]" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfWarrantAndEarnoutShareLiabilityMeasuredOnRecurringBasisUsingUnobservableInputDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock": { "auth_ref": [ "r358", "r359" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset.", "label": "Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]", "terseLabel": "Schedule of Liabilities Measured at Fair Value on Recurring Basis" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": { "auth_ref": [ "r364" ], "lang": { "en-us": { "role": { "documentation": "Represents classes of liabilities measured and disclosed at fair value.", "label": "Fair Value by Liability Class [Domain]", "terseLabel": "Fair Value by Liability Class" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssumptionsUsedInDeterminingFairValueOfEarnoutSharesDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssumptionsUsedInDeterminingFairValueOfPrivatePlacementWarrantsDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfWarrantAndEarnoutShareLiabilityMeasuredOnRecurringBasisUsingUnobservableInputDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsTables" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsTables" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": { "auth_ref": [ "r364", "r366" ], "lang": { "en-us": { "role": { "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of liabilities using significant unobservable inputs (level 3). Separately presenting changes during the period, attributable to: (1) total gains or losses for the period (realized and unrealized) and location reported in the statement of income (or activities); (2) purchases, sales, issuances, and settlements (net); (3) transfers in and/or out of Level 3.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsTables" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": { "auth_ref": [ "r364", "r366" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]", "terseLabel": "Schedule of Assumptions Used in Determining Fair Value of Private Placement Warrants and Earnout Shares" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementFrequencyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement frequency.", "label": "Measurement Frequency [Domain]", "terseLabel": "Measurement Frequency" } } }, "localname": "FairValueMeasurementFrequencyDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease": { "auth_ref": [ "r364" ], "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease)", "terseLabel": "Change in the fair value of liability", "totalLabel": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease), Total" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfWarrantAndEarnoutShareLiabilityMeasuredOnRecurringBasisUsingUnobservableInputDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": { "auth_ref": [ "r364" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value", "periodEndLabel": "Balance", "periodStartLabel": "Balance" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfWarrantAndEarnoutShareLiabilityMeasuredOnRecurringBasisUsingUnobservableInputDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r204", "r213", "r214", "r250", "r251", "r252", "r253", "r254", "r255", "r256", "r258", "r408", "r409", "r410" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]", "terseLabel": "Fair Value Hierarchy and NAV" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfWarrantAndEarnoutShareLiabilityMeasuredOnRecurringBasisUsingUnobservableInputDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsRecurringMember": { "auth_ref": [ "r365", "r367" ], "lang": { "en-us": { "role": { "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.", "label": "Fair Value, Recurring [Member]", "terseLabel": "Fair Value, Recurring" } } }, "localname": "FairValueMeasurementsRecurringMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r57" ], "calculation": { "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsUnaudited": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and Administrative Expense", "terseLabel": "General and administrative", "totalLabel": "General and Administrative Expense, Total" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpenseMember": { "auth_ref": [ "r56" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing general and administrative expense.", "label": "General and Administrative Expense [Member]", "terseLabel": "General and Administrative [Member]" } } }, "localname": "GeneralAndAdministrativeExpenseMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfStockBasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r165", "r166", "r403", "r435" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "periodEndLabel": "Goodwill, Ending Balance", "periodStartLabel": "Goodwill, Beginning Balance", "totalLabel": "Goodwill, Total" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureMergerAndRecapitalizationAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r171", "r173" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]", "terseLabel": "Income Statement Location" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfStockBasedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [ "r173" ], "lang": { "en-us": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]", "terseLabel": "Income Statement Location" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfStockBasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r50", "r316", "r317", "r319", "r320", "r322", "r324" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax, Policy [Policy Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r66" ], "calculation": { "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Increase (Decrease) in Accounts Payable", "terseLabel": "Accounts payable", "totalLabel": "Increase (Decrease) in Accounts Payable, Total" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "auth_ref": [ "r66" ], "calculation": { "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.", "label": "Increase (Decrease) in Accrued Liabilities", "terseLabel": "Accrued expenses", "totalLabel": "Increase (Decrease) in Accrued Liabilities, Total" } } }, "localname": "IncreaseDecreaseInAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Change in assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": { "auth_ref": [ "r66" ], "calculation": { "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in noncurrent assets classified as other.", "label": "Increase (Decrease) in Other Noncurrent Assets", "negatedLabel": "Other assets" } } }, "localname": "IncreaseDecreaseInOtherNoncurrentAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidExpense": { "auth_ref": [ "r66" ], "calculation": { "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.", "label": "Increase (Decrease) in Prepaid Expense", "negatedLabel": "Prepaid expense" } } }, "localname": "IncreaseDecreaseInPrepaidExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsNetIncludingGoodwill": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount of finite-lived intangible assets, indefinite-lived intangible assets and goodwill. Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Intangible assets are assets, not including financial assets, lacking physical substance.", "label": "Intangible Assets, Net (Including Goodwill)", "terseLabel": "Other intangible assets", "totalLabel": "Intangible Assets, Net (Including Goodwill), Total" } } }, "localname": "IntangibleAssetsNetIncludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureMergerAndRecapitalizationAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestIncomeExpenseNet": { "auth_ref": [ "r443" ], "calculation": { "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsUnaudited": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net amount of operating interest income (expense).", "label": "Interest Income (Expense), Net", "terseLabel": "Interest income", "totalLabel": "Interest Income (Expense), Net, Total" } } }, "localname": "InterestIncomeExpenseNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentTypeAxis": { "auth_ref": [ "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r483", "r484" ], "lang": { "en-us": { "role": { "documentation": "Information by type of investments.", "label": "Investment Type [Axis]", "terseLabel": "Investment Type" } } }, "localname": "InvestmentTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureMergerAndRecapitalizationSummaryOfElementsOfNetProceedsFromMergerDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentTypeCategorizationMember": { "auth_ref": [ "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r483", "r484" ], "lang": { "en-us": { "role": { "documentation": "Asset obtained to generate income or appreciate in value.", "label": "Investments [Domain]", "terseLabel": "Investments" } } }, "localname": "InvestmentTypeCategorizationMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureMergerAndRecapitalizationSummaryOfElementsOfNetProceedsFromMergerDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LesseeOperatingSubleaseExistenceOfOptionToExtend": { "auth_ref": [ "r391" ], "lang": { "en-us": { "role": { "documentation": "Indicates (true false) whether sublessee has option to extend operating sublease.", "label": "Lessee, Operating Sublease, Existence of Option to Extend [true false]" } } }, "localname": "LesseeOperatingSubleaseExistenceOfOptionToExtend", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" ], "xbrltype": "booleanItemType" }, "us-gaap_LesseeOperatingSubleaseOptionToExtend": { "auth_ref": [ "r391" ], "lang": { "en-us": { "role": { "documentation": "Description of terms and conditions of option to extend operating sublease.", "label": "Lessee, Operating Sublease, Option to Extend" } } }, "localname": "LesseeOperatingSubleaseOptionToExtend", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r38", "r76", "r142", "r151", "r182", "r183", "r184", "r187", "r188", "r189", "r190", "r191", "r193", "r194", "r338", "r341", "r342", "r368", "r401", "r402" ], "calculation": { "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1": { "order": 0.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r31", "r76", "r151", "r368", "r403", "r439", "r450" ], "calculation": { "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and stockholders\u2019 equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY (DEFICIT)" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r40", "r76", "r151", "r182", "r183", "r184", "r187", "r188", "r189", "r190", "r191", "r193", "r194", "r338", "r341", "r342", "r368", "r401", "r402", "r403" ], "calculation": { "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1": { "order": 0.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesFairValueDisclosure": { "auth_ref": [ "r358" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial and nonfinancial obligations.", "label": "Financial and Nonfinancial Liabilities, Fair Value Disclosure", "terseLabel": "Liabilities fair value" } } }, "localname": "LiabilitiesFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesFairValueDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Fair Value Disclosure [Abstract]", "terseLabel": "Liabilities" } } }, "localname": "LiabilitiesFairValueDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_MeasurementInputExercisePriceMember": { "auth_ref": [ "r361" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using agreed upon price for exchange of underlying asset.", "label": "Measurement Input, Exercise Price [Member]", "terseLabel": "Strike Price [Member]" } } }, "localname": "MeasurementInputExercisePriceMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssumptionsUsedInDeterminingFairValueOfPrivatePlacementWarrantsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputExpectedDividendRateMember": { "auth_ref": [ "r361" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using expected dividend rate to be paid to holder of share per year.", "label": "Measurement Input, Expected Dividend Rate [Member]", "terseLabel": "Expected Dividend Yield [Member]" } } }, "localname": "MeasurementInputExpectedDividendRateMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssumptionsUsedInDeterminingFairValueOfEarnoutSharesDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssumptionsUsedInDeterminingFairValueOfPrivatePlacementWarrantsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputExpectedTermMember": { "auth_ref": [ "r361" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date.", "label": "Measurement Input, Expected Term [Member]", "terseLabel": "Expected Life (Years) [Member]" } } }, "localname": "MeasurementInputExpectedTermMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssumptionsUsedInDeterminingFairValueOfEarnoutSharesDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssumptionsUsedInDeterminingFairValueOfPrivatePlacementWarrantsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputPriceVolatilityMember": { "auth_ref": [ "r361" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns.", "label": "Measurement Input, Price Volatility [Member]", "terseLabel": "Expected Volatility [Member]" } } }, "localname": "MeasurementInputPriceVolatilityMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssumptionsUsedInDeterminingFairValueOfEarnoutSharesDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssumptionsUsedInDeterminingFairValueOfPrivatePlacementWarrantsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputRiskFreeInterestRateMember": { "auth_ref": [ "r361" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss.", "label": "Measurement Input, Risk Free Interest Rate [Member]", "terseLabel": "Risk-Free Interest Rate [Member]" } } }, "localname": "MeasurementInputRiskFreeInterestRateMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssumptionsUsedInDeterminingFairValueOfEarnoutSharesDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssumptionsUsedInDeterminingFairValueOfPrivatePlacementWarrantsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputSharePriceMember": { "auth_ref": [ "r361" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using share price of saleable stock.", "label": "Measurement Input, Share Price [Member]", "terseLabel": "Stock Price [Member]" } } }, "localname": "MeasurementInputSharePriceMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssumptionsUsedInDeterminingFairValueOfEarnoutSharesDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssumptionsUsedInDeterminingFairValueOfPrivatePlacementWarrantsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputTypeAxis": { "auth_ref": [ "r361" ], "lang": { "en-us": { "role": { "documentation": "Information by type of measurement input used to determine value of asset and liability.", "label": "Measurement Input Type [Axis]", "terseLabel": "Measurement Input Type" } } }, "localname": "MeasurementInputTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssumptionsUsedInDeterminingFairValueOfEarnoutSharesDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssumptionsUsedInDeterminingFairValueOfPrivatePlacementWarrantsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_MeasurementInputTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement input used to determine value of asset and liability.", "label": "Measurement Input Type [Domain]", "terseLabel": "Measurement Input Type" } } }, "localname": "MeasurementInputTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssumptionsUsedInDeterminingFairValueOfEarnoutSharesDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssumptionsUsedInDeterminingFairValueOfPrivatePlacementWarrantsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MoneyMarketFundsMember": { "auth_ref": [ "r250" ], "lang": { "en-us": { "role": { "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.", "label": "Money Market Funds [Member]" } } }, "localname": "MoneyMarketFundsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r64" ], "calculation": { "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash used in financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "CASH FLOWS FROM FINANCING ACTIVITIES:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r64" ], "calculation": { "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "CASH FLOWS FROM INVESTING ACTIVITIES:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r64", "r65", "r68" ], "calculation": { "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 0.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "CASH FLOWS FROM OPERATING ACTIVITIES:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r5", "r48", "r49", "r53", "r54", "r68", "r76", "r85", "r89", "r90", "r92", "r93", "r97", "r98", "r112", "r139", "r140", "r143", "r144", "r146", "r151", "r182", "r183", "r184", "r187", "r188", "r189", "r190", "r191", "r193", "r194", "r357", "r368", "r441", "r453" ], "calculation": { "http://renovacor.com/20220331/taxonomy/role/DisclosureNetIncomeLossPerShareNetIncomeLossAttributableToCommonStockholdersOfBasicAndDilutedDetails2": { "order": 0.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted", "weight": 1.0 }, "http://renovacor.com/20220331/taxonomy/role/DisclosureNetIncomeLossPerShareNetIncomeLossAttributableToCommonStockholdersOfBasicAndDilutedDetails3": { "order": 0.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0 }, "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsUnaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net income (loss)", "negatedLabel": "Net losses", "terseLabel": "Net loss", "totalLabel": "Net income (loss)", "verboseLabel": "Net income (loss)" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureNetIncomeLossPerShareNetIncomeLossAttributableToCommonStockholdersOfBasicAndDilutedDetails3", "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "auth_ref": [ "r89", "r90", "r92", "r93", "r101", "r102", "r114", "r119", "r139", "r140", "r143", "r144", "r146" ], "calculation": { "http://renovacor.com/20220331/taxonomy/role/DisclosureNetIncomeLossPerShareNetIncomeLossAttributableToCommonStockholdersOfBasicAndDilutedDetails3": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "totalLabel": "Net income (loss) attributable to common stockholders" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureNetIncomeLossPerShareNetIncomeLossAttributableToCommonStockholdersOfBasicAndDilutedDetails3" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Income (Loss) Available to Common Stockholders, Basic [Abstract]", "terseLabel": "Net income (loss) per share - Basic:" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasicAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureNetIncomeLossPerShareNetIncomeLossAttributableToCommonStockholdersOfBasicAndDilutedDetails3" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": { "auth_ref": [ "r103", "r106", "r107", "r108", "r109", "r114", "r119" ], "calculation": { "http://renovacor.com/20220331/taxonomy/role/DisclosureNetIncomeLossPerShareNetIncomeLossAttributableToCommonStockholdersOfBasicAndDilutedDetails2": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Diluted", "totalLabel": "Numerator for diluted net income (loss) per share" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureNetIncomeLossPerShareNetIncomeLossAttributableToCommonStockholdersOfBasicAndDilutedDetails3" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Income (Loss) Available to Common Stockholders, Diluted [Abstract]", "terseLabel": "Net income (loss) per share - Diluted:" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersDilutedAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureNetIncomeLossPerShareNetIncomeLossAttributableToCommonStockholdersOfBasicAndDilutedDetails3" ], "xbrltype": "stringItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "New Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Expenses [Abstract]", "terseLabel": "Operating expenses:" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r139", "r140", "r143", "r144", "r146" ], "calculation": { "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsUnaudited": { "order": 0.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "negatedLabel": "Loss from operations", "terseLabel": "Loss from operations", "totalLabel": "Loss from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "auth_ref": [ "r13", "r14", "r15", "r39" ], "calculation": { "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails": { "order": 4.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other Accrued Liabilities, Current", "terseLabel": "Other" } } }, "localname": "OtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r36" ], "calculation": { "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets, Noncurrent", "terseLabel": "Other", "totalLabel": "Other Assets, Noncurrent, Total" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherExpenses": { "auth_ref": [ "r58", "r455" ], "calculation": { "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsUnaudited": { "order": 5.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense classified as other.", "label": "Other Expenses", "negatedLabel": "Other expense", "terseLabel": "Other expense", "totalLabel": "Other Expenses, Total" } } }, "localname": "OtherExpenses", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherMachineryAndEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other tangible personal property, nonconsumable in nature, with finite lives used to produce goods and services.", "label": "Other Machinery and Equipment [Member]", "terseLabel": "Equipment and Other Long-lived Assets [Member]" } } }, "localname": "OtherMachineryAndEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherNonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Nonoperating Income (Expense) [Abstract]", "terseLabel": "Other income (expense):" } } }, "localname": "OtherNonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_OtherPrepaidExpenseCurrent": { "auth_ref": [ "r8", "r11", "r164" ], "calculation": { "http://renovacor.com/20220331/taxonomy/role/DisclosurePrepaidExpensesSummaryOfPrepaidExpensesDetails": { "order": 2.0, "parentTag": "us-gaap_PrepaidExpenseCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Other Prepaid Expense, Current", "terseLabel": "Other" } } }, "localname": "OtherPrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosurePrepaidExpensesSummaryOfPrepaidExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PayablesAndAccrualsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Payables and Accruals [Abstract]" } } }, "localname": "PayablesAndAccrualsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities": { "auth_ref": [ "r62" ], "calculation": { "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 0.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for financing costs associated with business combinations.", "label": "Payments of Merger Related Costs, Financing Activities", "negatedLabel": "Merger-related costs", "terseLabel": "Merger-related costs" } } }, "localname": "PaymentsOfMergerRelatedCostsFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r59" ], "calculation": { "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 0.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Acquisitions of property and equipment", "totalLabel": "Payments to Acquire Property, Plant, and Equipment, Total" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r267", "r298" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]", "terseLabel": "Plan Name" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureStockholdersEquityScheduleOfCommonStockSharesReservedForFutureIssuanceDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement.", "label": "Plan Name [Domain]", "terseLabel": "Plan Name" } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureStockholdersEquityScheduleOfCommonStockSharesReservedForFutureIssuanceDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r25", "r223" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred stock, par value" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureMergerAndRecapitalizationAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockholderSEquityAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r25" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred stock, shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockholderSEquityAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r25", "r223" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "terseLabel": "Preferred stock, shares issued", "totalLabel": "Preferred Stock, Shares Issued, Total" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r25" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "periodEndLabel": "Preferred Stock, Shares Outstanding, Ending Balance", "periodStartLabel": "Preferred Stock, Shares Outstanding, Beginning Balance", "terseLabel": "Preferred stock, shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r25", "r403" ], "calculation": { "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1": { "order": 0.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "periodEndLabel": "Preferred Stock, Value, Issued, Ending Balance", "periodStartLabel": "Preferred Stock, Value, Issued, Beginning Balance", "terseLabel": "Preferred stock, $0.0001 par value per share; 1,000,000 shares authorized; none issued or outstanding at March 31, 2022 and December 31, 2021", "totalLabel": "Preferred Stock, Value, Issued, Total" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockVotingRights": { "auth_ref": [ "r25", "r240" ], "lang": { "en-us": { "role": { "documentation": "Description of voting rights of nonredeemable preferred stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights.", "label": "Preferred Stock, Voting Rights", "terseLabel": "Number of voting rights" } } }, "localname": "PreferredStockVotingRights", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockholderSEquityAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Prepaid Expense and Other Assets, Current [Abstract]" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_PrepaidExpenseCurrent": { "auth_ref": [ "r8", "r11", "r163", "r164" ], "calculation": { "http://renovacor.com/20220331/taxonomy/role/DisclosurePrepaidExpensesSummaryOfPrepaidExpensesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1": { "order": 0.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid Expense, Current", "terseLabel": "Prepaid expenses", "totalLabel": "Total prepaid expense" } } }, "localname": "PrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosurePrepaidExpensesSummaryOfPrepaidExpensesDetails", "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidInsurance": { "auth_ref": [ "r9", "r11", "r162", "r164" ], "calculation": { "http://renovacor.com/20220331/taxonomy/role/DisclosurePrepaidExpensesSummaryOfPrepaidExpensesDetails": { "order": 1.0, "parentTag": "us-gaap_PrepaidExpenseCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid Insurance", "terseLabel": "Insurance" } } }, "localname": "PrepaidInsurance", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosurePrepaidExpensesSummaryOfPrepaidExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrivatePlacementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts.", "label": "Private Placement [Member]", "terseLabel": "Private Placement [Member]", "verboseLabel": "April 2020 Private Placement Warrants" } } }, "localname": "PrivatePlacementMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureRelatedPartiesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProceedsFromConvertibleDebt": { "auth_ref": [ "r61" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.", "label": "Proceeds from Convertible Debt", "terseLabel": "Proceeds from convertible debt", "verboseLabel": "Proceeds from issuance of convertible promissory note, net of issuance costs" } } }, "localname": "ProceedsFromConvertibleDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureRelatedPartiesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceInitialPublicOffering": { "auth_ref": [ "r60" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public.", "label": "Proceeds from Issuance Initial Public Offering", "terseLabel": "Proceeds from initial public offer" } } }, "localname": "ProceedsFromIssuanceInitialPublicOffering", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockholderSEquityAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfWarrants": { "auth_ref": [ "r60" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).", "label": "Proceeds from Issuance of Warrants", "terseLabel": "Purchase price of warrants" } } }, "localname": "ProceedsFromIssuanceOfWarrants", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureRelatedPartiesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r5", "r48", "r49", "r53", "r63", "r76", "r85", "r97", "r98", "r139", "r140", "r143", "r144", "r146", "r151", "r182", "r183", "r184", "r187", "r188", "r189", "r190", "r191", "r193", "r194", "r336", "r339", "r340", "r343", "r344", "r357", "r368", "r444" ], "calculation": { "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 0.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Net income (loss)", "totalLabel": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r35", "r170" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]", "terseLabel": "Long-Lived Tangible Asset" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "auth_ref": [ "r172", "r486", "r487", "r488" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment Disclosure [Text Block]", "terseLabel": "Property and Equipment" } } }, "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosurePropertyAndEquipment" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r34", "r168" ], "calculation": { "http://renovacor.com/20220331/taxonomy/role/DisclosurePropertyAndEquipmentScheduleOfPropertyAndEquipmentNetDetails": { "order": 0.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Gross", "periodEndLabel": "Property, Plant and Equipment, Gross, Ending Balance", "periodStartLabel": "Property, Plant and Equipment, Gross, Beginning Balance", "terseLabel": "Laboratory equipment", "totalLabel": "Property, Plant and Equipment, Gross, Total" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosurePropertyAndEquipmentScheduleOfPropertyAndEquipmentNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r18", "r19", "r170", "r403", "r445", "r451" ], "calculation": { "http://renovacor.com/20220331/taxonomy/role/DisclosurePropertyAndEquipmentScheduleOfPropertyAndEquipmentNetDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "periodEndLabel": "Property, Plant and Equipment, Net, Ending Balance", "periodStartLabel": "Property, Plant and Equipment, Net, Beginning Balance", "terseLabel": "Property and equipment, net", "totalLabel": "Property and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosurePropertyAndEquipmentScheduleOfPropertyAndEquipmentNetDetails", "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r33", "r170", "r486", "r487" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment, Policy [Policy Text Block]", "terseLabel": "Property and Equipment, net" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r18", "r170" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table Text Block]", "terseLabel": "Schedule of Property and Equipment, Net" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosurePropertyAndEquipmentTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r18", "r168" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Long-Lived Tangible Asset [Domain]", "terseLabel": "Long-Lived Tangible Asset" } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Property, Plant and Equipment, Useful Life", "terseLabel": "Useful life" } } }, "localname": "PropertyPlantAndEquipmentUsefulLife", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r257", "r395", "r396" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]", "terseLabel": "Related Party" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureMergerAndRecapitalizationSummaryOfElementsOfNetProceedsFromMergerDetails", "http://renovacor.com/20220331/taxonomy/role/DisclosureMergerAndRecapitalizationSummaryOfNumberOfSharesCommonStockIssuedImmediatelyFollowingConsummationOfMergerDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureMergerAndRecapitalizationAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureRelatedPartiesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionAxis": { "auth_ref": [ "r257", "r395", "r396", "r398" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party transaction.", "label": "Related Party Transaction [Axis]", "terseLabel": "Related Party Transaction" } } }, "localname": "RelatedPartyTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureMergerAndRecapitalizationSummaryOfEarnoutSharesDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureRelatedPartiesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionDomain": { "auth_ref": [ "r257" ], "lang": { "en-us": { "role": { "documentation": "Transaction between related party.", "label": "Related Party Transaction [Domain]", "terseLabel": "Related Party Transaction" } } }, "localname": "RelatedPartyTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureMergerAndRecapitalizationSummaryOfEarnoutSharesDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureRelatedPartiesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Related Party Transaction [Line Items]", "terseLabel": "Related Party Transaction [Line Items]" } } }, "localname": "RelatedPartyTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureRelatedPartiesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r257", "r395", "r398", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r434" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]", "terseLabel": "Related Party" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureMergerAndRecapitalizationSummaryOfElementsOfNetProceedsFromMergerDetails", "http://renovacor.com/20220331/taxonomy/role/DisclosureMergerAndRecapitalizationSummaryOfNumberOfSharesCommonStockIssuedImmediatelyFollowingConsummationOfMergerDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureMergerAndRecapitalizationAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureRelatedPartiesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r393", "r394", "r396", "r399", "r400" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]", "terseLabel": "Related Parties" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureRelatedParties" ], "xbrltype": "textBlockItemType" }, "us-gaap_ResearchAndDevelopmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Research and Development [Abstract]" } } }, "localname": "ResearchAndDevelopmentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis": { "auth_ref": [ "r313", "r314" ], "lang": { "en-us": { "role": { "documentation": "Information by form of arrangement related to research and development.", "label": "Research and Development Arrangement, Contract to Perform for Others, Type [Axis]", "terseLabel": "Research and Development Arrangement, Contract to Perform for Others, Type" } } }, "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureLicenseAndSponsoredResearchAgreementsAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureRelatedPartiesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Research and Development Arrangement, Contract to Perform for Others [Line Items]", "terseLabel": "Research And Development Arrangement Contract To Perform For Others [Line Items]" } } }, "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureLicenseAndSponsoredResearchAgreementsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain": { "auth_ref": [ "r313", "r314" ], "lang": { "en-us": { "role": { "documentation": "Listing of significant agreements under research and development arrangements accounted for as a contract to perform research and development for others.", "label": "Research and Development Arrangement, Contract to Perform for Others, Type [Domain]", "terseLabel": "Research and Development Arrangement, Contract to Perform for Others, Type" } } }, "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureLicenseAndSponsoredResearchAgreementsAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureRelatedPartiesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r312", "r418", "r491" ], "calculation": { "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsUnaudited": { "order": 0.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and Development Expense", "terseLabel": "Research and development", "totalLabel": "Research and Development Expense, Total", "verboseLabel": "Research and development expenses" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureLicenseAndSponsoredResearchAgreementsAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureRelatedPartiesAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.", "label": "Research and Development Expense [Member]", "terseLabel": "Research and Development [Member]" } } }, "localname": "ResearchAndDevelopmentExpenseMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfStockBasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ResearchAndDevelopmentExpensePolicy": { "auth_ref": [ "r312" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.", "label": "Research and Development Expense, Policy [Policy Text Block]", "terseLabel": "Research and Development Expense" } } }, "localname": "ResearchAndDevelopmentExpensePolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RestrictedStockMember": { "auth_ref": [ "r120" ], "lang": { "en-us": { "role": { "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.", "label": "Restricted Stock [Member]", "terseLabel": "Restricted Stock [Member]" } } }, "localname": "RestrictedStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.", "label": "Restricted stock units (Earnout RSUs) [Member]", "terseLabel": "Restricted stock units [Member]", "verboseLabel": "Restricted Stock Units [Member]" } } }, "localname": "RestrictedStockUnitsRSUMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureNetIncomeLossPerShareScheduleOfPotentiallyAntidilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetail", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r28", "r246", "r306", "r403", "r449", "r464", "r469" ], "calculation": { "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "negatedLabel": "Accumulated deficit", "periodEndLabel": "Retained Earnings (Accumulated Deficit), Ending Balance", "periodStartLabel": "Retained Earnings (Accumulated Deficit), Beginning Balance", "terseLabel": "Accumulated deficit", "totalLabel": "Retained Earnings (Accumulated Deficit), Total" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureBusinessAndOrganizationAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r2", "r81", "r82", "r83", "r86", "r95", "r98", "r158", "r303", "r304", "r305", "r327", "r328", "r355", "r460", "r462" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Accumulated Equity (Deficit)" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.", "label": "Sale of Stock [Domain]", "terseLabel": "Sale of Stock" } } }, "localname": "SaleOfStockNameOfTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureStockholdersEquitySummaryOfOutstandingWarrantsToPurchaseSharesOfCommonStockDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureRelatedPartiesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.", "label": "Sale of Stock, Number of Shares Issued in Transaction", "terseLabel": "Common stock purchased", "verboseLabel": "Number of shares issue and sell to investors (in Shares)" } } }, "localname": "SaleOfStockNumberOfSharesIssuedInTransaction", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureMergerAndRecapitalizationAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_SaleOfStockPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.", "label": "Sale of Stock, Price Per Share", "terseLabel": "Common stock par value", "verboseLabel": "Share price (in Dollars per share)" } } }, "localname": "SaleOfStockPricePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureMergerAndRecapitalizationAdditionalInformationDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of accrued liabilities.", "label": "Schedule of Accrued Liabilities [Table Text Block]", "terseLabel": "Schedule of Accrued Expenses" } } }, "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureAccruedExpensesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "auth_ref": [ "r120" ], "lang": { "en-us": { "role": { "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]", "terseLabel": "Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureNetIncomeLossPerShareScheduleOfPotentiallyAntidilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "auth_ref": [ "r120" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]", "terseLabel": "Schedule of Potentially Antidilutive Securities Excluded from Computation of Diluted Net Loss Per Share" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureNetIncomeLossPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "auth_ref": [ "r332", "r333" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.", "label": "Schedule of Business Acquisitions, by Acquisition [Table]", "terseLabel": "Schedule Of Business Acquisitions By Acquisition [Table]" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureMergerAndRecapitalizationSummaryOfElementsOfNetProceedsFromMergerDetails", "http://renovacor.com/20220331/taxonomy/role/DisclosureMergerAndRecapitalizationSummaryOfNumberOfSharesCommonStockIssuedImmediatelyFollowingConsummationOfMergerDetails", "http://renovacor.com/20220331/taxonomy/role/DisclosureMergerAndRecapitalizationSummaryOfNumberOfSharesCommonStockIssuedImmediatelyFollowingConsummationOfMergerParentheticalDetail", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureMergerAndRecapitalizationAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r119" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Net Income (Loss) Attributable to Common Stockholders of Basic and Diluted" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureNetIncomeLossPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": { "auth_ref": [ "r266", "r295", "r308" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.", "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfStockBasedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": { "auth_ref": [ "r266", "r295", "r308" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.", "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]", "terseLabel": "Schedule of Stock-based Compensation Expense" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock": { "auth_ref": [ "r280" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock units.", "label": "Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]", "terseLabel": "Summary of Restricted Stock Unit Activity" } } }, "localname": "ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "auth_ref": [ "r397", "r398" ], "lang": { "en-us": { "role": { "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Schedule of Related Party Transactions, by Related Party [Table]", "terseLabel": "Schedule Of Related Party Transactions By Related Party [Table]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureRelatedPartiesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable": { "auth_ref": [ "r313", "r314" ], "lang": { "en-us": { "role": { "documentation": "A schedule reflecting the terms of significant agreements under research and development arrangements accounted for as a contract to perform research and development for others (including royalty arrangements, purchase provisions, license agreements, and commitments to provide additional funding), aggregated by similar arrangements or individually if necessary to understand the effects on the financial statements.", "label": "Schedule of Research and Development Arrangement, Contract to Perform for Others [Table]", "terseLabel": "Schedule Of Research And Development Arrangement Contract To Perform For Others [Table]" } } }, "localname": "ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureLicenseAndSponsoredResearchAgreementsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r267", "r298" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]", "terseLabel": "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureStockbasedCompensationScheduleOfAssumptionsUsedInDeterminingTheFairValueOfOptionAwardsDetails", "http://renovacor.com/20220331/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitActivityDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r273", "r285", "r287" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]", "terseLabel": "Summary of Stock Option Activity" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "auth_ref": [ "r289" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.", "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]", "terseLabel": "Schedule of Assumptions Used in Determining the Fair Value of Option Awards" } } }, "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfStockByClassTable": { "auth_ref": [ "r43", "r73", "r127", "r128", "r219", "r221", "r222", "r223", "r224", "r225", "r226", "r228", "r232", "r237", "r240", "r241", "r242", "r243", "r244", "r245", "r246" ], "lang": { "en-us": { "role": { "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.", "label": "Schedule of Stock by Class [Table]", "terseLabel": "Schedule Of Stock By Class [Table]" } } }, "localname": "ScheduleOfStockByClassTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureStockholdersEquityScheduleOfCommonStockSharesReservedForFutureIssuanceDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockholderSEquityAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": { "auth_ref": [ "r247", "r265" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.", "label": "Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]", "terseLabel": "Summary of Outstanding Warrants to Purchase Shares of Common Stock" } } }, "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockholderSEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r66" ], "calculation": { "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-based Payment Arrangement, Noncash Expense", "terseLabel": "Stock-based compensation", "totalLabel": "Share-based Payment Arrangement, Noncash Expense, Total" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "auth_ref": [ "r268" ], "lang": { "en-us": { "role": { "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period", "terseLabel": "Vesting period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "auth_ref": [ "r278" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "negatedLabel": "Number of shares, Forfeited" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "auth_ref": [ "r284" ], "lang": { "en-us": { "role": { "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value", "terseLabel": "Weighted-Average Grant Date Fair Value, Forfeited" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r282" ], "lang": { "en-us": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period", "terseLabel": "Number of shares, Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r282" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Weighted-Average Grant Date Fair Value, Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "auth_ref": [ "r281" ], "lang": { "en-us": { "role": { "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "periodEndLabel": "Number of shares, Nonvested, Ending Balance", "periodStartLabel": "Number of shares, Nonvested, Beginning Balance", "terseLabel": "Number of shares, RSUs outstanding" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitActivityDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [ "r281" ], "lang": { "en-us": { "role": { "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "periodEndLabel": "Weighted-Average Grant Date Fair Value, Nonvested Shares, Ending Balance", "periodStartLabel": "Weighted-Average Grant Date Fair Value, Nonvested Shares, Beginning Balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "auth_ref": [ "r283" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period", "negatedLabel": "Number of shares, Vested", "terseLabel": "Number of shares, Vested" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r283" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Weighted-Average Grant Date Fair Value, Vested" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [ "r292" ], "lang": { "en-us": { "role": { "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate", "terseLabel": "Expected dividend yield" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureStockbasedCompensationScheduleOfAssumptionsUsedInDeterminingTheFairValueOfOptionAwardsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r291" ], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate", "terseLabel": "Expected volatility" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureStockbasedCompensationScheduleOfAssumptionsUsedInDeterminingTheFairValueOfOptionAwardsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r293" ], "lang": { "en-us": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate", "terseLabel": "Risk-free interest rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureStockbasedCompensationScheduleOfAssumptionsUsedInDeterminingTheFairValueOfOptionAwardsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]", "terseLabel": "Share Based Compensation Arrangement By Share Based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureStockbasedCompensationScheduleOfAssumptionsUsedInDeterminingTheFairValueOfOptionAwardsDetails", "http://renovacor.com/20220331/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitActivityDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "auth_ref": [ "r269" ], "lang": { "en-us": { "role": { "documentation": "Number of shares authorized for issuance under share-based payment arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized", "terseLabel": "Number of shares authorized for issuance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "auth_ref": [ "r298" ], "lang": { "en-us": { "role": { "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant", "terseLabel": "Remain available for future issuance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r276" ], "lang": { "en-us": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number", "terseLabel": "Stock Options, Exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r276" ], "lang": { "en-us": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "terseLabel": "Weighted-Average Exercise Price, Exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": { "auth_ref": [ "r279" ], "lang": { "en-us": { "role": { "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period", "terseLabel": "Stock Options, Expired" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "auth_ref": [ "r278" ], "lang": { "en-us": { "role": { "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period", "negatedLabel": "Stock Options, Forfeited", "terseLabel": "Stock Options, Forfeited" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross", "terseLabel": "Stock Options, Granted", "verboseLabel": "Options granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r286" ], "lang": { "en-us": { "role": { "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Weighted average fair value of options granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "auth_ref": [ "r298" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value", "terseLabel": "Aggregate Intrinsic Value, Outstanding" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r275", "r298" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number", "periodEndLabel": "Stock Options Outstanding, Ending Balance", "periodStartLabel": "Stock Options Outstanding, Beginning balance", "terseLabel": "Number of shares, options outstanding" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r274" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Weighted-Average Exercise Price, Outstanding, Ending Balance", "periodStartLabel": "Weighted-Average Exercise Price, Outstanding" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward": { "auth_ref": [ "r265", "r298" ], "lang": { "en-us": { "role": { "documentation": "Number of shares purchased for issuance under share-based payment arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Shares Purchased for Award", "terseLabel": "Number of shares purchased for issuance under share-based payment arrangement" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r265", "r270" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Award Type [Domain]", "terseLabel": "Award Type" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureStockbasedCompensationScheduleOfAssumptionsUsedInDeterminingTheFairValueOfOptionAwardsDetails", "http://renovacor.com/20220331/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitActivityDetails", "http://renovacor.com/20220331/taxonomy/role/DisclosureStockholdersEquityScheduleOfCommonStockSharesReservedForFutureIssuanceDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureMergerAndRecapitalizationAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price", "terseLabel": "Weighted-Average Exercise Price, Exercised" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price", "terseLabel": "Weighted-Average Exercise Price, Expired" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price", "terseLabel": "Weighted-Average Exercise Price, Forfeited" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price", "terseLabel": "Weighted-Average Exercise Price, Granted" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r290", "r307" ], "lang": { "en-us": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term", "terseLabel": "Expected term (years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureStockbasedCompensationScheduleOfAssumptionsUsedInDeterminingTheFairValueOfOptionAwardsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": { "auth_ref": [ "r298" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value", "terseLabel": "Aggregate Intrinsic Value, Exercisable" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r298" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term", "terseLabel": "Weighted-Average Remaining Contractual Life, Exercisable" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r288" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term", "terseLabel": "Weighted-Average Remaining Contractual Life, Outstanding" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": { "auth_ref": [ "r272" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value", "terseLabel": "Fair value of options, vested in period" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Purchase price of common stock expressed as a percentage of its fair value.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent", "terseLabel": "Percentage of outstanding shares" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_SharesIssued": { "auth_ref": [ "r239" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.", "label": "Shares, Issued", "periodEndLabel": "Shares, Issued, Ending Balance", "periodStartLabel": "Shares, Issued, Beginning Balance", "terseLabel": "Shares issued in PIPE Financing", "verboseLabel": "Shares issued" } } }, "localname": "SharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureMergerAndRecapitalizationSummaryOfNumberOfSharesCommonStockIssuedImmediatelyFollowingConsummationOfMergerDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_SharesIssuedPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share or per unit amount of equity securities issued.", "label": "Shares Issued, Price Per Share", "terseLabel": "Price per share" } } }, "localname": "SharesIssuedPricePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureMergerAndRecapitalizationAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockholderSEquityAdditionalInformationDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Balance (in Shares)", "periodStartLabel": "Balance (in Shares)" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited" ], "xbrltype": "sharesItemType" }, "us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares": { "auth_ref": [ "r218" ], "calculation": { "http://renovacor.com/20220331/taxonomy/role/DisclosureMergerAndRecapitalizationSummaryOfNumberOfSharesCommonStockIssuedImmediatelyFollowingConsummationOfMergerDetails": { "order": 1.0, "parentTag": "us-gaap_CommonStockSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "The number of shares that would be issued, determined under the conditions specified in the contract, if the settlement were to occur at the reporting date.", "label": "Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Number of Shares", "negatedLabel": "Less: redemption of CHAQ shares" } } }, "localname": "SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureMergerAndRecapitalizationSummaryOfNumberOfSharesCommonStockIssuedImmediatelyFollowingConsummationOfMergerDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r72", "r80" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "terseLabel": "Summary of Significant Accounting Policies" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r24", "r25", "r26", "r73", "r76", "r104", "r105", "r110", "r115", "r119", "r127", "r128", "r129", "r151", "r182", "r187", "r188", "r189", "r193", "r194", "r223", "r224", "r228", "r232", "r239", "r368", "r497" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]", "terseLabel": "Class of Stock" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureMergerAndRecapitalizationAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureRelatedPartiesAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockholderSEquityAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DocumentDocumentAndEntityInformation", "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical", "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r2", "r45", "r51", "r52", "r53", "r81", "r82", "r83", "r86", "r95", "r98", "r126", "r158", "r239", "r246", "r303", "r304", "r305", "r327", "r328", "r355", "r379", "r380", "r381", "r382", "r383", "r384", "r460", "r461", "r462", "r504" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]", "terseLabel": "Equity Components" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureStockholdersEquityScheduleOfCommonStockSharesReservedForFutureIssuanceDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureLicenseAndSponsoredResearchAgreementsAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical", "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r81", "r82", "r83", "r126", "r419" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical", "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": { "auth_ref": [ "r25", "r26", "r246" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.", "label": "Stock Issued During Period, Shares, Acquisitions", "terseLabel": "Common stock purchased" } } }, "localname": "StockIssuedDuringPeriodSharesAcquisitions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureRelatedPartiesAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r25", "r26", "r239", "r246" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period, Shares, New Issues", "terseLabel": "Issuance of Series A Preferred, shares", "verboseLabel": "Common stock, shares issued" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureLicenseAndSponsoredResearchAgreementsAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureRelatedPartiesAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesOther": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued attributable to transactions classified as other.", "label": "Stock Issued During Period, Shares, Other", "terseLabel": "Remaining shares owned by sponsor (in Shares)" } } }, "localname": "StockIssuedDuringPeriodSharesOther", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureRelatedPartiesAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": { "auth_ref": [ "r25", "r26", "r239", "r246" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.", "label": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures", "terseLabel": "Issuance of restricted common stock, shares", "totalLabel": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures, Total" } } }, "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r25", "r26", "r239", "r246", "r277" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period", "terseLabel": "Stock Options, Exercised" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r25", "r26", "r239", "r246" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Stock Issued During Period, Value, New Issues", "terseLabel": "Aggregate purchase price", "verboseLabel": "Issuance of Series A Preferred" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureRelatedPartiesAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r26", "r29", "r30", "r76", "r147", "r151", "r368", "r403" ], "calculation": { "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Balance", "periodStartLabel": "Balance", "totalLabel": "Total stockholders\u2019 equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1", "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "verboseLabel": "Stockholders' equity:**" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Note [Abstract]" } } }, "localname": "StockholdersEquityNoteAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r74", "r224", "r227", "r228", "r229", "r230", "r231", "r232", "r233", "r234", "r235", "r236", "r238", "r246", "r248" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "terseLabel": "Stockholder's Equity" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockholderSEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.", "label": "Subsequent Event [Line Items]" } } }, "localname": "SubsequentEventLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r385", "r405" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureRelatedPartiesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTable": { "auth_ref": [ "r385", "r405" ], "lang": { "en-us": { "role": { "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.", "label": "Subsequent Event [Table]" } } }, "localname": "SubsequentEventTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r385", "r405" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureRelatedPartiesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r385", "r405" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureRelatedPartiesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r404", "r407" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "Subsequent Events" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureSubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of sale of the entity's stock.", "label": "Sale of Stock [Axis]", "terseLabel": "Sale of Stock" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureStockholdersEquitySummaryOfOutstandingWarrantsToPurchaseSharesOfCommonStockDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureRelatedPartiesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TargetedOrTrackingStockIssuanceDates": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Date the targeted stock was issued, in YYYY-MM-DD format.", "label": "Targeted or Tracking Stock, Issuance Date", "terseLabel": "Targeted Issuance Date", "verboseLabel": "Earn out period end date" } } }, "localname": "TargetedOrTrackingStockIssuanceDates", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureMergerAndRecapitalizationAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureMergerAndRecapitalizationSummaryOfEarnoutSharesDetails" ], "xbrltype": "dateItemType" }, "us-gaap_TargetedOrTrackingStockStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Targeted or Tracking Stock, Stock [Line Items]", "terseLabel": "Targeted Or Tracking Stock Stock [Line Items]" } } }, "localname": "TargetedOrTrackingStockStockLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureMergerAndRecapitalizationSummaryOfEarnoutSharesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TargetedOrTrackingStockStockTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about quantitative and qualitative information related to target or tracking stock issued, including, but not limited to, pricing of transactions and cost allocation method used.", "label": "Targeted or Tracking Stock, Stock [Table]", "terseLabel": "Targeted Or Tracking Stock Stock [Table]" } } }, "localname": "TargetedOrTrackingStockStockTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureMergerAndRecapitalizationSummaryOfEarnoutSharesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": { "auth_ref": [ "r182", "r187", "r188", "r189", "r193", "r194" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Carrying Amount, Attributable to Parent", "periodEndLabel": "Temporary equity, Balance", "periodStartLabel": "Temporary equity, Balance" } } }, "localname": "TemporaryEquityCarryingAmountAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityParOrStatedValuePerShare": { "auth_ref": [ "r16", "r220" ], "lang": { "en-us": { "role": { "documentation": "Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.", "label": "Temporary Equity, Par or Stated Value Per Share", "terseLabel": "Temporary equity, par value" } } }, "localname": "TemporaryEquityParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockholderSEquityAdditionalInformationDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_TemporaryEquitySharesAuthorized": { "auth_ref": [ "r23" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Shares Authorized", "terseLabel": "Temporary equity, authorized" } } }, "localname": "TemporaryEquitySharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockholderSEquityAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_TemporaryEquitySharesIssued": { "auth_ref": [ "r23" ], "lang": { "en-us": { "role": { "documentation": "The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Shares Issued", "terseLabel": "Temporary equity, issued" } } }, "localname": "TemporaryEquitySharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockholderSEquityAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_TemporaryEquitySharesOutstanding": { "auth_ref": [ "r23" ], "lang": { "en-us": { "role": { "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Shares Outstanding", "periodEndLabel": "Temporary equity, Balance (in Shares)", "periodStartLabel": "Temporary equity, Balance (in Shares)", "terseLabel": "Temporary equity, outstanding" } } }, "localname": "TemporaryEquitySharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockholderSEquityAdditionalInformationDetails", "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited" ], "xbrltype": "sharesItemType" }, "us-gaap_TypeOfAdoptionMember": { "auth_ref": [ "r0", "r1", "r2", "r3", "r4", "r85", "r86", "r87", "r88", "r100", "r148", "r149", "r155", "r156", "r157", "r158", "r160", "r161", "r181", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r306", "r325", "r326", "r327", "r328", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r369", "r370", "r372", "r373", "r374", "r375", "r376", "r377", "r392", "r420", "r421", "r422", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r500", "r501", "r502", "r503", "r504" ], "lang": { "en-us": { "role": { "documentation": "Amendment to accounting standards.", "label": "Accounting Standards Update [Domain]" } } }, "localname": "TypeOfAdoptionMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TypeOfArrangementAxis": { "auth_ref": [ "r335" ], "lang": { "en-us": { "role": { "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]" } } }, "localname": "TypeOfArrangementAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureMergerAndRecapitalizationSummaryOfNumberOfSharesCommonStockIssuedImmediatelyFollowingConsummationOfMergerParentheticalDetail", "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureMergerAndRecapitalizationAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic": { "auth_ref": [ "r113", "r116", "r117" ], "calculation": { "http://renovacor.com/20220331/taxonomy/role/DisclosureNetIncomeLossPerShareNetIncomeLossAttributableToCommonStockholdersOfBasicAndDilutedDetails3": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of undistributed earnings (loss) allocated to participating securities for the basic earnings (loss) per share or per unit calculation under the two-class method.", "label": "Undistributed Earnings (Loss) Allocated to Participating Securities, Basic", "negatedLabel": "Less: Undistributed earnings to participating securities", "totalLabel": "Undistributed Earnings (Loss) Allocated to Participating Securities, Basic, Total" } } }, "localname": "UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureNetIncomeLossPerShareNetIncomeLossAttributableToCommonStockholdersOfBasicAndDilutedDetails3" ], "xbrltype": "monetaryItemType" }, "us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted": { "auth_ref": [ "r111", "r113", "r116", "r117" ], "calculation": { "http://renovacor.com/20220331/taxonomy/role/DisclosureNetIncomeLossPerShareNetIncomeLossAttributableToCommonStockholdersOfBasicAndDilutedDetails2": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of undistributed earnings (loss) allocated to participating securities for the diluted earnings (loss) per share or per unit calculation under the two-class method.", "label": "Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted", "negatedLabel": "Less: Undistributed earnings to participating securities", "totalLabel": "Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted, Total" } } }, "localname": "UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureNetIncomeLossPerShareNetIncomeLossAttributableToCommonStockholdersOfBasicAndDilutedDetails3" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefits": { "auth_ref": [ "r315", "r318" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrecognized tax benefits.", "label": "Unrecognized Tax Benefits", "periodEndLabel": "Unrecognized Tax Benefits, Ending Balance", "periodStartLabel": "Unrecognized Tax Benefits, Beginning Balance", "terseLabel": "Uncertain tax positions" } } }, "localname": "UnrecognizedTaxBenefits", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r130", "r131", "r133", "r134", "r135", "r136", "r137" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]", "terseLabel": "Warrants [Member]" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureStockholdersEquityScheduleOfCommonStockSharesReservedForFutureIssuanceDetails", "http://renovacor.com/20220331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantsAndRightsOutstandingMaturityDate": { "auth_ref": [ "r363" ], "lang": { "en-us": { "role": { "documentation": "Expiration date of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in YYYY-MM-DD format.", "label": "Warrants and Rights Outstanding, Maturity Date", "terseLabel": "Expiration Date", "verboseLabel": "Warrant expiration date" } } }, "localname": "WarrantsAndRightsOutstandingMaturityDate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureStockholdersEquitySummaryOfOutstandingWarrantsToPurchaseSharesOfCommonStockDetails" ], "xbrltype": "dateItemType" }, "us-gaap_WarrantsAndRightsOutstandingTerm": { "auth_ref": [ "r363" ], "lang": { "en-us": { "role": { "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Warrants and Rights Outstanding, Term", "terseLabel": "Redemption written notice period" } } }, "localname": "WarrantsAndRightsOutstandingTerm", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/Role_DisclosureStockholderSEquityAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r103", "r119" ], "calculation": { "http://renovacor.com/20220331/taxonomy/role/DisclosureNetIncomeLossPerShareNetIncomeLossAttributableToCommonStockholdersOfBasicAndDilutedDetails3": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Diluted", "totalLabel": "Denominator for diluted net income (loss) per share", "verboseLabel": "Denominator for diluted net income (loss) per share" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureNetIncomeLossPerShareNetIncomeLossAttributableToCommonStockholdersOfBasicAndDilutedDetails3", "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]", "terseLabel": "Weighted-average number of common shares used in computing net income (loss) per share -- (Note 13)" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r101", "r119" ], "calculation": { "http://renovacor.com/20220331/taxonomy/role/DisclosureNetIncomeLossPerShareNetIncomeLossAttributableToCommonStockholdersOfBasicAndDilutedDetails3": { "order": 0.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Denominator for basic net income (loss) per share", "terseLabel": "Basic", "totalLabel": "Weighted Average Number of Shares Outstanding, Basic, Total", "verboseLabel": "Denominator for basic net income (loss) per share" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://renovacor.com/20220331/taxonomy/role/DisclosureNetIncomeLossPerShareNetIncomeLossAttributableToCommonStockholdersOfBasicAndDilutedDetails3", "http://renovacor.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "sharesItemType" } }, "unitCount": 6 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1377-109256" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6787-107765" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "60", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2740-109256" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "65", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2793-109256" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "66", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2814-109256" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258" }, "r125": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "http://asc.fasb.org/topic&trid=2144383" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r138": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "http://asc.fasb.org/topic&trid=2134479" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e7018-107765" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(d)(1)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL120254519-210437" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL120320025-210437" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL120320025-210437" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(27)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(4)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=123349782&loc=d3e5879-108316" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=123349782&loc=d3e5879-108316" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r172": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "360", "URI": "http://asc.fasb.org/topic&trid=2155823" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r176": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349" }, "r179": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S65", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359872&loc=SL124427846-239511" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=109262497&loc=d3e20148-110875" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=109262807&loc=d3e22047-110879" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(CFRR 211.02)", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21553-112644" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21484-112644" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21488-112644" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "50", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775" }, "r248": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "http://asc.fasb.org/topic&trid=2208762" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4534-113899" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b),(f(1))", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(4)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.F)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11149-113907" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11178-113907" }, "r311": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "http://asc.fasb.org/topic&trid=2228938" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "730", "URI": "http://asc.fasb.org/extlink&oid=6420387&loc=d3e23199-108380" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "730", "URI": "http://asc.fasb.org/extlink&oid=6420387&loc=d3e23221-108380" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "10B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(4)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "808", "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121577181&loc=SL110061172-113977" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121483254&loc=SL120254523-199619" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)(2)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)(3)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.14)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)(2)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(2)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.17)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(1)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123341672&loc=SL77916155-209984" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123341672&loc=SL120154346-209984" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "848", "URI": "http://asc.fasb.org/extlink&oid=122150657&loc=SL122150809-237846" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r400": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "http://asc.fasb.org/topic&trid=2122745" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662" }, "r407": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "http://asc.fasb.org/topic&trid=2122774" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "730", "Topic": "912", "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.28,29)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.10)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=123345438&loc=d3e61044-112788" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04.7)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iv)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column A))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column B))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column C))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column D))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r492": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r493": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r494": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r495": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r496": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r497": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402" }, "r498": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r499": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "848" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "848" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "848" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(01)", "Topic": "848" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(4))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4,6)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585" }, "r6": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "http://asc.fasb.org/topic&trid=2122149" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r80": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(4)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)(1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=SL124452830-107794" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31010-122693" } }, "version": "2.1" } ZIP 77 0000950170-22-009663-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000950170-22-009663-xbrl.zip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�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end